No., subject, TM-score, RMSD, Sequence Identity, Subject length, Aligned length, Description
1, 1ov8A, 0.7216, 2.17, 0.202, 139, 119, AURACYANIN B STRUCTURE IN SPACE GROUP P65
2, 1ov8C, 0.7215, 2.17, 0.202, 139, 119, AURACYANIN B STRUCTURE IN SPACE GROUP P65
3, 1ov8B, 0.7211, 2.18, 0.202, 139, 119, AURACYANIN B STRUCTURE IN SPACE GROUP P65
4, 1ov8D, 0.7205, 2.18, 0.202, 139, 119, AURACYANIN B STRUCTURE IN SPACE GROUP P65
5, 1qhqA, 0.7201, 2.18, 0.202, 139, 119, AURACYANIN A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUM CHLOROFLEXUS AURANTIACUS
6, 1azbA, 0.7081, 2.43, 0.168, 129, 119, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
7, 1azcA, 0.7079, 2.43, 0.168, 129, 119, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
8, 1a4bA, 0.7078, 2.53, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
9, 1aizA, 0.7062, 2.55, 0.175, 129, 120, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
10, 1a4aA, 0.7061, 2.40, 0.168, 129, 119, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
11, 1azbB, 0.7059, 2.53, 0.175, 129, 120, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
12, 1azcB, 0.7056, 2.53, 0.175, 129, 120, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
13, 1a4cB, 0.7055, 2.48, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
14, 1uriA, 0.7054, 2.41, 0.168, 129, 119, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
15, 1a4cA, 0.7053, 2.55, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
16, 2azaA, 0.7047, 2.42, 0.176, 129, 119, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
17, 2ccwA, 0.7038, 2.44, 0.151, 129, 119, CRYSTAL STRUCTURE OF AZURIN II AT ATOMIC RESOLUTION (1.13 ANGSTROM)
18, 2azaB, 0.7036, 2.59, 0.175, 129, 120, STRUCTURE OF AZURIN FROM ALCALIGENES DENITRIFICANS. REFINEMENT AT 1.8 ANGSTROMS RESOLUTION AND COMPARISON OF THE TWO CRYSTALLOGRAPHICALLY INDEPENDENT MOLECULES
19, 1aizB, 0.7033, 2.56, 0.175, 129, 120, STRUCTURE OF APO-AZURIN FROM ALCALIGENES DENITRIFICANS AT 1.8 ANGSTROMS RESOLUTION
20, 1dyzA, 0.7029, 2.45, 0.151, 129, 119, OXIDISED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
21, 1dz0A, 0.7025, 2.46, 0.151, 129, 119, REDUCED AZURIN II FROM ALCALIGENES XYLOSOXIDANS
22, 1uriB, 0.7015, 2.52, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY GLN
23, 1a4aB, 0.7005, 2.58, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT 16 DEGREES CELSIUS
24, 1a4bB, 0.7004, 2.56, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 6.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
25, 1rkrD, 0.7002, 2.62, 0.158, 129, 120, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
26, 1rkrB, 0.6998, 2.62, 0.158, 129, 120, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
27, 1rkrA, 0.6997, 2.61, 0.158, 129, 120, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
28, 1rkrC, 0.6996, 2.63, 0.158, 129, 120, CRYSTAL STRUCTURE OF AZURIN-I FROM ALCALIGENES XYLOSOXIDANS NCIMB 11015
29, 1uatA, 0.6995, 2.67, 0.183, 129, 120, THE SIGNIFICANCE OF THE FLEXIBLE LOOP IN THE AZURIN (AZ-ISO2) FROM THE OBLIGATE METHYLOTROPH METHYLOMONAS SP. STRAIN J
30, 1a4cD, 0.6990, 2.64, 0.167, 129, 120, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
31, 2oj1B, 0.6971, 2.49, 0.144, 128, 118, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
32, 2oj1A, 0.6966, 2.40, 0.145, 128, 117, DISULFIDE-LINKED DIMER OF AZURIN N42C/M64E DOUBLE MUTANT
33, 1a4cC, 0.6964, 2.52, 0.168, 129, 119, AZURIN MUTANT WITH MET 121 REPLACED BY HIS PH 3.5 CRYSTAL FORM DATA COLLECTED AT-180 DEGREES CELSIUS
34, 2n0mA, 0.6958, 2.58, 0.118, 130, 119, THE SOLUTION STRUCTURE OF THE SOLUBLE FORM OF THE LIPID-MODIFIED AZURIN FROM NEISSERIA GONORRHOEAE
35, 2fnwB, 0.6956, 2.31, 0.138, 128, 116, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
36, 1cuoA, 0.6950, 2.63, 0.183, 129, 120, CRYSTAL STRUCTURE ANALYSIS OF ISOMER-2 AZURIN FROM METHYLOMONAS J
37, 4ko5B, 0.6947, 2.52, 0.143, 128, 119, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
38, 2aanA, 0.6945, 2.50, 0.203, 123, 118, AURACYANIN A: A BLUE COPPER PROTEIN FROM THE GREEN THERMOPHILIC PHOTOSYNTHETIC BACTERIUMCHLOROFLEXUS AURANTIACUS
39, 3ay2B, 0.6930, 2.64, 0.126, 126, 119, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
40, 3ay2A, 0.6929, 2.65, 0.126, 126, 119, CRYSTAL STRUCTURE OF NEISSERIAL AZURIN
41, 3fswB, 0.6927, 2.41, 0.137, 128, 117, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
42, 1xb8A, 0.6922, 2.46, 0.154, 127, 117, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
43, 4ko6C, 0.6909, 2.52, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
44, 6mjtB, 0.6907, 2.49, 0.153, 128, 118, AZURIN 122F/124W/126RE 
45, 2iaaC, 0.6906, 2.63, 0.126, 128, 119, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 2)
46, 4ko6B, 0.6903, 2.52, 0.144, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
47, 2tsaA, 0.6903, 2.44, 0.145, 128, 117, AZURIN MUTANT M121A
48, 4ko7D, 0.6901, 2.53, 0.144, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
49, 6mjrA, 0.6893, 2.52, 0.154, 128, 117, AZURIN 122W/124F/126RE 
50, 4kobD, 0.6891, 2.56, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
51, 4hz1D, 0.6891, 2.51, 0.153, 128, 118, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
52, 2xv3A, 0.6890, 2.70, 0.133, 129, 120, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
53, 2tsbA, 0.6890, 2.45, 0.145, 128, 117, AZURIN MUTANT M121A-AZIDE
54, 4mfhC, 0.6889, 2.66, 0.134, 128, 119, CRYSTAL STRUCTURE OF M121G AZURIN
55, 2h47C, 0.6889, 2.60, 0.126, 128, 119, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEPHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 1)
56, 6mjrC, 0.6888, 2.54, 0.153, 128, 118, AZURIN 122W/124F/126RE 
57, 6gyiB, 0.6888, 2.45, 0.154, 127, 117, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
58, 4ko9D, 0.6888, 2.67, 0.134, 128, 119, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
59, 1vlxD, 0.6888, 2.44, 0.145, 128, 117, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
60, 3jtbD, 0.6887, 2.41, 0.137, 128, 117, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
61, 2tsbD, 0.6887, 2.46, 0.145, 128, 117, AZURIN MUTANT M121A-AZIDE
62, 4ko7C, 0.6886, 2.59, 0.144, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
63, 3fswD, 0.6886, 2.44, 0.137, 127, 117, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
64, 4jknD, 0.6885, 2.45, 0.145, 128, 117, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
65, 1jziA, 0.6885, 2.60, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
66, 3fszA, 0.6883, 2.64, 0.134, 129, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
67, 2h3xF, 0.6883, 2.62, 0.126, 128, 119, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
68, 2h3xC, 0.6883, 2.62, 0.126, 128, 119, CRYSTAL STRUCTURE OF AN ELECTRON TRANSFER COMPLEX BETWEEN AROMATIC AMINE DEHYDROGENASE AND AZURIN FROM ALCALIGENES FAECALIS (FORM 3)
69, 1nwpA, 0.6883, 2.62, 0.143, 128, 119, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
70, 1jzhA, 0.6882, 2.59, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA AZURIN RU(TPY)(BPY)(HIS83)
71, 3iboC, 0.6881, 2.53, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
72, 3azuD, 0.6881, 2.45, 0.154, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
73, 1vlxC, 0.6881, 2.62, 0.136, 128, 118, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
74, 1e65D, 0.6881, 2.37, 0.155, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
75, 2azuD, 0.6880, 2.44, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
76, 2ghzA, 0.6879, 2.59, 0.136, 128, 118, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
77, 1jzjA, 0.6879, 2.57, 0.161, 128, 118, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
78, 6mjsA, 0.6877, 2.54, 0.144, 128, 118, AZURIN 122W/124W/126RE 
79, 6gyiC, 0.6877, 2.70, 0.143, 128, 119, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
80, 3azuA, 0.6877, 2.46, 0.154, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
81, 2gi0A, 0.6877, 2.58, 0.136, 128, 118, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
82, 1e5zD, 0.6877, 2.54, 0.144, 128, 118, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
83, 3ft0B, 0.6876, 2.63, 0.134, 129, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
84, 2tsaD, 0.6876, 2.47, 0.145, 128, 117, AZURIN MUTANT M121A
85, 1jzeA, 0.6876, 2.60, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA AZURIN RU(BPY)2(IM)(HIS83)
86, 1jvoC, 0.6876, 2.39, 0.155, 128, 116, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
87, 4kobC, 0.6874, 2.55, 0.136, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
88, 1jvoD, 0.6874, 2.47, 0.154, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
89, 1nzrD, 0.6873, 2.47, 0.137, 128, 117, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
90, 4ko9C, 0.6872, 2.57, 0.136, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
91, 1e65C, 0.6872, 2.64, 0.144, 128, 118, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
92, 1cc3B, 0.6871, 2.83, 0.132, 130, 121, PURPLE CUA CENTER
93, 4qlwA, 0.6870, 2.55, 0.136, 128, 118, AZURIN MUTANT M121E WITH IRON
94, 3ugeD, 0.6870, 2.46, 0.154, 128, 117, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
95, 1nzrC, 0.6870, 2.63, 0.136, 128, 118, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
96, 1nwoB, 0.6870, 2.66, 0.143, 128, 119, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
97, 1ilsD, 0.6870, 2.45, 0.137, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
98, 1nwoA, 0.6869, 2.65, 0.143, 128, 119, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
99, 1e67D, 0.6869, 2.39, 0.155, 128, 116, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
100, 1aznB, 0.6868, 2.46, 0.154, 128, 117, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
101, 5azuD, 0.6867, 2.56, 0.153, 128, 118, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
102, 1xb3A, 0.6866, 2.59, 0.153, 128, 118, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
103, 1vlxA, 0.6866, 2.41, 0.155, 128, 116, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
104, 1jvoF, 0.6866, 2.41, 0.147, 128, 116, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
105, 1ezlD, 0.6865, 2.50, 0.154, 128, 117, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
106, 3u25B, 0.6864, 2.56, 0.136, 127, 118, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
107, 3ft0A, 0.6864, 2.65, 0.134, 129, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED
108, 2ghzB, 0.6864, 2.61, 0.136, 128, 118, CRYSTAL STRUCTURE OF AZURIN PHE114PRO MUTANT
109, 1nwpB, 0.6864, 2.64, 0.143, 128, 119, CRYSTALLOGRAPHIC STUDY OF AZURIN FROM PSEUDOMONAS PUTIDA
110, 1i53A, 0.6864, 2.56, 0.154, 128, 117, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
111, 1jvoI, 0.6863, 2.47, 0.137, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
112, 4jknA, 0.6862, 2.48, 0.145, 128, 117, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
113, 1jvoL, 0.6862, 2.40, 0.155, 128, 116, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
114, 1aznA, 0.6862, 2.46, 0.154, 128, 117, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
115, 4k9jA, 0.6861, 2.55, 0.144, 127, 118, STRUCTURE OF RE(CO)3(47-DIMETHYL-PHEN)(THR126HIS)(LYS122TRP) (HIS83GLU)(TRP48PHE)(TYR72PHE)(TYR108PHE)AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
116, 4hz1A, 0.6861, 2.47, 0.154, 127, 117, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
117, 2azuA, 0.6861, 2.48, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
118, 1etjA, 0.6861, 2.40, 0.138, 128, 116, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
119, 1e67C, 0.6861, 2.65, 0.144, 128, 118, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
120, 1e65A, 0.6861, 2.40, 0.155, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
121, 1e5yD, 0.6861, 2.55, 0.153, 128, 118, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
122, 1e5yA, 0.6861, 2.40, 0.147, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
123, 4azuD, 0.6860, 2.46, 0.137, 128, 117, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
124, 1jvoJ, 0.6860, 2.47, 0.145, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
125, 1jvoA, 0.6860, 2.48, 0.145, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
126, 1etjC, 0.6860, 2.48, 0.137, 128, 117, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
127, 4ko6A, 0.6859, 2.52, 0.145, 128, 117, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
128, 3fszB, 0.6859, 2.66, 0.134, 129, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM)
129, 1ezlA, 0.6859, 2.39, 0.155, 128, 116, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
130, 1etjB, 0.6859, 2.40, 0.138, 128, 116, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
131, 1e5zC, 0.6859, 2.65, 0.153, 128, 118, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
132, 4azuA, 0.6858, 2.41, 0.155, 128, 116, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
133, 2xv3B, 0.6858, 2.67, 0.134, 129, 119, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAAM) CHEMICALLY REDUCED PH5.3
134, 2gi0B, 0.6858, 2.62, 0.136, 128, 118, CRYSTAL STRUCTURE OF CU(I) PHE114PRO AZURIN MUTANT
135, 1jvoG, 0.6858, 2.47, 0.145, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
136, 5azuA, 0.6857, 2.49, 0.137, 128, 117, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
137, 1jvoE, 0.6857, 2.48, 0.137, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
138, 1ag0B, 0.6857, 2.63, 0.136, 128, 118, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
139, 1ag0A, 0.6857, 2.63, 0.136, 128, 118, STRUCTURE OF CYS 112 ASP AZURIN FROM PSEUDOMONAS AERUGINOSA
140, 1nzrA, 0.6856, 2.41, 0.155, 128, 116, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
141, 1gr7B, 0.6856, 2.41, 0.155, 125, 116, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
142, 4ko9A, 0.6855, 2.59, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
143, 1jvoH, 0.6855, 2.49, 0.154, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
144, 1cc3A, 0.6855, 2.84, 0.133, 130, 120, PURPLE CUA CENTER
145, 1jvoB, 0.6854, 2.50, 0.154, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
146, 5azuC, 0.6853, 2.66, 0.144, 128, 118, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
147, 4kobA, 0.6852, 2.60, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
148, 4jknC, 0.6852, 2.50, 0.154, 128, 117, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
149, 1r1cA, 0.6852, 2.57, 0.161, 128, 118, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
150, 1e5zA, 0.6852, 2.49, 0.137, 128, 117, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
151, 4azuC, 0.6851, 2.64, 0.136, 128, 118, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
152, 3jt2A, 0.6851, 2.41, 0.147, 128, 116, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
153, 2hxaB, 0.6851, 2.62, 0.144, 127, 118, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
154, 1ilsC, 0.6851, 2.65, 0.144, 128, 118, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
155, 3ugeA, 0.6849, 2.49, 0.154, 128, 117, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
156, 1e67A, 0.6849, 2.42, 0.147, 128, 116, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
157, 6mjsB, 0.6848, 2.39, 0.172, 126, 116, AZURIN 122W/124W/126RE 
158, 6iavA, 0.6848, 2.48, 0.154, 127, 117, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
159, 3jtbB, 0.6848, 2.46, 0.137, 128, 117, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
160, 2tsaB, 0.6848, 2.48, 0.128, 128, 117, AZURIN MUTANT M121A
161, 4jknB, 0.6847, 2.67, 0.153, 128, 118, MERCURY METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.54 A
162, 1jvoK, 0.6847, 2.48, 0.145, 128, 117, AZURIN DIMER CROSSLINKED VIA DISULFIDE BRIDGE
163, 1ilsA, 0.6847, 2.42, 0.138, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
164, 1i53B, 0.6847, 2.63, 0.153, 128, 118, RE(I)-TRICARBONLY DIIMINE (Q107H)) AZURIN
165, 1gr7C, 0.6847, 2.42, 0.155, 125, 116, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
166, 2fnwA, 0.6846, 2.55, 0.145, 128, 117, PSEUDOMONAS AERUGINOSA E2Q/H83Q/M109H-AZURIN RE(PHEN)(CO)3
167, 2azuC, 0.6846, 2.42, 0.147, 128, 116, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
168, 6gyiD, 0.6844, 2.48, 0.154, 127, 117, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
169, 2i7sB, 0.6844, 2.58, 0.136, 128, 118, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
170, 4qlwC, 0.6843, 2.42, 0.147, 128, 116, AZURIN MUTANT M121E WITH IRON
171, 2i7sD, 0.6843, 2.61, 0.153, 128, 118, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
172, 1iluD, 0.6843, 2.42, 0.147, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
173, 1gr7D, 0.6843, 2.44, 0.147, 126, 116, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
174, 3jtbC, 0.6842, 2.51, 0.137, 128, 117, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
175, 1aznC, 0.6841, 2.49, 0.145, 128, 117, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
176, 1jzjB, 0.6840, 2.67, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA AZURIN OS(BPY)2(IM)(HIS83)
177, 1jzgA, 0.6840, 2.64, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA REDUCED AZURIN (CU1+) RU(TPY)(PHEN) (HIS83)
178, 1gr7A, 0.6840, 2.60, 0.144, 126, 118, CRYSTAL STRUCTURE OF THE DOUBLE MUTANT CYS3SER/SER100PRO FROM PSEUDOMONAS AERUGINOSA AT 1.8 A RESOLUTION
179, 1azrC, 0.6840, 2.67, 0.144, 128, 118, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
180, 4qlwB, 0.6839, 2.59, 0.137, 128, 117, AZURIN MUTANT M121E WITH IRON
181, 1etjD, 0.6839, 2.41, 0.138, 128, 116, AZURIN MUTANT WITH MET 121 REPLACED BY GLU
182, 1e5zB, 0.6838, 2.44, 0.155, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 9.0
183, 4kobB, 0.6837, 2.61, 0.136, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I)
184, 3in0C, 0.6837, 2.44, 0.138, 128, 116, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
185, 1e5yC, 0.6837, 2.49, 0.137, 128, 117, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
186, 1azrD, 0.6837, 2.50, 0.154, 128, 117, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
187, 3jt2B, 0.6836, 2.43, 0.147, 128, 116, CU(II) N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
188, 2i7sC, 0.6836, 2.62, 0.153, 128, 118, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
189, 6gyiA, 0.6835, 2.40, 0.155, 127, 116, AZURIN FOM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
190, 3ugeC, 0.6835, 2.51, 0.154, 128, 117, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
191, 4mfhB, 0.6834, 2.70, 0.134, 128, 119, CRYSTAL STRUCTURE OF M121G AZURIN
192, 4ko6D, 0.6834, 2.65, 0.144, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95K/Y108F)
193, 3azuB, 0.6834, 2.49, 0.137, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
194, 1jzfA, 0.6834, 2.65, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA OXIDIZED AZURIN(CU2+) RU(TPY)(PHEN) (HIS83)
195, 6iavC, 0.6833, 2.50, 0.154, 127, 117, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
196, 5i28J, 0.6833, 2.62, 0.162, 127, 117, AZURIN T30R1 CRYSTAL FORM II
197, 4ko9B, 0.6833, 2.71, 0.134, 128, 119, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V95I/Y108F)
198, 4ko5A, 0.6833, 2.61, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48L/V95I/Y108F)
199, 3azuC, 0.6833, 2.48, 0.137, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35GLN AND HIS35LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
200, 1xb6A, 0.6833, 2.62, 0.153, 128, 118, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
201, 1nzrB, 0.6832, 2.44, 0.147, 128, 116, CRYSTAL STRUCTURE OF THE AZURIN MUTANT NICKEL-TRP48MET FROM PSEUDOMONAS AERUGINOSA AT 2.2 ANGSTROMS RESOLUTION
202, 1jziB, 0.6832, 2.71, 0.143, 128, 119, PSEUDOMONAS AERUGINOSA AZURIN RE(PHEN)(CO)3(HIS83)
203, 1iluI, 0.6832, 2.56, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
204, 1iluE, 0.6832, 2.45, 0.147, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
205, 1vlxB, 0.6831, 2.44, 0.147, 128, 116, STRUCTURE OF ELECTRON TRANSFER (COBALT-PROTEIN)
206, 5i26A, 0.6830, 2.61, 0.154, 127, 117, AZURIN T30R1 CRYSTAL FORM I
207, 5azuB, 0.6830, 2.44, 0.155, 128, 116, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
208, 3iboA, 0.6830, 2.54, 0.145, 128, 117, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
209, 2idfA, 0.6830, 2.63, 0.153, 128, 118, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
210, 1e65B, 0.6830, 2.44, 0.147, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA APO FORM
211, 1ilsB, 0.6829, 2.44, 0.138, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
212, 1e5yB, 0.6829, 2.44, 0.147, 128, 116, AZURIN FROM PSEUDOMONAS AERUGINOSA REDUCED FORM PH 5.5
213, 1aznD, 0.6829, 2.52, 0.145, 128, 117, CRYSTAL STRUCTURE OF THE AZURIN MUTANT PHE114ALA FROM PSEUDOMONAS AERUGINOSA AT 2.6 ANGSTROMS RESOLUTION
214, 3iboD, 0.6828, 2.53, 0.154, 128, 117, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
215, 3iboB, 0.6828, 2.64, 0.153, 128, 118, PSEUDOMONAS AERUGINOSA E2Q/H83Q/T126H-AZURIN RE(PHEN)(CO)3
216, 2tsaC, 0.6828, 2.53, 0.137, 128, 117, AZURIN MUTANT M121A
217, 2azuB, 0.6827, 2.52, 0.154, 128, 117, X-RAY CRYSTAL STRUCTURE OF THE TWO SITE-SPECIFIC MUTANTS HIS35*GLN AND HIS35*LEU OF AZURIN FROM PSEUDOMONAS AERUGINOSA
218, 3u25A, 0.6826, 2.64, 0.136, 127, 118, CRYSTAL STRUCTURE OF P. AERUGINOAS AZURIN CONTAINING A TYR-HIS HYDROGEN BONDED PAIR
219, 1xb8C, 0.6825, 2.52, 0.145, 126, 117, ZN SUBSTITUTED FORM OF D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
220, 1r1cD, 0.6825, 2.59, 0.161, 128, 118, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
221, 6mjsD, 0.6824, 2.41, 0.147, 126, 116, AZURIN 122W/124W/126RE 
222, 4azuB, 0.6824, 2.45, 0.147, 128, 116, CRYSTAL STRUCTURE ANALYSIS OF OXIDIZED PSEUDOMONAS AERUGINOSA AZURIN AT PH 5.5 AND PH 9.0. A PH-INDUCED CONFORMATIONAL TRANSITION INVOLVES A PEPTIDE BOND FLIP
223, 3jtbA, 0.6824, 2.61, 0.136, 128, 118, CU(II) N47S/F114N VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN
224, 3fpyA, 0.6824, 2.64, 0.136, 128, 118, AZURIN C112D/M121L
225, 1ezlB, 0.6824, 2.46, 0.147, 128, 116, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
226, 5i28P, 0.6823, 2.56, 0.147, 127, 116, AZURIN T30R1 CRYSTAL FORM II
227, 3n2jL, 0.6823, 2.54, 0.137, 128, 117, AZURIN H117G OXIDIZED FORM
228, 2i7oA, 0.6823, 2.56, 0.154, 128, 117, STRUCTURE OF RE(47-DIMETHYL-PHEN)(THR124HIS)(LYS122TRP)(HIS83GLN) AZCU(II) A RHENIUM MODIFIED AZURIN MUTANT
229, 2tsbB, 0.6822, 2.59, 0.136, 128, 118, AZURIN MUTANT M121A-AZIDE
230, 2idfB, 0.6822, 2.64, 0.153, 128, 118, P. AERUGINOSA AZURIN N42C/M64E DOUBLE MUTANT BMME-LINKED DIMER
231, 1jvlB, 0.6822, 2.65, 0.153, 128, 118, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
232, 1e67B, 0.6822, 2.45, 0.147, 128, 116, ZN-AZURIN FROM PSEUDOMONAS AERUGINOSA
233, 5i28A, 0.6821, 2.55, 0.155, 127, 116, AZURIN T30R1 CRYSTAL FORM II
234, 1jvlA, 0.6821, 2.65, 0.153, 128, 118, AZURIN DIMER COVALENTLY CROSSLINKED THROUGH BIS- MALEIMIDOMETHYLETHER
235, 5i28G, 0.6820, 2.62, 0.162, 127, 117, AZURIN T30R1 CRYSTAL FORM II
236, 3ugeB, 0.6820, 2.53, 0.154, 128, 117, SILVER METALLATED PSEUDOMONAS AERUGINOSA AZURIN AT 1.70 A
237, 4ko7B, 0.6819, 2.65, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
238, 4ko7A, 0.6819, 2.65, 0.161, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/W48F/V95I)
239, 4hz1C, 0.6817, 2.51, 0.137, 127, 117, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
240, 4hhgA, 0.6817, 2.52, 0.164, 127, 116, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN RUH107NO YOH109
241, 1r1cC, 0.6817, 2.59, 0.162, 128, 117, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
242, 5i28E, 0.6815, 2.57, 0.155, 127, 116, AZURIN T30R1 CRYSTAL FORM II
243, 4mfhA, 0.6815, 2.64, 0.144, 128, 118, CRYSTAL STRUCTURE OF M121G AZURIN
244, 3fq1A, 0.6815, 2.66, 0.136, 128, 118, AZURIN C112D/M121I
245, 1azrA, 0.6815, 2.45, 0.147, 128, 116, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
246, 6iavB, 0.6814, 2.53, 0.154, 127, 117, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
247, 1xb3B, 0.6813, 2.59, 0.145, 128, 117, THE D62C/K74C DOUBLE MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
248, 4bwwC, 0.6811, 2.57, 0.154, 127, 117, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
249, 3in0A, 0.6811, 2.49, 0.138, 128, 116, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
250, 2tsbC, 0.6811, 2.61, 0.127, 128, 118, AZURIN MUTANT M121A-AZIDE
251, 1iluF, 0.6811, 2.54, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
252, 1iluM, 0.6810, 2.46, 0.147, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
253, 1iluK, 0.6810, 2.62, 0.136, 128, 118, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
254, 4bwwA, 0.6809, 2.58, 0.145, 127, 117, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
255, 6mjtA, 0.6808, 2.63, 0.153, 128, 118, AZURIN 122F/124W/126RE 
256, 6iavD, 0.6806, 2.41, 0.147, 127, 116, CO-AZURIN FROM PSEUDOMONAS AERUGINOSA TREATED WITH HYDROSULFIDE 
257, 5i26B, 0.6805, 2.53, 0.147, 127, 116, AZURIN T30R1 CRYSTAL FORM I
258, 3np3A, 0.6805, 2.66, 0.136, 128, 118, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
259, 4kocA, 0.6804, 2.69, 0.153, 128, 118, INVESTIGATING THE FUNCTIONAL SIGNIFICANCE OF THE INTERLOCKED PAIR STRUCTURAL DETERMINANTS IN PSEUDOMONAS AERUGINOSA AZURIN (V31I/V95I/Y108F)
260, 4bwwB, 0.6804, 2.56, 0.154, 127, 117, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
261, 5i28H, 0.6802, 2.66, 0.137, 127, 117, AZURIN T30R1 CRYSTAL FORM II
262, 5i28N, 0.6801, 2.57, 0.155, 127, 116, AZURIN T30R1 CRYSTAL FORM II
263, 1azrB, 0.6801, 2.46, 0.155, 128, 116, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA ZINC AZURIN MUTANT ASP47ASP AT 2.4 ANGSTROMS RESOLUTION
264, 1iluH, 0.6800, 2.49, 0.147, 128, 116, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
265, 1r1cB, 0.6799, 2.58, 0.171, 128, 117, PSEUDOMONAS AERUGINOSA W48F/Y72F/H83Q/Y108W-AZURIN RE(PHEN) (CO)3(HIS107)
266, 1bexA, 0.6799, 2.76, 0.144, 128, 118, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
267, 3n2jK, 0.6798, 2.56, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
268, 3fqyA, 0.6798, 2.68, 0.144, 128, 118, AZURIN C112D
269, 1joiA, 0.6798, 2.57, 0.154, 128, 117, STRUCTURE OF PSEUDOMONAS FLUORESCENS HOLO AZURIN
270, 2i7sA, 0.6797, 2.68, 0.153, 128, 118, CRYSTAL STRUCTURE OF RE(PHEN)(CO)3 (THR124HIS)(HIS83GLN) AZURIN CU(II) FROM PSEUDOMONAS AERUGINOSA
271, 1bexB, 0.6797, 2.71, 0.136, 128, 118, STRUCTURE OF RUTHENIUM-MODIFIED PSEUDOMONAS AERUGINOSA AZURIN
272, 5i28K, 0.6796, 2.50, 0.155, 127, 116, AZURIN T30R1 CRYSTAL FORM II
273, 1iluB, 0.6796, 2.58, 0.162, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
274, 5i28D, 0.6794, 2.68, 0.145, 127, 117, AZURIN T30R1 CRYSTAL FORM II
275, 5i28C, 0.6794, 2.42, 0.148, 127, 115, AZURIN T30R1 CRYSTAL FORM II
276, 3fswA, 0.6794, 2.50, 0.147, 127, 116, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
277, 3np4A, 0.6793, 2.66, 0.136, 128, 118, C112D/M121E PSEUDOMONAS AERUGINOSA AZURIN
278, 3in0D, 0.6793, 2.56, 0.137, 128, 117, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
279, 1xb6B, 0.6793, 2.66, 0.136, 128, 118, THE K24R MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN
280, 5i28M, 0.6791, 2.61, 0.147, 127, 116, AZURIN T30R1 CRYSTAL FORM II
281, 4bwwD, 0.6790, 2.55, 0.154, 127, 117, CRYSTAL STRUCTURE OF SPIN LABELLED AZURIN T21R1.
282, 5i28F, 0.6789, 2.58, 0.155, 127, 116, AZURIN T30R1 CRYSTAL FORM II
283, 6mjrD, 0.6788, 2.59, 0.162, 128, 117, AZURIN 122W/124F/126RE 
284, 5i28I, 0.6788, 2.51, 0.147, 127, 116, AZURIN T30R1 CRYSTAL FORM II
285, 2hxaA, 0.6788, 2.35, 0.158, 125, 114, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH3.5
286, 3n2jE, 0.6787, 2.56, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
287, 5i28O, 0.6785, 2.45, 0.157, 127, 115, AZURIN T30R1 CRYSTAL FORM II
288, 1ezlC, 0.6784, 2.61, 0.145, 128, 117, CRYSTAL STRUCTURE OF THE DISULPHIDE BOND-DEFICIENT AZURIN MUTANT C3A/C26A: HOW IMPORTANT IS THE S-S BOND FOR FOLDING AND STABILITY 
289, 4qlwD, 0.6783, 2.50, 0.147, 128, 116, AZURIN MUTANT M121E WITH IRON
290, 3fswC, 0.6783, 2.58, 0.137, 124, 117, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAAHAAAM)
291, 5i28B, 0.6782, 2.43, 0.148, 127, 115, AZURIN T30R1 CRYSTAL FORM II
292, 1iluC, 0.6782, 2.58, 0.154, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
293, 6mjsC, 0.6780, 2.48, 0.155, 125, 116, AZURIN 122W/124W/126RE 
294, 1iluL, 0.6780, 2.59, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
295, 3n2jG, 0.6779, 2.58, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
296, 3n2jF, 0.6779, 2.58, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
297, 3in0B, 0.6778, 2.50, 0.138, 128, 116, CRYSTAL STRUCTURE OF THE F114P/M121Q VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
298, 1azuA, 0.6777, 2.50, 0.155, 126, 116, STRUCTURAL FEATURES OF AZURIN AT 2.7 ANGSTROMS RESOLUTION
299, 3n2jH, 0.6773, 2.58, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
300, 5i28L, 0.6772, 2.69, 0.145, 127, 117, AZURIN T30R1 CRYSTAL FORM II
301, 6mjrB, 0.6771, 2.71, 0.153, 128, 118, AZURIN 122W/124F/126RE 
302, 4wkxB, 0.6770, 2.62, 0.128, 128, 117, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
303, 3n2jD, 0.6765, 2.59, 0.137, 128, 117, AZURIN H117G OXIDIZED FORM
304, 3fq2A, 0.6765, 2.70, 0.136, 128, 118, AZURIN C112D/M121F
305, 2iweA, 0.6764, 2.75, 0.127, 128, 118, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
306, 3n2jB, 0.6763, 2.59, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
307, 1iluG, 0.6760, 2.59, 0.145, 128, 117, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
308, 3n2jI, 0.6759, 2.85, 0.134, 128, 119, AZURIN H117G OXIDIZED FORM
309, 3n2jJ, 0.6757, 2.68, 0.144, 128, 118, AZURIN H117G OXIDIZED FORM
310, 1iluA, 0.6755, 2.67, 0.136, 128, 118, X-RAY CRYSTAL STRUCTURE THE TWO SITE-SPECIFIC MUTANTS ILE7SER AND PHE110SER OF AZURIN FROM PSEUDOMONAS AERUGINOSA
311, 3n2jA, 0.6752, 2.61, 0.145, 128, 117, AZURIN H117G OXIDIZED FORM
312, 2hx8B, 0.6751, 2.73, 0.144, 127, 118, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
313, 3in2A, 0.6747, 2.50, 0.147, 128, 116, CRYSTAL STRUCTURE OF THE N47S/M121L VARIANT OF PSEUDOMONAS AERUGINOSA AZURIN IN THE CU(II) STATE
314, 2iweG, 0.6747, 2.65, 0.136, 128, 118, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
315, 2hx7B, 0.6745, 2.65, 0.145, 127, 117, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
316, 2iweD, 0.6744, 2.57, 0.145, 128, 117, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
317, 2iweJ, 0.6743, 2.65, 0.136, 128, 118, STRUCTURE OF A CAVITY MUTANT (H117G) OF PSEUDOMONAS AERUGINOSA AZURIN
318, 2hx9A, 0.6739, 2.48, 0.165, 124, 115, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
319, 4hz1B, 0.6736, 2.74, 0.136, 127, 118, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA AZURIN WITH IRON(II) AT THE COPPER-BINDING SITE.
320, 3n2jC, 0.6735, 2.82, 0.126, 128, 119, AZURIN H117G OXIDIZED FORM
321, 2hx8A, 0.6733, 2.47, 0.148, 125, 115, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH5
322, 5i26D, 0.6732, 2.52, 0.148, 126, 115, AZURIN T30R1 CRYSTAL FORM I
323, 4hhwB, 0.6726, 2.76, 0.161, 127, 118, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
324, 4hipB, 0.6725, 2.80, 0.153, 127, 118, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
325, 4hipA, 0.6720, 2.69, 0.162, 127, 117, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H126NO YOH109
326, 4hhwA, 0.6717, 2.61, 0.147, 127, 116, CRYSTAL STRUCTURE OF THE PSEUDOMONAS AERUGINOSA AZURIN H124NO YOH122
327, 5i26C, 0.6713, 2.45, 0.158, 124, 114, AZURIN T30R1 CRYSTAL FORM I
328, 2hx9B, 0.6709, 2.82, 0.144, 125, 118, CRYSTAL STRUCTURE OF CU(I) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM AT PH4
329, 2hx7A, 0.6709, 2.51, 0.148, 125, 115, CRYSTAL STRUCTURE OF CU(II) AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CSPHQGAGM
330, 2xv0A, 0.6705, 2.64, 0.139, 125, 115, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.8
331, 2ftaC, 0.6705, 2.45, 0.140, 124, 114, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
332, 4qktB, 0.6691, 2.64, 0.147, 125, 116, AZURIN MUTANT M121EM44K WITH COPPER
333, 4wkxA, 0.6684, 2.75, 0.136, 128, 118, REVERSIBLE S-NITROSYLATION IN AN ENGINEERED MUTANT OF PSEUDOMONAS AERUGINOSA AZURIN WITH RED COPPER SITE
334, 4qktA, 0.6659, 2.67, 0.147, 125, 116, AZURIN MUTANT M121EM44K WITH COPPER
335, 2xv2A, 0.6631, 2.75, 0.148, 124, 115, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM) CHEMICALLY REDUCED PH4.2
336, 3fs9A, 0.6627, 2.77, 0.139, 125, 115, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM)
337, 2ftaD, 0.6627, 2.44, 0.142, 122, 113, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
338, 2ftaB, 0.6614, 2.49, 0.142, 123, 113, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
339, 2ftaA, 0.6603, 2.40, 0.152, 122, 112, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPFM
340, 3fsaA, 0.6587, 2.77, 0.140, 122, 114, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAHAAM); CHEMICALLY REDUCED.
341, 3oqrA, 0.6585, 2.66, 0.132, 123, 114, C112D/M121E AZURIN PH 10.0
342, 2ft8A, 0.6555, 2.51, 0.152, 122, 112, STRUCTURE OF CU(I)AZURIN PH8 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
343, 2ft7A, 0.6555, 2.51, 0.152, 122, 112, STRUCTURE OF CU(I)AZURIN AT PH 6 WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
344, 2ft6A, 0.6542, 2.52, 0.143, 122, 112, STRUCTURE OF CU(II)AZURIN WITH THE METAL-BINDING LOOP SEQUENCE CTFPGHSALM REPLACED WITH CTPHPM
345, 1n70A, 0.6245, 2.38, 0.214, 334, 103, THE CRYSTAL STRUCTURE OF NITRITE REDUCTASE MUTANT HIS287ALA FROM RHODOBACTER SPHAEROIDES
346, 1gs7A, 0.6244, 2.39, 0.223, 336, 103, CRYSTAL STRUCTURE OF H254F MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
347, 1oe1A, 0.6241, 2.40, 0.223, 335, 103, ATOMIC RESOLUTION STRUCTURE OF THE WILDTYPE NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
348, 1ndrB, 0.6239, 2.39, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
349, 2xwzD, 0.6237, 2.39, 0.223, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
350, 1wa0X, 0.6237, 2.39, 0.223, 335, 103, CRYSTAL STRUCTURE OF W138H MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
351, 1ndrC, 0.6237, 2.39, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
352, 1ndrA, 0.6237, 2.39, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
353, 1mzyA, 0.6237, 2.39, 0.214, 331, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE
354, 1as8B, 0.6237, 2.39, 0.214, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
355, 2xxfA, 0.6236, 2.40, 0.223, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
356, 2vw6B, 0.6236, 2.39, 0.223, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
357, 2vw4B, 0.6235, 2.39, 0.223, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
358, 2vm4A, 0.6235, 2.40, 0.223, 334, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE IN SPACE GROUP R3 - 2 OF 2
359, 2vm3A, 0.6235, 2.40, 0.223, 333, 103, STRUCTURE OF ALCALIGENES XYLOSOXIDANS IN SPACE GROUP R3 - 1 OF 2
360, 5onxA, 0.6234, 2.40, 0.223, 335, 103, RESTING STATE COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY
361, 2xxgC, 0.6234, 2.40, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
362, 2vw7A, 0.6234, 2.39, 0.223, 335, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
363, 2avfC, 0.6234, 2.39, 0.214, 316, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
364, 2xwzF, 0.6233, 2.40, 0.223, 334, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
365, 2avfE, 0.6233, 2.41, 0.214, 315, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
366, 1oe2A, 0.6233, 2.41, 0.223, 334, 103, ATOMIC RESOLUTION STRUCTURE OF D92E MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
367, 1as6B, 0.6233, 2.39, 0.214, 336, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
368, 2jfcF, 0.6232, 2.40, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
369, 1wa1X, 0.6232, 2.40, 0.223, 335, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
370, 2xxfB, 0.6231, 2.41, 0.223, 335, 103, CU METALLATED H254F MUTANT OF NITRITE REDUCTASE
371, 2xx0B, 0.6231, 2.40, 0.223, 336, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
372, 2xwzA, 0.6231, 2.40, 0.223, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
373, 2jfcA, 0.6231, 2.40, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
374, 1wa2X, 0.6231, 2.40, 0.223, 334, 103, CRYSTAL STRUCTURE OF H313Q MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE WITH NITRITE BOUND
375, 2xx0A, 0.6230, 2.41, 0.223, 335, 103, STRUCTURE OF THE N90S-H254F MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
376, 2ppaB, 0.6230, 2.39, 0.214, 337, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
377, 1aq8B, 0.6230, 2.39, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
378, 5onyA, 0.6229, 2.40, 0.223, 335, 103, AS-ISOLATED RESTING STATE COPPER NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
379, 5b1kA, 0.6229, 2.40, 0.223, 334, 103, CRYSTAL STRUCTURE OF THE CHLORIDE-BOUND FORM OF BLUE COPPER NITRITE REDUCTASE
380, 4cszA, 0.6228, 2.41, 0.223, 335, 103, STRUCTURE OF F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS WITH NITRITE BOUND
381, 2zonC, 0.6228, 2.40, 0.223, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
382, 2xwzE, 0.6228, 2.41, 0.223, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
383, 2vw4A, 0.6228, 2.40, 0.223, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 2 OF 3
384, 2xwzB, 0.6227, 2.41, 0.223, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
385, 2vw6A, 0.6227, 2.40, 0.223, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 3 OF 3
386, 2ppaA, 0.6227, 2.40, 0.214, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
387, 2pp9B, 0.6227, 2.39, 0.214, 337, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
388, 2jfcD, 0.6227, 2.41, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
389, 1mzzC, 0.6227, 2.39, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
390, 1j9rC, 0.6227, 2.39, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
391, 2yqbA, 0.6226, 2.37, 0.204, 454, 103, STRUCTURE OF P93A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.4 A RESOLUTION
392, 2ppaC, 0.6226, 2.39, 0.214, 336, 103, ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR BOUND TO NITROUS OXIDE
393, 2pp9C, 0.6226, 2.40, 0.214, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
394, 1rzqB, 0.6226, 2.41, 0.214, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
395, 2pp9A, 0.6225, 2.39, 0.214, 336, 103, NITRATE BOUND WILD TYPE OXIDIZED AFNIR
396, 2b08C, 0.6225, 2.40, 0.204, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
397, 2b08B, 0.6225, 2.39, 0.204, 336, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
398, 1l9qC, 0.6225, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
399, 1l9pC, 0.6225, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
400, 1as7B, 0.6225, 2.40, 0.214, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
401, 5b1jA, 0.6224, 2.41, 0.223, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
402, 3h4fB, 0.6224, 2.40, 0.214, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
403, 2vw7B, 0.6224, 2.41, 0.223, 334, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS - 1 OF 3
404, 1snrC, 0.6224, 2.40, 0.214, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
405, 1npjC, 0.6224, 2.40, 0.204, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
406, 1l9qB, 0.6224, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
407, 1l9pB, 0.6224, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
408, 1l9oB, 0.6224, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
409, 3h4hB, 0.6223, 2.41, 0.214, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
410, 2zonA, 0.6223, 2.40, 0.223, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
411, 2vn3A, 0.6223, 2.42, 0.223, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
412, 1l9oC, 0.6223, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
413, 1as8C, 0.6223, 2.40, 0.214, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
414, 5d4hC, 0.6222, 2.40, 0.214, 339, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
415, 3h4fC, 0.6222, 2.40, 0.214, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
416, 3h4fA, 0.6222, 2.40, 0.214, 336, 103, MET62LEU VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECLIS
417, 2zonB, 0.6222, 2.41, 0.223, 334, 103, CRYSTAL STRUCTURE OF ELECTRON TRANSFER COMPLEX OF NITRITE REDUCTASE WITH CYTOCHROME C
418, 2xx1A, 0.6222, 2.40, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
419, 2pp7C, 0.6222, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
420, 2pp7B, 0.6222, 2.40, 0.214, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
421, 1npjB, 0.6222, 2.39, 0.204, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
422, 1j9sB, 0.6222, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
423, 1as6C, 0.6222, 2.40, 0.214, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
424, 2xx1F, 0.6221, 2.40, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
425, 2dwtA, 0.6221, 2.41, 0.214, 329, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 6.0 WITH BOUND NITRITE
426, 1l9sC, 0.6221, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
427, 1l9rC, 0.6221, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
428, 3h56A, 0.6220, 2.40, 0.204, 335, 103, MET150LEU/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
429, 2ppcC, 0.6220, 2.40, 0.214, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
430, 2ppcB, 0.6220, 2.40, 0.214, 337, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
431, 2ppcA, 0.6220, 2.40, 0.214, 336, 103, OXIDIZED WILD TYPE AFNIR EXPOSED TO NO (NITRITE BOUND)
432, 2pp8C, 0.6220, 2.40, 0.214, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
433, 1zdsC, 0.6220, 2.40, 0.204, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
434, 1j9qC, 0.6220, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
435, 1as8A, 0.6220, 2.40, 0.214, 336, 103, STRUCTURE OF NITRITE BOUND TO REDUCED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
436, 1as7C, 0.6220, 2.40, 0.214, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
437, 1aq8C, 0.6220, 2.40, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
438, 2xxgA, 0.6219, 2.42, 0.223, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
439, 2fjsC, 0.6219, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
440, 2e86B, 0.6219, 2.40, 0.214, 337, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
441, 1l9rB, 0.6219, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
442, 5d4iA, 0.6218, 2.40, 0.214, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
443, 2xwzC, 0.6218, 2.41, 0.223, 335, 103, STRUCTURE OF THE RECOMBINANT NATIVE NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
444, 2pp7A, 0.6218, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY MANIPULATED WILD TYPE OXIDIZED AFNIR (ACETATE BOUND)
445, 2e86C, 0.6218, 2.40, 0.214, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
446, 2a3tA, 0.6218, 2.40, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE
447, 1zv2A, 0.6218, 2.41, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE
448, 1snrB, 0.6218, 2.41, 0.214, 337, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
449, 1rzqC, 0.6218, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
450, 1l9sB, 0.6218, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
451, 3ziyA, 0.6217, 2.38, 0.194, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE  FROM RALSTONIA PICKETTII AT 1.01 A RESOLUTION
452, 3zbmA, 0.6217, 2.38, 0.194, 455, 103, STRUCTURE OF M92A VARIANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII
453, 3h4hC, 0.6217, 2.41, 0.214, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
454, 2pp8B, 0.6217, 2.40, 0.214, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
455, 2fjsB, 0.6217, 2.40, 0.214, 337, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
456, 2fjsA, 0.6217, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF ANAEROBICALLY REDUCED WILD TYPE NITRITE REDUCTASE FROM A. FAECALIS
457, 2bo0A, 0.6217, 2.42, 0.214, 335, 103, CRYSTAL STRUCTURE OF THE C130A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
458, 1sjmC, 0.6217, 2.41, 0.214, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
459, 1l9tC, 0.6217, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
460, 1l9tB, 0.6217, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
461, 1j9rB, 0.6217, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
462, 2pp8A, 0.6216, 2.40, 0.214, 336, 103, FORMATE BOUND TO OXIDIZED WILD TYPE AFNIR
463, 2b08A, 0.6216, 2.40, 0.204, 335, 103, REDUCED ACETAMIDE-BOUND M150G NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
464, 1snrA, 0.6216, 2.41, 0.214, 336, 103, NITRIC OXIDE BOUND TO CU NITRITE REDUCTASE
465, 1npnB, 0.6216, 2.40, 0.204, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
466, 1j9tC, 0.6216, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
467, 1j9tA, 0.6216, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
468, 6gt0A, 0.6215, 2.42, 0.214, 333, 103, NITRITE-BOUND COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
469, 6gsqA, 0.6215, 2.42, 0.214, 333, 103, OXIDISED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
470, 5d4hB, 0.6215, 2.41, 0.214, 341, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
471, 2afnC, 0.6215, 2.40, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
472, 1npnC, 0.6215, 2.40, 0.204, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
473, 1gs8A, 0.6215, 2.41, 0.223, 336, 103, CRYSTAL STRUCTURE OF  MUTANT D92N ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
474, 1as6A, 0.6215, 2.41, 0.214, 335, 103, STRUCTURE OF NITRITE BOUND TO OXIDIZED ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
475, 6gtiA, 0.6214, 2.41, 0.214, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.0 
476, 5i6oA, 0.6214, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 20.70 MGY
477, 5i6kA, 0.6214, 2.42, 0.214, 334, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 0.69 MGY
478, 4cspF, 0.6214, 2.41, 0.223, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
479, 2ppdC, 0.6214, 2.41, 0.204, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
480, 2dwsA, 0.6214, 2.40, 0.214, 328, 103, CU-CONTAINING NITRITE REDUCTASE AT PH 8.4 WITH BOUND NITRITE
481, 1j9sC, 0.6214, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
482, 1j9qB, 0.6214, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
483, 6fjaA, 0.6213, 2.38, 0.194, 455, 103, CRYSTAL STRUCTURE OF T2D THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
484, 5i6pA, 0.6213, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 27.60 MGY
485, 5i6mA, 0.6213, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 7.59 MGY
486, 5d4hA, 0.6213, 2.42, 0.214, 337, 103, HIGH-RESOLUTION NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SYNCHROTRON RADIATION CRYSTALLOGRAPHY
487, 2ppdB, 0.6213, 2.39, 0.204, 337, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
488, 1sjmB, 0.6213, 2.41, 0.214, 336, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
489, 1j9qA, 0.6213, 2.40, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED D98N AFNIR
490, 1as7A, 0.6213, 2.40, 0.214, 337, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AT CRYO TEMPERATURE
491, 6gtkA, 0.6212, 2.42, 0.214, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 5.5 
492, 5i6nA, 0.6212, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 11.73 MGY
493, 5i6lA, 0.6212, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE AT 100K AFTER 2.76 MGY
494, 5d4jC, 0.6212, 2.41, 0.214, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
495, 5d4jA, 0.6212, 2.41, 0.214, 335, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
496, 5b1jB, 0.6212, 2.41, 0.223, 334, 103, CRYSTAL STRUCTURE OF THE ELECTRON-TRANSFER COMPLEX OF COPPER NITRITE REDUCTASE WITH A CUPREDOXIN
497, 3h4hA, 0.6212, 2.41, 0.214, 334, 103, MET94THR/PHE312CYS VARIANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
498, 1rzqA, 0.6212, 2.42, 0.214, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH5.0
499, 1oe3A, 0.6212, 2.42, 0.223, 335, 103, ATOMIC RESOLUTION STRUCTURE OF  HALF APO  NIR
500, 2ppeC, 0.6211, 2.41, 0.204, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
501, 2jfcE, 0.6211, 2.42, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
502, 1ntdA, 0.6211, 2.41, 0.204, 336, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE MUTANT M150E THAT CONTAINS ZINC
503, 1l9sA, 0.6211, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257T VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
504, 6gtnA, 0.6210, 2.42, 0.214, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.5 
505, 6gtlA, 0.6210, 2.42, 0.214, 333, 103, ACHROMOBACTER CYCLOCLASTES COPPER NITRITE REDUCTASE AT PH 6.0 
506, 2ppfB, 0.6210, 2.40, 0.214, 337, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
507, 2ppdA, 0.6210, 2.41, 0.204, 336, 103, OXIDIZED H145A MUTANT OF AFNIR BOUND TO NITRIC OXIDE
508, 2e86A, 0.6210, 2.41, 0.214, 336, 103, AZIDE BOUND TO COPPER CONTAINING NITRITE REDUCTASE FROM A. FAECALIS S- 2 6
509, 2afnB, 0.6210, 2.40, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
510, 2afnA, 0.6210, 2.41, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE AND A COPPER SITE MUTANT M150E THAT CONTAINS ZINC
511, 1npjA, 0.6210, 2.41, 0.204, 336, 103, CRYSTAL STRUCTURE OF H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
512, 1l9rA, 0.6210, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257M VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
513, 1l9pA, 0.6210, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257G VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIES S-6
514, 1j9tB, 0.6210, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED H255N AFNIR
515, 1j9sA, 0.6210, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED OXIDIZED H255N AFNIR
516, 4yseB, 0.6209, 2.42, 0.214, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
517, 4cspA, 0.6209, 2.42, 0.223, 335, 103, STRUCTURE OF THE F306C MUTANT OF NITRITE REDUCTASE FROM ACHROMOBACTER XYLOSOXIDANS
518, 2y1aA, 0.6209, 2.42, 0.214, 332, 103, CRYSTAL STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH BOUND NO
519, 2ppfC, 0.6209, 2.40, 0.214, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
520, 2jfcC, 0.6209, 2.43, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
521, 2jfcB, 0.6209, 2.42, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS IN SPACE GROUP P212121
522, 1zdsB, 0.6209, 2.41, 0.204, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
523, 1sjmA, 0.6209, 2.41, 0.214, 335, 103, NITRITE BOUND COPPER CONTAINING NITRITE REDUCTASE
524, 1nibB, 0.6209, 2.41, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
525, 1ndsA, 0.6209, 2.41, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
526, 1l9tA, 0.6209, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257V VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
527, 1l9oA, 0.6209, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED I257A VARIANT OF THE COPPER-CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
528, 1aq8A, 0.6209, 2.41, 0.214, 331, 103, STRUCTURE OF ALCALIGENES FAECALIS NITRITE REDUCTASE REDUCED WITH ASCORBATE
529, 2ppfA, 0.6208, 2.41, 0.214, 336, 103, REDUCED MUTANT D98N OF AFNIR EXPOSED TO NITRIC OXIDE
530, 2dy2A, 0.6208, 2.42, 0.214, 329, 103, NITRITE REDUCTASE PH 6.0
531, 1mzzB, 0.6208, 2.41, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
532, 1mzzA, 0.6208, 2.40, 0.204, 334, 103, CRYSTAL STRUCTURE OF MUTANT (M182T)OF NITRITE REDUCTASE
533, 1j9rA, 0.6208, 2.42, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE SOAKED REDUCED D98N AFNIR
534, 1hawA, 0.6208, 2.41, 0.223, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9A RESOLUTION
535, 2ppeA, 0.6207, 2.41, 0.204, 336, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
536, 2bw5A, 0.6207, 2.42, 0.214, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NO-BOUND ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
537, 1ndsB, 0.6207, 2.41, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
538, 4ax3C, 0.6206, 2.38, 0.194, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
539, 1rzpB, 0.6206, 2.42, 0.214, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
540, 1ndsC, 0.6206, 2.42, 0.204, 330, 103, CRYSTALLOGRAPHIC STRUCTURE OF A SUBSTRATE BOUND BLUE COPPER NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
541, 1l9qA, 0.6206, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF THE I257L VARIANT OF THE COPPER- CONTAINING NITRITE REDUCTASE FROM ALCALIGENES FAECALIS S-6
542, 6gt2A, 0.6205, 2.42, 0.214, 333, 103, REDUCED COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES DETERMINED BY SERIAL FEMTOSECOND ROTATION CRYSTALLOGRAPHY 
543, 5d4jB, 0.6205, 2.42, 0.214, 336, 103, CHLORIDE-BOUND FORM OF A COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALS
544, 4ax3D, 0.6205, 2.39, 0.194, 457, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
545, 1npnA, 0.6205, 2.41, 0.204, 336, 103, CRYSTAL STRUCTURE OF A COPPER RECONSTITUTED H145A MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
546, 4yseA, 0.6204, 2.42, 0.214, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
547, 2ppeB, 0.6204, 2.40, 0.204, 337, 103, REDUCED H145A MUTANT OF AFNIR EXPOSED TO NO
548, 2p80C, 0.6204, 2.42, 0.214, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
549, 1et7A, 0.6204, 2.41, 0.214, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASP MUTANT FROM ALCALIGENES FAECALIS S-6
550, 5n8hA, 0.6203, 2.42, 0.214, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 3.
551, 5d4iB, 0.6203, 2.41, 0.214, 341, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
552, 2p80B, 0.6203, 2.42, 0.214, 336, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
553, 1rzpC, 0.6203, 2.43, 0.214, 332, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
554, 1kbvA, 0.6203, 2.41, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
555, 5n8fA, 0.6202, 2.42, 0.214, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 1.
556, 5d4iC, 0.6202, 2.41, 0.214, 334, 103, INTACT NITRITE COMPLEX OF A COPPER NITRITE REDUCTASE DETERMINED BY SERIAL FEMTOSECOND CRYSTALLOGRAPHY
557, 1rzpA, 0.6202, 2.43, 0.214, 328, 103, CRYSTAL STRUCTURE OF C-TERMINAL DESPENTAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT PH6.2
558, 5n8gA, 0.6201, 2.42, 0.214, 333, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 240K. DATASET 2.
559, 5f7bA, 0.6201, 2.42, 0.214, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
560, 5f7aA, 0.6201, 2.41, 0.214, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
561, 1hauA, 0.6201, 2.42, 0.223, 336, 103, X-RAY STRUCTURE OF A BLUE COPPER NITRITE REDUCTASE AT HIGH PH AND IN COPPER FREE FORM AT 1.9 A RESOLUTION
562, 1gs6X, 0.6200, 2.41, 0.214, 336, 103, CRYSTAL STRUCTURE OF M144A MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
563, 5f7aB, 0.6199, 2.41, 0.214, 337, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
564, 2p80A, 0.6199, 2.42, 0.214, 335, 103, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN NITRITE REDUCTASE AND PSEUDOAZURIN FROM A. FAECALIS
565, 1zdqC, 0.6199, 2.42, 0.204, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
566, 1niaB, 0.6199, 2.42, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
567, 5n8iA, 0.6198, 2.43, 0.214, 334, 103, SERIAL CU NITRITE REDUCTASE STRUCTURES AT ELEVATED CRYOGENIC TEMPERATURE 100K REFERENCE DATASET.
568, 1zdsA, 0.6198, 2.42, 0.204, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH ACETAMIDE BOUND
569, 5akrA, 0.6197, 2.43, 0.214, 337, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE BOUND STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE AT 0.87 A RESOLUTION
570, 2bw4A, 0.6197, 2.43, 0.214, 334, 103, ATOMIC RESOLUTION STRUCTURE OF RESTING STATE OF THE ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
571, 1nibC, 0.6197, 2.42, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
572, 6f1qA, 0.6196, 2.40, 0.194, 456, 103, CRYSTAL STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII IN I213 SPACE GROUP 
573, 1et8A, 0.6196, 2.41, 0.214, 339, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE HIS255ASN MUTANT FROM ALCALIGENES FAECALIS
574, 5oboA, 0.6195, 2.40, 0.194, 456, 103, CRYSTAL STRUCTURE OF NITRITE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
575, 5f7bB, 0.6195, 2.42, 0.214, 337, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
576, 4yscA, 0.6195, 2.42, 0.214, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
577, 4ax3B, 0.6195, 2.40, 0.194, 455, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
578, 1niaC, 0.6195, 2.42, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
579, 1kcbA, 0.6195, 2.43, 0.214, 333, 103, CRYSTAL STRUCTURE OF A NO-FORMING NITRITE REDUCTASE MUTANT: AN ANALOG OF A TRANSITION STATE IN ENZYMATIC REACTION
580, 1kbvD, 0.6195, 2.42, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
581, 1waeA, 0.6194, 2.42, 0.223, 334, 103, CRYSTAL STRUCTURE OF H129V MUTANT OF ALCALIGENES XYLOSOXIDANS NITRITE REDUCTASE
582, 1bq5A, 0.6193, 2.43, 0.223, 333, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS GIFU 1051
583, 5f7bC, 0.6192, 2.42, 0.214, 336, 103, RESTING STATE STRUCTURE OF CUNIR FORM ALCALIGENES FAECALIS DETERMINED AT 293 K
584, 5f7aC, 0.6192, 2.42, 0.214, 336, 103, NITRITE COMPLEX STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS DETERMINED AT 293 K
585, 4yscB, 0.6192, 2.42, 0.214, 336, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
586, 1zdqB, 0.6192, 2.43, 0.204, 336, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
587, 5ocbA, 0.6191, 2.40, 0.194, 453, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND D97N MUTANT OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
588, 1kbwC, 0.6191, 2.42, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
589, 5oggA, 0.6190, 2.44, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.30MGY 
590, 5og6A, 0.6190, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.24MGY 
591, 4yseC, 0.6190, 2.42, 0.214, 337, 103, HIGH RESOLUTION SYNCHROTRON STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
592, 1nibA, 0.6190, 2.43, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
593, 1ndtA, 0.6190, 2.42, 0.223, 336, 103, NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
594, 1kbwF, 0.6189, 2.43, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
595, 1kbwA, 0.6189, 2.43, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
596, 6gbbA, 0.6188, 2.43, 0.214, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE CELL POLYMORPH DATASET 1 
597, 5ogfA, 0.6188, 2.44, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.27MGY 
598, 5og4A, 0.6188, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.18MGY 
599, 5og3A, 0.6188, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
600, 5ofhA, 0.6188, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.15MGY 
601, 4yscC, 0.6188, 2.43, 0.214, 335, 103, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM ALCALIGENES FAECALIS
602, 2bp0B, 0.6188, 2.42, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
603, 1kbwB, 0.6188, 2.43, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
604, 6gb8A, 0.6187, 2.43, 0.214, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: SMALL CELL POLYMORPH DATASET 1 
605, 5tb7C, 0.6187, 2.38, 0.204, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
606, 5ofgA, 0.6187, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.06MGY 
607, 5of6A, 0.6187, 2.44, 0.214, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
608, 4ax3A, 0.6187, 2.40, 0.194, 456, 103, STRUCTURE OF THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII AT 1.6 A RESOLUTION
609, 5ue6C, 0.6186, 2.43, 0.204, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
610, 5og5A, 0.6186, 2.44, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.21MGY 
611, 5og2A, 0.6186, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.09MGY 
612, 5offA, 0.6186, 2.43, 0.214, 332, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES RT 0.03MGY 
613, 5of8A, 0.6186, 2.43, 0.214, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
614, 5of7A, 0.6186, 2.44, 0.214, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
615, 2bwdA, 0.6186, 2.43, 0.214, 334, 103, ATOMIC RESOLUTION STRUCTURE OF ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE WITH ENDOGENOUSLY BOUND NITRITE AND NO
616, 1zdqA, 0.6186, 2.43, 0.204, 335, 103, CRYSTAL STRUCTURE OF MET150GLY AFNIR WITH METHYLSULFANYL METHANE BOUND
617, 1kbwD, 0.6186, 2.43, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
618, 1kbvF, 0.6186, 2.43, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
619, 6gtjA, 0.6185, 2.43, 0.214, 333, 103, NEUTRON CRYSTAL STRUCTURE FOR COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.8 A RESOLUTION 
620, 5ue6F, 0.6185, 2.43, 0.214, 307, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
621, 2xx1D, 0.6185, 2.48, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
622, 1nidA, 0.6185, 2.42, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
623, 1niaA, 0.6185, 2.44, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
624, 1kbwE, 0.6185, 2.38, 0.204, 302, 103, CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
625, 1kbvC, 0.6184, 2.44, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
626, 1et5A, 0.6184, 2.44, 0.214, 336, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE ASP98ASN MUTANT FROM ALCALIGENES FAECALIS S-6
627, 5ofcA, 0.6183, 2.44, 0.214, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 21.65MGY 
628, 2zooA, 0.6183, 2.40, 0.194, 438, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM PSEUDOALTEROMONAS HALOPLANKTIS TAC125
629, 1kbvE, 0.6183, 2.38, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
630, 5ue6I, 0.6181, 2.43, 0.204, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
631, 5ofdA, 0.6181, 2.44, 0.214, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
632, 2nrdA, 0.6181, 2.43, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
633, 2bwiA, 0.6181, 2.44, 0.214, 334, 103, ATOMIC RESOLUTION STRUCTURE OF NITRITE -SOAKED ACHROMOBACTER CYCLOCLASTES CU NITRITE REDUCTASE
634, 1nifA, 0.6181, 2.43, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
635, 6gcgA, 0.6180, 2.44, 0.214, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: LARGE POLYMORPH DATASET 15 
636, 2xx1E, 0.6179, 2.50, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
637, 5ofeA, 0.6178, 2.44, 0.214, 334, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 190K 0.48MGY 
638, 2bp8B, 0.6178, 2.43, 0.214, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
639, 1nieA, 0.6178, 2.43, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
640, 1nicA, 0.6178, 2.43, 0.214, 333, 103, THE STRUCTURE OF CU-NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT FIVE PH VALUES WITH NITRITE BOUND AND WITH TYPE II CU DEPLETED
641, 1kbvB, 0.6177, 2.43, 0.204, 302, 103, NITRITE-SOAKED CRYSTAL STRUCTURE OF THE SOLUBLE DOMAIN OF ANIA FROM NEISSERIA GONORRHOEAE
642, 5ue6H, 0.6173, 2.39, 0.204, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
643, 2bp8A, 0.6173, 2.44, 0.214, 335, 103, M144Q STRUCTURE OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
644, 5tb7B, 0.6172, 2.44, 0.204, 311, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
645, 2bp0A, 0.6172, 2.44, 0.214, 335, 103, M144L MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS
646, 5ue6E, 0.6171, 2.44, 0.204, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
647, 5ue6B, 0.6170, 2.44, 0.204, 310, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
648, 6gbyA, 0.6169, 2.45, 0.214, 333, 103, COPPER NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES: NON- POLYMORPH SEPARATED DATASET 1 
649, 5tb7A, 0.6166, 2.44, 0.204, 312, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP P212121
650, 2xx1C, 0.6165, 2.51, 0.223, 334, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
651, 2xx1B, 0.6165, 2.50, 0.223, 335, 103, STRUCTURE OF THE N90S MUTANT OF NITRITE REDUCTASE FROM ALCALIGENES XYLOSOXIDANS COMPLEXED WITH NITRITE
652, 5ue6D, 0.6163, 2.45, 0.204, 309, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
653, 5ocfA, 0.6162, 2.42, 0.194, 455, 103, CRYSTAL STRUCTURE OF NITRIC OXIDE BOUND TO THREE-DOMAIN HEME-CU NITRITE REDUCTASE FROM RALSTONIA PICKETTII 
654, 5of5A, 0.6159, 2.50, 0.214, 333, 103, CU NITRITE REDUCTASE SERIAL DATA AT VARYING TEMPERATURES 
655, 5ue6G, 0.6157, 2.45, 0.204, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
656, 5zl1D, 0.6151, 2.07, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
657, 5ue6A, 0.6151, 2.46, 0.204, 314, 103, STRUCTURE OF NITRITE REDUCTASE ANIA FROM NEISSERIA GONORRHOEAE SPACE GROUP I4122
658, 5zl1C, 0.6150, 2.07, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
659, 5zl1A, 0.6150, 2.07, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
660, 5zl1B, 0.6148, 2.08, 0.160, 306, 100, HEXAMERIC STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE OF AN ANAMMOX ORGANISM KSU-1 
661, 2dv6D, 0.6143, 2.48, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
662, 1qniA, 0.6143, 1.85, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
663, 2dv6B, 0.6141, 2.49, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
664, 2avfF, 0.6139, 2.50, 0.216, 323, 102, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
665, 1qniB, 0.6139, 1.86, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
666, 2dv6E, 0.6138, 2.48, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
667, 4knuD, 0.6135, 2.66, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
668, 2dv6F, 0.6134, 2.49, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
669, 4knsB, 0.6133, 2.67, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
670, 2dv6A, 0.6132, 2.48, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
671, 4knsC, 0.6131, 2.66, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
672, 1qniE, 0.6130, 1.88, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
673, 1qniC, 0.6127, 1.88, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
674, 4knuB, 0.6126, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
675, 2dv6C, 0.6126, 2.49, 0.194, 422, 103, CRYSTAL STRUCTURE OF NITRITE REDUCTASE FROM HYPHOMICROBIUM DENITRIFICANS
676, 4knuF, 0.6125, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
677, 4knuA, 0.6125, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
678, 1qniF, 0.6123, 1.88, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
679, 1qniD, 0.6123, 1.88, 0.186, 572, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM PSEUDOMONAS NAUTICA AT 2.4A RESOLUTION
680, 4knuC, 0.6120, 2.68, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
681, 4kntA, 0.6119, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
682, 4kntC, 0.6118, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
683, 4kntB, 0.6116, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA PH 8.5
684, 4knuE, 0.6114, 2.67, 0.194, 285, 103, COPPER NITRITE REDUCTASE FROM NITROSOMONAS EUROPAEA AT PH 6.5
685, 4knsD, 0.6112, 2.68, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
686, 4knsE, 0.6111, 2.67, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
687, 4knsA, 0.6110, 2.68, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
688, 4knsF, 0.6108, 2.68, 0.194, 285, 103, REDUCED CRYSTAL STRUCTURE OF THE NITROSOMONAS EUROPAEA COPPER NITRITE REDUCTASE AT PH 6.5
689, 6rkzB, 0.6101, 1.98, 0.214, 586, 98, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
690, 5i5mA, 0.6094, 1.92, 0.124, 575, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
691, 2avfD, 0.6094, 2.25, 0.218, 320, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
692, 2avfB, 0.6093, 2.25, 0.218, 316, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
693, 5i5mB, 0.6092, 1.93, 0.124, 576, 97, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE CA2+-RECONSTITUTED FORM
694, 2avfA, 0.6087, 2.28, 0.218, 314, 101, CRYSTAL STRUCTURE OF C-TERMINAL DESUNDECAPEPTIDE NITRITE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
695, 4bdvA, 0.6085, 2.96, 0.123, 612, 106, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
696, 1e30A, 0.6069, 2.60, 0.173, 153, 104, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
697, 1fwxC, 0.6065, 2.00, 0.175, 590, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
698, 6rl0B, 0.6062, 1.96, 0.216, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
699, 6rl0D, 0.6059, 1.96, 0.206, 581, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
700, 2iwfA, 0.6059, 1.89, 0.187, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
701, 3gdcC, 0.6057, 2.40, 0.168, 286, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
702, 6rl0C, 0.6056, 1.97, 0.206, 582, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
703, 3gdcA, 0.6054, 2.42, 0.168, 288, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
704, 3gdcB, 0.6053, 2.42, 0.168, 285, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE
705, 1fwxA, 0.6053, 1.97, 0.175, 591, 97, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
706, 6rl0A, 0.6052, 1.97, 0.206, 584, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM I 
707, 2iwkA, 0.6052, 1.90, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
708, 3sbpF, 0.6050, 1.97, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
709, 2iwfB, 0.6050, 1.90, 0.198, 590, 96, RESTING FORM OF PINK NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES
710, 1e30B, 0.6049, 2.63, 0.173, 153, 104, CRYSTAL STRUCTURE OF THE MET148GLN MUTANT OF RUSTICYANIN AT 1.5 ANGSTROM RESOLUTION
711, 3sbpG, 0.6047, 1.98, 0.216, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
712, 3sbrF, 0.6046, 1.99, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
713, 2iwkB, 0.6046, 1.91, 0.187, 590, 96, INHIBITOR-BOUND FORM OF NITROUS OXIDE REDUCTASE FROM ACHROMOBACTER CYCLOCLASTES AT 1.7 ANGSTROM RESOLUTION
714, 3sbrE, 0.6044, 1.98, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
715, 4enzA, 0.6043, 3.03, 0.179, 1029, 106, STRUCTURE OF HUMAN CERULOPLASMIN AT 2.6 A RESOLUTION
716, 6rkzA, 0.6040, 1.98, 0.206, 586, 97, RECOMBINANT PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE; FORM II 
717, 5yt7C, 0.6039, 2.65, 0.125, 130, 104, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
718, 3sbpE, 0.6039, 1.98, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
719, 3sbpD, 0.6038, 1.99, 0.206, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
720, 3sbrG, 0.6036, 1.99, 0.206, 585, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
721, 3sbrD, 0.6035, 1.99, 0.216, 588, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
722, 3x1gA, 0.6032, 2.67, 0.186, 296, 102, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS SHOWING TWO COORDINATION GEOMETRIES AT THE T2CU SITE
723, 3x1fA, 0.6032, 2.67, 0.186, 296, 102, H294M MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
724, 3sbqA, 0.6032, 2.00, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
725, 5yt7A, 0.6031, 2.63, 0.115, 133, 104, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
726, 3sbpH, 0.6030, 1.99, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
727, 1gy2B, 0.6028, 2.66, 0.163, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
728, 5yt7D, 0.6027, 2.68, 0.115, 133, 104, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
729, 3sbqB, 0.6026, 1.99, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P65 CRYSTAL FORM
730, 5yt7B, 0.6025, 2.62, 0.135, 132, 104, CRYSTAL STRUCTURE OF CIRCULARLY PERMUTATED AZURIN 3 
731, 1gy2A, 0.6024, 2.67, 0.163, 155, 104, CRYSTAL STRUCTURE OF MET148LEU RUSTICYANIN
732, 3x1eA, 0.6023, 2.68, 0.176, 295, 102, STRUCTURE OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS WITHOUT CHLORIDE
733, 3wkqA, 0.6023, 2.68, 0.186, 299, 102, COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH FORMATE
734, 3wiaD, 0.6023, 2.68, 0.186, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
735, 4yspA, 0.6022, 2.68, 0.176, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.32 MGY
736, 3wiaG, 0.6021, 2.68, 0.176, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
737, 1gy1B, 0.6021, 2.67, 0.173, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
738, 4zk8A, 0.6020, 2.68, 0.186, 294, 102, COPPER-CONTAINING NITRITE REDUCTASE FROM THERMOPHILIC BACTERIUM GEOBACILLUS THERMODENITRIFICANS (RE-REFINED)
739, 4ysqA, 0.6020, 2.68, 0.176, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 8.38 MGY
740, 1fwxD, 0.6020, 1.99, 0.177, 588, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
741, 4ysrA, 0.6019, 2.68, 0.176, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.6 MGY
742, 4ysoA, 0.6019, 2.68, 0.186, 295, 102, COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 0.064 MGY
743, 3sbrH, 0.6019, 2.00, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
744, 4ysaA, 0.6018, 2.68, 0.176, 294, 102, COMPLETELY OXIDIZED STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
745, 3sbpC, 0.6018, 2.01, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
746, 3sbpB, 0.6018, 2.01, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
747, 3wiaA, 0.6017, 2.69, 0.176, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
748, 3sbrC, 0.6017, 2.01, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
749, 1gy1A, 0.6016, 2.66, 0.173, 154, 104, CRYSTAL STRUCTURES OF SER86ASP AND MET148LEU RUSTICYANIN
750, 1fwxB, 0.6016, 1.94, 0.177, 589, 96, CRYSTAL STRUCTURE OF NITROUS OXIDE REDUCTASE FROM P. DENITRIFICANS
751, 4ystA, 0.6015, 2.69, 0.176, 294, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 24.9 MGY
752, 4ysdA, 0.6015, 2.68, 0.186, 299, 102, ROOM TEMPERATURE STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
753, 3wi9A, 0.6015, 2.68, 0.186, 303, 102, CRYSTAL STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS KAUSTOPHILUS
754, 5ytmA, 0.6014, 2.69, 0.176, 298, 102, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS DETERMINED BY IN-OUSE SOURCE 
755, 3wnjA, 0.6014, 2.69, 0.186, 298, 102, 1.20 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
756, 3wiaB, 0.6014, 2.70, 0.176, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
757, 3sbpA, 0.6014, 2.03, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM
758, 5ytlA, 0.6013, 2.69, 0.176, 294, 102, CRYSTAL STRUCTURE OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE DETERMINED WITH AN ANAEROBICALLY MANIPULATED CRYSTAL 
759, 4ysuA, 0.6013, 2.69, 0.176, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 25.0 MGY
760, 4yssA, 0.6013, 2.68, 0.186, 295, 102, STRUCTURE OF COPPER NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS - 16.7 MGY
761, 3wkpA, 0.6013, 2.69, 0.167, 295, 102, C135A MUTANT OF GEOBACILLUS THERMODENITRIFICANS COPPER-CONTAINING NITRITE REDUCTASE IN COMPLEX WITH NITRITE
762, 5ytnA, 0.6012, 2.69, 0.167, 298, 102, C135A MUTANT OF COPPER-CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS IN COMPLEX WITH PEROXIDE 
763, 3wniA, 0.6012, 2.69, 0.186, 298, 102, 1.50 A RESOLUTION CRYSTAL STRUCTURE OF DIOXYGEN BOUND COPPER- CONTAINING NITRITE REDUCTASE FROM GEOBACILLUS THERMODENITRIFICANS
764, 3sbrB, 0.6011, 2.02, 0.216, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
765, 3sbrA, 0.6006, 2.04, 0.206, 581, 97, PSEUDOMONAS STUTZERI NITROUS OXIDE REDUCTASE P1 CRYSTAL FORM WITH SUBSTRATE
766, 1sddA, 0.6006, 3.00, 0.132, 268, 106, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
767, 3x1nA, 0.6005, 2.69, 0.176, 298, 102, NITRITE-BOUND THERMOSTABLE COPPER NITRITE REDUCTASE AT 320 K
768, 5lwwA, 0.6004, 2.54, 0.160, 550, 100, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM ASPERGILLUS NIGER BOUND TO ZINC
769, 3wiaH, 0.6004, 2.70, 0.186, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
770, 3wiaE, 0.6003, 2.71, 0.176, 273, 102, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
771, 1a3zA, 0.6000, 2.68, 0.173, 150, 104, REDUCED RUSTICYANIN AT 1.9 ANGSTROMS
772, 5ehfA, 0.5997, 2.72, 0.117, 497, 103, LACCASE FROM ANTRODIELLA FAGINEA
773, 1a8zA, 0.5995, 2.68, 0.173, 153, 104, STRUCTURE DETERMINATION OF A 16.8KDA COPPER PROTEIN RUSTICYANIN AT 2.1A RESOLUTION USING ANOMALOUS SCATTERING DATA WITH DIRECT METHODS
774, 5n0kA, 0.5993, 2.55, 0.180, 1034, 100, RAT CERULOPLASMIN ORTHORHOMBIC FORM
775, 5e9nA, 0.5993, 2.60, 0.147, 495, 102, STECCHERINUM MURASHKINSKYI LACCASE AT 0.95 RESOLUTION
776, 2calA, 0.5993, 2.68, 0.163, 153, 104, CRYSTAL STRUCTURE OF HIS143MET RUSTICYANIN
777, 2cakA, 0.5988, 2.67, 0.173, 154, 104, 1.27ANGSTROM STRUCTURE OF RUSTICYANIN FROM THIOBACILLUS FERROOXIDANS
778, 1rcyA, 0.5988, 2.69, 0.173, 151, 104, RUSTICYANIN (RC) FROM THIOBACILLUS FERROOXIDANS
779, 6iqyB, 0.5987, 2.49, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
780, 5zd7B, 0.5987, 2.49, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
781, 1aozB, 0.5985, 2.49, 0.178, 552, 101, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
782, 4q89A, 0.5984, 2.82, 0.105, 501, 105, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
783, 3cdzA, 0.5984, 3.00, 0.123, 630, 106, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
784, 1asoB, 0.5984, 2.50, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
785, 3j2qA, 0.5983, 3.00, 0.123, 630, 106, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
786, 5lwxA, 0.5982, 2.57, 0.160, 554, 100, CRYSTAL STRUCTURE OF THE H253D MUTANT OF MCOG FROM ASPERGILLUS NIGER
787, 5lm8A, 0.5982, 2.57, 0.160, 549, 100, CRYSTAL STRUCTURE OF A LACCASE-LIKE MULTICOPPER OXIDASE MCOG FROM FROM ASPERGILLUS NIGER
788, 3t6vA, 0.5982, 2.72, 0.126, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
789, 6iqyA, 0.5981, 2.49, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
790, 5zd7A, 0.5981, 2.49, 0.079, 536, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; ANAEROBICALLY PREPARED 
791, 3t6vB, 0.5980, 2.74, 0.126, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
792, 1asqB, 0.5980, 2.50, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
793, 6rilA, 0.5979, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTEENTH STRUCTURE OF THE SERIES WITH 5600 KGY DOSE (DATA WAS COLLECTED AFTER REFREEZING). 
794, 6rhpA, 0.5979, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTY FIRST STRUCTURE OF THE SERIES WITH 4415 KGY DOSE (COLLECTED AFTER REFREEZING). 
795, 3x1bB, 0.5979, 2.82, 0.097, 500, 103, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
796, 6rikA, 0.5978, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRTEENTH STRUCTURE OF THE SERIES WITH 5200 KGY DOSE. 
797, 6ri4A, 0.5978, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 13 KGY DOSE. 
798, 6iqxB, 0.5978, 2.50, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
799, 5z1xB, 0.5978, 2.73, 0.136, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
800, 5z1xA, 0.5978, 2.72, 0.136, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
801, 6riiA, 0.5977, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FOURTH STRUCTURE OF THE SERIES WITH 1200 KGY DOSE. 
802, 6ri8A, 0.5977, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 800 KGY DOSE. 
803, 6ri6A, 0.5977, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY FLUORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 400 KGY DOSE. 
804, 6ri2A, 0.5977, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
805, 6iqxA, 0.5977, 2.50, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - M467Q MUTANT; AEROBICALLY PREPARED 
806, 3t6xA, 0.5977, 2.73, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
807, 2bhfA, 0.5977, 2.82, 0.105, 504, 105, 3D STRUCTURE OF THE REDUCED FORM OF COTA
808, 6ri0A, 0.5976, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
809, 6rhuA, 0.5976, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
810, 6rhrA, 0.5976, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
811, 5n4lA, 0.5976, 2.57, 0.180, 1034, 100, RAT CERULOPLASMIN TRIGONAL FORM
812, 3t6zA, 0.5976, 2.73, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
813, 6rhhA, 0.5975, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
814, 6rgpA, 0.5975, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. SECOND STRUCTURE OF THE SERIES WITH 165 KGY DOSE. 
815, 5z22A, 0.5975, 2.73, 0.136, 494, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA SP. RSD1 
816, 1gskA, 0.5975, 2.83, 0.105, 502, 105, CRYSTAL STRUCTURE OF COTA AN ENDOSPORE COAT PROTEIN FROM BACILLUS SUBTILIS
817, 1aspB, 0.5975, 2.51, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
818, 6rghA, 0.5974, 2.73, 0.146, 499, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. FIRST STRUCTURE OF THE SERIES WITH 15 KGY DOSE. 
819, 3x1bA, 0.5974, 2.81, 0.097, 500, 103, CRYSTAL STRUCTURE OF LACCASE FROM LENTINUS SP. AT 1.8 A RESOLUTION
820, 3t6wA, 0.5974, 2.73, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
821, 1of0A, 0.5974, 2.83, 0.105, 502, 105, CRYSTAL STRUCTURE OF BACILLUS SUBTILIS COTA AFTER 1H SOAKING WITH EBS
822, 6rhiA, 0.5973, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. NINTH STRUCTURE OF THE SERIES WITH 1215 KGY DOSE. 
823, 6iqzA, 0.5973, 2.52, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
824, 5zd6A, 0.5973, 2.52, 0.079, 535, 101, HIGH RESOLUTION STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA - WILD TYPE 
825, 5i5iB, 0.5973, 1.64, 0.129, 537, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
826, 6rhoA, 0.5972, 2.73, 0.146, 497, 103, SINGLE CRYSTAL SERIAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI AT SUB-ATOMIC RESOLUTION. TWENTIETH STRUCTURE OF THE SERIES WITH 4065 KGY DOSE. 
827, 6rhxA, 0.5971, 2.61, 0.147, 497, 102, SINGLE CRYSTAL SERIAL STUDY OF THE INHIBITION OF LACCASES FROM STECCHERINUM MURASHKINSKYI BY CHLORIDE ANIONS AT SUB-ATOMIC RESOLUTION. THIRD STRUCTURE OF THE SERIES WITH 315 KGY DOSE. 
828, 4q8bA, 0.5971, 2.83, 0.105, 499, 105, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
829, 3t71A, 0.5971, 2.74, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
830, 1w6wA, 0.5971, 2.83, 0.105, 502, 105, 3D STRUCTURE OF COTA INCUBATED WITH SODIUM AZIDE
831, 1asoA, 0.5971, 2.52, 0.188, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
832, 5i5iA, 0.5970, 1.66, 0.118, 539, 93, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE APP FORM
833, 3zdwA, 0.5969, 2.83, 0.105, 502, 105, SUBSTRATE AND DIOXYGEN BINDING TO THE ENDOSPORE COAT LACCASE COTA FROM BACILLUS SUBTILIS
834, 2xllD, 0.5969, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
835, 2xllA, 0.5969, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
836, 1aspA, 0.5969, 2.47, 0.178, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
837, 2xllC, 0.5968, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
838, 2xllB, 0.5968, 2.51, 0.079, 533, 101, THE CRYSTAL STRUCTURE OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA
839, 3t6wB, 0.5967, 2.75, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
840, 2x87A, 0.5967, 2.83, 0.105, 504, 105, CRYSTAL STRUCTURE OF THE RECONSTITUTED COTA
841, 1asqA, 0.5967, 2.47, 0.188, 552, 101, X-RAY STRUCTURES AND MECHANISTIC IMPLICATIONS OF THREE FUNCTIONAL DERIVATIVES OF ASCORBATE OXIDASE FROM ZUCCHINI: REDUCED- PEROXIDE- AND AZIDE-FORMS
842, 5migA, 0.5966, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 16-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 453 MIN. THE CRYSTAL WAS QUICK REFREEZING BEFORE THIS DATA COLLECTION.
843, 5micA, 0.5966, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 13-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 363 MIN.
844, 5miaA, 0.5966, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 11-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 303 MIN.
845, 5mejA, 0.5966, 2.74, 0.146, 499, 103, STRUCTURAL STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. FIRST STRUCTURE OF THE SERIES WITH 3 MIN TOTAL X-RAY EXPOSITION TIME.
846, 4yvnA, 0.5966, 2.74, 0.087, 505, 104, CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH ABTS AT A NOVEL BINDING SITE
847, 5mieA, 0.5965, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 15-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 423 MIN.
848, 5mhyA, 0.5965, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SEVENTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 183 MIN.
849, 5mhwA, 0.5965, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FIFTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 123 MIN.
850, 5mewA, 0.5965, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI. SECOND STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 33 MIN.
851, 4yvuA, 0.5965, 2.84, 0.105, 506, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME IN THE ACID CONDITION PH5.6
852, 4a68A, 0.5965, 2.84, 0.105, 502, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116N MUTANT
853, 5zlmA, 0.5964, 2.84, 0.105, 502, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H491C MUTANT; PH 8.0 
854, 5zljA, 0.5964, 2.84, 0.105, 503, 105, CRYSTAL STRUCTURE OF COTA NATIVE ENZYME; PH8.0 
855, 5midA, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 14-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 393 MIN.
856, 5mi2A, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 10-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 273 MIN.
857, 5mi1A, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 9-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 243 MIN.
858, 5mhzA, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 8-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 213 MIN.
859, 5mhxA, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE SIXTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 153 MIN.
860, 5mhvA, 0.5964, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE FOURTH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 93 MIN.
861, 4e9vC, 0.5964, 2.64, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA1)
862, 3t71B, 0.5964, 2.63, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
863, 3t6vC, 0.5964, 2.75, 0.126, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM STECCHERINUM OCHRACEUM
864, 1w8eA, 0.5964, 2.83, 0.105, 505, 105, 3D STRUCTURE OF COTA INCUBATED WITH HYDROGEN PEROXIDE
865, 4e9vA, 0.5963, 2.65, 0.186, 317, 102, MULTICOPPER OXIDASE MGLAC (DATA1)
866, 2j5wA, 0.5963, 2.56, 0.180, 1029, 100, CERULOPLASMIN REVISITED: STRUCTURAL AND FUNCTIONAL ROLES OF VARIOUS METAL CATION BINDING SITES
867, 5zllA, 0.5962, 2.83, 0.105, 503, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493C MUTANT; PH 8.0 
868, 5mibA, 0.5962, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE 12-TH STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 333 MIN.
869, 5mhuA, 0.5962, 2.74, 0.146, 499, 103, THE STUDY OF THE X-RAY INDUCED ENZYMATIC REDUCTION OF MOLECULAR OXYGEN TO WATER FOR LACCASE FROM STECCHERINUM MURASHKINSKYI.THE THIRD STRUCTURE OF THE SERIES WITH TOTAL EXPOSITION TIME 63 MIN.
870, 4e9wC, 0.5962, 2.64, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA2)
871, 4e9wA, 0.5962, 2.66, 0.186, 317, 102, MULTICOPPER OXIDASE MGLAC (DATA2)
872, 3t6zC, 0.5962, 2.75, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
873, 4e9yC, 0.5961, 2.64, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA4)
874, 4e9xA, 0.5961, 2.65, 0.186, 317, 102, MULTICOPPER OXIDASE MGLAC (DATA3)
875, 3wiaI, 0.5961, 2.70, 0.188, 272, 101, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
876, 4a67A, 0.5960, 2.74, 0.087, 504, 104, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116E MUTANT
877, 3t6xB, 0.5960, 2.64, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
878, 2x88A, 0.5960, 2.84, 0.105, 504, 105, CRYSTAL STRUCTURE OF HOLOCOTA
879, 1w6lA, 0.5960, 2.83, 0.105, 503, 105, 3D STRUCTURE OF COTA INCUBATED WITH CUCL2
880, 4e9yA, 0.5959, 2.66, 0.186, 317, 102, MULTICOPPER OXIDASE MGLAC (DATA4)
881, 4e9xC, 0.5958, 2.64, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA3)
882, 4akqA, 0.5958, 2.84, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498D MUTANT
883, 4akpA, 0.5958, 2.84, 0.105, 504, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE:E498T MUTANT
884, 3t6zB, 0.5958, 2.65, 0.127, 495, 102, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (60 percent DOSE)
885, 4akoA, 0.5957, 2.84, 0.105, 505, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: E498L MUTANT
886, 2wsdA, 0.5957, 2.84, 0.105, 504, 105, PROXIMAL MUTATIONS AT THE TYPE 1 CU SITE OF COTA-LACCASE: I494A MUTANT
887, 2zwnC, 0.5956, 2.65, 0.186, 316, 102, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
888, 2zwnA, 0.5956, 2.66, 0.186, 317, 102, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
889, 4q8bB, 0.5955, 2.76, 0.096, 499, 104, THE CRYSTAL STRUCTURE OF COTA LACCASE COMPLEXED WITH SINAPIC ACID
890, 3t6wC, 0.5955, 2.75, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (10 percent DOSE)
891, 3t6xC, 0.5954, 2.76, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (20 percent DOSE)
892, 1kcwA, 0.5953, 2.47, 0.182, 1017, 99, X-RAY CRYSTAL STRUCTURE OF HUMAN CERULOPLASMIN AT 3.0 ANGSTROMS
893, 4x4kA, 0.5952, 2.57, 0.140, 525, 100, STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA WITH FULL COPPER CONTENT
894, 4q89B, 0.5951, 2.76, 0.096, 499, 104, CRYSTAL STRUCTURE OF THE COTA NATIVE ENZYME
895, 3t71C, 0.5951, 2.77, 0.126, 495, 103, CRYSTAL STRUCTURE OF STECCHERINUM OCHRACEUM LACCASE OBTAINED BY MULTI- CRYSTALS COMPOSITE DATA COLLECTION TECHNIQUE (90 percent DOSE)
896, 4a66A, 0.5950, 2.85, 0.114, 501, 105, MUTATIONS IN THE NEIGHBOURHOOD OF COTA-LACCASE TRINUCLEAR SITE: D116A MUTANT
897, 1v10A, 0.5950, 2.78, 0.117, 487, 103, STRUCTURE OF RIGIDOPORUS LIGNOSUS LACCASE FROM HEMIHEDRALLY TWINNED CRYSTALS
898, 6fc7G, 0.5949, 2.61, 0.127, 281, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
899, 4ejxA, 0.5949, 2.57, 0.180, 1034, 100, STRUCTURE OF CERULOPLASMIN-MYELOPEROXIDASE COMPLEX
900, 2ih8A, 0.5948, 2.65, 0.139, 559, 101, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
901, 1kyaC, 0.5948, 2.81, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
902, 3g5wA, 0.5947, 2.65, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
903, 5n4lB, 0.5946, 2.58, 0.180, 1034, 100, RAT CERULOPLASMIN TRIGONAL FORM
904, 1kyaB, 0.5945, 2.76, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
905, 1kyaA, 0.5944, 2.76, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
906, 3v9eA, 0.5943, 2.57, 0.140, 539, 100, STRUCTURE OF THE L499M MUTANT OF THE LACCASE FROM B.ACLADA
907, 3v9cA, 0.5943, 2.77, 0.107, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA AT LOW DOSE OF IONIZATION RADIATION
908, 3kw7A, 0.5943, 2.75, 0.126, 502, 103, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
909, 5zlkA, 0.5942, 2.86, 0.105, 506, 105, MUTATION IN THE TRINUCLEAR SITE OF COTA-LACCASE: H493A MUTANT; PH 8.0 
910, 3sqrA, 0.5942, 2.57, 0.140, 539, 100, CRYSTAL STRUCTURE OF LACCASE FROM BOTRYTIS ACLADA AT 1.67 A RESOLUTION
911, 3pxlA, 0.5941, 2.77, 0.107, 499, 103, TYPE-2 CU-DEPLETED FUNGUS LACCASE FROM TRAMETES HIRSUTA
912, 1kyaD, 0.5941, 2.75, 0.126, 499, 103, ACTIVE LACCASE FROM TRAMETES VERSICOLOR COMPLEXED WITH 25-XYLIDINE
913, 5o4iA, 0.5940, 2.63, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
914, 3tasA, 0.5940, 2.60, 0.118, 300, 102, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
915, 2ih8B, 0.5939, 2.66, 0.139, 559, 101, A LOW-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARPUS ALBOMYCES LACCASE
916, 6fc7J, 0.5937, 2.62, 0.127, 281, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
917, 6fc7A, 0.5937, 2.62, 0.127, 281, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
918, 4uahB, 0.5934, 2.62, 0.118, 271, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
919, 3g5wE, 0.5933, 2.66, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
920, 3tasC, 0.5932, 2.61, 0.118, 300, 102, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
921, 3kw7B, 0.5932, 2.76, 0.126, 502, 103, CRYSTAL STRUCTURE OF LACB FROM TRAMETES SP. AH28-2
922, 2q9oB, 0.5932, 2.58, 0.140, 558, 100, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
923, 6rh9J, 0.5931, 2.63, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
924, 6fc7D, 0.5931, 2.63, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
925, 6rhqF, 0.5930, 2.64, 0.127, 276, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
926, 3fpxA, 0.5929, 2.79, 0.107, 499, 103, NATIVE FUNGUS LACCASE FROM TRAMETES HIRSUTA
927, 3divA, 0.5929, 2.79, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.76A RESOLUTION
928, 5o4iB, 0.5927, 2.64, 0.127, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
929, 5o3kB, 0.5927, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
930, 4uanB, 0.5927, 2.63, 0.118, 270, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
931, 3g5wC, 0.5927, 2.67, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
932, 6fc7H, 0.5926, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
933, 2h5uA, 0.5926, 2.79, 0.126, 497, 103, CRYSTAL STRUCTURE OF LACCASE FROM CERRENA MAXIMA AT 1.9A RESOLUTION
934, 4uanC, 0.5925, 2.63, 0.118, 272, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
935, 6fc7L, 0.5924, 2.65, 0.127, 276, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
936, 4uahA, 0.5922, 2.62, 0.118, 272, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
937, 3ta4D, 0.5922, 2.64, 0.137, 273, 102, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
938, 3t9wA, 0.5922, 2.66, 0.147, 270, 102, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116
939, 3fu9A, 0.5922, 2.67, 0.139, 559, 101, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
940, 2hzhA, 0.5922, 2.79, 0.126, 499, 103, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLUS ZONATUS AT 2.6 A RESOLUTION
941, 3g5wF, 0.5921, 2.67, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
942, 2zwnB, 0.5920, 2.70, 0.186, 316, 102, CRYSTAL STRUCTURE OF THE NOVEL TWO-DOMAIN TYPE LACCASE FROM A METAGENOME
943, 5o4qD, 0.5919, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
944, 2xybA, 0.5919, 2.78, 0.126, 497, 103, CRYSTAL STRUCTURE OF A FULLY FUNCTIONAL LACCASE FROM THE LIGNINOLYTIC FUNGUS PYCNOPORUS CINNABARINUS
945, 6fdjA, 0.5918, 2.65, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
946, 6s0oB, 0.5917, 2.64, 0.127, 280, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
947, 5o4iG, 0.5917, 2.65, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
948, 4e9yB, 0.5917, 2.71, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA4)
949, 4e9xB, 0.5917, 2.70, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA3)
950, 5o4qA, 0.5916, 2.63, 0.127, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
951, 4e9wB, 0.5916, 2.71, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA2)
952, 4e9vB, 0.5916, 2.71, 0.186, 316, 102, MULTICOPPER OXIDASE MGLAC (DATA1)
953, 3tbbC, 0.5916, 2.64, 0.118, 277, 102, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
954, 3dkhA, 0.5916, 2.69, 0.139, 558, 101, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
955, 6fdjG, 0.5915, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
956, 5o4qJ, 0.5915, 2.64, 0.127, 280, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
957, 5o4qG, 0.5915, 2.63, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
958, 5o4iK, 0.5915, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
959, 3g5wD, 0.5914, 2.68, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
960, 6rh9G, 0.5913, 2.64, 0.137, 279, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
961, 5nq9A, 0.5913, 2.79, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
962, 3tbcC, 0.5913, 2.63, 0.118, 277, 102, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
963, 6s0oA, 0.5912, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
964, 6s0oD, 0.5911, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
965, 3fu7A, 0.5911, 2.60, 0.140, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
966, 3dkhB, 0.5911, 2.68, 0.139, 558, 101, L559A MUTANT OF MELANOCARPUS ALBOMYCES LACCASE
967, 6rhqB, 0.5910, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
968, 5mkmE, 0.5910, 2.65, 0.127, 277, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
969, 4w1tA, 0.5910, 2.64, 0.118, 272, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
970, 6rhqA, 0.5909, 2.65, 0.127, 282, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
971, 3g5wB, 0.5909, 2.68, 0.176, 318, 102, CRYSTAL STRUCTURE OF BLUE COPPER OXIDASE FROM NITROSOMONAS EUROPAEA
972, 5mkmA, 0.5908, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
973, 3kw8A, 0.5908, 2.65, 0.137, 273, 102, TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR AT 2.3 A RESOLUTION
974, 2qt6B, 0.5908, 2.80, 0.136, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
975, 6fdjD, 0.5907, 2.65, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
976, 5o4iE, 0.5907, 2.66, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
977, 6rhqD, 0.5906, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
978, 5o4iD, 0.5906, 2.67, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
979, 6fdjB, 0.5905, 2.64, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
980, 5o4qL, 0.5905, 2.65, 0.127, 275, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
981, 5lhlD, 0.5905, 2.66, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
982, 3fu8A, 0.5904, 2.60, 0.140, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
983, 2qt6A, 0.5904, 2.80, 0.136, 498, 103, CRYSTAL STRUCTURE DETERMINATION OF A BLUE LACCASE FROM LENTINUS TIGRINUS
984, 5o3kA, 0.5903, 2.66, 0.137, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
985, 6rh9C, 0.5902, 2.66, 0.147, 277, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
986, 6rh9D, 0.5901, 2.65, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
987, 6rh9F, 0.5900, 2.66, 0.137, 276, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
988, 5o3kG, 0.5900, 2.66, 0.137, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
989, 5o3kD, 0.5900, 2.66, 0.127, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
990, 5lduA, 0.5900, 2.81, 0.107, 499, 103, RECOMBINANT HIGH-REDOX POTENTIAL LACCASE FROM BASIDIOMYCETE TRAMETES HIRSUTA
991, 1curA, 0.5900, 2.75, 0.183, 155, 104, REDUCED RUSTICYANIN NMR
992, 6fc7B, 0.5898, 2.65, 0.127, 281, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
993, 5o4qE, 0.5898, 2.67, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
994, 5o4iC, 0.5898, 2.66, 0.137, 277, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
995, 4a2fA, 0.5898, 2.86, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 12.65 KEV
996, 5o4qH, 0.5897, 2.65, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
997, 5o3kK, 0.5897, 2.67, 0.127, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
998, 3ta4E, 0.5897, 2.68, 0.137, 267, 102, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
999, 6fc7I, 0.5896, 2.67, 0.127, 281, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1000, 3fu8B, 0.5895, 2.60, 0.140, 558, 100, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (10 SEC) WITH 26- DIMETHOXYPHENOL
1001, 3cg8B, 0.5895, 2.64, 0.137, 272, 102, LACCASE FROM STREPTOMYCES COELICOLOR
1002, 6rhqC, 0.5894, 2.66, 0.127, 275, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1003, 4wtqC, 0.5894, 2.65, 0.118, 269, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
1004, 6fc7K, 0.5893, 2.67, 0.137, 282, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1005, 4gxfB, 0.5893, 2.67, 0.127, 279, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1006, 1gycA, 0.5893, 2.81, 0.126, 499, 103, CRYSTAL STRUCTURE DETERMINATION AT ROOM TEMPERATURE OF A LACCASE FROM TRAMETES VERSICOLOR IN ITS OXIDISED FORM CONTAINING A FULL COMPLEMENT OF COPPER IONS
1007, 4uanA, 0.5892, 2.65, 0.118, 276, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Q WITH DEPLETED TYPE-2 COPPER ION
1008, 4uahC, 0.5892, 2.65, 0.118, 276, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99N WITH DEPLETED TYPE-2 COPPER ION
1009, 6fdjE, 0.5891, 2.65, 0.137, 277, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1010, 4gxfC, 0.5890, 2.68, 0.127, 279, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1011, 3cg8C, 0.5890, 2.68, 0.137, 272, 102, LACCASE FROM STREPTOMYCES COELICOLOR
1012, 6fc7E, 0.5889, 2.67, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1013, 5o4qB, 0.5889, 2.67, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1014, 5o4iJ, 0.5889, 2.67, 0.137, 279, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1015, 5nq9C, 0.5889, 2.83, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II MONOCLINIC
1016, 6rh9A, 0.5888, 2.67, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1017, 4a2dA, 0.5888, 2.87, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE T2 COPPER DEPLETED AT PH  4.5
1018, 4jhuA, 0.5887, 2.88, 0.126, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA SOAKED WITH CUCL
1019, 2vmjA, 0.5887, 2.42, 0.216, 326, 97, TYPE 1 COPPER-BINDING LOOP OF NITRITE REDUCTASE MUTANT: 130- CAPEGMVPWHVVSGM-144 TO 130-CTPHPFM-136
1020, 4w1tC, 0.5886, 2.67, 0.118, 276, 102, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
1021, 4n8uA, 0.5886, 2.66, 0.127, 275, 102, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1022, 2hrgA, 0.5886, 2.88, 0.136, 496, 103, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII COMPLEXED WITH P-METHYLBENZOATE
1023, 6rh9K, 0.5885, 2.67, 0.147, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1024, 4a2hA, 0.5885, 2.87, 0.126, 495, 103, CRYSTAL STRUCTURE OF LACCASE FROM CORIOLOPSIS GALLICA PH 7.0
1025, 2hrhA, 0.5885, 2.87, 0.136, 496, 103, CRYSTAL STRUCTURE OF BLUE LACCASE FROM TRAMETES TROGII
1026, 5lhlE, 0.5884, 2.68, 0.127, 275, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1027, 4a2gA, 0.5884, 2.87, 0.126, 495, 103, CORIOLOPSIS GALLICA LACCASE COLLECTED AT 8.98 KEV
1028, 5o4qK, 0.5883, 2.67, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1029, 5o4qF, 0.5883, 2.65, 0.127, 275, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1030, 5o3kJ, 0.5882, 2.66, 0.137, 281, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1031, 4gxfA, 0.5882, 2.68, 0.127, 279, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1032, 3cg8A, 0.5882, 2.66, 0.137, 270, 102, LACCASE FROM STREPTOMYCES COELICOLOR
1033, 4m3hA, 0.5881, 2.68, 0.118, 269, 102, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
1034, 5mkmB, 0.5880, 2.67, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1035, 4jhvA, 0.5880, 2.88, 0.126, 496, 103, T2-DEPLETED LACCASE FROM CORIOLOPSIS CAPERATA
1036, 5o3kE, 0.5879, 2.69, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1037, 5o3kH, 0.5878, 2.69, 0.137, 278, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1038, 5anhA, 0.5878, 2.90, 0.136, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1039, 3fsvA, 0.5878, 3.01, 0.114, 118, 105, PSEUDOMONAS AERUGINOSA AZURIN WITH MUTATED METAL-BINDING LOOP SEQUENCE (CAAAHAAAM)
1040, 4m3hC, 0.5877, 2.68, 0.118, 270, 102, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
1041, 4n8uC, 0.5874, 2.69, 0.127, 275, 102, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1042, 6fdjK, 0.5873, 2.68, 0.137, 276, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1043, 6fdjH, 0.5873, 2.66, 0.137, 277, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1044, 5nq8A, 0.5871, 2.85, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM II
1045, 5lhlA, 0.5870, 2.66, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1046, 5o3kI, 0.5869, 2.70, 0.137, 275, 102, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1047, 5k8dB, 0.5867, 2.76, 0.140, 619, 100, CRYSTAL STRUCTURE OF RFVIIIFC
1048, 4a2eA, 0.5867, 2.89, 0.126, 495, 103, CRYSTAL STRUCTURE OF A CORIOLOPSIS GALLICA LACCASE AT 1.7 A RESOLUTION PH 5.5
1049, 6s0oE, 0.5866, 2.68, 0.137, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1050, 4gy4B, 0.5865, 2.71, 0.127, 278, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1051, 4gy4A, 0.5863, 2.70, 0.137, 276, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1052, 5nq7A, 0.5862, 2.91, 0.117, 497, 103, CRYSTAL STRUCTURE OF LACCASES FROM PYCNOPORUS SANGUINEUS IZOFORM I
1053, 5anhC, 0.5862, 2.91, 0.136, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1054, 4gy4C, 0.5862, 2.71, 0.127, 278, 102, ROLE OF THE BIRADICAL INTERMEDIATE OBSERVED DURING THE TURNOVER OF SLAC: A TWO-DOMAIN LACCASE FROM STREPTOMYCES COELICOLOR
1055, 6rhqE, 0.5859, 2.69, 0.137, 282, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170A FROM STREPTOMYCES GRISEOFLAVUS 
1056, 4bxsV, 0.5859, 2.63, 0.192, 1262, 99, CRYSTAL STRUCTURE OF THE PROTHROMBINASE COMPLEX FROM THE VENOM OF PSEUDONAJA TEXTILIS
1057, 6rh9L, 0.5858, 2.70, 0.137, 275, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1058, 5lhlB, 0.5857, 2.69, 0.127, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1059, 4n8uB, 0.5853, 2.69, 0.118, 276, 102, TWO-DOMAIN LACCASE FROM STREPTOMYCES VIRIDOCHROMOGENES AT 2.4 A RESOLUTION AC629
1060, 5anhB, 0.5850, 2.91, 0.136, 496, 103, CRYSTAL STRUCTURE OF LACCASE FROM BASIDIOMYCETE PM1 (CECT 2971)
1061, 6rh9E, 0.5846, 2.68, 0.137, 277, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1062, 6rh9H, 0.5845, 2.70, 0.147, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1063, 3abgA, 0.5844, 2.70, 0.079, 508, 101, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1064, 6rh9B, 0.5842, 2.69, 0.147, 278, 102, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1065, 1sddB, 0.5841, 2.12, 0.126, 601, 95, CRYSTAL STRUCTURE OF BOVINE FACTOR VAI
1066, 5a7eA, 0.5836, 2.86, 0.127, 495, 102, CRYSTALLOGRAPHIC STRUCTURAL DETERMINATION OF A TRIGONAL LACCASE FROM CORIOLOPSIS GALLICA (CGL) TO 1.5 A RESOLUTION
1067, 5b7mB, 0.5830, 2.76, 0.119, 464, 101, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1068, 3abgB, 0.5826, 2.70, 0.079, 518, 101, X-RAY CRYSTAL ANALYSIS OF BILIRUBIN OXIDASE FROM MYROTHECIUM VERRUCARIA AT 2.3 ANGSTROM RESOLUTION USING A TWIN CRYSTAL
1069, 2fqdA, 0.5822, 2.75, 0.119, 464, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
1070, 5b7mC, 0.5821, 2.77, 0.119, 462, 101, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1071, 2fqeA, 0.5816, 2.75, 0.119, 463, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
1072, 1kv7A, 0.5816, 2.78, 0.119, 463, 101, CRYSTAL STRUCTURE OF CUEO A MULTI-COPPER OXIDASE FROM E. COLI INVOLVED IN COPPER HOMEOSTASIS
1073, 2fqgA, 0.5815, 2.75, 0.119, 464, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
1074, 2fqfA, 0.5815, 2.75, 0.119, 465, 101, CRYSTAL STRUCTURES OF E. COLI LACCASE CUEO UNDER DIFFERENT COPPER BINDING SITUATIONS
1075, 3nsfA, 0.5809, 2.78, 0.119, 480, 101, APO FORM OF THE MULTICOPPER OXIDASE CUEO
1076, 2uxtA, 0.5808, 2.67, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1077, 3pauA, 0.5807, 2.74, 0.119, 464, 101, CUEO IN THE RESTING OXIDIZED STATE
1078, 1n68A, 0.5806, 2.60, 0.120, 464, 100, COPPER BOUND TO THE MULTICOPPER OXIDASE CUEO
1079, 5b7eA, 0.5804, 2.77, 0.119, 477, 101, STRUCTURE OF PERDEUTERATED CUEO
1080, 5b7mA, 0.5803, 2.61, 0.120, 463, 100, STRUCTURE OF PERDEUTERATED CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1081, 2yxvA, 0.5803, 2.79, 0.119, 444, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1082, 2yxvB, 0.5801, 2.78, 0.119, 440, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1083, 4hakA, 0.5800, 2.79, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT E506A
1084, 2yxwA, 0.5799, 2.79, 0.119, 440, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1085, 6im8A, 0.5798, 2.79, 0.119, 469, 101, CUEO-PM2 MULTICOPPER OXIDASE 
1086, 4halA, 0.5798, 2.79, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT E506I
1087, 3uaaA, 0.5797, 2.79, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA1)
1088, 3nsyA, 0.5797, 2.79, 0.119, 465, 101, THE MULTI-COPPER OXIDASE CUEO WITH SIX MET TO SER MUTATIONS (M358S M361SM362SM364SM366SM368S)
1089, 5gnoA, 0.5796, 2.81, 0.119, 463, 101, STRUCTURE OF MULTICOPPER OXIDASE CUEO - SIGNAL PEPTIDE-FREE
1090, 5b7fA, 0.5796, 2.81, 0.119, 463, 101, STRUCTURE OF CUEO - THE SIGNAL PEPTIDE WAS TRUNCATED BY HRV3C PROTEASE
1091, 4nerA, 0.5794, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO (DATA1)
1092, 4e9rA, 0.5794, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO (DATA4)
1093, 4e9qA, 0.5794, 2.79, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO (DATA2)
1094, 4e9tA, 0.5793, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO (DATA6)
1095, 3uacA, 0.5793, 2.79, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA4)
1096, 2uxtB, 0.5793, 2.77, 0.099, 420, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1097, 4e9sA, 0.5792, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO (DATA5)
1098, 3uaeA, 0.5792, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA6)
1099, 3uabA, 0.5792, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA2)
1100, 3pavA, 0.5792, 2.81, 0.119, 466, 101, THE REDUCED FORM OF CUEO
1101, 3uadA, 0.5790, 2.80, 0.119, 476, 101, MULTICOPPER OXIDASE CUEO MUTANT C500SE506Q (DATA5)
1102, 3od3A, 0.5790, 2.80, 0.119, 488, 101, CUEO AT 1.1 A RESOLUTION INCLUDING RESIDUES IN PREVIOUSLY DISORDERED REGION
1103, 3qqxA, 0.5787, 2.80, 0.119, 474, 101, REDUCED NATIVE INTERMEDIATE OF THE MULTICOPPER OXIDASE CUEO
1104, 3nscA, 0.5787, 2.61, 0.120, 470, 100, C500S MUTANT OF CUEO BOUND TO CU(II)
1105, 2yxwB, 0.5787, 2.79, 0.119, 444, 101, THE DELETION MUTANT OF MULTICOPPER OXIDASE CUEO
1106, 3nsdA, 0.5785, 2.81, 0.119, 462, 101, SILVER BOUND TO THE MULTICOPPER OXIDASE CUEO (UNTAGGED)
1107, 3gyrG, 0.5783, 3.12, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1108, 3gyrK, 0.5782, 3.18, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1109, 3gyrA, 0.5782, 3.08, 0.057, 587, 106, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1110, 3gyrE, 0.5781, 3.12, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1111, 3gyrF, 0.5777, 3.12, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1112, 4ef3A, 0.5776, 2.64, 0.120, 466, 100, MULTICOPPER OXIDASE CUEO (CITRATE BUFFER)
1113, 1pf3A, 0.5775, 2.62, 0.120, 463, 100, CRYSTAL STRUCTURE OF THE M441L MUTANT OF THE MULTICOPPER OXIDASE CUEO
1114, 3gyrB, 0.5772, 3.22, 0.056, 587, 108, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1115, 3gyrD, 0.5771, 3.13, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1116, 5ys1A, 0.5769, 2.82, 0.129, 461, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT 
1117, 3gyrL, 0.5765, 3.24, 0.046, 587, 108, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1118, 3gyrI, 0.5765, 3.13, 0.056, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1119, 3gyrH, 0.5761, 3.14, 0.047, 587, 107, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1120, 3gyrC, 0.5760, 3.24, 0.056, 587, 108, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1121, 5ys5A, 0.5759, 2.83, 0.129, 457, 101, CRYSTAL STRUCTURE OF MULTICOPPER OXIDASE CUEO G304K MUTANT WITH SEVEN COPPER IONS 
1122, 3gyrJ, 0.5757, 3.25, 0.046, 587, 108, STRUCTURE OF PHENOXAZINONE SYNTHASE FROM STREPTOMYCES ANTIBIOTICUS REVEALS A NEW TYPE 2 COPPER CENTER.
1123, 1a65A, 0.5756, 3.06, 0.117, 504, 103, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS
1124, 6evgA, 0.5750, 2.80, 0.089, 444, 101, STRUCTURAL AND FUNCTIONAL CHARACTERISATION OF A BACTERIAL LACCASE-LIKE MULTI-COPPER OXIDASE CUEO FROM LIGNIN-DEGRADING BACTERIUM OCHROBACTRUM SP. WITH OXIDASE ACTIVITY TOWARDS LIGNIN MODEL COMPOUNDS AND LIGNOSULFONATE 
1125, 2uxvB, 0.5750, 2.79, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1126, 3nt0A, 0.5749, 2.65, 0.120, 468, 100, C500S (T1D) MUTANT OF CUEO SOAKED IN AND BOUND TO CU(I)
1127, 3ta4F, 0.5748, 2.58, 0.235, 282, 98, SMALL LACCASE FROM AMYCOLATOPSIS SP. ATCC 39116 COMPLEXED WITH 1-(34- DIMETHOXYPHENYL)-2-(2-METHOXYPHENOXY)-13-DIHYDROXYPROPANE
1128, 3wiaC, 0.5739, 2.40, 0.211, 273, 95, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
1129, 3wiaF, 0.5735, 2.40, 0.211, 273, 95, CRYSTAL STRUCTURE OF THE N-TERMINAL 1-37 RESIDUES DELETED MUTANT OF GEOBACILLUS COPPER NITRITE REDUCTASE
1130, 3j2sB, 0.5734, 2.44, 0.155, 631, 97, MEMBRANE-BOUND FACTOR VIII LIGHT CHAIN
1131, 5k5kA, 0.5730, 2.71, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASSE FROM THERMUS THERMOPHILUS HB27 (ASCORBIC ACID 10 MIN)
1132, 5jrrA, 0.5727, 2.71, 0.188, 439, 101, CRYSTAL STRUCTURE OF NATIVE LACCASE FROM THERMUS THERMOPHILUS HB27
1133, 5jx9A, 0.5723, 2.71, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 5 MIN)
1134, 4bdvB, 0.5722, 2.44, 0.134, 606, 97, CRYSTAL STRUCTURE OF A TRUNCATED B-DOMAIN HUMAN FACTOR VIII
1135, 3j2qB, 0.5722, 2.47, 0.155, 631, 97, MODEL OF MEMBRANE-BOUND FACTOR VIII ORGANIZED IN 2D CRYSTALS
1136, 3cdzB, 0.5722, 2.47, 0.155, 631, 97, CRYSTAL STRUCTURE OF HUMAN FACTOR VIII
1137, 5k84A, 0.5720, 2.72, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 10 MIN)
1138, 5k15A, 0.5720, 2.72, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU2PO 8 MIN)
1139, 6im9A, 0.5719, 2.79, 0.120, 490, 100, MDM2 BOUND CUEO-PM2 SENSOR 
1140, 5k3kA, 0.5717, 2.72, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CUSO4 20 MIN)
1141, 2yaoA, 0.5717, 2.72, 0.188, 437, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (50.0-62.5 PERCENT DOSE)
1142, 5afaA, 0.5716, 2.87, 0.186, 439, 102, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH AG CRYSTAL OF THE HOLOENZYME SOAKED FOR 30 M IN 5 MM AGNO3 AT 278 K.
1143, 2uxvA, 0.5715, 2.84, 0.099, 422, 101, SUFI PROTEIN FROM ESCHERICHIA COLI
1144, 5k7aA, 0.5712, 2.73, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FRON THERMUS THERMOPHILUS HB27 (SODIUM NITRATE 1.5 MIN)
1145, 5g3cA, 0.5712, 2.73, 0.188, 435, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS TERMOPHILUS MULTICOPPER OXIDASE
1146, 2yamA, 0.5712, 2.72, 0.188, 436, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (37.5-50.0 PERCENT DOSE)
1147, 5g3eA, 0.5711, 2.73, 0.188, 437, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1148, 2yapA, 0.5711, 2.73, 0.188, 437, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (62.5-75.0 PERCENT DOSE)
1149, 2yafA, 0.5711, 2.73, 0.188, 438, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (12.5-25.0 PERCENT DOSE)
1150, 2yaeA, 0.5711, 2.73, 0.188, 438, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27(0.0-12.5 PERCENT DOSE)
1151, 2xu9A, 0.5710, 2.72, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27
1152, 5k8dA, 0.5709, 2.73, 0.112, 611, 98, CRYSTAL STRUCTURE OF RFVIIIFC
1153, 5g3dA, 0.5709, 2.73, 0.188, 438, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CCASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1154, 2yarA, 0.5708, 2.73, 0.188, 436, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (87.5-100.0 PERCENT DOSE)
1155, 2yahA, 0.5708, 2.73, 0.188, 436, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (25.0-37.5 PERCENT DOSE)
1156, 6hbeB, 0.5707, 2.76, 0.111, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1157, 5k0dA, 0.5707, 2.73, 0.188, 439, 101, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 (CU(II)- CYCLOPHANES 3 MIN)
1158, 2yaqA, 0.5706, 2.73, 0.188, 436, 101, X-RAY INDUCED REDUCTION OF LACCASE FROM THERMUS THERMOPHILUS HB27 (75.0-87.5 PERCENT DOSE)
1159, 5g3hA, 0.5702, 2.74, 0.188, 438, 101, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1160, 2xuwA, 0.5696, 2.74, 0.188, 437, 101, CRYSTAL STRUCTURE OF APOLACCASE FROM THERMUS THERMOPHILUS HB27
1161, 3zx1A, 0.5694, 2.64, 0.188, 471, 101, MULTICOPPER OXIDASE FROM CAMPYLOBACTER JEJUNI: A METALLO-OXIDASE
1162, 6im7A, 0.5693, 2.68, 0.121, 461, 99, CUEO-12.1 MULTICOPPER OXIDASE 
1163, 6hbeA, 0.5693, 2.76, 0.111, 425, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1164, 6hbeC, 0.5690, 2.76, 0.111, 427, 99, CU-CONTAINING NITRITE REDUCTASE (NIRK) FROM THERMUS SCOTODUCTUS SA-01 
1165, 3pnrB, 0.5676, 4.05, 0.059, 129, 118, STRUCTURE OF PBICP-C IN COMPLEX WITH FALCIPAIN-2
1166, 6fc7C, 0.5663, 2.48, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1167, 2r7eA, 0.5653, 3.01, 0.110, 693, 100, CRYSTAL STRUCTURE ANALYSIS OF COAGULATION FACTOR VIII
1168, 5g3bA, 0.5652, 2.73, 0.190, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE: THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1169, 5o4qC, 0.5647, 2.51, 0.175, 275, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1170, 4wtqA, 0.5647, 2.46, 0.165, 270, 97, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
1171, 5o4qI, 0.5646, 2.50, 0.175, 275, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 0.25 MM COPPER SULFATE ON GROWTH MEDIUM
1172, 5g3fA, 0.5644, 2.74, 0.190, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1173, 5g3gA, 0.5643, 2.74, 0.190, 437, 100, PRESERVING METALLIC SITES AFFECTED BY RADIATION DAMAGE THE CUT2 CASE IN THERMUS THERMOPHILUS MULTICOPPER OXIDASE
1174, 6fdjL, 0.5642, 2.51, 0.175, 276, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1175, 6s0oF, 0.5634, 2.51, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1176, 6rh9I, 0.5634, 2.51, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT I170F FROM STREPTOMYCES GRISEOFLAVUS 
1177, 5o3kF, 0.5634, 2.51, 0.175, 276, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1178, 4ai7A, 0.5633, 2.75, 0.190, 437, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 2 H IN 5 MM HGCL2 AT 278 K.
1179, 1zpuB, 0.5633, 3.00, 0.147, 529, 102, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1180, 6fc7F, 0.5632, 2.51, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1181, 5o4iI, 0.5630, 2.86, 0.173, 275, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1182, 1zpuA, 0.5629, 3.00, 0.147, 529, 102, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1183, 1zpuF, 0.5628, 3.00, 0.147, 529, 102, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1184, 1zpuD, 0.5628, 3.00, 0.147, 529, 102, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1185, 5mkmF, 0.5626, 2.53, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1186, 1zpuE, 0.5626, 3.01, 0.147, 529, 102, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1187, 6fdjF, 0.5625, 2.52, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1188, 5o3kL, 0.5625, 2.53, 0.175, 276, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1189, 2xvbA, 0.5624, 2.76, 0.190, 438, 100, CRYSTAL STRUCTURE OF LACCASE FROM THERMUS THERMOPHILUS HB27 COMPLEXED WITH HG CRYSTAL OF THE APOENZYME SOAKED FOR 5 MIN. IN 5 MM HGCL2 AT 278 K.
1190, 5o3kC, 0.5623, 2.52, 0.175, 277, 97, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS WITH 1 MM COPPER SULFATE ON GROWTH MEDIUM
1191, 5mkmC, 0.5623, 2.53, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1192, 4w1tB, 0.5621, 2.52, 0.175, 269, 97, STRUCTURE OF THE SSL1 LACCASE MUTANT H99Y WITH DEPLETED TYPE-2 COPPER ION
1193, 4m3hB, 0.5621, 2.52, 0.175, 269, 97, CRYSTAL STRUCTURE OF SMALL LACCASE SSL1 FROM STREPTOMYCES SVICEUS
1194, 5lhlC, 0.5620, 2.52, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1195, 4wtqB, 0.5618, 2.52, 0.165, 269, 97, STRUCTURE OF THE SSL1 LACCASE MUTANT M295L
1196, 3tbbB, 0.5618, 2.53, 0.175, 278, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1197, 5o4iF, 0.5614, 2.88, 0.173, 277, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1198, 3tbcB, 0.5612, 2.54, 0.175, 278, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1199, 6fdjC, 0.5610, 2.89, 0.173, 275, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1200, 5mkmD, 0.5610, 2.54, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165F FROM STREPTOMYCES GRISEOFLAVUS
1201, 3tbcA, 0.5610, 2.54, 0.175, 279, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM COMPLEXED WITH ACETOVANILLONE.
1202, 5o4iH, 0.5609, 2.88, 0.173, 277, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1203, 3tbbA, 0.5609, 2.55, 0.175, 279, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A; ALTERNATE CRYSTAL FORM.
1204, 6s0oC, 0.5605, 2.54, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS PRODUCED AT 0.25 MM COPPER SULFATE IN GROWTH MEDIUM 
1205, 6fdjI, 0.5605, 2.89, 0.173, 276, 98, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1206, 5lhlF, 0.5601, 2.55, 0.175, 275, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS
1207, 5o4iL, 0.5600, 2.89, 0.173, 280, 98, CRYSTAL STRUCTURE OF MUTANT M54L/M64L/M96L OF TWO-DOMAIN LACCASE FROM STREPTOMYCES GRISEOFLAVUS DIALYZED AGAINST SOLUTION CONTAINING 0.25 MM COPPER SULFATE
1208, 6fdjJ, 0.5599, 2.56, 0.175, 277, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE MUTANT H165A FROM STREPTOMYCES GRISEOFLAVUS WITH HIGH COPPER IONS OCCUPANCY 
1209, 3aw5A, 0.5592, 3.39, 0.078, 438, 103, STRUCTURE OF A MULTICOPPER OXIDASE FROM THE HYPERTHERMOPHILIC ARCHAEON PYROBACULUM AEROPHILUM
1210, 4nb7A, 0.5590, 2.57, 0.175, 280, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 180 MIN SOAKING
1211, 4najA, 0.5588, 2.57, 0.175, 279, 97, CRYSTAL STRUCTURE OF TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AC1709 IN COMPLEX WITH AZIDE AFTER 90 MIN SOAKING
1212, 4gybA, 0.5587, 2.57, 0.175, 279, 97, TWO-DOMAIN LACCASE FROM STREPTOMYCES LIVIDANS AT 2.4 A RESOLUTION AC1709
1213, 3heiB, 0.5587, 3.31, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1214, 3tasB, 0.5586, 2.57, 0.175, 301, 97, SMALL LACCASE FROM STREPTOMYCES VIRIDOSPORUS T7A
1215, 3heiJ, 0.5565, 3.31, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1216, 3heiL, 0.5564, 3.35, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1217, 1aozA, 0.5564, 2.79, 0.113, 552, 97, REFINED CRYSTAL STRUCTURE OF ASCORBATE OXIDASE AT 1.9 ANGSTROMS RESOLUTION
1218, 4m4rF, 0.5552, 3.56, 0.018, 138, 111, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1219, 3heiN, 0.5549, 3.36, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1220, 3czuB, 0.5548, 3.42, 0.064, 130, 109, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2- EPHRIN A1 COMPLEX
1221, 3heiP, 0.5536, 3.33, 0.046, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1222, 3heiH, 0.5533, 3.38, 0.064, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1223, 1ayrA, 0.5533, 3.70, 0.045, 368, 112, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1224, 5i5jB, 0.5530, 1.53, 0.118, 529, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1225, 5i5jA, 0.5530, 1.53, 0.118, 531, 85, SHEWANELLA DENITRIFICANS NITROUS OXIDE REDUCTASE REDUCED APO FORM
1226, 4l0pB, 0.5530, 3.65, 0.044, 139, 113, STRUCTURE OF THE HUMAN EPHA3 RECEPTOR LIGAND BINDING DOMAIN COMPLEXED WITH EPHRIN-A5
1227, 3uguA, 0.5529, 3.47, 0.056, 345, 108, CRYSTAL STRUCTURE OF P44 (SPLICE VARIANT OF VISUAL ARRESTIN)
1228, 1ayrC, 0.5521, 3.71, 0.045, 368, 112, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1229, 2wo3B, 0.5517, 3.88, 0.052, 142, 115, CRYSTAL STRUCTURE OF THE EPHA4-EPHRINA2 COMPLEX
1230, 4ydjH, 0.5515, 3.71, 0.080, 238, 112, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1231, 1hfuA, 0.5515, 3.06, 0.153, 500, 98, TYPE-2 CU-DEPLETED LACCASE FROM COPRINUS CINEREUS AT 1.68 A RESOLUTION
1232, 4zrgA, 0.5513, 3.41, 0.047, 343, 107, VISUAL ARRESTIN MUTANT - R175E
1233, 3heiD, 0.5510, 3.40, 0.046, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1234, 3heiF, 0.5509, 3.39, 0.055, 132, 109, LIGAND RECOGNITION BY A-CLASS EPH RECEPTORS: CRYSTAL STRUCTURES OF THE EPHA2 LIGAND-BINDING DOMAIN AND THE EPHA2/EPHRIN-A1 COMPLEX
1235, 4m4rB, 0.5508, 3.71, 0.027, 141, 113, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1236, 3ugxC, 0.5503, 3.51, 0.046, 358, 109, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1237, 3ugxA, 0.5488, 3.70, 0.045, 369, 111, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1238, 3ppsD, 0.5480, 3.14, 0.143, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1239, 3ppsA, 0.5480, 3.14, 0.143, 564, 98, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1240, 1gw0A, 0.5480, 3.34, 0.162, 559, 99, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1241, 4m4rD, 0.5479, 3.67, 0.027, 140, 112, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1242, 1shwA, 0.5478, 3.69, 0.027, 138, 112, EPHB2 / EPHRINA5 COMPLEX STRUCTURE
1243, 1ibyA, 0.5474, 2.12, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1244, 1gw0B, 0.5474, 3.24, 0.143, 559, 98, CRYSTAL STRUCTURE OF LACCASE FROM MELANOCARPUS ALBOMYCES IN FOUR COPPER FORM
1245, 1ibyB, 0.5468, 2.17, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1246, 6f5kA, 0.5467, 3.21, 0.133, 557, 98, CRYSTAL STRUCTURE OF LACCASE FROM MYCELIOPHTHORA THERMOPHILA 
1247, 4ydjA, 0.5467, 3.67, 0.063, 238, 111, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 44- VRC13.01 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120
1248, 3fu9B, 0.5465, 3.13, 0.144, 559, 97, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (20 MIN) WITH 26- DIMETHOXYPHENOL
1249, 1ibzA, 0.5465, 2.01, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1250, 1ayrB, 0.5465, 3.36, 0.047, 363, 106, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1251, 2q9oA, 0.5464, 3.10, 0.144, 558, 97, NEAR-ATOMIC RESOLUTION STRUCTURE OF A MELANOCARPUS ALBOMYCES LACCASE
1252, 1shxA, 0.5461, 3.89, 0.035, 138, 114, EPHRIN A5 LIGAND STRUCTURE
1253, 1cf1B, 0.5460, 3.55, 0.046, 360, 109, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1254, 1ic0E, 0.5459, 2.04, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1255, 1ic0C, 0.5459, 2.03, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1256, 3ppsB, 0.5458, 3.26, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1257, 3fu7B, 0.5457, 3.26, 0.143, 559, 98, MELANOCARPUS ALBOMYCES LACCASE CRYSTAL SOAKED (4 SEC) WITH 26- DIMETHOXYPHENOL
1258, 2ih9A, 0.5457, 3.19, 0.163, 559, 98, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1259, 4jqiA, 0.5456, 3.73, 0.045, 353, 110, STRUCTURE OF ACTIVE BETA-ARRESTIN1 BOUND TO A G PROTEIN-COUPLED RECEPTOR PHOSPHOPEPTIDE
1260, 3ppsC, 0.5456, 3.26, 0.152, 564, 99, CRYSTAL STRUCTURE OF AN ASCOMYCETE FUNGAL LACCASE FROM THIELAVIA ARENARIA
1261, 2ih9B, 0.5454, 3.37, 0.162, 559, 99, A HIGH-DOSE CRYSTAL STRUCTURE OF A RECOMBINANT MELANOCARBUS ALBOMYCES LACCASE
1262, 1shxB, 0.5452, 3.91, 0.035, 138, 114, EPHRIN A5 LIGAND STRUCTURE
1263, 3mx0D, 0.5450, 3.94, 0.035, 138, 115, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1264, 1ayrD, 0.5449, 3.63, 0.037, 363, 109, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1265, 1ibzB, 0.5448, 2.24, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1266, 1ibyC, 0.5448, 2.22, 0.211, 112, 90, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1267, 1ic0D, 0.5447, 2.06, 0.213, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1268, 1cf1C, 0.5442, 3.46, 0.056, 380, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1269, 4oiiI, 0.5441, 3.67, 0.109, 217, 110, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1270, 4oiiH, 0.5441, 3.67, 0.109, 217, 110, WEST NILE VIRUS NS1 IN COMPLEX WITH NEUTRALIZING 22NS1 ANTIBODY FAB
1271, 3qpkB, 0.5441, 3.15, 0.144, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1272, 1cf1D, 0.5440, 3.54, 0.046, 368, 109, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1273, 1zpuC, 0.5438, 2.79, 0.179, 529, 95, CRYSTAL STRUCTURE OF FET3P A MULTICOPPER OXIDASE THAT FUNCTIONS IN IRON IMPORT
1274, 1ic0B, 0.5437, 2.10, 0.225, 111, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1275, 1g4mA, 0.5437, 3.61, 0.064, 356, 109, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1276, 1ibyD, 0.5435, 2.05, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1277, 2x11B, 0.5434, 3.98, 0.052, 138, 115, CRYSTAL STRUCTURE OF THE COMPLETE EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN A5 RECEPTOR BINDING DOMAIN
1278, 1hxmC, 0.5434, 3.57, 0.074, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1279, 4m4rH, 0.5433, 4.00, 0.052, 138, 115, EPHA4 ECTODOMAIN COMPLEX WITH EPHRIN A5
1280, 3qpkA, 0.5433, 3.17, 0.144, 559, 97, PROBING OXYGEN CHANNELS IN MELANOCARPUS ALBOMYCES LACCASE
1281, 3gd1C, 0.5431, 3.38, 0.075, 345, 107, STRUCTURE OF AN ARRESTIN/CLATHRIN COMPLEX REVEALS A NOVEL CLATHRIN BINDING DOMAIN THAT MODULATES RECEPTOR TRAFFICKING
1282, 2wtrB, 0.5431, 3.57, 0.073, 367, 109, FULL LENGTH ARRESTIN2
1283, 1ibzC, 0.5431, 1.91, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1284, 1cf1A, 0.5430, 3.47, 0.046, 373, 108, ARRESTIN FROM BOVINE ROD OUTER SEGMENTS
1285, 3ugxB, 0.5428, 3.56, 0.046, 352, 109, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1286, 5mqcB, 0.5427, 4.07, 0.035, 231, 113, STRUCTURE OF BLACK QUEEN CELL VIRUS
1287, 4f2fA, 0.5427, 2.01, 0.148, 100, 88, CRYSTAL STRUCTURE OF THE METAL BINDING DOMAIN (MBD) OF THE STREPTOCOCCUS PNEUMONIAE D39 CU(I) EXPORTING P-TYPE ATPASE COPA WITH CU(I)
1288, 3mx0B, 0.5426, 3.90, 0.044, 138, 114, CRYSTAL STRUCTURE OF EPHA2 ECTODOMAIN IN COMPLEX WITH EPHRIN-A5
1289, 3ehbB, 0.5425, 2.49, 0.149, 252, 94, A D-PATHWAY MUTATION DECOUPLES THE PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE BY ALTERING THE SIDE CHAIN ORIENTATION OF A DISTANT CONSERVED GLUTAMATE
1290, 1hxmE, 0.5425, 3.59, 0.074, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1291, 3mbwB, 0.5423, 3.32, 0.066, 127, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHRIN A2 LBD AND CRD DOMAINS IN COMPLEX WITH EPHRIN A1
1292, 5aooB, 0.5422, 4.14, 0.054, 314, 112, X-RAY STRUCTURE OF A HUMAN KOBUVIRUS: AICHI VIRUS A (AIV)
1293, 1ic0F, 0.5422, 1.91, 0.205, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1294, 1hxmG, 0.5421, 3.59, 0.074, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1295, 6dzrL, 0.5420, 3.46, 0.120, 218, 108, CRYSTAL STRUCTURE OF H38C2 K99R MUTATION 
1296, 1g4mB, 0.5419, 3.52, 0.074, 357, 108, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1297, 1ar1B, 0.5419, 2.51, 0.149, 252, 94, STRUCTURE AT 2.7 ANGSTROM RESOLUTION OF THE PARACOCCUS DENITRIFICANS TWO-SUBUNIT CYTOCHROME C OXIDASE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1298, 1sujA, 0.5417, 3.49, 0.056, 363, 107, X-RAY CRYSTAL STRUCTURE OF AMBYSTOMA TIGRINUM CONE ARRESTIN
1299, 3hb3B, 0.5416, 2.50, 0.149, 252, 94, HIGH RESOLUTION CRYSTAL STRUCTURE OF PARACOCCUS DENITRIFICANS CYTOCHROME C OXIDASE
1300, 1ibzD, 0.5415, 2.09, 0.213, 112, 89, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1301, 3ugxD, 0.5412, 3.59, 0.046, 348, 109, CRYSTAL STRUCTURE OF VISUAL ARRESTIN
1302, 1hxmA, 0.5412, 3.60, 0.074, 206, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1303, 5mv5B, 0.5407, 4.12, 0.045, 250, 112, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
1304, 4w9zA, 0.5406, 2.54, 0.128, 138, 94, CRYSTAL STRUCTURE OF THE PERIPLASMIC DOMAIN OF SUBUNIT II OF CYTOCHROME OXIDASE (COXB) OF BRADYRHIZOBIUM JAPONICUM
1305, 4j2qB, 0.5405, 3.65, 0.064, 346, 109, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1306, 6ci0D, 0.5400, 2.54, 0.106, 257, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1307, 5l8qB, 0.5399, 4.14, 0.045, 250, 112, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
1308, 4j2qA, 0.5399, 3.69, 0.055, 340, 109, CRYSTAL STRUCTURE OF C-TERMINALLY TRUNCATED ARRESTIN REVEALS MECHANISM OF ARRESTIN ACTIVATION
1309, 1ngqH, 0.5397, 3.67, 0.118, 215, 110, N1G9 (IGG1-LAMBDA) FAB FRAGMENT
1310, 3omiD, 0.5396, 2.55, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1311, 5lvcb, 0.5392, 3.97, 0.055, 289, 110, AICHI VIRUS 1: EMPTY PARTICLE
1312, 3dtuD, 0.5392, 2.55, 0.106, 258, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1313, 2oslH, 0.5392, 3.69, 0.100, 224, 110, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1314, 3omnD, 0.5391, 2.55, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1315, 3omiB, 0.5390, 2.56, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION
1316, 3om3D, 0.5390, 2.55, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1317, 3omaD, 0.5389, 2.55, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1318, 3fyeD, 0.5389, 2.55, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1319, 1qleB, 0.5389, 2.52, 0.149, 252, 94, CRYO-STRUCTURE OF THE PARACOCCUS DENITRIFICANS FOUR-SUBUNIT CYTOCHROME C OXIDASE IN THE COMPLETELY OXIDIZED STATE COMPLEXED WITH AN ANTIBODY FV FRAGMENT
1320, 5mupB, 0.5388, 4.15, 0.045, 248, 112, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
1321, 3omnB, 0.5388, 2.56, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH D132A MUTATION IN THE REDUCED STATE
1322, 3om3B, 0.5388, 2.56, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION IN THE REDUCED STATE
1323, 3fyeB, 0.5388, 2.56, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1324, 2gsmD, 0.5388, 2.55, 0.106, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1325, 3omaB, 0.5387, 2.57, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH K362M MUTATION
1326, 2gsmB, 0.5386, 2.56, 0.106, 256, 94, CATALYTIC CORE (SUBUNITS I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES
1327, 4yhkH, 0.5385, 3.73, 0.100, 222, 110, REVERSAL AGENT FOR DABIGATRAN
1328, 3fyiD, 0.5385, 2.56, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1329, 3fyiB, 0.5384, 2.57, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE BOUND WITH CYANIDE
1330, 1g4rA, 0.5384, 3.84, 0.072, 353, 111, CRYSTAL STRUCTURE OF BOVINE BETA-ARRESTIN 1
1331, 6ci0B, 0.5383, 2.57, 0.106, 256, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES WITH E101A (II) MUTATION 
1332, 1ic0A, 0.5383, 2.04, 0.216, 110, 88, RED COPPER PROTEIN NITROSOCYANIN FROM NITROSOMONAS EUROPAEA
1333, 2y06H, 0.5381, 3.68, 0.100, 215, 110, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE GDPRPSYISHLL
1334, 3dtuB, 0.5378, 2.58, 0.106, 259, 94, CATALYTIC CORE SUBUNITS (I AND II) OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES COMPLEXED WITH DEOXYCHOLIC ACID
1335, 4yhdG, 0.5377, 4.00, 0.071, 281, 113, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1336, 2oslA, 0.5373, 3.72, 0.100, 221, 110, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
1337, 3m4eG, 0.5372, 4.04, 0.070, 293, 114, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
1338, 4zsoB, 0.5371, 3.71, 0.091, 218, 110, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1339, 2y07H, 0.5371, 3.72, 0.109, 215, 110, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL) -ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE PPYPAWHAPGNI
1340, 2vl5C, 0.5371, 3.76, 0.118, 218, 110, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
1341, 1ngpH, 0.5371, 3.69, 0.118, 215, 110, N1G9 (IGG1-LAMBDA) FAB FRAGMENT COMPLEXED WITH (4-HYDROXY-3- NITROPHENYL) ACETATE
1342, 5lk8B, 0.5370, 4.13, 0.036, 215, 111, SINGLE PARTICLE RECONSTRUCTION OF SLOW BEE PARALYSIS VIRUS EMPTY PARTICLE
1343, 5l7oB, 0.5370, 4.26, 0.026, 179, 115, X-RAY STRUCTURE OF TRIATOMA VIRUS EMPTY CAPSID
1344, 4m43H, 0.5369, 3.74, 0.091, 219, 110, CRYSTAL STRUCTURE OF ANTI-RABIES GLYCOPROTEIN FAB 523-11
1345, 3napB, 0.5369, 4.30, 0.035, 247, 115, STRUCTURE OF TRIATOMA VIRUS (TRV)
1346, 6aniI, 0.5368, 3.70, 0.100, 214, 110, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1347, 3p2dA, 0.5368, 3.98, 0.062, 354, 113, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1348, 4etqA, 0.5367, 3.70, 0.100, 217, 110, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
1349, 5whzH, 0.5366, 3.64, 0.064, 341, 110, PGDM1400-10E8V4 CODV FAB
1350, 2y36H, 0.5366, 3.68, 0.109, 215, 110, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)- ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE DLWTTAIPTIPS
1351, 5w0pA, 0.5365, 3.86, 0.036, 847, 112, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1352, 5lsfB, 0.5362, 4.03, 0.027, 239, 110, SACBROOD HONEYBEE VIRUS 
1353, 4a6yH, 0.5362, 3.72, 0.099, 215, 111, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1354, 1m56B, 0.5361, 2.63, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1355, 5wehB, 0.5360, 2.59, 0.106, 254, 94, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1356, 5tv1A, 0.5360, 3.69, 0.045, 337, 110, ACTIVE ARRESTIN-3 WITH INOSITOL HEXAKISPHOSPHATE
1357, 5w0pC, 0.5359, 3.87, 0.036, 849, 112, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1358, 5d8jH, 0.5359, 3.75, 0.127, 216, 110, DEVELOPMENT OF A THERAPEUTIC MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT TYPE 2 DIABETES.
1359, 5mv6B, 0.5357, 4.07, 0.045, 249, 111, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
1360, 5w0pB, 0.5356, 3.91, 0.036, 802, 112, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN DETERMINED BY X-RAY FREE ELECTRON LASER
1361, 5epmA, 0.5356, 3.69, 0.092, 218, 109, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1362, 3ulvF, 0.5356, 3.83, 0.108, 217, 111, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
1363, 3l5wA, 0.5356, 3.45, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
1364, 4yhdD, 0.5355, 3.99, 0.071, 282, 113, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1365, 3m3rB, 0.5355, 4.01, 0.071, 293, 113, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
1366, 7ahlA, 0.5354, 3.98, 0.071, 293, 113, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1367, 7ahlF, 0.5353, 3.98, 0.071, 293, 113, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1368, 5j98B, 0.5353, 4.09, 0.036, 260, 111, CRYSTAL STRUCTURE OF SLOW BEE PARALYSIS VIRUS AT 2.6A RESOLUTION
1369, 4yhdA, 0.5353, 4.02, 0.071, 281, 113, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1370, 5t5fH, 0.5352, 3.78, 0.118, 212, 110, NEISSERIA MENINGITIDIS FACTOR H BINDING PROTEIN IN COMPLEX WITH MONOCLONAL ANTIBODY JAR5
1371, 4m62M, 0.5352, 3.48, 0.104, 113, 106, ONTOGENY OF RECOGNITION SPECIFICITY AND FUNCTIONALITY FOR THE ANTI-HIV NEUTRALIZING ANTIBODY 4E10
1372, 2xzqH, 0.5351, 3.68, 0.109, 215, 110, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE MONOCLONAL ANTIBODY BBE6.12H3 FAB FRAGMENT IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE YQLRPNAETLRF
1373, 1m56H, 0.5351, 2.64, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTOR SPHAEROIDES (WILD TYPE)
1374, 4p24E, 0.5349, 4.07, 0.070, 291, 114, PORE FORMING TOXIN
1375, 3rifJ, 0.5348, 3.70, 0.082, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1376, 3rifG, 0.5348, 3.70, 0.082, 214, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1377, 2wtrA, 0.5348, 4.08, 0.071, 356, 113, FULL LENGTH ARRESTIN2
1378, 7ahlE, 0.5347, 3.96, 0.062, 293, 112, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1379, 5yslA, 0.5347, 3.65, 0.083, 211, 109, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1380, 5nhrB, 0.5347, 3.33, 0.125, 114, 104, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
1381, 4bcuA, 0.5347, 4.76, 0.041, 188, 123, SATELLITE TOBACCO NECROSIS VIRUS (STNV) VIRUS LIKE PARTICLE IN COMPLEX WITH THE B3 APTAMER
1382, 3m2lB, 0.5347, 4.00, 0.071, 293, 113, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1383, 1m57B, 0.5347, 2.64, 0.106, 260, 94, STRUCTURE OF CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES (EQ(I-286) MUTANT))
1384, 5oypB, 0.5346, 4.05, 0.027, 239, 110, SACBROOD VIRUS OF HONEYBEE 
1385, 4v4mC, 0.5346, 4.75, 0.041, 184, 123, 
1386, 4ak2A, 0.5346, 4.76, 0.049, 184, 123, STRUCTURE OF BT4661 A SUSE-LIKE SURFACE LOCATED POLYSACCHARIDE BINDING PROTEIN FROM THE BACTEROIDES THETAIOTAOMICRON HEPARIN UTILISATION LOCUS
1387, 6aniH, 0.5345, 4.77, 0.049, 184, 123, COLTUXIMAB FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
1388, 3rifH, 0.5345, 4.66, 0.025, 286, 122, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1389, 3ri5G, 0.5345, 3.77, 0.100, 216, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1390, 1s5hB, 0.5345, 3.70, 0.082, 221, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
1391, 4v4mA, 0.5344, 3.70, 0.082, 200, 110, 
1392, 3ri5J, 0.5344, 3.84, 0.099, 219, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1393, 1afvH, 0.5344, 4.82, 0.040, 184, 124, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1394, 5dgyD, 0.5343, 4.76, 0.041, 184, 123, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1395, 5dgyA, 0.5343, 4.62, 0.041, 184, 121, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1396, 4zwjD, 0.5343, 3.70, 0.082, 215, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1397, 4zwjA, 0.5343, 3.71, 0.109, 220, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1398, 4v4mUA, 0.5343, 3.99, 0.027, 833, 112, 
1399, 4v4mT, 0.5343, 3.85, 0.027, 833, 111, 
1400, 4v4mRA, 0.5343, 3.99, 0.027, 833, 112, 
1401, 4v4mPA, 0.5343, 3.85, 0.027, 833, 111, 
1402, 4v4mB, 0.5343, 4.76, 0.041, 184, 123, 
1403, 4amkH, 0.5343, 4.76, 0.041, 184, 123, FAB FRAGMENT OF ANTIPORPHRIN ANTIBODY 13G10
1404, 3or7A, 0.5343, 4.77, 0.041, 184, 123, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
1405, 3m2lF, 0.5343, 4.76, 0.041, 184, 123, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
1406, 1oaxJ, 0.5343, 4.76, 0.041, 184, 123, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1407, 1n7mL, 0.5343, 4.76, 0.041, 184, 123, GERMLINE 7G12 WITH N-METHYLMESOPORPHYRIN
1408, 5wehH, 0.5342, 4.69, 0.041, 184, 122, CYTOCHROME C OXIDASE FROM RHODOBACTER SPHAEROIDES IN THE REDUCED STATE
1409, 5um8D, 0.5342, 4.64, 0.058, 184, 121, CRYSTAL STRUCTURE OF HIV-1 ENVELOPE TRIMER 16055 NFL TD CC (T569G) IN COMPLEX WITH FABS 35022 AND PGT124
1410, 4v4mP, 0.5342, 3.52, 0.093, 215, 107, 
1411, 4v4mMA, 0.5342, 3.85, 0.099, 219, 111, 
1412, 4v4mDB, 0.5342, 3.99, 0.071, 293, 113, 
1413, 3ri5H, 0.5342, 3.66, 0.109, 122, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1414, 5ec2A, 0.5341, 3.74, 0.091, 216, 110, KCSA WITH V76ESTER+G77DA MUTATIONS
1415, 4v4mM, 0.5341, 2.62, 0.106, 253, 94, 
1416, 4v4mHA, 0.5341, 3.63, 0.101, 240, 109, 
1417, 4r97C, 0.5341, 4.76, 0.041, 184, 123, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
1418, 4ak1A, 0.5341, 4.76, 0.041, 184, 123, STRUCTURE OF BT4661 A SUSE-LIKE SURFACE LOCATED POLYSACCHARIDE BINDING PROTEIN FROM THE BACTEROIDES THETAIOTAOMICRON HEPARIN UTILISATION LOCUS
1419, 2op4H, 0.5341, 4.76, 0.041, 184, 123, CRYSTAL STRUCTURE OF QUORUM-QUENCHING ANTIBODY 1G9
1420, 1oarJ, 0.5341, 4.76, 0.041, 184, 123, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1421, 1oarH, 0.5341, 3.71, 0.082, 221, 110, FV IGE SPE-7 IN COMPLEX WITH ALIZARIN RED
1422, 1iqwH, 0.5341, 3.81, 0.100, 219, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
1423, 7ahlB, 0.5340, 4.76, 0.041, 184, 123, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1424, 6by3A, 0.5340, 4.76, 0.041, 184, 123, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
1425, 4v4mSA, 0.5340, 4.76, 0.041, 184, 123, 
1426, 4v4mR, 0.5340, 3.69, 0.092, 218, 109, 
1427, 4v4mL, 0.5340, 4.63, 0.025, 600, 122, 
1428, 3p2dB, 0.5340, 3.76, 0.100, 217, 110, CRYSTAL STRUCTURE OF ARRESTIN-3 REVEALS THE BASIS OF THE DIFFERENCE IN RECEPTOR BINDING BETWEEN TWO NON-VISUAL SUBTYPES
1429, 1afvK, 0.5340, 3.66, 0.109, 122, 110, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
1430, 3rifI, 0.5339, 3.66, 0.109, 122, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1431, 3rifF, 0.5339, 3.74, 0.100, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND GLUTAMATE.
1432, 3rhwG, 0.5339, 3.97, 0.071, 293, 113, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1433, 7ahlC, 0.5338, 3.92, 0.099, 219, 111, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
1434, 5vkhA, 0.5338, 4.76, 0.041, 184, 123, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
1435, 5epmE, 0.5338, 4.76, 0.041, 184, 123, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
1436, 5eblA, 0.5338, 4.76, 0.041, 184, 123, KCSA T75G IN THE CONDUCTIVE STATE
1437, 4v4mZ, 0.5338, 4.77, 0.041, 184, 123, 
1438, 4v4mNA, 0.5338, 4.69, 0.049, 184, 122, 
1439, 4v4mJ, 0.5338, 4.01, 0.062, 352, 113, 
1440, 3riaJ, 0.5338, 3.71, 0.109, 220, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1441, 3riaG, 0.5338, 3.72, 0.082, 192, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1442, 3ri5F, 0.5338, 3.73, 0.082, 171, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1443, 3rhwJ, 0.5338, 3.71, 0.082, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1444, 1oaxH, 0.5338, 3.99, 0.071, 293, 113, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH ACENAPHTHENEQUINONE
1445, 1nmaH, 0.5338, 3.84, 0.099, 219, 111, N9 NEURAMINIDASE COMPLEXES WITH ANTIBODIES NC41 AND NC10: EMPIRICAL FREE-ENERGY CALCULATIONS CAPTURE SPECIFICITY TRENDS OBSERVED WITH MUTANT BINDING DATA
1446, 5tkjJ, 0.5337, 3.70, 0.092, 218, 109, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1447, 5l7qB, 0.5337, 3.81, 0.100, 219, 110, STRUCTURE OF DEFORMED WING VIRUS A HONEYBEE PATHOGEN
1448, 5h2bA, 0.5337, 4.76, 0.041, 184, 123, STRUCTURE OF A NOVEL ANTIBODY G196
1449, 5cddC, 0.5337, 4.77, 0.041, 184, 123, CRYSTAL STRUCTURE OF ISRAEL ACUTE PARALYSIS VIRUS PENTAMER
1450, 4v4mW, 0.5337, 4.77, 0.041, 184, 123, 
1451, 4v4mN, 0.5337, 4.76, 0.049, 184, 123, 
1452, 4a6yB, 0.5337, 4.70, 0.049, 184, 122, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-(4-HYDROXY-3- NITROPHENYL)-ACETYL MURINE GERMLINE ANTIBODY BBE6.12H3
1453, 3s4gA, 0.5337, 3.71, 0.082, 215, 110, LOW RESOLUTION STRUCTURE OF STNV COMPLEXED WITH RNA
1454, 3ri5I, 0.5337, 3.71, 0.082, 200, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND PICROTOXIN
1455, 2ygtA, 0.5337, 3.73, 0.082, 188, 110, CLOSTRIDIUM PERFRINGENS DELTA-TOXIN
1456, 2ntfB, 0.5337, 3.71, 0.082, 215, 110, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1457, 1oazH, 0.5337, 3.66, 0.109, 122, 110, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1458, 1oauJ, 0.5337, 3.61, 0.083, 122, 108, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1459, 1oauH, 0.5337, 3.75, 0.108, 211, 111, FV STRUCTURE OF THE IGE SPE-7 IN COMPLEX WITH DNP-SER (IMMUNISING HAPTEN)
1460, 5dgyC, 0.5336, 4.22, 0.045, 250, 112, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1461, 4zwjC, 0.5336, 3.76, 0.100, 216, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1462, 4v4mX, 0.5336, 3.93, 0.036, 200, 111, 
1463, 4v4mI, 0.5336, 4.76, 0.049, 184, 123, 
1464, 4v4mHB, 0.5336, 4.76, 0.041, 184, 123, 
1465, 4u6vB, 0.5336, 4.77, 0.041, 184, 123, MECHANISMS OF NEUTRALIZATION OF A HUMAN ANTI-ALPHA TOXIN ANTIBODY
1466, 1oayH, 0.5336, 4.76, 0.041, 184, 123, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1467, 6admB, 0.5335, 3.68, 0.100, 214, 110, ANTHRAX TOXIN RECEPTOR 1-BOUND FULL PARTICLES OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
1468, 4v4mO, 0.5335, 4.76, 0.049, 184, 123, 
1469, 4v4mH, 0.5335, 3.72, 0.082, 199, 110, 
1470, 4v4mGB, 0.5335, 3.96, 0.108, 282, 111, 
1471, 4v4mAA, 0.5335, 3.72, 0.091, 222, 110, 
1472, 4al8H, 0.5335, 3.67, 0.109, 122, 110, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
1473, 3bj91, 0.5335, 3.67, 0.109, 122, 110, CRYSTAL STRUCTURE OF THE SURROGATE LIGHT CHAIN VARIABLE DOMAIN VPREBJ
1474, 1oazJ, 0.5335, 3.67, 0.109, 122, 110, IGE FV SPE7 COMPLEXED WITH A RECOMBINANT THIOREDOXIN
1475, 1oayJ, 0.5335, 3.81, 0.027, 789, 111, ANTIBODY MULTISPECIFICITY MEDIATED BY CONFORMATIONAL DIVERSITY
1476, 4v4mZA, 0.5334, 3.81, 0.027, 789, 111, 
1477, 3riaH, 0.5334, 4.69, 0.041, 184, 122, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1478, 3rhwH, 0.5334, 4.77, 0.049, 184, 123, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1479, 4v4mYA, 0.5333, 4.77, 0.041, 184, 123, 
1480, 4v4mWA, 0.5333, 4.69, 0.041, 184, 122, 
1481, 4v4mV, 0.5333, 4.77, 0.041, 184, 123, 
1482, 4v4mFB, 0.5333, 4.08, 0.070, 272, 114, 
1483, 4v4mEB, 0.5333, 3.60, 0.110, 121, 109, 
1484, 4v4mE, 0.5333, 4.29, 0.054, 267, 112, 
1485, 4u6hA, 0.5333, 4.76, 0.049, 184, 123, VACCINIA L1/M12B9-FAB COMPLEX
1486, 1r3kB, 0.5333, 4.65, 0.050, 184, 121, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
1487, 1e4wH, 0.5333, 4.76, 0.041, 184, 123, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1488, 6fn1C, 0.5332, 4.77, 0.041, 184, 123, ZOSUQUIDAR AND UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
1489, 5yslC, 0.5332, 4.77, 0.049, 184, 123, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1490, 4v4mU, 0.5332, 4.76, 0.041, 184, 123, 
1491, 4v4mS, 0.5332, 4.76, 0.041, 184, 123, 
1492, 4v4mCA, 0.5332, 3.77, 0.091, 212, 110, 
1493, 3fb8A, 0.5332, 3.70, 0.139, 116, 108, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
1494, 3fb6A, 0.5332, 3.68, 0.109, 122, 110, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
1495, 3f7yA, 0.5332, 3.60, 0.110, 121, 109, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
1496, 3f5wA, 0.5332, 4.77, 0.041, 184, 123, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
1497, 1zshA, 0.5332, 3.72, 0.082, 221, 110, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2 IN COMPLEX WITH INOSITOL HEXAKISPHOSPHATE (IP6)
1498, 1k4cA, 0.5332, 3.72, 0.082, 221, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
1499, 4v4mLA, 0.5331, 4.76, 0.049, 184, 123, 
1500, 4v4mDA, 0.5331, 4.76, 0.041, 184, 123, 
1501, 4v4mCB, 0.5331, 4.76, 0.041, 184, 123, 
1502, 4etqH, 0.5331, 4.77, 0.049, 184, 123, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
1503, 3stlA, 0.5331, 4.77, 0.041, 184, 123, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
1504, 2nljB, 0.5331, 4.76, 0.041, 184, 123, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
1505, 1r3iH, 0.5331, 4.76, 0.041, 184, 123, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
1506, 6egvB, 0.5330, 4.77, 0.049, 184, 123, SACBROOD VIRUS OF HONEYBEE 
1507, 5j9pA, 0.5330, 4.76, 0.041, 184, 123, KCSA IN VITRO
1508, 4v4mXA, 0.5330, 3.73, 0.082, 217, 110, 
1509, 4v4mVA, 0.5330, 3.87, 0.099, 219, 111, 
1510, 4v4mEA, 0.5330, 3.73, 0.109, 213, 110, 
1511, 4u6hC, 0.5330, 3.76, 0.100, 225, 110, VACCINIA L1/M12B9-FAB COMPLEX
1512, 3riaI, 0.5330, 3.64, 0.083, 210, 108, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1513, 3riaF, 0.5330, 4.76, 0.041, 184, 123, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IVERMECTIN AND IODIDE.
1514, 3rhwI, 0.5330, 4.76, 0.049, 184, 123, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1515, 3rhwF, 0.5330, 4.76, 0.041, 184, 123, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND IVERMECTIN
1516, 1k4dA, 0.5330, 4.76, 0.041, 184, 123, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
1517, 6igtC, 0.5329, 4.76, 0.049, 184, 123, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
1518, 5tkjA, 0.5329, 3.84, 0.099, 219, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1519, 5lk7B, 0.5329, 3.84, 0.099, 219, 111, SINGLE PARTICLE RECONSTRUCTION OF SLOW BEE PARALYSIS VIRUS VIRION AT PH 5.5
1520, 5ebmA, 0.5329, 3.84, 0.099, 219, 111, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
1521, 4v4mTA, 0.5329, 3.84, 0.099, 219, 111, 
1522, 4v4mK, 0.5329, 3.82, 0.081, 354, 111, 
1523, 4v4mGA, 0.5329, 3.84, 0.099, 219, 111, 
1524, 4f2eA, 0.5329, 4.69, 0.049, 184, 122, CRYSTAL STRUCTURE OF THE STREPTOCOCCUS PNEUMONIAE D39 COPPER CHAPERONE CUPA WITH CU(I)
1525, 2ntfH, 0.5329, 4.77, 0.041, 184, 123, CRYSTAL STRUCTURE OF A QUORUM-QUENCHING ANTIBODY IN COMPLEX WITH AN N- ACYL-L-HOMOSERINE LACTONE ANALOG
1526, 2itcA, 0.5329, 4.77, 0.049, 184, 123, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
1527, 2bukA, 0.5329, 3.73, 0.091, 215, 110, SATELLITE TOBACCO NECROSIS VIRUS
1528, 1r3jB, 0.5329, 3.86, 0.099, 219, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
1529, 1fbiH, 0.5329, 3.87, 0.099, 218, 111, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
1530, 6mxrB, 0.5328, 3.85, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
1531, 6b5rL, 0.5328, 4.06, 0.045, 239, 110, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1532, 5tkjD, 0.5328, 3.88, 0.099, 219, 111, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1533, 4v4mBB, 0.5328, 4.77, 0.049, 184, 123, 
1534, 3qpqH, 0.5328, 4.77, 0.049, 184, 123, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1535, 6eiwB, 0.5327, 4.76, 0.041, 184, 123, SACBROOD VIRUS OF HONEYBEE EMPTY PARTICLE 
1536, 5vkeA, 0.5327, 3.67, 0.083, 217, 109, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
1537, 5tkjG, 0.5327, 3.73, 0.082, 199, 110, STRUCTURE OF VACCINE-ELICITED DIVERSE HIV-1 NEUTRALIZING ANTIBODY VFP1.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519
1538, 5cdcC, 0.5327, 3.74, 0.082, 191, 110, CRYSTAL STRUCTURE OF ISRAEL ACUTE PARALYSIS VIRUS
1539, 4v4mJA, 0.5327, 3.73, 0.082, 199, 110, 
1540, 4tnwY, 0.5327, 3.74, 0.082, 191, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1541, 4tnvV, 0.5327, 3.86, 0.099, 219, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1542, 4mswA, 0.5327, 3.75, 0.109, 116, 110, Y78 ESTER MUTANT OF KCSA IN HIGH K+
1543, 2hg5A, 0.5327, 3.74, 0.108, 211, 111, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1544, 1ahwE, 0.5327, 4.22, 0.036, 252, 112, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1545, 6dc9L, 0.5326, 3.86, 0.099, 218, 111, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1546, 4v4mQA, 0.5326, 4.77, 0.041, 184, 123, 
1547, 4v4mFA, 0.5326, 4.77, 0.049, 184, 123, 
1548, 4tnvJ, 0.5326, 4.69, 0.041, 184, 122, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1549, 4aehH, 0.5326, 4.77, 0.049, 184, 123, CRYSTAL STRUCTURE OF THE ANTI-AAHI FAB9C2 ANTIBODY
1550, 3b9kF, 0.5326, 2.04, 0.161, 98, 87, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1551, 2d7tL, 0.5326, 3.73, 0.091, 222, 110, CRYSTAL STRUCTURE OF HUMAN ANTI POLYHYDROXYBUTYRATE ANTIBODY FV
1552, 1r3lB, 0.5326, 3.84, 0.099, 219, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
1553, 6gv4A, 0.5325, 4.71, 0.041, 184, 122, HIGH-RESOLUTION CRYO-EM OF FAB-LABELED HUMAN PARECHOVIRUS 3 
1554, 6f5jB, 0.5325, 3.86, 0.099, 219, 111, STRUCTURE OF DEFORMED WING VIRUS CARRYING THE GFP GENE 
1555, 4v4mIA, 0.5325, 3.81, 0.089, 221, 112, 
1556, 4v4mD, 0.5325, 3.54, 0.102, 217, 108, 
1557, 4uujA, 0.5325, 3.59, 0.112, 212, 107, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
1558, 4tnwG, 0.5325, 3.75, 0.108, 211, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1559, 4tnvY, 0.5325, 4.69, 0.041, 184, 122, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1560, 4tnvW, 0.5325, 3.67, 0.110, 215, 109, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1561, 3wihH, 0.5325, 4.07, 0.027, 199, 110, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
1562, 3b9kB, 0.5325, 3.94, 0.099, 219, 111, CRYSTAL STRUCTURE OF CD8ALPHA-BETA IN COMPLEX WITH YTS 156.7 FAB
1563, 3anza, 0.5325, 3.75, 0.108, 208, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1564, 3anzX, 0.5325, 3.98, 0.036, 243, 111, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1565, 2h8pA, 0.5325, 4.70, 0.049, 184, 122, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1566, 1nmbH, 0.5325, 3.72, 0.082, 221, 110, THE STRUCTURE OF A COMPLEX BETWEEN THE NC10 ANTIBODY AND INFLUENZA VIRUS NEURAMINIDASE AND COMPARISON WITH THE OVERLAPPING BINDING SITE OF THE NC41 ANTIBODY
1567, 6mxsB, 0.5324, 3.71, 0.082, 224, 110, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
1568, 5fhxH, 0.5324, 3.86, 0.099, 219, 111, CRYSTAL STRUCTURE OF CODV IN COMPLEX WITH IL4 AT 2.55 ANG. RESOLUTION.
1569, 4tnwH, 0.5324, 3.87, 0.099, 219, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1570, 4tnvU, 0.5324, 3.76, 0.100, 214, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1571, 3n9gL, 0.5324, 3.48, 0.094, 215, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE HUMAN NEUTRALIZING ANTI- WEST NILE VIRUS MAB CR4354
1572, 3anzJ, 0.5324, 4.77, 0.041, 184, 123, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1573, 5ebwA, 0.5323, 4.97, 0.056, 184, 125, KCSA WITH G77ESTER MUTATION
1574, 4v4mG, 0.5323, 3.72, 0.082, 223, 110, 
1575, 4tnvH, 0.5323, 3.76, 0.109, 219, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1576, 3uluF, 0.5323, 3.64, 0.092, 117, 109, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
1577, 3anzW, 0.5323, 3.47, 0.113, 110, 106, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
1578, 2itdA, 0.5323, 3.87, 0.099, 219, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
1579, 2ih1A, 0.5323, 3.96, 0.064, 256, 109, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1580, 2hfeA, 0.5323, 4.20, 0.045, 249, 112, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
1581, 1jsyA, 0.5323, 4.69, 0.041, 184, 122, CRYSTAL STRUCTURE OF BOVINE ARRESTIN-2
1582, 6adsB, 0.5322, 4.76, 0.041, 184, 123, STRUCTURE OF SENECA VALLEY VIRUS IN ACIDIC CONDITIONS 
1583, 4v4mY, 0.5322, 4.77, 0.041, 184, 123, 
1584, 4v4mF, 0.5322, 4.77, 0.049, 184, 123, 
1585, 4uihF, 0.5322, 3.87, 0.099, 219, 111, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
1586, 4uifI, 0.5322, 3.72, 0.082, 222, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
1587, 4tnvX, 0.5322, 3.72, 0.082, 221, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1588, 4tnvI, 0.5322, 3.73, 0.082, 224, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1589, 4tnvF, 0.5322, 3.76, 0.136, 219, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1590, 2p7tA, 0.5322, 3.64, 0.092, 117, 109, CRYSTAL STRUCTURE OF KCSA MUTANT
1591, 2hvkA, 0.5322, 3.99, 0.071, 294, 113, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
1592, 2g60H, 0.5322, 3.99, 0.071, 294, 113, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
1593, 2dweA, 0.5322, 3.86, 0.099, 219, 111, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
1594, 1za3A, 0.5322, 3.59, 0.083, 122, 108, THE CRYSTAL STRUCTURE OF THE YSD1 FAB BOUND TO DR5
1595, 1nezG, 0.5322, 3.54, 0.102, 217, 108, THE CRYSTAL STRUCTURE OF A TL/CD8AA COMPLEX AT 2.1A RESOLUTION:IMPLICATIONS FOR MEMORY T CELL GENERATION CO-RECEPTOR PREFERENCE AND AFFINITY
1596, 6igtD, 0.5321, 3.58, 0.093, 340, 108, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
1597, 6igtA, 0.5321, 3.71, 0.082, 223, 110, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
1598, 6h5nE, 0.5321, 3.72, 0.082, 221, 110, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
1599, 5g52B, 0.5321, 3.42, 0.135, 220, 104, CRYSTALLOGRAPHIC STRUCTURE OF FULL PARTICLE OF DEFORMED WING VIRUS
1600, 3stzA, 0.5321, 3.99, 0.071, 294, 113, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
1601, 3mxvH, 0.5321, 3.84, 0.100, 218, 110, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
1602, 6rcuB, 0.5320, 4.76, 0.041, 184, 123, PFRH5 BOUND TO MONOCLONAL ANTIBODIES R5.004 AND R5.016 
1603, 6be2L, 0.5320, 4.77, 0.049, 184, 123, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598)
1604, 3ujtH, 0.5320, 4.69, 0.049, 184, 122, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
1605, 1e4xH, 0.5320, 3.72, 0.082, 223, 110, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1606, 1a6wH, 0.5320, 3.87, 0.108, 217, 111, B1-8 FV FRAGMENT COMPLEXED WITH A (4-HYDROXY-5-IODO-3- NITROPHENYL) ACETATE COMPOUND
1607, 4v4mBA, 0.5319, 3.99, 0.071, 294, 113, 
1608, 3f7vA, 0.5319, 3.87, 0.099, 219, 111, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
1609, 6dcaI, 0.5318, 3.86, 0.099, 219, 111, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
1610, 6be4L, 0.5318, 3.87, 0.099, 219, 111, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH NONA-N-ACETYL-D-GLUCOSAMINE (9NAC)
1611, 4zsoD, 0.5318, 3.81, 0.081, 358, 111, CRYSTAL STRUCTURE OF A COMPLEX BETWEEN B7-H6 A TUMOR CELL LIGAND FOR NATURAL CYTOTOXICITY RECEPTOR NKP30 AND AN INHIBITORY ANTIBODY
1612, 4v4mQ, 0.5318, 4.28, 0.054, 254, 112, 
1613, 4v4mAB, 0.5318, 4.76, 0.049, 184, 123, 
1614, 4tnwX, 0.5318, 4.64, 0.050, 184, 121, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1615, 4tnwW, 0.5318, 4.77, 0.041, 184, 123, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1616, 3wihI, 0.5318, 4.97, 0.056, 184, 125, CRYSTAL STRUCTURE OF THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B2212A.
1617, 3qpqJ, 0.5318, 4.69, 0.041, 184, 122, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1618, 3gb7A, 0.5318, 3.58, 0.065, 120, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
1619, 3fb7A, 0.5318, 3.58, 0.065, 120, 107, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
1620, 3fb5A, 0.5318, 3.72, 0.082, 224, 110, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
1621, 3cvhH, 0.5318, 3.72, 0.082, 222, 110, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
1622, 6my4L, 0.5317, 3.72, 0.082, 222, 110, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
1623, 5vk6A, 0.5317, 3.86, 0.099, 219, 111, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
1624, 5ihzF, 0.5317, 3.82, 0.100, 219, 110, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
1625, 4v4mKA, 0.5317, 3.77, 0.091, 208, 110, 
1626, 4tnwI, 0.5317, 3.86, 0.099, 219, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1627, 1xcqD, 0.5317, 3.53, 0.084, 213, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
1628, 1rjlB, 0.5317, 3.82, 0.135, 122, 111, STRUCTURE OF THE COMPLEX BETWEEN OSPB-CT AND BACTERICIDAL FAB-H6831
1629, 4tnvG, 0.5316, 3.77, 0.109, 116, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB IN A NON-CONDUCTING CONFORMATION
1630, 4lcuA, 0.5316, 3.77, 0.109, 117, 110, STRUCTURE OF KCSA WITH E118A MUTATION
1631, 4ebqH, 0.5316, 3.69, 0.130, 212, 108, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
1632, 3or6A, 0.5316, 4.22, 0.045, 250, 112, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
1633, 2bocA, 0.5316, 3.81, 0.100, 219, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRAETHYLARSONIUM (TEAS)
1634, 2bobA, 0.5316, 3.79, 0.091, 220, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
1635, 2atkA, 0.5316, 3.73, 0.073, 222, 110, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
1636, 1hxmH, 0.5316, 3.68, 0.120, 213, 108, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1637, 6r2sA, 0.5315, 3.79, 0.101, 207, 109, THE STRUCTURE OF PLASMODIUM VIVAX DUFFY BINDING PROTEIN (PVDBP) BOUND TO HUMAN ANTIBODY DB9 
1638, 6mxsL, 0.5315, 3.73, 0.109, 216, 110, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M] 
1639, 5xj4L, 0.5315, 3.65, 0.102, 120, 108, COMPLEX STRUCTURE OF DURVALUMAB-SCFV/PD-L1 
1640, 5kqvC, 0.5315, 4.64, 0.058, 184, 121, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
1641, 4yhoH, 0.5315, 3.86, 0.099, 219, 111, REVERSAL AGENT FOR DABIGATRAN
1642, 4lbeA, 0.5315, 3.78, 0.083, 213, 109, STRUCTURE OF KCSA WITH R122A MUTATION
1643, 3opzI, 0.5315, 3.68, 0.120, 213, 108, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
1644, 2hjfA, 0.5315, 3.76, 0.091, 219, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
1645, 6ieaL, 0.5314, 4.77, 0.041, 184, 123, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R13 
1646, 6egxB, 0.5314, 4.65, 0.050, 184, 121, SACBROOD VIRUS OF HONEYBEE - EXPANSION STATE I 
1647, 6cjkC, 0.5314, 4.62, 0.041, 184, 121, ANTI HIV FAB 10A 
1648, 4tnwV, 0.5314, 3.74, 0.082, 224, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1649, 3igaA, 0.5314, 3.74, 0.082, 224, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
1650, 2ih3A, 0.5314, 3.75, 0.136, 219, 110, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
1651, 1uweU, 0.5314, 3.67, 0.110, 216, 109, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1652, 6dg2A, 0.5313, 3.87, 0.099, 219, 111, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1653, 6cjkA, 0.5313, 3.87, 0.099, 219, 111, ANTI HIV FAB 10A 
1654, 5kqvP, 0.5313, 3.86, 0.099, 219, 111, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1CRL2 FNIII-1 AND ALPHACT PEPTIDE IN COMPLEX WITH BOVINE INSULIN AND FAB 83-14 (REVISED STRUCTURE)
1655, 5ec1A, 0.5313, 3.67, 0.110, 213, 109, KCSA WITH V76ESTER MUTATION
1656, 4yxlH, 0.5313, 3.55, 0.111, 218, 108, CRYSTAL STRUCTURE OF SYRIAN HAMSTER PRION PROTEIN COMPLEXED WITH POM1 FAB
1657, 6be3L, 0.5312, 3.83, 0.100, 219, 110, CRYSTAL STRUCTURE OF A POLYSACCHARIDE-BINDING HUMAN FAB (F598) IN COMPLEX WITH N-ACETYL-D-GLUCOSAMINE (GLCNAC)
1658, 6adtB, 0.5312, 3.72, 0.139, 213, 108, STRUCTURE OF SENECA VALLEY VIRUS IN NEUTRAL CONDITION 
1659, 4kaqH, 0.5312, 4.69, 0.041, 184, 122, STRUCTURE OF RITUXIMAB FAB
1660, 1ahwB, 0.5312, 3.73, 0.082, 222, 110, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
1661, 3hplA, 0.5311, 3.73, 0.092, 218, 109, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
1662, 6didH, 0.5310, 3.79, 0.100, 221, 110, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1663, 6didE, 0.5310, 3.73, 0.082, 224, 110, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1664, 6didC, 0.5310, 3.89, 0.099, 219, 111, HIV ENV BG505 SOSIP WITH POLYCLONAL FABS FROM IMMUNIZED RABBIT  3417 POST-BOOST 1 
1665, 5ihzL, 0.5310, 3.74, 0.091, 218, 110, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
1666, 4tnwU, 0.5310, 3.86, 0.099, 219, 111, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1667, 4tnwJ, 0.5310, 3.81, 0.100, 219, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1668, 2y5tA, 0.5310, 3.88, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
1669, 2vweE, 0.5310, 3.86, 0.100, 219, 110, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
1670, 1hxmB, 0.5310, 3.81, 0.136, 230, 110, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1671, 6my5L, 0.5309, 3.52, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
1672, 6dg2C, 0.5309, 3.61, 0.110, 218, 109, ANTIGEN BINDING FRAGMENT OF THE PAN-EBOLAVIRUS MONOCLONAL ANTIBODY 6D6 
1673, 6adrB, 0.5309, 3.50, 0.085, 113, 106, ANTHRAX TOXIN RECEPTOR 1-BOUND THE SENECA VALLEY VIRUS IN NEUTRAL CONDITIONS 
1674, 5w5xH, 0.5309, 3.68, 0.083, 211, 108, CRYSTAL STRUCTURE OF BAXP168G IN COMPLEX WITH AN ACTIVATING ANTIBODY 
1675, 3qpqD, 0.5309, 3.72, 0.100, 222, 110, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1676, 2w0fA, 0.5309, 3.84, 0.100, 219, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
1677, 2qk7A, 0.5309, 3.74, 0.100, 220, 110, A COVALENT S-F HETERODIMER OF STAPHYLOCOCCAL GAMMA-HEMOLYSIN
1678, 2dwdA, 0.5309, 3.85, 0.099, 219, 111, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
1679, 6my5B, 0.5308, 3.79, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98F;HC- G99M;LC-S30BR] 
1680, 6by2A, 0.5308, 4.12, 0.045, 199, 110, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
1681, 5a1zI, 0.5308, 3.47, 0.104, 217, 106, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
1682, 4kphL, 0.5308, 3.73, 0.082, 224, 110, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
1683, 1zwiA, 0.5308, 3.83, 0.100, 219, 110, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
1684, 6fqaA, 0.5307, 3.87, 0.099, 219, 111, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
1685, 5e1aA, 0.5307, 3.52, 0.123, 213, 106, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
1686, 4v4mOA, 0.5307, 3.70, 0.110, 217, 109, 
1687, 3v4vM, 0.5307, 3.48, 0.104, 216, 106, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1688, 1qfuH, 0.5307, 3.70, 0.083, 220, 108, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
1689, 4u59A, 0.5306, 3.82, 0.100, 219, 110, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN REACTED WITH METHYLAMINE
1690, 4llyB, 0.5306, 3.77, 0.082, 218, 110, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
1691, 4am0H, 0.5306, 3.68, 0.120, 213, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1692, 3v4vH, 0.5306, 4.33, 0.054, 267, 112, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1 AND RO0505376
1693, 3gi9H, 0.5306, 3.73, 0.101, 220, 109, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
1694, 3g6jE, 0.5306, 3.77, 0.100, 214, 110, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1695, 2hb0B, 0.5306, 3.88, 0.099, 219, 111, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1696, 1yuhB, 0.5306, 3.48, 0.104, 217, 106, FAB FRAGMENT
1697, 1uweL, 0.5306, 3.48, 0.104, 217, 106, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1698, 6my4B, 0.5305, 3.48, 0.104, 217, 106, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M;LC-S30BR] 
1699, 6idgL, 0.5305, 3.76, 0.130, 215, 108, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
1700, 6dcaJ, 0.5305, 3.73, 0.082, 221, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
1701, 5lqbH, 0.5305, 3.74, 0.082, 222, 110, COMPLEX STRUCTURE OF HUMAN IL2 MUTANT PROLEUKIN WITH FAB FRAGMENT OF NARA1 ANTIBODY
1702, 5gzoL, 0.5305, 3.91, 0.109, 222, 110, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
1703, 4ffyH, 0.5305, 3.79, 0.100, 219, 110, CRYSTAL STRUCTURE OF DENV1-E111 SINGLE CHAIN VARIABLE FRAGMENT BOUND TO DENV-1 DIII STRAIN 16007.
1704, 3mxwH, 0.5305, 3.90, 0.126, 230, 111, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
1705, 2jk5A, 0.5305, 3.55, 0.102, 218, 108, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
1706, 1rzgC, 0.5305, 3.78, 0.109, 211, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
1707, 6hu9b, 0.5304, 4.33, 0.035, 267, 113, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1708, 5yslG, 0.5304, 3.67, 0.092, 211, 109, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1709, 5yslE, 0.5304, 3.71, 0.110, 218, 109, CRYSTAL STRUCTURE OF ANTIBODY 1H1 FAB
1710, 5b1bO, 0.5304, 3.84, 0.100, 218, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
1711, 3ogcA, 0.5304, 4.10, 0.088, 259, 113, KCSA E71A VARIANT IN PRESENCE OF NA+
1712, 3au0A, 0.5304, 3.87, 0.099, 219, 111, STRUCTURAL AND BIOCHEMICAL CHARACTERIZATION OF CLFB:LIGAND INTERACTIONS
1713, 2xqyJ, 0.5304, 3.55, 0.111, 218, 108, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
1714, 2hvjA, 0.5304, 3.86, 0.099, 219, 111, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
1715, 1e6jH, 0.5304, 3.61, 0.065, 120, 108, CRYSTAL STRUCTURE OF HIV-1 CAPSID PROTEIN (P24) IN COMPLEX WITH FAB13B5
1716, 6qexC, 0.5303, 3.42, 0.124, 209, 105, NANODISC RECONSTITUTED HUMAN ABCB1 IN COMPLEX WITH UIC2 FAB AND TAXOL 
1717, 6azzF, 0.5303, 3.89, 0.099, 219, 111, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
1718, 4u4jA, 0.5303, 3.27, 0.088, 229, 102, CRYSTAL STRUCTURE OF SALMONELLA ALPHA-2-MACROGLOBULIN MUTANT Y1175G
1719, 4llyD, 0.5303, 3.94, 0.099, 219, 111, CRYSTAL STRUCTURE OF PERTUZUMAB CLAMBDA FAB WITH VARIABLE AND CONSTANT DOMAIN REDESIGNS (VRD2 AND CRD2) AT 1.6A
1720, 3abkO, 0.5303, 4.65, 0.050, 184, 121, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1721, 2uylW, 0.5303, 3.78, 0.091, 213, 110, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
1722, 6b5rH, 0.5302, 3.77, 0.100, 223, 110, STRUCTURE OF PFCSP PEPTIDE 21 WITH HUMAN ANTIBODY CIS42
1723, 5dgyB, 0.5302, 3.60, 0.067, 1537, 105, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO VISUAL ARRESTIN
1724, 5cusO, 0.5302, 3.50, 0.094, 209, 106, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
1725, 4zwjB, 0.5302, 3.79, 0.091, 214, 110, CRYSTAL STRUCTURE OF RHODOPSIN BOUND TO ARRESTIN BY FEMTOSECOND X-RAY LASER
1726, 4tnwF, 0.5302, 3.78, 0.091, 211, 110, C. ELEGANS GLUTAMATE-GATED CHLORIDE CHANNEL (GLUCL) IN COMPLEX WITH FAB AND POPC IN A LIPID-MODULATED CONFORMATION
1727, 2jixL, 0.5302, 3.80, 0.100, 217, 110, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
1728, 6jfiI, 0.5301, 3.48, 0.066, 214, 106, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
1729, 6jfhI, 0.5301, 4.12, 0.096, 355, 114, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
1730, 6jepI, 0.5301, 3.77, 0.100, 218, 110, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
1731, 4ma8H, 0.5301, 3.53, 0.123, 213, 106, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH CHLORPROMAZINE
1732, 3s96B, 0.5301, 3.55, 0.111, 217, 108, CRYSTAL STRUCTURE OF 3B5H10
1733, 1eajA, 0.5301, 3.56, 0.131, 217, 107, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
1734, 6mxrL, 0.5300, 3.81, 0.083, 213, 109, CRYSTAL STRUCTURE OF THE DIMERIC BH1-FAB VARIANT [HC-Y33W;HC-D98M;HC- G99M] 
1735, 5yhlH, 0.5300, 3.75, 0.082, 219, 110, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1736, 5wk3U, 0.5300, 3.51, 0.094, 213, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1737, 4janH, 0.5300, 3.73, 0.092, 119, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
1738, 4gq9H, 0.5300, 3.76, 0.092, 220, 109, CHIKUNGUNYA VIRUS NEUTRALIZING ANTIBODY 9.8B FAB FRAGMENT
1739, 2vl5A, 0.5300, 3.84, 0.100, 219, 110, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
1740, 2jelH, 0.5300, 3.67, 0.073, 213, 109, JEL42 FAB/HPR COMPLEX
1741, 1yntD, 0.5300, 2.65, 0.149, 236, 94, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1742, 6cdmD, 0.5299, 3.64, 0.083, 210, 108, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1743, 5nyxN, 0.5299, 3.63, 0.083, 210, 108, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
1744, 4yhiH, 0.5299, 2.62, 0.106, 226, 94, REVERSAL AGENT FOR DABIGATRAN
1745, 3jabQ, 0.5299, 3.91, 0.099, 219, 111, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1746, 3jabH, 0.5299, 3.92, 0.063, 339, 111, DOMAIN ORGANIZATION AND CONFORMATIONAL PLASTICITY OF THE G PROTEIN EFFECTOR PDE6
1747, 3iywL, 0.5299, 3.86, 0.091, 216, 110, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
1748, 3fo1A, 0.5299, 3.82, 0.100, 218, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
1749, 2xqyG, 0.5299, 3.80, 0.091, 219, 110, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
1750, 2uylN, 0.5299, 3.78, 0.100, 225, 110, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
1751, 1uweX, 0.5299, 3.71, 0.082, 220, 110, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1752, 12e8H, 0.5299, 3.47, 0.048, 1538, 104, 2E8 FAB FRAGMENT
1753, 6j8mO, 0.5298, 3.50, 0.094, 209, 106, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
1754, 6iuvC, 0.5298, 2.62, 0.106, 226, 94, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
1755, 6azzC, 0.5298, 3.88, 0.099, 213, 111, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1190
1756, 5mjvC, 0.5298, 3.64, 0.083, 211, 108, REBUILD AND RE-REFINED MODEL FOR HUMAN PARECHOVIRUS 1
1757, 5j96B, 0.5298, 3.90, 0.036, 673, 112, CRYSTAL STRUCTURE OF SLOW BEE PARALYSIS VIRUS AT 3.4A RESOLUTION
1758, 4ygvA, 0.5298, 3.45, 0.096, 200, 104, REVERSAL AGENT FOR DABIGATRAN
1759, 4ncdA, 0.5298, 3.90, 0.036, 673, 112, CRYSTAL STRUCTURE OF CLASS 5 FIMBRIAE CHAPERONE CFAA
1760, 4jo4M, 0.5298, 3.74, 0.082, 221, 110, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
1761, 3ag2O, 0.5298, 3.49, 0.085, 214, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
1762, 2vweL, 0.5298, 3.42, 0.067, 214, 104, CRYSTAL STRUCTURE OF VASCULAR ENDOTHELIAL GROWTH FACTOR-B IN COMPLEX WITH A NEUTRALIZING ANTIBODY FAB FRAGMENT
1763, 1yntB, 0.5298, 3.42, 0.067, 214, 104, STRUCTURE OF THE IMMUNODOMINANT EPITOPE DISPLAYED BY THE SURFACE ANTIGEN 1 (SAG1) OF TOXOPLASMA GONDII COMPLEXED TO A MONOCLONAL ANTIBODY
1764, 1fbiQ, 0.5298, 3.42, 0.067, 214, 104, CRYSTAL STRUCTURE OF A CROSS-REACTION COMPLEX BETWEEN FAB F9.13.7 AND GUINEA-FOWL LYSOZYME
1765, 6avrL, 0.5297, 3.77, 0.082, 218, 110, HUMAN ALPHA-V BETA-3 INTEGRIN (INTERMEDIATE CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
1766, 6avqL, 0.5297, 3.70, 0.111, 204, 108, THE THERAPEUTIC ANTIBODY LM609 SELECTIVELY INHIBITS LIGAND BINDING TO HUMAN ALPHA-V BETA-3 INTEGRIN VIA STERIC HINDRANCE
1767, 5ywyH, 0.5297, 4.02, 0.061, 124, 114, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY. 
1768, 4yhnA, 0.5297, 3.62, 0.110, 218, 109, DABIGATRAN REVERSAL AGENT
1769, 4h88H, 0.5297, 3.63, 0.101, 223, 109, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC FRAGMENT 120- 230
1770, 4am0C, 0.5297, 3.66, 0.074, 221, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1771, 3j2zH, 0.5297, 3.89, 0.081, 218, 111, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
1772, 3j2zF, 0.5297, 3.80, 0.100, 218, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
1773, 3j2zD, 0.5297, 3.84, 0.109, 218, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
1774, 3j2zB, 0.5297, 3.78, 0.106, 218, 113, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M10
1775, 3j2yH, 0.5297, 3.74, 0.100, 218, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
1776, 3j2yF, 0.5297, 3.74, 0.100, 218, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
1777, 3j2yD, 0.5297, 3.50, 0.094, 210, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
1778, 3j2yB, 0.5297, 3.78, 0.100, 222, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB 9.8B
1779, 3ag4O, 0.5297, 3.63, 0.092, 221, 109, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
1780, 1hxmF, 0.5297, 3.63, 0.092, 221, 109, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1781, 6cdoA, 0.5296, 3.51, 0.124, 220, 105, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1782, 5lwgB, 0.5296, 3.56, 0.113, 216, 106, ISRAELI ACUTE PARALYSIS VIRUS HEATED TO 63 DEGREE - FULL PARTICLE
1783, 5kvlL, 0.5296, 3.87, 0.091, 216, 110, HUMANIZED 10G4 ANTI-LEUKOTRIENE C4 ANTIBODY FAB FRAGMENT IN COMPLEX WITH LEUKOTRIENE C4
1784, 5b3sO, 0.5296, 3.88, 0.099, 213, 111, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
1785, 4mwfH, 0.5296, 3.53, 0.123, 213, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
1786, 3wiiH, 0.5296, 3.63, 0.092, 221, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
1787, 3iywM, 0.5296, 2.67, 0.106, 226, 94, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
1788, 3bkyH, 0.5296, 3.76, 0.083, 224, 109, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
1789, 1dbaH, 0.5296, 3.72, 0.082, 217, 110, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1790, 1b35B, 0.5296, 3.92, 0.064, 257, 109, CRICKET PARALYSIS VIRUS (CRPV)
1791, 1a4kB, 0.5296, 4.16, 0.027, 252, 111, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
1792, 6dcaK, 0.5295, 3.78, 0.100, 220, 110, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
1793, 5ig7E, 0.5295, 3.35, 0.087, 211, 104, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
1794, 5ifjE, 0.5295, 3.58, 0.084, 214, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
1795, 4xzuA, 0.5295, 2.63, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
1796, 4p3dB, 0.5295, 3.81, 0.100, 219, 110, MT1-MMP:FAB COMPLEX (FORM II)
1797, 3lh8B, 0.5295, 3.74, 0.100, 218, 110, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
1798, 3fctB, 0.5295, 3.80, 0.100, 221, 110, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
1799, 2uylB, 0.5295, 3.54, 0.113, 211, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
1800, 2hb0A, 0.5295, 3.54, 0.113, 211, 106, CRYSTAL STRUCTURE OF CFAE THE ADHESIVE SUBUNIT OF CFA/I FIMBRIA OF ENTEROTOXIGENIC ESCHERICHIA COLI
1801, 2gcyA, 0.5295, 3.64, 0.101, 223, 109, HUMANIZED ANTIBODY C25 FAB FRAGMENT
1802, 6ocbL, 0.5294, 3.78, 0.100, 220, 110, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H3 (A/HONG KONG/1/1968) 
1803, 6igwA, 0.5294, 3.77, 0.082, 218, 110, MPZL1 MUTANT - S86G; V145G; Q146K;P147T;G148S 
1804, 6dc7I, 0.5294, 3.80, 0.091, 211, 110, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
1805, 4yxhH, 0.5294, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF DEER PRION PROTEIN COMPLEXED WITH POM1 FAB
1806, 4xhjG, 0.5294, 3.80, 0.100, 218, 110, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
1807, 4osuL, 0.5294, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF HCMV GB-NEUTRALIZING SM5-1 FAB FRAGMENT
1808, 4j1uC, 0.5294, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
1809, 3fo2L, 0.5294, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
1810, 3dggD, 0.5294, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF FABOX108
1811, 2gkiB, 0.5294, 3.80, 0.100, 218, 110, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
1812, 6nz7L, 0.5293, 3.80, 0.100, 218, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
1813, 6e64B, 0.5293, 2.63, 0.106, 226, 94, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
1814, 6a0xC, 0.5293, 3.91, 0.126, 230, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
1815, 5zcpO, 0.5293, 3.73, 0.110, 230, 109, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1816, 4yhiA, 0.5293, 4.05, 0.036, 247, 111, REVERSAL AGENT FOR DABIGATRAN
1817, 4m6mH, 0.5293, 3.54, 0.085, 214, 106, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
1818, 4jo3L, 0.5293, 2.64, 0.106, 226, 94, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
1819, 4hbcL, 0.5293, 3.59, 0.083, 228, 108, CRYSTAL STRUCTURE OF A CONFORMATION-DEPENDENT RABBIT IGG FAB SPECIFIC FOR AMYLOID PREFIBRILLAR OLIGOMERS
1820, 3v4pM, 0.5293, 3.78, 0.127, 220, 110, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
1821, 3uzqA, 0.5293, 3.51, 0.124, 220, 105, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 1 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
1822, 3g6jG, 0.5293, 3.84, 0.098, 226, 112, C3B IN COMPLEX WITH A C3B SPECIFIC FAB
1823, 2xraL, 0.5293, 3.75, 0.091, 219, 110, CRYSTAL STRUCTURE OF THE HK20 FAB IN COMPLEX WITH A GP41 MIMETIC 5-HELIX
1824, 1aj7H, 0.5293, 4.15, 0.062, 255, 112, IMMUNOGLOBULIN 48G7 GERMLINE FAB ANTIBODY COMPLEXED WITH HAPTEN 5-(PARA-NITROPHENYL PHOSPHONATE)-PENTANOIC ACID. AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
1825, 6igtB, 0.5292, 3.83, 0.091, 219, 110, MPZL1 MUTANT - V145G; Q146K; P147T AND G148S 
1826, 6h5nB, 0.5292, 3.73, 0.083, 213, 109, PLASMODIUM FALCIPARUM PFS48/45 C-TERMINAL DOMAIN BOUND TO MONOCLONAL ANTIBODY 85RF45.1 
1827, 6a0xA, 0.5292, 3.72, 0.130, 213, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
1828, 4p3cL, 0.5292, 3.74, 0.130, 213, 108, MT1-MMP:FAB COMPLEX (FORM I)
1829, 1zeaH, 0.5292, 3.76, 0.083, 213, 109, STRUCTURE OF THE ANTI-CHOLERA TOXIN ANTIBODY FAB FRAGMENT TE33 IN COMPLEX WITH A D-PEPTIDE
1830, 1yuhH, 0.5292, 3.54, 0.132, 218, 106, FAB FRAGMENT
1831, 1f5wA, 0.5292, 3.49, 0.019, 282, 103, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
1832, 1e4xI, 0.5292, 3.79, 0.100, 216, 110, CROSSREACTIVE BINDING OF A CIRCULARIZED PEPTIDE TO AN ANTI-TGFALPHA ANTIBODY FAB-FRAGMENT
1833, 6oc3B, 0.5291, 3.88, 0.099, 213, 111, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1834, 6iicB, 0.5291, 4.14, 0.096, 356, 114, CRYOEM STRUCTURE OF MUD CRAB DICISTROVIRUS 
1835, 4risH, 0.5291, 3.50, 0.085, 216, 106, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1836, 4p3dL, 0.5291, 3.53, 0.075, 213, 106, MT1-MMP:FAB COMPLEX (FORM II)
1837, 4kroC, 0.5291, 3.84, 0.108, 119, 111, NANOBODY/VHH DOMAIN EGA1 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
1838, 4gmsJ, 0.5291, 3.82, 0.109, 211, 110, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
1839, 4dgiH, 0.5291, 3.79, 0.082, 218, 110, STRUCTURE OF POM1 FAB FRAGMENT COMPLEXED WITH HUMAN PRPC FRAGMENT 120- 230
1840, 1igjD, 0.5291, 3.58, 0.075, 196, 107, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
1841, 6fg1L, 0.5290, 3.46, 0.067, 212, 105, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA32. 
1842, 5zcqO, 0.5290, 3.53, 0.085, 213, 106, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
1843, 5z85O, 0.5290, 3.56, 0.113, 216, 106, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
1844, 5ywoR, 0.5290, 3.79, 0.100, 215, 110, STRUCTURE OF JEV-2F2 FAB COMPLEX
1845, 5ywoN, 0.5290, 3.54, 0.132, 238, 106, STRUCTURE OF JEV-2F2 FAB COMPLEX
1846, 5wk3W, 0.5290, 3.48, 0.075, 214, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1847, 5ig7K, 0.5290, 3.75, 0.110, 213, 109, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
1848, 4rgnC, 0.5290, 3.71, 0.083, 223, 109, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1849, 4gmsH, 0.5290, 2.64, 0.106, 226, 94, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
1850, 6avuL, 0.5289, 3.77, 0.100, 222, 110, HUMAN ALPHA-V BETA-3 INTEGRIN (OPEN CONFORMATION) IN COMPLEX WITH THE THERAPEUTIC ANTIBODY LM609
1851, 5opyL, 0.5289, 3.69, 0.073, 215, 109, CRYSTAL STRUCTURE OF ANTI-ALPHAVBETA3 INTEGRIN FAB LM609
1852, 5ihzD, 0.5289, 3.71, 0.073, 214, 109, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
1853, 5bzdA, 0.5289, 3.53, 0.066, 213, 106, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1854, 4rgnL, 0.5289, 3.80, 0.091, 211, 110, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1855, 3ze1H, 0.5289, 3.71, 0.083, 234, 109, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
1856, 3sqoL, 0.5289, 3.56, 0.065, 214, 107, PCSK9 J16 FAB COMPLEX
1857, 3clfH, 0.5289, 3.58, 0.103, 215, 107, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
1858, 3ag3O, 0.5289, 3.82, 0.117, 217, 111, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1859, 2qadH, 0.5289, 3.71, 0.109, 117, 110, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1860, 2bdnH, 0.5289, 3.68, 0.111, 212, 108, CRYSTAL STRUCTURE OF HUMAN MCP-1 BOUND TO A BLOCKING ANTIBODY 11K2
1861, 1uwgL, 0.5289, 3.71, 0.083, 223, 109, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1862, 6mi2A, 0.5288, 3.55, 0.132, 218, 106, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
1863, 6mg5B, 0.5288, 3.68, 0.092, 209, 109, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO IN COMPLEX WITH COUMARIN 1 
1864, 6cdpA, 0.5288, 3.77, 0.100, 218, 110, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
1865, 5z86O, 0.5288, 3.95, 0.071, 124, 113, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
1866, 4xhjC, 0.5288, 3.73, 0.109, 217, 110, GHGL OF VARICELLA-ZOSTER VIRUS IN COMPLEX WITH HUMAN NEUTRALIZING ANTIBODIES.
1867, 4ma7H, 0.5288, 3.54, 0.075, 213, 106, CRYSTAL STRUCTURE OF MOUSE PRION PROTEIN COMPLEXED WITH PROMAZINE
1868, 4dcqA, 0.5288, 3.90, 0.037, 250, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
1869, 3v4pH, 0.5288, 3.68, 0.074, 228, 108, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB ACT-1
1870, 3phqA, 0.5288, 3.54, 0.132, 218, 106, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH KDO
1871, 3lhpL, 0.5288, 3.51, 0.094, 211, 106, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10_D0_1ISEA_004_N 4E10 FV COMPLEX
1872, 3gi8H, 0.5288, 3.73, 0.083, 211, 109, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
1873, 3asoO, 0.5288, 3.79, 0.082, 218, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
1874, 2qhrL, 0.5288, 3.73, 0.054, 217, 111, CRYSTAL STRUCTURE OF THE 13F6-1-2 FAB FRAGMENT BOUND TO ITS EBOLA VIRUS GLYCOPROTEIN PEPTIDE EPITOPE.
1875, 2qadD, 0.5288, 3.51, 0.075, 211, 106, STRUCTURE OF TYROSINE-SULFATED 412D ANTIBODY COMPLEXED WITH HIV-1 YU2 GP120 AND CD4
1876, 1hxmD, 0.5288, 2.65, 0.106, 226, 94, CRYSTAL STRUCTURE OF A HUMAN VGAMMA9/VDELTA2 T CELL RECEPTOR
1877, 1fgnH, 0.5288, 2.65, 0.106, 226, 94, MONOCLONAL MURINE ANTIBODY 5G9-ANTI-HUMAN TISSUE FACTOR
1878, 5zcoO, 0.5287, 3.74, 0.082, 218, 110, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
1879, 5xdxO, 0.5287, 3.74, 0.082, 218, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
1880, 5bzwA, 0.5287, 3.69, 0.074, 221, 108, CRYSTAL STRUCTURE OF PCDN-27B AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
1881, 1dbbH, 0.5287, 3.73, 0.130, 213, 108, THREE-DIMENSIONAL STRUCTURE OF AN ANTI-STEROID FAB  AND PROGESTERONE-FAB  COMPLEX
1882, 6eyoI, 0.5286, 3.60, 0.103, 213, 107, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
1883, 6dcaH, 0.5286, 3.75, 0.083, 217, 109, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
1884, 5muqH, 0.5286, 3.54, 0.113, 211, 106, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
1885, 5muqA, 0.5286, 3.56, 0.113, 212, 106, CRYSTAL STRUCTURE OF DC8E8 FAB AT PH 7.0 CONTAINING A ZN ATOM 
1886, 5lxaH, 0.5286, 3.76, 0.130, 213, 108, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 3.0 ANGSTROM RESOLUTION
1887, 5k59B, 0.5286, 3.57, 0.113, 213, 106, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1888, 5b1aO, 0.5286, 3.60, 0.103, 213, 107, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
1889, 4ywgM, 0.5286, 3.82, 0.090, 216, 111, CRYSTAL STRUCTURE OF 830A IN COMPLEX WITH V1V2
1890, 4lluB, 0.5286, 3.52, 0.104, 213, 106, STRUCTURE OF PERTUZUMAB FAB WITH LIGHT CHAIN CLAMBDA AT 2.16A
1891, 3asnO, 0.5286, 3.74, 0.100, 220, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
1892, 2r6pF, 0.5286, 2.63, 0.106, 226, 94, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
1893, 2r6pD, 0.5286, 3.80, 0.073, 229, 110, FIT OF E PROTEIN AND FAB 1A1D-2 INTO 24 ANGSTROM RESOLUTION CRYOEM MAP OF FAB COMPLEXED WITH DENGUE 2 VIRUS.
1894, 2r29H, 0.5286, 3.80, 0.100, 217, 110, NEUTRALIZATION OF DENGUE VIRUS BY A SEROTYPE CROSS-REACTIVE ANTIBODY ELUCIDATED BY CRYOELECTRON MICROSCOPY AND X-RAY CRYSTALLOGRAPHY
1895, 1z3gI, 0.5286, 3.52, 0.123, 213, 106, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
1896, 1lo4L, 0.5286, 3.70, 0.074, 209, 108, RETRO-DIELS-ALDERASE CATALYTIC ANTIBODY 9D9
1897, 6dc9M, 0.5285, 3.61, 0.121, 215, 107, FAB/EPITOPE COMPLEX OF HUMAN CHIMERIC MONOCLONAL ANTIBODY H4E6 TARGETING A PHOSPHORYLATED TAU EPITOPE. 
1898, 5xdqO, 0.5285, 3.71, 0.110, 221, 109, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
1899, 5wk3Q, 0.5285, 2.65, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
1900, 5npiA, 0.5285, 3.59, 0.075, 207, 107, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1901, 5ig7B, 0.5285, 3.76, 0.082, 218, 110, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
1902, 5guxH, 0.5285, 3.63, 0.104, 218, 106, CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH XENON
1903, 4ztoM, 0.5285, 3.81, 0.091, 211, 110, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
1904, 3ujjH, 0.5285, 3.58, 0.112, 216, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 4025 IN COMPLEX WITH CON A PEPTIDE
1905, 3opzJ, 0.5285, 3.50, 0.075, 111, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
1906, 3fo1L, 0.5285, 3.80, 0.100, 220, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)ALA MUTANT)
1907, 1a5fH, 0.5285, 2.69, 0.106, 226, 94, FAB FRAGMENT OF A MONOCLONAL ANTI-E-SELECTIN ANTIBODY
1908, 6igoC, 0.5284, 3.75, 0.120, 218, 108, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
1909, 6ddrB, 0.5284, 3.80, 0.073, 229, 110, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
1910, 5x0tD, 0.5284, 3.92, 0.126, 230, 111, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
1911, 4ztoL, 0.5284, 3.80, 0.100, 214, 110, FAB/EPITOPE COMPLEX STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
1912, 4z92C, 0.5284, 2.65, 0.106, 226, 94, CRYSTAL STRUCTURE OF PARECHOVIRUS-1 VIRION
1913, 4yhmH, 0.5284, 2.63, 0.106, 226, 94, REVERSAL AGENT FOR DABIGATRAN
1914, 4yhdC, 0.5284, 3.62, 0.112, 213, 107, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
1915, 4gmtI, 0.5284, 3.73, 0.091, 219, 110, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
1916, 4ffzZ, 0.5284, 3.63, 0.072, 208, 111, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
1917, 4ffzH, 0.5284, 3.78, 0.083, 213, 109, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
1918, 3s96D, 0.5284, 3.76, 0.083, 219, 109, CRYSTAL STRUCTURE OF 3B5H10
1919, 2fd6H, 0.5284, 3.76, 0.083, 219, 109, STRUCTURE OF HUMAN UROKINASE PLASMINOGEN ACTIVATOR IN COMPLEX WITH UROKINASE RECEPTOR AND AN ANTI-UPAR ANTIBODY AT 1.9 A
1920, 1uwgX, 0.5284, 3.72, 0.100, 238, 110, MOLECULAR MECHANISM OF ENANTIOSELECTIVE PROTON TRANSFER TO CARBON IN CATALYTIC ANTIBODY 14D9
1921, 6foeL, 0.5283, 4.08, 0.106, 293, 113, BAXB01 FAB FRAGMENT
1922, 6bzuB, 0.5283, 2.65, 0.106, 226, 94, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1923, 5z84O, 0.5283, 3.55, 0.094, 215, 106, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
1924, 5jo4C, 0.5283, 3.51, 0.094, 210, 106, ANTIBODY FAB FRAGMENT COMPLEX
1925, 5ihzB, 0.5283, 2.69, 0.106, 226, 94, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT
1926, 5ifjH, 0.5283, 3.81, 0.091, 216, 110, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
1927, 5dr5L, 0.5283, 3.81, 0.091, 216, 110, CRYSTAL STRUCTURE OF THE SCLEROSTIN-NEUTRALIZING FAB ABD09097
1928, 4okvA, 0.5283, 3.81, 0.091, 216, 110, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
1929, 4f24A, 0.5283, 3.73, 0.102, 214, 108, CRYSTAL STRUCTURES REVEAL THE MULTI-LIGAND BINDING MECHANISM OF THE STAPHYLOCOCCUS AUREUS CLFB
1930, 4d3cL, 0.5283, 3.58, 0.113, 217, 106, CRYSTAL STRUCTURE OF THE NK1 DOMAIN OF HGF IN COMPLEX WITH ANTI-HGF MONOCLONAL ANTIBODY SFN68.
1931, 2einB, 0.5283, 3.53, 0.094, 215, 106, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
1932, 2eikO, 0.5283, 2.65, 0.106, 226, 94, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1933, 2eikB, 0.5283, 3.71, 0.073, 221, 109, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1934, 1v55O, 0.5283, 3.75, 0.082, 232, 110, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1935, 1dbkH, 0.5283, 3.73, 0.130, 213, 108, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
1936, 12e8P, 0.5283, 3.79, 0.082, 225, 110, 2E8 FAB FRAGMENT
1937, 6ogxH, 0.5282, 3.52, 0.075, 216, 106, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
1938, 6e64L, 0.5282, 3.68, 0.073, 230, 109, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
1939, 5x0tB, 0.5282, 3.76, 0.101, 221, 109, CRYSTAL STRUCTURE OF CD147 C2 DOMAIN IN COMPLEX WITH FAB OF ITS MONOCLONAL ANTIBODY 6H8
1940, 5w0kE, 0.5282, 3.58, 0.123, 216, 106, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
1941, 5npiB, 0.5282, 3.81, 0.100, 212, 110, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
1942, 5k59A, 0.5282, 3.98, 0.116, 122, 112, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
1943, 4mwfA, 0.5282, 3.79, 0.109, 221, 110, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
1944, 4jamH, 0.5282, 3.54, 0.132, 213, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTI-HIV-1 ANTIBODY CH103
1945, 4hqqH, 0.5282, 3.53, 0.085, 216, 106, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
1946, 4d9rL, 0.5282, 3.95, 0.064, 257, 109, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
1947, 3wg7O, 0.5282, 3.71, 0.101, 222, 109, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
1948, 3t3mH, 0.5282, 3.88, 0.073, 279, 110, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
1949, 1v54O, 0.5282, 3.75, 0.083, 212, 109, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1950, 1q0xH, 0.5282, 3.80, 0.091, 217, 110, ANTI-MORPHINE ANTIBODY 9B1 UNLIGANDED FORM
1951, 1kiuO, 0.5282, 3.79, 0.091, 217, 110, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1952, 1kiuM, 0.5282, 3.67, 0.112, 203, 107, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1953, 1kiuK, 0.5282, 3.81, 0.082, 212, 110, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1954, 1kiuI, 0.5282, 3.52, 0.123, 213, 106, FIMH ADHESIN Q133N MUTANT-FIMC CHAPERONE COMPLEX WITH METHYL-ALPHA-D-MANNOSE
1955, 6oc3D, 0.5281, 3.54, 0.085, 214, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB IN COMPLEX WITH THE HEAD DOMAIN OF H1 (A/SOLOMON ISLANDS/3/2006) 
1956, 6obzL, 0.5281, 3.49, 0.123, 216, 106, CRYSTAL STRUCTURE OF FLUA-20 FAB 
1957, 6hu9n, 0.5281, 2.65, 0.106, 226, 94, III2-IV2 MITOCHONDRIAL RESPIRATORY SUPERCOMPLEX FROM S. CEREVISIAE 
1958, 6bzuH, 0.5281, 3.63, 0.083, 221, 108, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
1959, 5v7rL, 0.5281, 3.74, 0.130, 213, 108, CYRSTAL STRUCTURE OF ANTI-TAU ANTIBODY CBTAU-7.1 FAB
1960, 5jhlL, 0.5281, 3.75, 0.130, 213, 108, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
1961, 5ifjB, 0.5281, 3.60, 0.093, 215, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
1962, 5dmiL, 0.5281, 3.86, 0.119, 214, 109, STRUCTURE OF THE EXTRACELLULAR DOMAIN OF THE CD40 IN COMPLEX WITH CHI220 FAB
1963, 4rirH, 0.5281, 4.01, 0.054, 334, 111, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
1964, 4eowL, 0.5281, 3.52, 0.104, 209, 106, CRYSTAL STRUCTURE OF A DISEASE-ASSOCIATED ANTI-HUMAN GM-CSF AUTOANTIBODY MB007
1965, 4d9qL, 0.5281, 2.67, 0.106, 226, 94, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
1966, 3opzH, 0.5281, 2.65, 0.106, 226, 94, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
1967, 3ag3B, 0.5281, 2.66, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE NITRIC OXIDE-BOUND FULLY REDUCED STATE AT 100 K
1968, 3abmO, 0.5281, 2.65, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
1969, 2mcg1, 0.5281, 3.75, 0.091, 219, 110, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
1970, 1v55B, 0.5281, 3.72, 0.091, 221, 110, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY REDUCED STATE
1971, 6dfjL, 0.5280, 3.69, 0.074, 206, 108, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO DENV-1 ENVELOPE PROTEIN DIII 
1972, 5waub, 0.5280, 3.83, 0.118, 213, 110, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
1973, 5fyjD, 0.5280, 3.54, 0.132, 213, 106, CRYSTAL STRUCTURE AT 3.4 A RESOLUTION OF FULLY GLYCOSYLATED HIV-1 CLADE G X1193.C1 SOSIP.664 PREFUSION ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 35O22 AND VRC01
1974, 4uinH, 0.5280, 3.80, 0.109, 214, 110, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3 WITH QUININE
1975, 4n8cI, 0.5280, 3.74, 0.082, 233, 110, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
1976, 4ki5C, 0.5280, 4.04, 0.080, 292, 113, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
1977, 4am0A, 0.5280, 3.68, 0.092, 223, 109, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
1978, 3fo0L, 0.5280, 3.74, 0.082, 223, 110, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (WILD-TYPE)
1979, 3bn9E, 0.5280, 3.70, 0.074, 215, 108, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
1980, 3ablO, 0.5280, 3.54, 0.085, 214, 106, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
1981, 3abkB, 0.5280, 2.65, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE NO-BOUND FULLY REDUCED STATE (50K)
1982, 1v54B, 0.5280, 3.81, 0.090, 216, 111, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
1983, 1q0yH, 0.5280, 2.67, 0.106, 226, 94, ANTI-MORPHINE ANTIBODY 9B1 COMPLEXED WITH MORPHINE
1984, 1l7iL, 0.5280, 3.76, 0.082, 215, 110, CRYSTAL STRUCTURE OF THE ANTI-ERBB2 FAB2C4
1985, 1gafH, 0.5280, 2.89, 0.072, 205, 97, 48G7 HYBRIDOMA LINE FAB COMPLEXED WITH HAPTEN 5-(PARA- NITROPHENYL PHOSPHONATE)-PENTANOIC ACID
1986, 5x1fO, 0.5279, 2.89, 0.072, 205, 97, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
1987, 5nyxL, 0.5279, 2.89, 0.072, 205, 97, HUMAN FAB FRAGMENT 5H2 AGAINST NHBA FROM NEISSERIA MENINGITIDIS 
1988, 4yxkH, 0.5279, 2.89, 0.072, 205, 97, CRYSTAL STRUCTURE OF ELK PRION PROTEIN COMPLEXED WITH POM1 FAB
1989, 4yx2H, 0.5279, 3.53, 0.085, 213, 106, CRYSTAL STRUCTURE OF BOVINE PRION PROTEIN COMPLEXED WITH POM1 FAB
1990, 4rgnF, 0.5279, 3.52, 0.085, 213, 106, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1991, 4rgnD, 0.5279, 2.70, 0.138, 236, 94, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
1992, 4r96B, 0.5279, 3.50, 0.123, 215, 106, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
1993, 4bz1H, 0.5279, 3.55, 0.113, 215, 106, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
1994, 3qpqF, 0.5279, 3.55, 0.104, 211, 106, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
1995, 2jixA, 0.5279, 3.73, 0.130, 213, 108, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
1996, 2eijO, 0.5279, 3.53, 0.094, 213, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
1997, 5x1bO, 0.5278, 3.68, 0.074, 219, 108, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
1998, 5o4gA, 0.5278, 3.45, 0.105, 211, 105, HER2 IN COMPLEX WITH FAB MF3958 
1999, 4uihG, 0.5278, 3.55, 0.085, 213, 106, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN NEW GUINEA-C COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREE C. THE FAB MOLECULES WERE ADDED TO THE VIRUS BEFORE 37 DEGREE C INCUBATION.
2000, 4uifJ, 0.5278, 3.74, 0.092, 220, 109, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
2001, 4kxzH, 0.5278, 2.68, 0.106, 226, 94, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
2002, 4gmtH, 0.5278, 2.65, 0.106, 226, 94, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1
2003, 4am0B, 0.5278, 3.53, 0.087, 215, 104, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2004, 3ze0H, 0.5278, 2.66, 0.106, 226, 94, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2005, 3x2qO, 0.5278, 3.54, 0.094, 214, 106, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
2006, 3ncyQ, 0.5278, 2.65, 0.106, 226, 94, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
2007, 3iy0H, 0.5278, 3.73, 0.100, 242, 110, VARIABLE DOMAINS OF THE X-RAY STRUCTURE OF FAB 14 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB 14 COMPLEX
2008, 2zxwO, 0.5278, 3.80, 0.091, 221, 110, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
2009, 2eijB, 0.5278, 3.83, 0.082, 221, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
2010, 1a6uH, 0.5278, 3.70, 0.083, 218, 108, B1-8 FV FRAGMENT
2011, 6qeeC, 0.5277, 3.81, 0.091, 211, 110, NANODISC RECONSTITUTED HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)-EQ MUTANT IN COMPLEX WITH UIC2 FAB AND ZOSUQUIDAR. 
2012, 6iekC, 0.5277, 3.57, 0.123, 216, 106, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
2013, 5ig7H, 0.5277, 3.59, 0.084, 211, 107, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPQQPFP
2014, 5gzoD, 0.5277, 2.66, 0.106, 226, 94, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
2015, 5girH, 0.5277, 2.68, 0.106, 226, 94, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2016, 3wiiI, 0.5277, 2.67, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF B2212A A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE THIRD FIBRONECTIN DOMAIN (FN3) OF HUMAN ROBO1.
2017, 3ffdB, 0.5277, 3.77, 0.082, 215, 110, STRUCTURE OF PARATHYROID HORMONE-RELATED PROTEIN COMPLEXED TO A NEUTRALIZING MONOCLONAL ANTIBODY
2018, 2y69O, 0.5277, 3.57, 0.075, 214, 107, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
2019, 2q8bL, 0.5277, 3.73, 0.108, 217, 111, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2020, 2gk0A, 0.5277, 2.69, 0.106, 226, 94, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2021, 2einO, 0.5277, 3.51, 0.094, 211, 106, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
2022, 1t5rD, 0.5277, 3.78, 0.082, 218, 110, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2023, 1igyA, 0.5277, 3.79, 0.082, 214, 110, STRUCTURE OF IMMUNOGLOBULIN
2024, 1fl6A, 0.5277, 3.76, 0.101, 210, 109, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2025, 6ol5B, 0.5276, 3.76, 0.101, 210, 109, STRUCTURE OF IGLB12 FAB IN COMPLEX WITH ANTI-IDIOTYPE IB3 FAB 
2026, 6nz7I, 0.5276, 3.90, 0.081, 213, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 429 B01 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968 
2027, 6jfiL, 0.5276, 3.80, 0.100, 212, 110, THE SYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
2028, 6jfhN, 0.5276, 3.73, 0.110, 220, 109, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
2029, 6jfhL, 0.5276, 3.53, 0.085, 214, 106, THE ASYMMETRIC-RECONSTRUCTED CRYO-EM STRUCTURE OF ZIKA VIRUS-FABZK2B10 COMPLEX 
2030, 6jepL, 0.5276, 2.66, 0.106, 226, 94, STRUCTURE OF A NEUTRALIZING ANTIBODY BOUND TO THE ZIKA ENVELOPE PROTEIN DOMAIN III 
2031, 6a0xG, 0.5276, 2.66, 0.106, 226, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
2032, 5x2nH, 0.5276, 3.54, 0.075, 214, 106, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2033, 5npjB, 0.5276, 3.42, 0.135, 111, 104, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2034, 5hdbE, 0.5276, 3.42, 0.135, 111, 104, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
2035, 4yk4B, 0.5276, 3.72, 0.073, 223, 109, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2036, 4xnyH, 0.5276, 3.79, 0.083, 212, 109, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08C IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
2037, 4o5iR, 0.5276, 3.55, 0.113, 212, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2038, 4d9rD, 0.5276, 3.82, 0.090, 216, 111, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2039, 3lhaA, 0.5276, 2.66, 0.106, 226, 94, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
2040, 3l7eA, 0.5276, 3.84, 0.092, 218, 109, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2041, 3idyL, 0.5276, 3.64, 0.104, 120, 106, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2042, 3idyC, 0.5276, 2.66, 0.106, 226, 94, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C2221
2043, 3gnmH, 0.5276, 2.66, 0.106, 226, 94, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
2044, 3dmmD, 0.5276, 3.62, 0.093, 120, 108, CRYSTAL STRUCTURE OF THE CD8 ALPHA BETA/H-2DD COMPLEX
2045, 3bn9C, 0.5276, 3.81, 0.100, 225, 110, CRYSTAL STRUCTURE OF MT-SP1 IN COMPLEX WITH FAB INHIBITOR E2
2046, 2dyrO, 0.5276, 3.82, 0.119, 218, 109, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2047, 1rhhA, 0.5276, 3.75, 0.130, 213, 108, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
2048, 1igfL, 0.5276, 3.53, 0.075, 213, 106, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
2049, 1acyL, 0.5276, 3.72, 0.111, 208, 108, CRYSTAL STRUCTURE OF THE PRINCIPAL NEUTRALIZING SITE OF HIV- 2 1
2050, 6fqaC, 0.5275, 3.75, 0.127, 220, 110, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
2051, 6bpaC, 0.5275, 3.72, 0.131, 217, 107, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
2052, 6b5tL, 0.5275, 2.66, 0.106, 226, 94, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
2053, 6b5sL, 0.5275, 3.62, 0.131, 213, 107, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
2054, 5xrqB, 0.5275, 3.59, 0.123, 217, 106, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
2055, 5xcqA, 0.5275, 2.67, 0.106, 226, 94, CRYSTAL STRUCTURE OF P20.1 FV-CLASP FRAGMENT WITH ITS ANTIGEN PEPTIDE
2056, 5njdO, 0.5275, 4.00, 0.062, 267, 112, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2057, 5mvjB, 0.5275, 3.65, 0.123, 213, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2058, 5ezjB, 0.5275, 3.62, 0.121, 217, 107, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - ORTHORHOMBIC FORM
2059, 3vfgL, 0.5275, 3.59, 0.112, 213, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 3F8 FAB FRAGMENT THAT BINDS TO GD2 GANGLIOSIDE
2060, 3s62H, 0.5275, 3.51, 0.085, 214, 106, STRUCTURE OF FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8 AGAINST P. VIVAX P25 PROTEIN
2061, 3jwnC, 0.5275, 3.44, 0.067, 214, 104, COMPLEX OF FIMC FIMF FIMG AND FIMH
2062, 3hi1L, 0.5275, 3.44, 0.067, 214, 104, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2063, 1rmfH, 0.5275, 3.44, 0.067, 214, 104, STRUCTURES OF A MONOCLONAL ANTI-ICAM-1 ANTIBODY R6.5 FRAGMENT AT 2.8 ANGSTROMS RESOLUTION
2064, 1rhhC, 0.5275, 3.44, 0.067, 214, 104, CRYSTAL STRUCTURE OF THE BROADLY HIV-1 NEUTRALIZING FAB X5 AT 1.90 ANGSTROM RESOLUTION
2065, 1mj8H, 0.5275, 3.67, 0.083, 223, 109, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-126
2066, 6obzB, 0.5274, 3.79, 0.082, 223, 110, CRYSTAL STRUCTURE OF FLUA-20 FAB 
2067, 6ewbE, 0.5274, 3.74, 0.091, 232, 110, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
2068, 6dwaA, 0.5274, 3.85, 0.090, 214, 111, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2069, 5wauB, 0.5274, 3.54, 0.094, 211, 106, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SYNCHROTRON X-RAY CRYSTALLOGRAPHY AT 100 K
2070, 5w42L, 0.5274, 3.81, 0.091, 234, 110, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
2071, 5o14D, 0.5274, 3.54, 0.114, 213, 105, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2072, 5npjA, 0.5274, 3.54, 0.085, 213, 106, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN JFH1 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE SINGLE CHAIN VARIABLE FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
2073, 5kg9L, 0.5274, 3.44, 0.039, 283, 103, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
2074, 5eocJ, 0.5274, 3.62, 0.084, 213, 107, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2075, 5ds8L, 0.5274, 3.68, 0.074, 214, 108, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE
2076, 4yk4Y, 0.5274, 3.68, 0.074, 214, 108, HUMAN ANTIBODY 641 I-9 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
2077, 4uimH, 0.5274, 3.81, 0.091, 218, 110, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2078, 4uikH, 0.5274, 3.72, 0.101, 123, 109, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1
2079, 4rirA, 0.5274, 3.59, 0.084, 210, 107, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
2080, 4o5lL, 0.5274, 2.67, 0.106, 226, 94, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092
2081, 4irzL, 0.5274, 3.53, 0.113, 215, 106, CRYSTAL STRUCTURE OF A4B7 HEADPIECE COMPLEXED WITH FAB NATALIZUMAB
2082, 3ulvH, 0.5274, 3.57, 0.113, 219, 106, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
2083, 3ag4B, 0.5274, 3.55, 0.104, 215, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE CYANIDE ION-BOUND FULLY REDUCED STATE AT 100 K
2084, 2xg4A, 0.5274, 3.31, 0.087, 228, 103, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 2C
2085, 2qscL, 0.5274, 3.63, 0.103, 212, 107, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3-FAB F425-B4E8 IN COMPLEX WITH A V3-PEPTIDE
2086, 2dysO, 0.5274, 3.58, 0.103, 212, 107, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
2087, 2dysB, 0.5274, 3.57, 0.103, 212, 107, BOVINE HEART CYTOCHROME C OXIDASE MODIFIED BY DCCD
2088, 2dyrB, 0.5274, 3.56, 0.104, 212, 106, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2089, 1ymhB, 0.5274, 3.76, 0.091, 166, 110, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2090, 1rz8A, 0.5274, 3.50, 0.086, 213, 105, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 17B
2091, 1ngxL, 0.5274, 3.55, 0.151, 218, 106, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2092, 1ngxA, 0.5274, 3.60, 0.103, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
2093, 6i8sH, 0.5273, 3.49, 0.105, 211, 105, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
2094, 6fn4C, 0.5273, 3.69, 0.101, 215, 109, APO FORM OF UIC2 FAB COMPLEX OF HUMAN-MOUSE CHIMERIC ABCB1 (ABCB1HM)
2095, 6dc8H, 0.5273, 2.80, 0.094, 199, 96, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
2096, 6a0xE, 0.5273, 3.55, 0.113, 215, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 
2097, 5wk3S, 0.5273, 3.84, 0.088, 216, 113, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN CCL17 AND M116 FAB
2098, 5ukoL, 0.5273, 3.54, 0.104, 215, 106, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522IA FAB
2099, 5k9kB, 0.5273, 3.81, 0.101, 216, 109, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2100, 5iy5O, 0.5273, 3.53, 0.085, 213, 106, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
2101, 5dtfL, 0.5273, 3.86, 0.082, 195, 110, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
2102, 4rqqH, 0.5273, 3.49, 0.124, 217, 105, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2103, 4r96D, 0.5273, 2.68, 0.106, 226, 94, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
2104, 4o5iT, 0.5273, 3.56, 0.113, 212, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2105, 4kq4L, 0.5273, 3.53, 0.094, 215, 106, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
2106, 4iytA, 0.5273, 3.73, 0.091, 232, 110, STRUCTURE OF THE Y184A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2107, 3lh9A, 0.5273, 3.72, 0.120, 218, 108, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2108, 2ombB, 0.5273, 3.81, 0.110, 214, 109, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(1)21 CRYSTAL FORM
2109, 1yedA, 0.5273, 3.73, 0.065, 211, 108, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2110, 1ocrO, 0.5273, 3.55, 0.094, 211, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
2111, 1fl6L, 0.5273, 3.76, 0.091, 222, 110, THE HAPTEN COMPLEXED GERMLINE PRECURSOR TO SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4
2112, 1cicB, 0.5273, 3.80, 0.091, 218, 110, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
2113, 1ahwD, 0.5273, 3.73, 0.073, 219, 109, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2114, 6dc7H, 0.5272, 3.54, 0.114, 215, 105, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
2115, 5x19O, 0.5272, 3.44, 0.076, 208, 105, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
2116, 5o14L, 0.5272, 3.68, 0.074, 225, 108, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
2117, 4ztpL, 0.5272, 2.68, 0.106, 226, 94, FAB STRUCTURE OF RABBIT MONOCLONAL ANTIBODY R53 TARGETING AN EPITOPE IN HIV-1 GP120 C4 REGION
2118, 4r96F, 0.5272, 3.04, 0.121, 216, 99, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
2119, 4p2aA, 0.5272, 3.50, 0.094, 215, 106, STRUCTURE OF MOUSE VPS26A BOUND TO RAT SNX27 PDZ DOMAIN
2120, 4n8cH, 0.5272, 2.67, 0.106, 226, 94, THREE-DIMENSIONAL STRUCTURE OF THE EXTRACELLULAR DOMAIN OF MATRIX PROTEIN 2 OF INFLUENZA A VIRUS
2121, 3ze1E, 0.5272, 2.67, 0.106, 226, 94, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2122, 3p0yL, 0.5272, 2.68, 0.106, 226, 94, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAIN III OF EGFR EXTRACELLULAR REGION
2123, 3o0rH, 0.5272, 3.70, 0.092, 218, 109, CRYSTAL STRUCTURE OF NITRIC OXIDE REDUCTASE FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2124, 3kj6H, 0.5272, 3.47, 0.143, 214, 105, CRYSTAL STRUCTURE OF A METHYLATED BETA2 ADRENERGIC RECEPTOR- FAB COMPLEX
2125, 3j93H, 0.5272, 3.63, 0.093, 213, 107, FITTING OF FAB INTO THE CRYOEM DENSITY MAP OF EV71 PROCAPSID IN COMPLEX WITH FAB22A12
2126, 3j3zH, 0.5272, 3.63, 0.093, 213, 107, STRUCTURE OF MA28-7 NEUTRALIZING ANTIBODY FAB FRAGMENT FROM ELECTRON CRYO-MICROSCOPY OF ENTEROVIRUS 71 COMPLEXED WITH A FAB FRAGMENT
2127, 3hi1A, 0.5272, 3.79, 0.073, 214, 109, STRUCTURE OF HIV-1 GP120 (CORE WITH V3) IN COMPLEX WITH CD4-BINDING- SITE ANTIBODY F105
2128, 3gk8H, 0.5272, 3.82, 0.100, 225, 110, X-RAY CRYSTAL STRUCTURE OF THE FAB FROM MAB 14 MOUSE ANTIBODY AGAINST CANINE PARVOVIRUS
2129, 3cviH, 0.5272, 3.79, 0.110, 217, 109, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2130, 2j5lB, 0.5272, 3.67, 0.083, 223, 109, STRUCTURE OF A PLASMODIUM FALCIPARUM APICAL MEMBRANE ANTIGEN 1-FAB F8.12.19 COMPLEX
2131, 1yedL, 0.5272, 3.69, 0.074, 221, 108, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2132, 1ocrB, 0.5272, 3.45, 0.096, 211, 104, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
2133, 1clzL, 0.5272, 3.55, 0.113, 215, 106, IGG FAB (IGG3 KAPPA) FRAGMENT (MBR96) COMPLEXED WITH LEWIS Y NONOATE METHYL ESTER
2134, 6jmrC, 0.5271, 2.67, 0.106, 226, 94, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
2135, 6b5pL, 0.5271, 3.68, 0.074, 211, 108, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
2136, 6al0L, 0.5271, 3.63, 0.074, 240, 108, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 267 
2137, 5trpL, 0.5271, 3.71, 0.073, 213, 109, CRYSTAL STRUCTURE OF THE UNLIGANDED DH270 COOPERATING LINEAGE MEMBER DH272
2138, 5t5nG, 0.5271, 3.54, 0.114, 213, 105, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2139, 5kg9B, 0.5271, 3.56, 0.104, 214, 106, CRYSTAL STRUCTURE OF THE GP120 V2 ANTIBODY RE505-22 FAB FROM IGH- AND IGK-HUMANIZED MOUSE
2140, 5dlmL, 0.5271, 3.98, 0.062, 275, 112, COMPLEX OF INFLUENZA M2E AND ANTIBODY
2141, 5b3sB, 0.5271, 3.62, 0.085, 286, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND MIXED- VALENCE STATE AT 1.68 ANGSTROM RESOLUTION (50 K)
2142, 4uimA, 0.5271, 3.53, 0.076, 216, 105, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2143, 4uilH, 0.5271, 3.61, 0.142, 219, 106, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.1 WITH QUININE
2144, 4rgoL, 0.5271, 2.68, 0.106, 227, 94, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 14G8
2145, 4g6mL, 0.5271, 3.63, 0.121, 217, 107, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB
2146, 4am0D, 0.5271, 3.76, 0.118, 217, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2147, 3fo2A, 0.5271, 3.61, 0.103, 214, 107, CRYSTAL STRUCTURE OF HAPTEN COMPLEX OF CATALYTIC ELIMINATION ANTIBODY 13G5 (GLU(L39)GLN MUTANT)
2148, 3fmgH, 0.5271, 3.85, 0.109, 210, 110, STRUCTURE OF ROTAVIRUS OUTER CAPSID PROTEIN VP7 TRIMER IN COMPLEX WITH A NEUTRALIZING FAB
2149, 3ag2B, 0.5271, 2.70, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 100 K
2150, 3ag1O, 0.5271, 3.54, 0.094, 212, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
2151, 2r4sH, 0.5271, 3.50, 0.113, 216, 106, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2152, 6nmfO, 0.5270, 3.87, 0.081, 213, 111, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
2153, 6mftB, 0.5270, 3.65, 0.066, 287, 106, CRYSTAL STRUCTURE OF GLYCOSYLATED 426C HIV-1 GP120 CORE G459C IN COMPLEX WITH GLVRC01 A60C HEAVY CHAIN 
2154, 6j8mB, 0.5270, 3.81, 0.082, 220, 110, LOW-DOSE STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE DETERMINED USING 30 KEV X-RAY 
2155, 6ch7D, 0.5270, 3.85, 0.090, 216, 111, XFEL CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED BG505 SOSIP.664 HIV- 1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
2156, 5zcpB, 0.5270, 3.60, 0.084, 213, 107, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
2157, 5tztB, 0.5270, 3.80, 0.082, 225, 110, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
2158, 5t5nI, 0.5270, 3.75, 0.110, 217, 109, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2159, 5t1kA, 0.5270, 3.75, 0.083, 220, 109, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
2160, 5sx4I, 0.5270, 3.75, 0.083, 220, 109, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2161, 5mvjD, 0.5270, 3.55, 0.113, 215, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2162, 5mp1D, 0.5270, 3.75, 0.083, 220, 109, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2163, 5dtfB, 0.5270, 3.70, 0.092, 213, 109, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98.61 IN COMPLEX WITH HYPUSINE
2164, 4z7oH, 0.5270, 3.50, 0.105, 212, 105, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2165, 4r7dB, 0.5270, 3.61, 0.142, 219, 106, FAB HU 15C1
2166, 3ze2H, 0.5270, 2.68, 0.106, 227, 94, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2167, 3zdyH, 0.5270, 3.55, 0.142, 219, 106, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2168, 3p0vM, 0.5270, 3.88, 0.072, 214, 111, ANTI-EGFR/HER3 FAB DL11 ALONE
2169, 3jb4B, 0.5270, 3.49, 0.123, 211, 106, STRUCTURE OF LJUNGAN VIRUS: INSIGHT INTO PICORNAVIRUS PACKAGING
2170, 3j7eL, 0.5270, 3.65, 0.130, 213, 108, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2171, 3j7eH, 0.5270, 3.65, 0.121, 217, 107, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2172, 3j7eE, 0.5270, 3.77, 0.100, 211, 110, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2173, 3j7eD, 0.5270, 3.75, 0.120, 218, 108, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2174, 3j7eC, 0.5270, 3.62, 0.132, 217, 106, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2175, 3j7eB, 0.5270, 2.70, 0.106, 226, 94, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2176, 3j7eA, 0.5270, 3.77, 0.091, 224, 110, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2177, 3g04B, 0.5270, 3.83, 0.091, 218, 110, CRYSTAL STRUCTURE OF THE TSH RECEPTOR IN COMPLEX WITH A THYROID- STIMULATING AUTOANTIBODY
2178, 3dpaA, 0.5270, 3.59, 0.103, 212, 107, CRYSTAL STRUCTURE OF CHAPERONE PROTEIN PAPD REVEALS AN IMMUNOGLOBULIN FOLD
2179, 2w07A, 0.5270, 3.55, 0.075, 213, 106, STRUCTURAL DETERMINANTS OF POLYMERIZATION REACTIVITY OF THE P PILUS ADAPTOR SUBUNIT PAPF
2180, 1eapB, 0.5270, 3.54, 0.113, 212, 106, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
2181, 6bftB, 0.5269, 3.62, 0.121, 216, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2182, 6attL, 0.5269, 3.79, 0.082, 221, 110, 39S FAB BOUND TO HER2 ECD 
2183, 6anaH, 0.5269, 2.68, 0.106, 226, 94, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
2184, 6a3wA, 0.5269, 2.71, 0.106, 226, 94, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2185, 5z86B, 0.5269, 3.75, 0.110, 217, 109, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 3 DAYS 
2186, 5lx9H, 0.5269, 2.72, 0.106, 226, 94, CRYSTAL STRUCTURE OF HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID AT 2.4 ANGSTROM RESOLUTION
2187, 5ggqL, 0.5269, 3.46, 0.106, 209, 104, CRYSTAL STRUCTURE OF NIVOLUMAB FAB FRAGMENT
2188, 5ff6A, 0.5269, 2.70, 0.106, 226, 94, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
2189, 5eukA, 0.5269, 3.95, 0.053, 226, 113, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
2190, 5d6cA, 0.5269, 2.70, 0.106, 226, 94, STRUCTURE OF 4497 FAB BOUND TO SYNTHETIC WALL TEICHOIC ACID FRAGMENT
2191, 5b1bB, 0.5269, 3.60, 0.113, 218, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE AT 1.6 ANGSTROM RESOLUTION
2192, 4pb9L, 0.5269, 3.78, 0.100, 211, 110, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB64
2193, 3ze0E, 0.5269, 3.55, 0.094, 213, 106, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2194, 3zdzH, 0.5269, 3.53, 0.085, 213, 106, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2195, 3zdzE, 0.5269, 3.50, 0.162, 218, 105, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2196, 3vw3L, 0.5269, 3.56, 0.151, 218, 106, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
2197, 3fzuL, 0.5269, 3.68, 0.074, 214, 108, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2198, 3cjiC, 0.5269, 3.83, 0.090, 216, 111, STRUCTURE OF SENECA VALLEY VIRUS-001
2199, 2eilB, 0.5269, 3.60, 0.093, 211, 107, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
2200, 2dblH, 0.5269, 3.86, 0.090, 216, 111, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2201, 1ztxH, 0.5269, 3.84, 0.090, 216, 111, WEST NILE VIRUS ENVELOPE PROTEIN DIII IN COMPLEX WITH NEUTRALIZING E16 ANTIBODY FAB
2202, 1igyC, 0.5269, 3.59, 0.084, 212, 107, STRUCTURE OF IMMUNOGLOBULIN
2203, 6mtoH, 0.5268, 3.91, 0.028, 222, 108, CRYSTAL STRUCTURE OF VRC42.01 FAB IN COMPLEX WITH T117-F MPER SCAFFOLD 
2204, 6ce0D, 0.5268, 3.54, 0.095, 115, 105, CRYSTAL STRUCTURE OF A HIV-1 CLADE B TIER-3 ISOLATE H078.14 UFO-BG ENV TRIMER IN COMPLEX WITH BROADLY NEUTRALIZING FABS PGT124 AND 35O22 AT 4.6 ANGSTROM 
2205, 6apbL, 0.5268, 3.65, 0.103, 121, 107, CRYSTAL STRUCTURE OF NON-NEUTRALIZING INFANT ANTIBODY ADI-14359 IN COMPLEX WITH POSTFUSION RSV F GLYCOPROTEIN
2206, 5x2qH, 0.5268, 3.54, 0.095, 115, 105, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2207, 5x2mH, 0.5268, 3.65, 0.103, 121, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2208, 5wuxD, 0.5268, 3.54, 0.095, 115, 105, TNFALPHA-CERTOLIZUMAB FAB
2209, 5mp5D, 0.5268, 3.65, 0.103, 121, 107, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2210, 5mp1L, 0.5268, 3.54, 0.095, 115, 105, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2211, 5iblH, 0.5268, 3.69, 0.074, 215, 108, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2212, 5cusN, 0.5268, 3.08, 0.111, 218, 99, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
2213, 4z7oE, 0.5268, 3.04, 0.111, 215, 99, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2214, 4rqqD, 0.5268, 3.81, 0.100, 216, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
2215, 4r7dJ, 0.5268, 3.54, 0.094, 214, 106, FAB HU 15C1
2216, 3l7eL, 0.5268, 3.56, 0.113, 220, 106, CRYSTAL STRUCTURE OF ANTI-IL-13 ANTIBODY C836
2217, 3j7eF, 0.5268, 3.77, 0.101, 208, 109, ELECTRON CRYO-MICROSCOPY OF HUMAN PAPILLOMAVIRUS 16 AND H16.V5 FAB FRAGMENTS
2218, 3cleH, 0.5268, 3.61, 0.066, 116, 106, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ23
2219, 2eimO, 0.5268, 2.70, 0.106, 226, 94, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
2220, 2eimB, 0.5268, 3.75, 0.100, 228, 110, ZINC ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY REDUCED STATE
2221, 2eilO, 0.5268, 3.52, 0.085, 211, 106, CADMIUM ION BINDING STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE
2222, 2b1hL, 0.5268, 3.55, 0.094, 213, 106, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2223, 6cs3C, 0.5267, 3.54, 0.094, 212, 106, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EXPANDED 1 PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) 
2224, 5zcqB, 0.5267, 3.50, 0.124, 219, 105, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 10 MM AZIDE SOLUTION FOR 2 DAYS 
2225, 5z85B, 0.5267, 2.69, 0.106, 226, 94, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE ANOTHER BATCH CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 2 DAYS 
2226, 5x2pH, 0.5267, 3.61, 0.123, 216, 106, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2227, 5nb5M, 0.5267, 3.85, 0.090, 216, 111, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
2228, 5mvzH, 0.5267, 3.83, 0.090, 216, 111, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
2229, 5gisH, 0.5267, 3.84, 0.090, 216, 111, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
2230, 5cusL, 0.5267, 3.55, 0.142, 215, 106, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
2231, 5az2L, 0.5267, 3.53, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 9E5 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR HUMAN EPIREGULIN
2232, 4uimC, 0.5267, 4.33, 0.054, 268, 112, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2233, 4okvC, 0.5267, 2.69, 0.106, 226, 94, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
2234, 4nwwA, 0.5267, 3.70, 0.092, 219, 109, CRYSTAL STRUCTURE OF AN N-TERMINALLY TRUNCATED CAPSID PROTEIN MUTANT OF ORSAY VIRUS
2235, 4m6nL, 0.5267, 3.81, 0.091, 219, 110, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
2236, 4l5fL, 0.5267, 3.66, 0.123, 213, 106, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
2237, 4jo3M, 0.5267, 3.79, 0.064, 219, 110, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB IN COMPLEX WITH V3 C-TERMINUS OF HIV-1 CONSENSUS B GP120
2238, 4g80B, 0.5267, 3.81, 0.045, 240, 112, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
2239, 4dwhA, 0.5267, 3.55, 0.075, 212, 106, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
2240, 4am0L, 0.5267, 3.80, 0.082, 219, 110, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2241, 3wfbH, 0.5267, 3.79, 0.082, 219, 110, REDUCED CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2242, 3ujtI, 0.5267, 3.52, 0.085, 201, 106, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
2243, 3phoA, 0.5267, 3.55, 0.151, 218, 106, CRYSTAL STRUCTURE OF S64-4 IN COMPLEX WITH PSBP
2244, 3p0vL, 0.5267, 3.58, 0.151, 218, 106, ANTI-EGFR/HER3 FAB DL11 ALONE
2245, 3nifE, 0.5267, 3.72, 0.074, 216, 108, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2246, 3lqaL, 0.5267, 3.39, 0.117, 184, 103, CRYSTAL STRUCTURE OF CLADE C GP120 IN COMPLEX WITH SCD4 AND 21C FAB
2247, 3f8uB, 0.5267, 3.85, 0.090, 216, 111, TAPASIN/ERP57 HETERODIMER
2248, 2nr6F, 0.5267, 3.71, 0.073, 237, 109, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2249, 2gsiC, 0.5267, 3.56, 0.094, 212, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2250, 1yedH, 0.5267, 3.54, 0.085, 213, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
2251, 1qblH, 0.5267, 3.63, 0.084, 121, 107, FAB E8 (FABE8A) X-RAY STRUCTURE AT 2.26 ANGSTROM RESOLUTION
2252, 1mlcD, 0.5267, 3.78, 0.080, 218, 112, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
2253, 1igiH, 0.5267, 2.67, 0.106, 226, 94, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
2254, 6ewbG, 0.5266, 2.67, 0.106, 226, 94, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
2255, 6enyC, 0.5266, 2.68, 0.106, 226, 94, STRUCTURE OF THE HUMAN PLC EDITING MODULE
2256, 6e0pM, 0.5266, 3.44, 0.105, 215, 105, CRYO-EM STRUCTURE OF THE CENTROMERIC NUCLEOSOME (NATIVE ALPHA SATELLITE DNA) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
2257, 6c08B, 0.5266, 4.62, 0.068, 233, 118, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2258, 5zcoB, 0.5266, 2.70, 0.106, 226, 94, AZIDE-BOUND CYTOCHROME C OXIDASE STRUCTURE DETERMINED USING THE CRYSTALS EXPOSED TO 2 MM AZIDE SOLUTION FOR 2 DAYS 
2259, 5xdxB, 0.5266, 2.70, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN THE REDUCED STATE WITH PH 7.3 AT 1.99 ANGSTROM RESOLUTION
2260, 5vlpH, 0.5266, 3.79, 0.082, 219, 110, PCSK9 COMPLEX WITH LDLR ANTAGONIST PEPTIDE AND FAB7G7
2261, 5ubzL, 0.5266, 3.56, 0.104, 218, 106, FAB STRUCTURE OF HIV GP120 SPECIFIC MAB 1E12
2262, 5ifjK, 0.5266, 3.73, 0.074, 221, 108, CRYSTAL STRUCTURE OF ANTI-GLIADIN 1002-1E01 FAB FRAGMENT IN COMPLEX OF PEPTIDE PLQPEQPFP
2263, 4z0xB, 0.5266, 3.73, 0.111, 210, 108, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 434-446 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HC26AM
2264, 4nwvA, 0.5266, 3.42, 0.106, 185, 104, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
2265, 4nrxL, 0.5266, 3.56, 0.103, 213, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2266, 4nobA, 0.5266, 3.78, 0.091, 221, 110, CRYSTAL STRUCTURE OF THE 1ST IG DOMAIN FROM MOUSE POLYMERIC IMMUNOGLOBULIN RECEPTOR [PSI-NYSGRC-006220]
2267, 4lciH, 0.5266, 3.86, 0.119, 215, 109, ANTI CANINE CD28 ANTIBODY 1C6
2268, 4f3fB, 0.5266, 4.52, 0.026, 341, 114, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
2269, 4am0F, 0.5266, 3.67, 0.139, 216, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2270, 3wfcH, 0.5266, 3.60, 0.103, 213, 107, REDUCED AND CARBONMONOXIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2271, 3i9gH, 0.5266, 3.68, 0.083, 214, 108, CRYSTAL STRUCTURE OF THE LT1009 (SONEPCIZUMAB) ANTIBODY FAB FRAGMENT IN COMPLEX WITH SPHINGOSINE-1-PHOSPHATE
2272, 2b4cL, 0.5266, 3.51, 0.075, 211, 106, CRYSTAL STRUCTURE OF HIV-1 JR-FL GP120 CORE PROTEIN CONTAINING THE THIRD VARIABLE REGION (V3) COMPLEXED WITH CD4 AND THE X5 ANTIBODY
2273, 1uywN, 0.5266, 2.82, 0.094, 197, 96, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2274, 1ngwB, 0.5266, 3.56, 0.113, 212, 106, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2275, 1mjjH, 0.5266, 3.81, 0.091, 225, 110, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2276, 1mjjA, 0.5266, 3.87, 0.101, 207, 109, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2277, 1mimH, 0.5266, 3.58, 0.112, 216, 107, IGG FAB FRAGMENT (CD25-BINDING)
2278, 1klfO, 0.5266, 3.59, 0.084, 212, 107, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2279, 1klfM, 0.5266, 3.85, 0.090, 216, 111, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2280, 1klfK, 0.5266, 3.51, 0.114, 213, 105, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
2281, 1jv5B, 0.5266, 4.34, 0.069, 361, 116, ANTI-BLOOD GROUP A FV
2282, 1i9iL, 0.5266, 3.76, 0.091, 213, 110, NATIVE CRYSTAL STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
2283, 6jbtH, 0.5265, 3.58, 0.113, 215, 106, COMPLEX STRUCTURE OF TORIPALIMAB-FAB AND PD-1 
2284, 6id4L, 0.5265, 3.78, 0.092, 226, 109, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
2285, 6e62L, 0.5265, 3.76, 0.100, 219, 110, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
2286, 6dcvB, 0.5265, 3.84, 0.082, 218, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2287, 6dcvA, 0.5265, 3.85, 0.080, 217, 112, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2288, 6bzuF, 0.5265, 3.88, 0.082, 211, 110, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
2289, 5z84B, 0.5265, 4.19, 0.052, 364, 115, THE STRUCTURE OF AZIDE-BOUND CYTOCHROME C OXIDASE DETERMINED USING THE CRYSTALS EXPOSED TO 20 MM AZIDE SOLUTION FOR 4 DAYS 
2290, 5x2oH, 0.5265, 3.61, 0.093, 229, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2291, 5w97b, 0.5265, 3.53, 0.113, 215, 106, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
2292, 5tztL, 0.5265, 2.71, 0.106, 226, 94, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B161
2293, 4z7qH, 0.5265, 2.69, 0.106, 226, 94, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2294, 4otxL, 0.5265, 3.79, 0.091, 220, 110, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
2295, 4laqL, 0.5265, 3.48, 0.105, 213, 105, CRYSTAL STRUCTURES OF A THERAPEUTIC SINGLE CHAIN ANTIBODY IN THE FREE FORM AND IN COMPLEX WITH AMPHETAMINE AND 4-HYDROXYMETHAMPHETAMINE
2296, 4janA, 0.5265, 3.75, 0.130, 213, 108, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH103 IN COMPLEX WITH HIV-1 GP120
2297, 4i2xC, 0.5265, 3.71, 0.064, 121, 109, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
2298, 4alaL, 0.5265, 4.46, 0.035, 355, 114, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2299, 3zdxH, 0.5265, 3.55, 0.085, 213, 106, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2300, 3mlwH, 0.5265, 3.54, 0.085, 112, 106, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
2301, 3l7fL, 0.5265, 3.69, 0.093, 120, 108, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2302, 3hfmL, 0.5265, 3.78, 0.083, 219, 109, STRUCTURE OF AN ANTIBODY-ANTIGEN COMPLEX. CRYSTAL STRUCTURE OF THE HY/HEL-10 FAB-LYSOZYME COMPLEX
2303, 3abmB, 0.5265, 3.55, 0.113, 212, 106, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (200-S X-RAY EXPOSURE DATASET)
2304, 2ojzH, 0.5265, 3.78, 0.082, 225, 110, ANTI-DNA ANTIBODY ED10
2305, 2gsiG, 0.5265, 3.72, 0.065, 222, 108, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
2306, 1za6F, 0.5265, 3.55, 0.123, 215, 106, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
2307, 1mh5B, 0.5265, 3.54, 0.123, 211, 106, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
2308, 1iaiL, 0.5265, 3.81, 0.091, 216, 110, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
2309, 1cz8L, 0.5265, 3.75, 0.101, 209, 109, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
2310, 1b6dA, 0.5265, 3.59, 0.123, 218, 106, BENCE JONES PROTEIN DEL: AN ENTIRE IMMUNOGLOBULIN KAPPA LIGHT-CHAIN DIMER
2311, 6icfL, 0.5264, 3.72, 0.102, 215, 108, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 263 AND 266 
2312, 6e0cM, 0.5264, 2.89, 0.103, 205, 97, CRYO-EM STRUCTURE OF THE CENP-A NUCLEOSOME (W601) IN COMPLEX WITH A SINGLE CHAIN ANTIBODY FRAGMENT 
2313, 6dw2A, 0.5264, 2.89, 0.103, 205, 97, STRUCTURE OF THE 6078 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
2314, 6cdmA, 0.5264, 2.89, 0.103, 205, 97, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2315, 5z62B, 0.5264, 3.65, 0.112, 117, 107, STRUCTURE OF HUMAN CYTOCHROME C OXIDASE 
2316, 5w0kH, 0.5264, 3.61, 0.132, 219, 106, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2317, 5tz2H, 0.5264, 3.63, 0.074, 217, 108, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF C47B222
2318, 5t5nK, 0.5264, 3.89, 0.091, 216, 110, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2319, 5mvjF, 0.5264, 3.81, 0.128, 213, 109, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2320, 5mp5L, 0.5264, 3.74, 0.073, 226, 109, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2321, 5mhrN, 0.5264, 3.50, 0.133, 220, 105, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2322, 4z7nH, 0.5264, 3.51, 0.123, 214, 106, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2323, 4wuuD, 0.5264, 2.70, 0.106, 226, 94, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
2324, 4rdqI, 0.5264, 3.80, 0.082, 219, 110, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2325, 4r7dH, 0.5264, 2.68, 0.106, 226, 94, FAB HU 15C1
2326, 4plkI, 0.5264, 3.60, 0.113, 219, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2327, 3x2qB, 0.5264, 3.85, 0.090, 216, 111, X-RAY STRUCTURE OF CYANIDE-BOUND BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 2.0 ANGSTROM RESOLUTION
2328, 3wg7B, 0.5264, 3.58, 0.113, 211, 106, A 1.9 ANGSTROM RADIATION DAMAGE FREE X-RAY STRUCTURE OF LARGE (420KDA) PROTEIN BY FEMTOSECOND CRYSTALLOGRAPHY
2329, 3wfdH, 0.5264, 3.56, 0.190, 118, 105, REDUCED AND ACETALDOXIME-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2330, 3vacB, 0.5264, 3.83, 0.082, 218, 110, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
2331, 3t3pH, 0.5264, 3.65, 0.121, 214, 107, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2332, 3ncyP, 0.5264, 3.65, 0.121, 212, 107, X-RAY CRYSTAL STRUCTURE OF AN ARGININE AGMATINE ANTIPORTER (ADIC) IN COMPLEX WITH A FAB FRAGMENT
2333, 3fzuD, 0.5264, 3.83, 0.090, 216, 111, IGG1 FAB CHARACTERIZED BY H/D EXCHANGE
2334, 3fctC, 0.5264, 3.72, 0.093, 228, 108, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2335, 3bt2H, 0.5264, 3.56, 0.094, 213, 106, STRUCTURE OF UROKINASE RECEPTOR UROKINASE AND VITRONECTIN COMPLEX
2336, 3ag1B, 0.5264, 3.56, 0.104, 214, 106, BOVINE HEART CYTOCHROME C OXIDASE IN THE CARBON MONOXIDE-BOUND FULLY REDUCED STATE AT 280 K
2337, 2oslB, 0.5264, 2.71, 0.106, 226, 94, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2338, 2nr6E, 0.5264, 3.65, 0.073, 216, 110, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2339, 1figL, 0.5264, 3.59, 0.104, 215, 106, ROUTES TO CATALYSIS: STRUCTURE OF A CATALYTIC ANTIBODY AND COMPARISON WITH ITS NATURAL COUNTERPART
2340, 1ai1L, 0.5264, 3.80, 0.091, 324, 110, HIV-1 V3 LOOP MIMIC
2341, 6fy3Y, 0.5263, 3.73, 0.101, 172, 109, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2342, 6eyoH, 0.5263, 3.55, 0.113, 214, 106, STRUCTURE OF EXTENDED IGE-FC IN COMPLEX WITH TWO ANTI-IGE FABS 
2343, 6ewbJ, 0.5263, 3.54, 0.094, 213, 106, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
2344, 6dcwL, 0.5263, 3.55, 0.104, 212, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
2345, 6bfsL, 0.5263, 3.64, 0.150, 213, 107, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2346, 5mp5F, 0.5263, 3.68, 0.093, 229, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2347, 5mp1K, 0.5263, 3.57, 0.085, 213, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2348, 5iy5B, 0.5263, 3.78, 0.100, 218, 110, ELECTRON TRANSFER COMPLEX OF CYTOCHROME C AND CYTOCHROME C OXIDASE AT 2.0 ANGSTROM RESOLUTION
2349, 5eziL, 0.5263, 2.63, 0.128, 227, 94, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - HEXAGONAL FORM
2350, 5eocH, 0.5263, 3.85, 0.100, 213, 110, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
2351, 5b4mD, 0.5263, 3.76, 0.073, 213, 109, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2352, 5alcL, 0.5263, 3.79, 0.100, 211, 110, TICAGRELOR ANTIDOTE CANDIDATE FAB 72 IN COMPLEX WITH TICAGRELOR
2353, 4q0xH, 0.5263, 3.56, 0.151, 218, 106, CRYSTAL STRUCTURE OF NON-NEUTRALIZING ANTIBODY IN COMPLEX WITH EPITOPE II OF HCV E2
2354, 4lkcA, 0.5263, 3.56, 0.151, 218, 106, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
2355, 4d9qD, 0.5263, 3.81, 0.062, 214, 112, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
2356, 4cadE, 0.5263, 3.84, 0.090, 216, 111, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
2357, 3ze2E, 0.5263, 3.49, 0.096, 212, 104, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2358, 3wfeH, 0.5263, 3.79, 0.100, 211, 110, REDUCED AND CYANIDE-BOUND CYTOCHROME C-DEPENDENT NITRIC OXIDE REDUCTASE (CNOR) FROM PSEUDOMONAS AERUGINOSA IN COMPLEX WITH ANTIBODY FRAGMENT
2359, 3vi4F, 0.5263, 3.56, 0.094, 212, 106, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
2360, 3vacA, 0.5263, 3.77, 0.093, 218, 108, CRYSTAL STRUCTURE OF THE CFA/I ENTEROTOXIGENIC E. COLI ADHESIN CFAE MUTANT G168D
2361, 3uluH, 0.5263, 2.70, 0.106, 226, 94, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM1)
2362, 3t3mE, 0.5263, 2.71, 0.106, 226, 94, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2363, 3ra7M, 0.5263, 3.78, 0.082, 225, 110, BISPECIFIC DIGOXIGENIN BINDING ANTIBODIES FOR TARGETED PAYLOAD DELIVERY
2364, 3okmA, 0.5263, 4.22, 0.070, 356, 115, CRYSTAL STRUCTURE OF UNLIGANDED S25-39
2365, 3nigE, 0.5263, 3.83, 0.090, 216, 111, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2366, 2j2zA, 0.5263, 3.88, 0.091, 219, 110, X-RAY STRUCTURE OF THE CHAPERONE PAPD IN COMPLEX WITH THE PILUS TERMINATOR SUBUNIT PAPH AT 2.3 ANGSTROM RESOLUTION
2367, 1seqL, 0.5263, 3.56, 0.075, 213, 106, FAB MNAC13
2368, 1ngwH, 0.5263, 3.63, 0.084, 213, 107, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
2369, 6iuvL, 0.5262, 3.81, 0.082, 212, 110, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
2370, 6i8sF, 0.5262, 2.70, 0.106, 226, 94, DISCOVERY AND CHARACTERISATION OF AN ANTIBODY THAT SELECTIVELY MODULATES THE INHIBITORY ACTIVITY OF PLASMINOGEN ACTIVATOR INHIBITOR- 1 
2371, 6f7tA, 0.5262, 3.48, 0.133, 213, 105, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
2372, 6cd2A, 0.5262, 3.61, 0.121, 211, 107, CRYSTAL STRUCTURE OF THE PAPC USHER BOUND TO THE CHAPERONE-ADHESIN PAPD-PAPG 
2373, 6awnB, 0.5262, 3.59, 0.113, 215, 106, X-RAY STRUCTURE OF THE S439T HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
2374, 5w0kL, 0.5262, 3.55, 0.104, 215, 106, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2375, 5vl3H, 0.5262, 3.67, 0.120, 202, 108, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
2376, 5uxqL, 0.5262, 3.70, 0.101, 204, 109, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
2377, 5i1jH, 0.5262, 3.86, 0.082, 207, 110, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-11
2378, 5i1aA, 0.5262, 3.56, 0.123, 219, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
2379, 4zd3H, 0.5262, 3.55, 0.104, 212, 106, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY FAB FRAGMENT
2380, 4y2oA, 0.5262, 3.56, 0.151, 216, 106, STRUCTURE OF CFA/I PILI CHAPERONE-MAJOR SUBUNIT COMPLEX (CFAA-CFAB)
2381, 4nrxB, 0.5262, 3.58, 0.151, 218, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
2382, 4m7kH, 0.5262, 2.70, 0.106, 226, 94, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
2383, 4g80F, 0.5262, 3.62, 0.103, 214, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
2384, 4g6kL, 0.5262, 3.95, 0.108, 212, 111, CRYSTAL STRUCTURE OF THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF GEVOKIZUMAB IN ITS UNBOUND STATE
2385, 4dvbB, 0.5262, 3.55, 0.104, 218, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
2386, 4dkfM, 0.5262, 3.34, 0.068, 210, 103, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
2387, 4dkeM, 0.5262, 3.76, 0.082, 216, 110, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2388, 3t3pE, 0.5262, 3.54, 0.085, 213, 106, A NOVEL HIGH AFFINITY INTEGRIN ALPHAIIBBETA3 RECEPTOR ANTAGONIST THAT UNEXPECTEDLY DISPLACES MG2+ FROM THE BETA3 MIDAS
2389, 3p11L, 0.5262, 3.55, 0.085, 213, 106, ANTI-EGFR/HER3 FAB DL11 IN COMPLEX WITH DOMAINS I-III OF THE HER3 EXTRACELLULAR REGION
2390, 3f8uD, 0.5262, 3.70, 0.083, 220, 109, TAPASIN/ERP57 HETERODIMER
2391, 3difB, 0.5262, 3.84, 0.090, 216, 111, CRYSTAL STRUCTURE OF FABOX117
2392, 3cvhQ, 0.5262, 3.78, 0.082, 225, 110, HOW TCR-LIKE ANTIBODY RECOGNIZES MHC-BOUND PEPTIDE
2393, 3be1L, 0.5262, 3.83, 0.082, 218, 110, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH THE EXTRACELLULAR DOMAIN OF HER2/ERBB-2
2394, 2zxwB, 0.5262, 4.22, 0.070, 356, 115, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (1-S X- RAY EXPOSURE DATASET)
2395, 2xg5A, 0.5262, 3.77, 0.073, 225, 109, E. COLI P PILUS CHAPERONE-SUBUNIT COMPLEX PAPD-PAPH BOUND TO PILUS BIOGENESIS INHIBITOR PILICIDE 5D
2396, 2uy7E, 0.5262, 3.84, 0.090, 214, 111, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2397, 2q8aL, 0.5262, 3.57, 0.085, 211, 106, STRUCTURE OF THE MALARIA ANTIGEN AMA1 IN COMPLEX WITH A GROWTH- INHIBITORY ANTIBODY
2398, 2oslL, 0.5262, 3.58, 0.113, 215, 106, CRYSTAL STRUCTURE OF RITUXIMAB FAB IN COMPLEX WITH AN EPITOPE PEPTIDE
2399, 1kcsL, 0.5262, 3.84, 0.090, 214, 111, CRYSTAL STRUCTURE OF ANTIBODY PC282 IN COMPLEX WITH PS1 PEPTIDE
2400, 1jpsL, 0.5262, 3.07, 0.111, 216, 99, CRYSTAL STRUCTURE OF TISSUE FACTOR IN COMPLEX WITH HUMANIZED FAB D3H44
2401, 6fq0C, 0.5261, 3.48, 0.124, 208, 105, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
2402, 6bfqD, 0.5261, 3.81, 0.091, 216, 110, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2403, 6aynA, 0.5261, 3.51, 0.114, 215, 105, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
2404, 5x2mJ, 0.5261, 3.79, 0.073, 214, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
2405, 5wkzL, 0.5261, 3.75, 0.121, 217, 107, VH1-69 GERMLINE ANTIBODY PREDICTED FROM CR6261 
2406, 5ukrL, 0.5261, 3.07, 0.121, 215, 99, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB IN COMPLEX WITH A GP120 CORE
2407, 5tlkB, 0.5261, 3.77, 0.091, 218, 110, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
2408, 5k9kL, 0.5261, 3.63, 0.112, 210, 107, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 IN COMPLEX WITH HEMAGGLUTININ HONG KONG 1968.
2409, 5icyA, 0.5261, 3.78, 0.082, 214, 110, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
2410, 5i30H, 0.5261, 3.60, 0.104, 209, 106, CRYSTAL STRUCTURE OF THE HUMAN ASTROVIRUS 2 NEUTRALIZING MONOCLONAL ANTIBODY PL-2 FAB FRAGMENT AT 1.9 A RESOLUTION
2411, 5hdbH, 0.5261, 3.76, 0.073, 213, 109, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH RO-435054
2412, 5hcgH, 0.5261, 3.55, 0.085, 211, 106, CRYSTAL STRUCTURE OF FREE-CODV.
2413, 4ziqA, 0.5261, 3.73, 0.073, 199, 109, CRYSTAL STRUCTURE OF TRYPSIN ACTIVATED ALPHA-2-MACROGLOBULIN FROM ESCHERICHIA COLI.
2414, 4z7nE, 0.5261, 3.41, 0.087, 211, 104, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV PEPTIDE
2415, 4mzrB, 0.5261, 3.55, 0.085, 207, 106, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
2416, 4mxvL, 0.5261, 3.78, 0.101, 228, 109, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2417, 4ktdL, 0.5261, 3.52, 0.075, 211, 106, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE136 FROM NON-HUMAN PRIMATE
2418, 4ki5E, 0.5261, 3.56, 0.075, 212, 106, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
2419, 4ag4H, 0.5261, 3.68, 0.112, 215, 107, CRYSTAL STRUCTURE OF A DDR1-FAB COMPLEX
2420, 3nigH, 0.5261, 3.53, 0.104, 207, 106, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2421, 3na9H, 0.5261, 3.52, 0.075, 212, 106, CRYSTAL STRUCTURE OF FAB15
2422, 3jwnI, 0.5261, 3.85, 0.090, 214, 111, COMPLEX OF FIMC FIMF FIMG AND FIMH
2423, 3iu4L, 0.5261, 3.56, 0.085, 211, 106, ANTI NEUGCGM3 GANGLIOSIDE CHIMERIC ANTIBODY CHP3
2424, 3difD, 0.5261, 4.34, 0.069, 361, 116, CRYSTAL STRUCTURE OF FABOX117
2425, 3asoB, 0.5261, 3.82, 0.082, 211, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 0.9 ANGSTROM WAVELENGTH
2426, 3asnB, 0.5261, 3.83, 0.117, 210, 111, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE MEASURED AT 1.7470 ANGSTROM WAVELENGTH
2427, 2y69B, 0.5261, 3.62, 0.102, 216, 108, BOVINE HEART CYTOCHROME C OXIDASE RE-REFINED WITH MOLECULAR OXYGEN
2428, 2vxqL, 0.5261, 2.70, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE MAJOR GRASS POLLEN ALLERGEN PHL P 2 IN COMPLEX WITH ITS SPECIFIC IGE-FAB
2429, 2uy7A, 0.5261, 3.06, 0.121, 216, 99, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2430, 1q72L, 0.5261, 3.07, 0.111, 216, 99, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH COCAINE
2431, 1mh5H, 0.5261, 3.55, 0.132, 214, 106, THE STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF THE ESTEROLYTIC ANTIBODY MS6-164 AND A TRANSITION-STATE ANALOG
2432, 6mdtD, 0.5260, 3.48, 0.133, 213, 105, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P63 SPACE GROUP 
2433, 6cdoB, 0.5260, 3.53, 0.123, 214, 106, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP16.02 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
2434, 6bftL, 0.5260, 3.61, 0.093, 213, 107, STRUCTURE OF BEVACIZUMAB FAB MUTANT IN COMPLEX WITH VEGF 
2435, 6bfqB, 0.5260, 3.39, 0.087, 207, 103, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2436, 6a4kL, 0.5260, 3.57, 0.094, 213, 106, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
2437, 5xkuB, 0.5260, 3.55, 0.094, 212, 106, CRYSTAL STRUCTURE OF HEMAGGLUTININ GLOBULAR HEAD FROM AN H7N9 INFLUENZA VIRUS IN COMPLEX WITH A NEUTRALIZING ANTIBODY HNIGGA6
2438, 5xdqB, 0.5260, 3.80, 0.082, 217, 110, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE WITH PH 7.3 AT 1.77 ANGSTROM RESOLUTION
2439, 5t5nO, 0.5260, 3.37, 0.078, 212, 103, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2440, 5mp5B, 0.5260, 3.39, 0.087, 210, 103, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
2441, 5hysD, 0.5260, 3.79, 0.083, 212, 109, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2442, 5fb8B, 0.5260, 3.56, 0.113, 215, 106, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
2443, 4x8jB, 0.5260, 3.56, 0.094, 212, 106, CRYSTAL STRUCTURE OF MURINE 12F4 FAB MONOCLONAL ANTIBODY AGAINST ADAMTS5
2444, 4rdqO, 0.5260, 3.73, 0.082, 212, 110, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2445, 4r7nD, 0.5260, 3.83, 0.090, 216, 111, FAB C2E3
2446, 4oqtL, 0.5260, 3.74, 0.091, 332, 110, LINGO-1/LI81 FAB COMPLEX
2447, 4i2xA, 0.5260, 3.45, 0.067, 1450, 104, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
2448, 4bh8B, 0.5260, 3.86, 0.090, 216, 111, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE GDPRPSYISHLL
2449, 4bh7B, 0.5260, 3.89, 0.074, 234, 108, CRYSTAL STRUCTURE OF GERMLINE ANTIBODY 36-65 IN COMPLEX WITH PEPTIDE PPYPAWHAPGNI
2450, 3mxwL, 0.5260, 3.54, 0.094, 211, 106, CRYSTAL STRUCTURE SONIC HEDGEHOG BOUND TO THE 5E1 FAB FRAGMENT
2451, 3lh9B, 0.5260, 3.90, 0.109, 216, 110, CRYSTAL STRUCTURE OF MOUSE VPS26B(L197S/R199E) IN SPACEGROUP P41 21 2
2452, 3l7fA, 0.5260, 3.84, 0.073, 224, 110, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2453, 3eoaL, 0.5260, 3.89, 0.127, 209, 110, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
2454, 2b0sL, 0.5260, 3.83, 0.090, 216, 111, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
2455, 1ncbH, 0.5260, 3.74, 0.073, 225, 109, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2456, 1ahwA, 0.5260, 2.91, 0.113, 198, 97, A COMPLEX OF EXTRACELLULAR DOMAIN OF TISSUE FACTOR WITH AN INHIBITORY FAB (5G9)
2457, 6h3hC, 0.5259, 3.62, 0.093, 213, 107, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
2458, 6a4kO, 0.5259, 3.81, 0.082, 213, 110, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
2459, 5yupL, 0.5259, 2.70, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF FVIIA ANTIBODY MAB4F5 
2460, 5ye3A, 0.5259, 2.70, 0.106, 226, 94, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 2A7D9 FAB FRAGMENT 
2461, 5vjqF, 0.5259, 2.71, 0.106, 227, 94, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2462, 5t3sD, 0.5259, 3.58, 0.093, 213, 107, HIV GP140 TRIMER MD39-10MUTA IN COMPLEX WITH FABS PGT124 AND 35022
2463, 5njdU, 0.5259, 3.07, 0.111, 216, 99, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2464, 5hyqA, 0.5259, 3.55, 0.152, 218, 105, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
2465, 5dubB, 0.5259, 3.74, 0.101, 190, 109, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
2466, 5b1aB, 0.5259, 3.82, 0.045, 240, 112, BOVINE HEART CYTOCHROME C OXIDASE IN THE FULLY OXIDIZED STATE AT 1.5 ANGSTROM RESOLUTION
2467, 4z7qE, 0.5259, 3.62, 0.123, 219, 106, INTEGRIN ALPHAIIBBETA3 IN COMPLEX WITH AGDV-NH2 PEPTIDE
2468, 4xr8D, 0.5259, 3.55, 0.085, 213, 106, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
2469, 4r7dN, 0.5259, 3.57, 0.094, 212, 106, FAB HU 15C1
2470, 4np4I, 0.5259, 3.66, 0.151, 216, 106, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
2471, 4jo2L, 0.5259, 3.55, 0.075, 211, 106, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
2472, 3j6lB, 0.5259, 2.71, 0.106, 226, 94, KINETIC AND STRUCTURAL ANALYSIS OF COXSACKIEVIRUS B3 RECEPTOR INTERACTIONS AND FORMATION OF THE A-PARTICLE
2473, 3fctD, 0.5259, 3.79, 0.100, 211, 110, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
2474, 2r4rH, 0.5259, 3.56, 0.151, 217, 106, CRYSTAL STRUCTURE OF THE HUMAN BETA2 ADRENOCEPTOR
2475, 2gk0L, 0.5259, 3.56, 0.085, 217, 106, STRUCTURE OF CATALYTIC ELIMINATION ANTIBODY 13G5 FROM A TWINNED CRYSTAL IN SPACE GROUP C2
2476, 2b1hH, 0.5259, 3.83, 0.091, 223, 110, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG29 PEPTIDE
2477, 1q9wC, 0.5259, 3.58, 0.132, 214, 106, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2478, 1ncdL, 0.5259, 3.79, 0.100, 211, 110, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
2479, 1mhhB, 0.5259, 3.57, 0.094, 211, 106, ANTIBODY-ANTIGEN COMPLEX
2480, 1f5wB, 0.5259, 3.57, 0.104, 214, 106, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN
2481, 1dbjH, 0.5259, 3.63, 0.112, 214, 107, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
2482, 6o3bA, 0.5258, 3.82, 0.082, 218, 110, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F6 FAB 
2483, 6k7oC, 0.5258, 3.84, 0.082, 218, 110, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2484, 6eayL, 0.5258, 3.54, 0.094, 212, 106, STRUCTURAL BASIS FOR BROAD NEUTRALIZATION OF EBOLAVIRUSES BY AN ANTIBODY TARGETING THE GLYCOPROTEIN FUSION LOOP 
2485, 5wcaL, 0.5258, 3.80, 0.083, 288, 108, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING INFLUENZA A ANTIBODY VRC 315 27-1C08 FAB.
2486, 5ur8B, 0.5258, 3.63, 0.093, 213, 107, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
2487, 5jhlH, 0.5258, 3.55, 0.085, 214, 106, CRYSTAL STRUCTURE OF ZIKA VIRUS ENVELOPE PROTEIN IN COMPLEX WITH A FLAVIVIRUS BROADLY-PROTECTIVE ANTIBODY
2488, 5bk5A, 0.5258, 3.46, 0.105, 215, 105, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2489, 4xzuE, 0.5258, 3.74, 0.101, 221, 109, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
2490, 4mzrC, 0.5258, 3.64, 0.103, 214, 107, CRYSTAL STRUCTURE OF A POLYPEPTIDE P53 MUTANT BOUND TO DNA
2491, 4lu5L, 0.5258, 3.75, 0.082, 214, 110, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
2492, 4krpC, 0.5258, 3.67, 0.151, 216, 106, NANOBODY/VHH DOMAIN 9G8 IN COMPLEX WITH THE EXTRACELLULAR REGION OF EGFR
2493, 4dn3L, 0.5258, 3.63, 0.104, 215, 106, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
2494, 4bkaC, 0.5258, 3.53, 0.104, 213, 106, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5
2495, 3nacH, 0.5258, 3.56, 0.104, 212, 106, CRYSTAL STRUCTURE OF FAB15 MUT7
2496, 3l7fD, 0.5258, 3.83, 0.045, 240, 112, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
2497, 3d85A, 0.5258, 3.50, 0.086, 215, 105, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
2498, 2occO, 0.5258, 3.56, 0.094, 213, 106, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2499, 1bj1J, 0.5258, 3.68, 0.074, 214, 108, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2500, 6medD, 0.5257, 2.71, 0.106, 226, 94, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2501, 6mamB, 0.5257, 3.86, 0.090, 214, 111, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2502, 6i9iB, 0.5257, 3.86, 0.065, 199, 108, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
2503, 6fq0A, 0.5257, 3.62, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE CSUC-CSUA/B CHAPERONE-SUBUNIT PREASSEMBLY COMPLEX OF THE ARCHAIC CHAPERONE-USHER CSU PILI OF ACINETOBACTER BAUMANNII 
2504, 6eynL, 0.5257, 3.86, 0.073, 221, 109, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2505, 6dcvL, 0.5257, 3.54, 0.104, 216, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2506, 6bliB, 0.5257, 4.00, 0.062, 121, 113, RSV G PEPTIDE BOUND TO FAB CB002.5
2507, 6a0zH, 0.5257, 3.83, 0.091, 216, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 BOUND TO H5N1 INFLUENZA HEMAGGLUTININ; HA HEAD REGION 
2508, 5xtiWD, 0.5257, 3.76, 0.110, 217, 109, struct.pdbx_descriptor              
2509, 5xtiUA, 0.5257, 3.61, 0.132, 217, 106, struct.pdbx_descriptor              
2510, 5xthUA, 0.5257, 3.73, 0.074, 226, 108, struct.pdbx_descriptor              
2511, 5x2nJ, 0.5257, 3.57, 0.142, 219, 106, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
2512, 5vshF, 0.5257, 3.64, 0.121, 214, 107, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2513, 5vshD, 0.5257, 3.76, 0.092, 215, 109, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2514, 5t5nM, 0.5257, 4.00, 0.062, 121, 113, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 (BEST1) TRIPLE MUTANT: I76A F80A F84A; IN COMPLEX WITH AN FAB ANTIBODY FRAGMENT CHLORIDE AND CALCIUM
2515, 5otjB, 0.5257, 3.74, 0.091, 219, 110, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2516, 5lufy, 0.5257, 3.56, 0.085, 213, 106, CRYO-EM OF BOVINE RESPIRASOME
2517, 5h2bB, 0.5257, 3.75, 0.056, 218, 108, STRUCTURE OF A NOVEL ANTIBODY G196
2518, 5gupVB, 0.5257, 3.61, 0.094, 211, 106, 
2519, 5gpnIB, 0.5257, 3.53, 0.093, 211, 107, 
2520, 5f9wB, 0.5257, 3.55, 0.065, 215, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
2521, 5dubL, 0.5257, 3.77, 0.089, 216, 112, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH DEOXYHYPUSINE
2522, 5dqdL, 0.5257, 3.57, 0.113, 219, 106, STRUCTURE OF S55-5 FAB IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
2523, 4rdqG, 0.5257, 3.70, 0.083, 208, 108, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2524, 4mxvE, 0.5257, 3.92, 0.073, 234, 109, STRUCTURE OF LYMPHOTOXIN ALPHA BOUND TO ANTI-LTA FAB
2525, 4j1uA, 0.5257, 3.59, 0.132, 219, 106, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
2526, 4hpoL, 0.5257, 3.55, 0.094, 211, 106, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58 IN COMPLEX WITH V2 PEPTIDE
2527, 4hfuH, 0.5257, 3.53, 0.094, 214, 106, CRYSTAL STRUCTURE OF FAB 8M2 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
2528, 4alaH, 0.5257, 3.97, 0.036, 136, 112, STRUCTURE OF DENGUE VIRUS DIII IN COMPLEX WITH FAB 2H12
2529, 2ybbM, 0.5257, 3.75, 0.083, 225, 109, FITTED MODEL FOR BOVINE  MITOCHONDRIAL SUPERCOMPLEX I1III2IV1 BY SINGLE PARTICLE CRYO-EM (EMD-1876)
2530, 2occB, 0.5257, 3.57, 0.094, 213, 106, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2531, 2fatH, 0.5257, 3.57, 0.094, 213, 106, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
2532, 2f19H, 0.5257, 2.71, 0.106, 227, 94, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
2533, 1vpoL, 0.5257, 3.55, 0.085, 213, 106, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB IN COMPLEX WITH TESTOSTERONE
2534, 1t04D, 0.5257, 3.58, 0.066, 212, 106, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
2535, 1occO, 0.5257, 3.81, 0.055, 215, 109, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2536, 1occB, 0.5257, 3.52, 0.094, 216, 106, STRUCTURE OF BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE
2537, 1moeA, 0.5257, 3.39, 0.087, 206, 103, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
2538, 1jnlH, 0.5257, 3.56, 0.104, 217, 106, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
2539, 1i9rK, 0.5257, 3.49, 0.133, 220, 105, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2540, 1a6tB, 0.5257, 3.56, 0.085, 214, 106, FAB FRAGMENT OF MAB1-IA MONOCLONAL ANTIBODY TO HUMAN RHINOVIRUS 14 NIM-IA SITE
2541, 1a4jB, 0.5257, 3.69, 0.083, 223, 109, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
2542, 6j11D, 0.5256, 2.71, 0.106, 227, 94, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
2543, 6f7tL, 0.5256, 2.71, 0.106, 227, 94, CRYSTAL STRUCTURE OF AN FAB FRAGMENT IN COMPLEX WITH A PEPTIDE FROM BACILLUS SUBTILIS RNASE Y 
2544, 6ellB, 0.5256, 2.71, 0.106, 227, 94, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2545, 6c08E, 0.5256, 3.80, 0.082, 219, 110, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2546, 6bckH, 0.5256, 3.53, 0.094, 211, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY N49P7 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057 GP120 CORE. 
2547, 5w6dD, 0.5256, 3.53, 0.094, 211, 106, CRYSTAL STRUCTURE OF BG505-SOSIP.V4.1-GT1-N137A IN COMPLEX WITH FABS 35022 AND 9H/109L
2548, 5w23H, 0.5256, 3.80, 0.100, 211, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2549, 5ukpL, 0.5256, 3.78, 0.082, 222, 110, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.1 FAB
2550, 5tljF, 0.5256, 2.71, 0.106, 227, 94, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND M2191
2551, 5t1mA, 0.5256, 3.57, 0.142, 211, 106, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
2552, 5mg7A, 0.5256, 2.71, 0.106, 227, 94, P53-DNA COMPLEX 7 
2553, 5kanL, 0.5256, 2.71, 0.106, 227, 94, CRYSTAL STRUCTURE OF MULTIDONOR HV1-18-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 16.G.07 IN COMPLEX WITH A/HONG KONG/1-4-MA21- 1/1968 (H3N2) HEMAGGLUTININ
2554, 5iv2A, 0.5256, 3.74, 0.064, 220, 109, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
2555, 5iblC, 0.5256, 3.75, 0.065, 211, 108, HUMAN ANTIBODY 6639 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 X-181
2556, 5f88A, 0.5256, 3.56, 0.113, 217, 106, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
2557, 5ezoL, 0.5256, 3.79, 0.100, 211, 110, CRYSTAL STRUCTURE OF PFCYRPA IN COMPLEX WITH AN INVASION-INHIBITORY ANTIBODY FAB.
2558, 5ewiL, 0.5256, 3.61, 0.084, 211, 107, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90
2559, 4r7nJ, 0.5256, 3.58, 0.085, 210, 106, FAB C2E3
2560, 4q2zL, 0.5256, 3.67, 0.120, 213, 108, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
2561, 4nryL, 0.5256, 3.76, 0.082, 224, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2562, 4gxuN, 0.5256, 3.88, 0.080, 208, 113, CRYSTAL STRUCTURE OF ANTIBODY 1F1 BOUND TO THE 1918 INFLUENZA HEMAGGLUTININ
2563, 3tt1H, 0.5256, 2.71, 0.106, 227, 94, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2564, 3sobL, 0.5256, 2.71, 0.106, 227, 94, THE STRUCTURE OF THE FIRST YWTD BETA PROPELLER DOMAIN OF LRP6 IN COMPLEX WITH A FAB
2565, 3iu3A, 0.5256, 3.81, 0.082, 214, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
2566, 3hi6Y, 0.5256, 3.80, 0.082, 221, 110, CRYSTAL STRUCTURE OF INTERMEDIATE AFFINITY I DOMAIN OF INTEGRIN LFA-1 WITH THE FAB FRAGMENT OF ITS ANTIBODY AL-57
2567, 3difA, 0.5256, 3.67, 0.112, 219, 107, CRYSTAL STRUCTURE OF FABOX117
2568, 3dggB, 0.5256, 3.77, 0.083, 218, 109, CRYSTAL STRUCTURE OF FABOX108
2569, 3ablB, 0.5256, 2.71, 0.106, 227, 94, BOVINE HEART CYTOCHROME C OXIDASE AT THE FULLY OXIDIZED STATE (15-S X-RAY EXPOSURE DATASET)
2570, 2arjL, 0.5256, 2.71, 0.106, 227, 94, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2571, 1zglT, 0.5256, 3.50, 0.114, 240, 105, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
2572, 1rzgA, 0.5256, 3.76, 0.101, 216, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120 REACTIVE ANTIBODY 412D
2573, 1rfdL, 0.5256, 3.77, 0.091, 219, 110, ANTI-COCAINE ANTIBODY M82G2
2574, 1nccL, 0.5256, 3.79, 0.091, 217, 110, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
2575, 1beyL, 0.5256, 3.71, 0.093, 217, 108, ANTIBODY TO CAMPATH-1H HUMANIZED FAB
2576, 6nmpO, 0.5255, 3.56, 0.113, 120, 106, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
2577, 6nmfB, 0.5255, 3.75, 0.121, 218, 107, SFX STRUCTURE OF REDUCED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
2578, 6nknO, 0.5255, 3.57, 0.085, 213, 106, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
2579, 6gk7L, 0.5255, 3.54, 0.113, 215, 106, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
2580, 6dwcA, 0.5255, 3.59, 0.083, 222, 108, STRUCTURE OF THE APO 4497 ANTIBODY FAB FRAGMENT 
2581, 5w0kF, 0.5255, 3.81, 0.045, 223, 112, CRYSTAL STRUCTURE OF EBV GHGL/CL40/GP42 N-DOMAIN
2582, 5t1lA, 0.5255, 3.77, 0.092, 219, 109, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
2583, 5otjH, 0.5255, 3.37, 0.097, 210, 103, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
2584, 5occL, 0.5255, 3.69, 0.093, 219, 107, CRYSTAL STRUCTURE OF CD32B (FC GAMMA RECEPTOR IIB) IN COMPLEX WITH HUMAN IGG1 FAB FRAGMENT (6G08) 
2585, 5i19L, 0.5255, 3.55, 0.094, 213, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV1-39
2586, 5bzdC, 0.5255, 3.84, 0.056, 199, 108, CRYSTAL STRUCTURE OF PCDN-27A AN ANTIBODY FROM THE PCDN FAMILY OF HIV-1 ANTIBODIES
2587, 4ynyB, 0.5255, 3.59, 0.075, 214, 106, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
2588, 4uifH, 0.5255, 3.56, 0.094, 213, 106, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 IN COMPLEX WITH ANTIGEN-BINDING FRAGMENTS OF HUMAN ANTIBODY 2D22
2589, 4s1sH, 0.5255, 3.65, 0.075, 216, 107, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H5.F-185917 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
2590, 4r7nF, 0.5255, 3.56, 0.085, 213, 106, FAB C2E3
2591, 4nryB, 0.5255, 3.63, 0.103, 213, 107, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
2592, 4ffzY, 0.5255, 3.55, 0.104, 217, 106, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2593, 4dvbL, 0.5255, 3.57, 0.094, 211, 106, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF PRO-UPA ANTIBODY MAB-112
2594, 3hnsH, 0.5255, 3.52, 0.095, 212, 105, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL HEXASACCHARIDE
2595, 2uylY, 0.5255, 3.56, 0.085, 207, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2596, 2b1aL, 0.5255, 3.51, 0.077, 213, 104, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
2597, 2arjA, 0.5255, 3.76, 0.100, 212, 110, CD8ALPHA-ALPHA IN COMPLEX WITH YTS 105.18 FAB
2598, 1qygL, 0.5255, 3.53, 0.085, 213, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH BENZOYLECGONINE
2599, 1ocoO, 0.5255, 3.72, 0.102, 215, 108, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
2600, 1ocoB, 0.5255, 3.55, 0.094, 209, 106, BOVINE HEART CYTOCHROME C OXIDASE IN CARBON MONOXIDE-BOUND STATE
2601, 1mlbB, 0.5255, 3.64, 0.121, 213, 107, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
2602, 1mfdH, 0.5255, 3.72, 0.101, 212, 109, THE SOLUTION STRUCTURE OF A TRISACCHARIDE-ANTIBODY COMPLEX: COMPARISON OF NMR MEASUREMENTS WITH A CRYSTAL STRUCTURE
2603, 1fj1A, 0.5255, 2.72, 0.106, 226, 94, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2604, 1ct8C, 0.5255, 3.54, 0.113, 211, 106, CATALYTIC ANTIBODY 7C8 COMPLEX
2605, 6medI, 0.5254, 3.78, 0.110, 226, 109, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2606, 6e9qB, 0.5254, 3.76, 0.073, 223, 110, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
2607, 6c08D, 0.5254, 3.56, 0.152, 218, 105, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2608, 5mx3H, 0.5254, 3.55, 0.123, 214, 106, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
2609, 5ikcH, 0.5254, 3.55, 0.085, 214, 106, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2610, 5icxA, 0.5254, 2.69, 0.106, 226, 94, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
2611, 5ibtH, 0.5254, 2.72, 0.106, 226, 94, UCA FAB (UNBOUND) FROM 6515 LINEAGE
2612, 5f89B, 0.5254, 2.70, 0.106, 226, 94, STRUCTURE OF THE UNLIGANDED FAB FROM HIV-1 NEUTRALISING ANTIBODY CAP248-2B THAT BINDS TO THE GP120 C-TERMINUS - GP41 INTERFACE
2613, 5bmfL, 0.5254, 3.56, 0.133, 216, 105, CRYSTAL STRUCTURE OF A THEOPHYLLINE BINDING ANTIBODY FAB FRAGMENT
2614, 4xr8C, 0.5254, 3.55, 0.123, 217, 106, CRYSTAL STRUCTURE OF THE HPV16 E6/E6AP/P53 TERNARY COMPLEX AT 2.25 A RESOLUTION
2615, 4x7tB, 0.5254, 3.64, 0.112, 212, 107, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2616, 4uimE, 0.5254, 3.57, 0.085, 213, 106, CRYSTAL STRUCTURE OF QUININE-DEPENDENT FAB 314.3
2617, 4tsbL, 0.5254, 3.79, 0.082, 222, 110, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
2618, 4rdqM, 0.5254, 3.48, 0.132, 216, 106, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2619, 4o5iV, 0.5254, 3.55, 0.075, 213, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2620, 4ffvH, 0.5254, 3.66, 0.121, 214, 107, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
2621, 3zdxE, 0.5254, 3.71, 0.159, 209, 107, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
2622, 3nidH, 0.5254, 3.44, 0.135, 111, 104, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2623, 3hntH, 0.5254, 3.76, 0.110, 228, 109, CS-35 FAB COMPLEX WITH A LINEAR TERMINAL OLIGOARABINOFURANOSYL TETRASACCHARIDE FROM LIPOARABINOMANNAN
2624, 3difC, 0.5254, 3.57, 0.094, 211, 106, CRYSTAL STRUCTURE OF FABOX117
2625, 2ok0H, 0.5254, 3.55, 0.085, 205, 106, FAB ED10-DNA COMPLEX
2626, 1ymhD, 0.5254, 3.54, 0.133, 216, 105, ANTI-HCV FAB 19D9D6 COMPLEXED WITH PROTEIN L (PPL) MUTANT A66W
2627, 1rziL, 0.5254, 3.75, 0.111, 215, 108, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
2628, 1qppA, 0.5254, 3.80, 0.082, 220, 110, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
2629, 1ngzB, 0.5254, 3.87, 0.133, 213, 113, CHIMERIC GERMLINE FAB 7G12-APO
2630, 1nakM, 0.5254, 3.49, 0.104, 215, 106, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2631, 1kzyA, 0.5254, 3.55, 0.113, 211, 106, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
2632, 1fj1C, 0.5254, 3.56, 0.162, 218, 105, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
2633, 1c5dA, 0.5254, 2.71, 0.106, 227, 94, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
2634, 6jmqC, 0.5253, 2.71, 0.106, 227, 94, LAT1-CD98HC COMPLEX BOUND TO MEM-108 FAB 
2635, 6igoF, 0.5253, 3.80, 0.082, 218, 110, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
2636, 6eynC, 0.5253, 3.79, 0.100, 211, 110, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2637, 6e63C, 0.5253, 3.51, 0.094, 213, 106, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
2638, 6c08A, 0.5253, 3.61, 0.093, 214, 107, ZEBRAFISH SLC38A9 WITH ARGININE BOUND IN THE CYTOSOL OPEN STATE 
2639, 6bjzL, 0.5253, 3.59, 0.066, 213, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY CONTAINING THE FLUORESCENT NON-CANONICAL AMINO ACID L-(7- HYDROXYCOUMARIN-4-YL)ETHYLGLYCINE AT PH 5.5 
2640, 6a3wG, 0.5253, 3.42, 0.135, 215, 104, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2641, 5vl3C, 0.5253, 3.77, 0.045, 214, 112, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
2642, 5n4gH, 0.5253, 3.72, 0.083, 219, 109, HUMAN FAB FRAGMENT 12E1 AGAINST NHBA FROM NEISSERIA MENINGITIDIS
2643, 5mg7B, 0.5253, 3.74, 0.101, 214, 109, P53-DNA COMPLEX 7 
2644, 5j74B, 0.5253, 3.61, 0.093, 212, 107, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
2645, 5ikcB, 0.5253, 3.74, 0.074, 218, 108, X-RAY STRUCTURE OF THE N-TERMINAL DOMAIN OF HUMAN DOUBLECORTIN IN COMPLEX WITH FAB
2646, 5id0A, 0.5253, 3.48, 0.096, 222, 104, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
2647, 5hysL, 0.5253, 3.58, 0.142, 216, 106, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2648, 5gjtL, 0.5253, 3.87, 0.065, 199, 108, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/WASHINGTON/05/2011 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
2649, 5g64M, 0.5253, 3.55, 0.094, 218, 106, THE COMPLEX BETWEEN HUMAN IGE-FC AND TWO ANTI-IGE FAB FRAGMENTS
2650, 5ecgB, 0.5253, 3.81, 0.091, 224, 110, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
2651, 5ds8B, 0.5253, 3.49, 0.133, 214, 105, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU98 IN COMPLEX WITH HYPUSINE
2652, 4x7sL, 0.5253, 3.82, 0.100, 211, 110, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 1
2653, 4s1rH, 0.5253, 3.56, 0.114, 213, 105, CRYSTAL STRUCTURE OF A VRC01-LINEAGE ANTIBODY 45-VRC01.H08.F-117225 IN COMPLEX WITH CLADE A/E HIV-1 GP120 CORE
2654, 4r7nH, 0.5253, 3.78, 0.082, 209, 110, FAB C2E3
2655, 4nztH, 0.5253, 3.86, 0.090, 216, 111, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
2656, 4m6nH, 0.5253, 3.83, 0.090, 216, 111, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 6.5
2657, 4lexL, 0.5253, 3.81, 0.082, 220, 110, UNLIGANDED CRYSTAL STRUCTURE OF MAB7
2658, 4jzjA, 0.5253, 3.64, 0.121, 214, 107, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2659, 4ffzL, 0.5253, 3.73, 0.107, 216, 112, CRYSTAL STRUCTURE OF DENV1-E111 FAB FRAGMENT BOUND TO DENV-1 DIII (WESTERN PACIFIC-74 STRAIN).
2660, 3nzhL, 0.5253, 3.73, 0.092, 218, 109, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 5F6 FAB
2661, 3hmxH, 0.5253, 3.80, 0.073, 215, 110, CRYSTAL STRUCTURE OF USTEKINUMAB FAB/IL-12 COMPLEX
2662, 2nyyC, 0.5253, 2.98, 0.102, 207, 98, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY CR1
2663, 2j12B, 0.5253, 3.88, 0.100, 220, 110, AD37 FIBRE HEAD IN COMPLEX WITH CAR D1
2664, 1ynlH, 0.5253, 3.58, 0.142, 217, 106, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETERNERS: CRYSTAL STRUCTURE OF NC6.8 CO- CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
2665, 1tupC, 0.5253, 4.00, 0.055, 195, 109, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
2666, 1tsrC, 0.5253, 3.50, 0.094, 213, 106, P53 CORE DOMAIN IN COMPLEX WITH DNA
2667, 1riuL, 0.5253, 3.52, 0.123, 213, 106, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH NORBENZOYLECGONINE
2668, 1k6qH, 0.5253, 3.85, 0.082, 214, 110, CRYSTAL STRUCTURE OF ANTIBODY FAB FRAGMENT D3
2669, 1h3pL, 0.5253, 3.79, 0.119, 119, 109, STRUCTURAL CHARACTERISATION OF A MONOCLONAL ANTIBODY SPECIFIC FOR THE PRES1 REGION OF THE HEPATITIS B VIRUS
2670, 1bqhH, 0.5253, 3.56, 0.104, 207, 106, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
2671, 1bj1L, 0.5253, 3.68, 0.111, 212, 108, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH A NEUTRALIZING ANTIBODY
2672, 6hkgB, 0.5252, 3.69, 0.045, 214, 111, STRUCTURE OF FISW84 FAB FRAGMENT 
2673, 6fy3X, 0.5252, 3.63, 0.093, 214, 107, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
2674, 6foeB, 0.5252, 3.63, 0.066, 116, 106, BAXB01 FAB FRAGMENT
2675, 6dcvH, 0.5252, 3.78, 0.082, 212, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 
2676, 6azkA, 0.5252, 3.77, 0.083, 216, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
2677, 5x2pJ, 0.5252, 3.84, 0.056, 199, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
2678, 5wk2H, 0.5252, 3.46, 0.096, 233, 104, CRYSTAL STRUCTURE OF ANTI-CCL17 ANTIBODY M116
2679, 5w97B, 0.5252, 3.68, 0.102, 210, 108, CRYSTAL STRUCTURE OF CO-BOUND CYTOCHROME C OXIDASE DETERMINED BY SERIAL FEMTOSECOND X-RAY CRYSTALLOGRAPHY AT ROOM TEMPERATURE
2680, 5vzxL, 0.5252, 3.57, 0.094, 212, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2681, 5vqmD, 0.5252, 3.56, 0.075, 217, 106, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
2682, 5o1rM, 0.5252, 3.55, 0.085, 211, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2683, 5mevL, 0.5252, 3.64, 0.084, 214, 107, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 21
2684, 5kmvL, 0.5252, 3.99, 0.064, 183, 109, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2685, 5j74A, 0.5252, 3.72, 0.093, 211, 108, FLUOROGEN ACTIVATING PROTEIN AM2.2 IN COMPLEX WITH TO1-2P
2686, 5i66B, 0.5252, 3.54, 0.094, 218, 106, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2687, 5f6iC, 0.5252, 3.84, 0.082, 235, 110, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH428 FROM A RHESUS MACAQUE
2688, 5cezD, 0.5252, 3.65, 0.093, 211, 107, CRYSTAL STRUCTURE OF THE BG505 SOSIP GP140 HIV-1 ENV TRIMER IN COMPLEX WITH AN EARLY PUTATIVE PRECURSOR OF THE PGT121 FAMILY AT 3.0 ANGSTROM
2689, 5c0nD, 0.5252, 3.69, 0.073, 222, 109, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
2690, 4rdqK, 0.5252, 3.77, 0.080, 213, 112, CALCIUM-ACTIVATED CHLORIDE CHANNEL BESTROPHIN-1 FROM CHICKEN IN COMPLEX WITH FAB ANTIBODY FRAGMENTS CHLORIDE AND CALCIUM
2691, 4plkJ, 0.5252, 3.61, 0.104, 217, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2692, 4ojfL, 0.5252, 3.73, 0.083, 214, 109, HUMANISED 3D6 FAB COMPLEXED TO AMYLOID BETA 1-8
2693, 4od3L, 0.5252, 3.58, 0.123, 216, 106, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.07 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2694, 4o5iP, 0.5252, 3.54, 0.104, 214, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2695, 4o5iN, 0.5252, 3.75, 0.073, 217, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2696, 4iycC, 0.5252, 3.61, 0.084, 216, 107, STRUCTURE OF THE T244A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN COMPONENT FROM STAPHYLOCOCCUS AUREUS
2697, 4hqqL, 0.5252, 3.84, 0.091, 120, 110, CRYSTAL STRUCTURE OF RV144-ELICITED ANTIBODY CH58
2698, 4bk5C, 0.5252, 3.79, 0.073, 219, 110, CRYSTAL STRUCTURE OF THE HUMAN EPHA4 ECTODOMAIN IN COMPLEX WITH HUMAN EPHRIN A5 (AMINE-METHYLATED SAMPLE)
2699, 3k2uL, 0.5252, 3.85, 0.065, 195, 108, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC INHIBITORY ANTIBODY FAB40
2700, 2iomA, 0.5252, 3.85, 0.065, 195, 108, MOUSE P53 CORE DOMAIN SOAKED WITH 2-PROPANOL
2701, 1tetH, 0.5252, 3.57, 0.152, 218, 105, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
2702, 1i9rH, 0.5252, 3.83, 0.100, 213, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2703, 1fskL, 0.5252, 3.61, 0.151, 219, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2704, 1fskI, 0.5252, 3.91, 0.135, 125, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2705, 1fskF, 0.5252, 3.55, 0.085, 213, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2706, 1eajB, 0.5252, 3.57, 0.113, 214, 106, DIMERIC STRUCTURE OF THE COXSACKIE VIRUS AND ADENOVIRUS RECEPTOR D1 DOMAIN AT 1.35 ANGSTROM RESOLUTION
2707, 6mamF, 0.5251, 3.82, 0.064, 178, 109, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2708, 6ieqD, 0.5251, 3.57, 0.075, 214, 106, CRYSTAL STRUCTURE OF HIV-1 ENV CONM SOSIP.V7 IN COMPLEX WITH BNAB PGT124 AND 35O22 
2709, 6iekF, 0.5251, 3.75, 0.073, 226, 109, STRUCTURE OF RVFV GN AND HUMAN MONOCLONAL ANTIBODY R12 
2710, 6flaB, 0.5251, 3.55, 0.094, 212, 106, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2711, 6eljB, 0.5251, 3.80, 0.082, 218, 110, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
2712, 6d9gC, 0.5251, 3.77, 0.073, 217, 110, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
2713, 5w3oC, 0.5251, 2.71, 0.106, 226, 94, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 EMPTY PARTICLE)
2714, 5vshL, 0.5251, 3.60, 0.104, 218, 106, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2715, 5ukqL, 0.5251, 3.70, 0.101, 216, 109, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522.2 FAB
2716, 5o1rL, 0.5251, 3.55, 0.094, 212, 106, HUMAN FAB 5H2 BOUND TO NHBA-C3 FROM NEISSERIA MENINGITIDIS SEROGROUP B 
2717, 5mhrR, 0.5251, 3.45, 0.077, 213, 104, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
2718, 5k93B, 0.5251, 3.60, 0.104, 218, 106, PAPD WILD-TYPE CHAPERONE
2719, 5i1hL, 0.5251, 3.35, 0.118, 231, 102, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-20
2720, 5f9wH, 0.5251, 3.63, 0.112, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
2721, 5drzL, 0.5251, 3.39, 0.087, 210, 104, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2722, 4r7nB, 0.5251, 3.85, 0.054, 240, 112, FAB C2E3
2723, 4hjeA, 0.5251, 3.58, 0.085, 216, 106, CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA
2724, 3zknL, 0.5251, 3.80, 0.109, 211, 110, BACE2 FAB INHIBITOR COMPLEX
2725, 3vi4H, 0.5251, 3.82, 0.102, 216, 108, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE IN COMPLEX WITH RGD PEPTIDE
2726, 3vi3H, 0.5251, 3.60, 0.104, 219, 106, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
2727, 3bgfB, 0.5251, 3.70, 0.093, 213, 107, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
2728, 2vxvH, 0.5251, 3.57, 0.114, 213, 105, CRYSTAL STRUCTURE OF HUMAN IGG ABT-325 FAB FRAGMENT
2729, 2uylM, 0.5251, 3.50, 0.096, 213, 104, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2730, 2uy7C, 0.5251, 4.00, 0.062, 280, 112, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2731, 2j1wA, 0.5251, 3.79, 0.119, 212, 109, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
2732, 2g60L, 0.5251, 3.98, 0.036, 136, 112, STRUCTURE OF ANTI-FLAG M2 FAB DOMAIN
2733, 1uywL, 0.5251, 3.62, 0.075, 208, 107, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2734, 1mjjB, 0.5251, 3.88, 0.037, 187, 108, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
2735, 1i9rX, 0.5251, 3.80, 0.091, 209, 110, STRUCTURE OF CD40L IN COMPLEX WITH THE FAB FRAGMENT OF HUMANIZED 5C8 ANTIBODY
2736, 1fskC, 0.5251, 3.77, 0.091, 219, 110, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
2737, 1ct8A, 0.5251, 3.92, 0.115, 220, 113, CATALYTIC ANTIBODY 7C8 COMPLEX
2738, 1b4jH, 0.5251, 3.92, 0.115, 220, 113, COMPARISON OF THE THREE-DIMENSIONAL STRUCTURES OF A HUMANIZED AND A CHIMERIC FAB OF AN ANTI-GAMMA-INTERFERON ANTIBODY
2739, 6medB, 0.5250, 3.92, 0.115, 220, 113, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2740, 6k7oE, 0.5250, 3.94, 0.071, 120, 112, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
2741, 6flaL, 0.5250, 3.74, 0.074, 216, 108, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
2742, 6eh1B, 0.5250, 3.84, 0.045, 229, 112, SACBROOD VIRUS OF HONEYBEE - EXPANSION STATE II 
2743, 6e62C, 0.5250, 3.97, 0.117, 218, 111, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
2744, 6e3hH, 0.5250, 3.55, 0.104, 216, 106, CRYSTAL STRUCTURE OF S9-3-37 BOUND TO H5 INFLUENZA HEMAGGLUTININ 
2745, 6bfqF, 0.5250, 3.58, 0.094, 213, 106, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2746, 6azlA, 0.5250, 3.82, 0.082, 221, 110, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
2747, 6a67D, 0.5250, 4.66, 0.050, 234, 119, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
2748, 5x1fB, 0.5250, 3.53, 0.094, 213, 106, CO BOUND CYTOCHROME C OXIDASE WITHOUT PUMP LASER IRRADIATION AT 278K
2749, 5w1kN, 0.5250, 3.45, 0.087, 213, 104, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2750, 5vshB, 0.5250, 3.56, 0.094, 211, 106, CH1/CLAMBDA FAB BASED ON PERTUZUMAB
2751, 5vl3A, 0.5250, 3.84, 0.071, 213, 112, CD22 D1-D3 IN COMPLEX WITH THERAPEUTIC FAB EPRATUZUMAB
2752, 5njdS, 0.5250, 2.91, 0.144, 210, 97, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2753, 5mvjL, 0.5250, 3.56, 0.104, 214, 106, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
2754, 5mthA, 0.5250, 3.72, 0.064, 219, 109, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
2755, 5mp1G, 0.5250, 3.58, 0.104, 216, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
2756, 5mo9H, 0.5250, 3.59, 0.094, 211, 106, STRUCTURE OF HUMAN TRKB RECEPTOR LIGAND BINDING DOMAIN IN COMPLEX WITH THE FAB FRGMENT OF ANTIBODY AB20
2757, 5jo4A, 0.5250, 3.94, 0.055, 200, 109, ANTIBODY FAB FRAGMENT COMPLEX
2758, 5i2iA, 0.5250, 3.52, 0.133, 217, 105, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
2759, 5cusM, 0.5250, 3.83, 0.082, 218, 110, CRYSTAL STRUCTURE OF SERBB3-FAB3379 COMPLEX
2760, 5bk5G, 0.5250, 3.83, 0.082, 218, 110, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2761, 5bk5E, 0.5250, 3.85, 0.109, 216, 110, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2762, 4ynyD, 0.5250, 3.78, 0.073, 222, 109, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1
2763, 4ubdP, 0.5250, 3.60, 0.132, 216, 106, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2764, 4qthA, 0.5250, 3.07, 0.111, 216, 99, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2765, 4oz4H, 0.5250, 3.86, 0.056, 195, 108, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
2766, 4jo1M, 0.5250, 3.58, 0.132, 213, 106, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
2767, 4hkbC, 0.5250, 3.55, 0.123, 212, 106, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
2768, 4hjeB, 0.5250, 3.78, 0.101, 210, 109, CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA
2769, 4gayB, 0.5250, 3.77, 0.091, 219, 110, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
2770, 4fqhB, 0.5250, 3.92, 0.115, 220, 113, CRYSTAL STRUCTURE OF FAB CR9114
2771, 3u9pM, 0.5250, 3.62, 0.093, 214, 107, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
2772, 3t0vA, 0.5250, 3.76, 0.101, 219, 109, UNLIGANDED FLUOROGEN ACTIVATING PROTEIN M8VL
2773, 3nifH, 0.5250, 3.58, 0.066, 213, 106, THE CLOSED HEADPIECE OF INTEGRIN IIB 3 AND ITS COMPLEX WITH AN IIB 3 - SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2774, 3nidE, 0.5250, 3.76, 0.056, 218, 108, THE CLOSED HEADPIECE OF INTEGRIN ALPHAIIB BETA3 AND ITS COMPLEX WITH AN ALPAHIIB BETA3 -SPECIFIC ANTAGONIST THAT DOES NOT INDUCE OPENING
2775, 3d08A, 0.5250, 3.56, 0.104, 216, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATION H168R
2776, 3cm9S, 0.5250, 4.03, 0.057, 179, 106, SOLUTION STRUCTURE OF HUMAN SIGA2
2777, 2z4qB, 0.5250, 3.69, 0.111, 213, 108, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
2778, 2wbwB, 0.5250, 3.71, 0.074, 226, 108, AD37 FIBRE HEAD IN COMPLEX WITH CAR D1 AND SIALIC ACID
2779, 2nr6C, 0.5250, 3.58, 0.104, 213, 106, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
2780, 2ahiB, 0.5250, 3.55, 0.094, 212, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
2781, 1q9wA, 0.5250, 3.38, 0.078, 212, 103, S45-18 FAB PENTASACCHARIDE BISPHOSPHATE COMPLEX
2782, 1oczB, 0.5250, 2.74, 0.106, 226, 94, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
2783, 1n64H, 0.5250, 3.60, 0.113, 211, 106, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
2784, 1mlcB, 0.5250, 3.53, 0.094, 213, 106, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
2785, 1mfbH, 0.5250, 3.79, 0.082, 214, 110, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
2786, 1ehlH, 0.5250, 3.51, 0.095, 214, 105, 64M-2 ANTIBODY FAB COMPLEXED WITH D(5HT)(6-4)T
2787, 6oknD, 0.5249, 3.56, 0.151, 219, 106, OX40R (TNFRSF4) BOUND TO FAB 1A7 
2788, 6njmJ, 0.5249, 3.72, 0.083, 220, 109, STRUCTURE OF A COMPLEX 
2789, 6medG, 0.5249, 3.55, 0.162, 218, 105, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2790, 6mcoD, 0.5249, 3.85, 0.091, 212, 110, CRYSTAL STRUCTURE OF THE B41 SOSIP.664 ENV TRIMER WITH PGT124 AND 35O22 FABS; IN P23 SPACE GROUP 
2791, 6iccL, 0.5249, 3.69, 0.073, 221, 109, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 186 
2792, 6csfB, 0.5249, 3.56, 0.094, 213, 106, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
2793, 6bliK, 0.5249, 3.46, 0.087, 203, 104, RSV G PEPTIDE BOUND TO FAB CB002.5
2794, 6bitI, 0.5249, 3.54, 0.124, 217, 105, SIRPALPHA ANTIBODY COMPLEX
2795, 6bb4I, 0.5249, 3.59, 0.104, 217, 106, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
2796, 6b5tH, 0.5249, 3.64, 0.140, 209, 107, STRUCTURE OF PFCSP PEPTIDE 29 WITH HUMAN ANTIBODY CIS42
2797, 5wuxB, 0.5249, 3.59, 0.094, 213, 106, TNFALPHA-CERTOLIZUMAB FAB
2798, 5w23I, 0.5249, 3.78, 0.091, 215, 110, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
2799, 5w1kC, 0.5249, 3.72, 0.083, 219, 109, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
2800, 5th2C, 0.5249, 3.53, 0.104, 216, 106, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
2801, 5esqA, 0.5249, 3.84, 0.072, 218, 111, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
2802, 5b4mL, 0.5249, 3.94, 0.055, 200, 109, CRYSTAL STRUCTURE OF AN FAB AGAINST HUMAN INFLUENZA A
2803, 5awnH, 0.5249, 3.57, 0.113, 216, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 BROADLY NEUTRALIZING ANTIBODY 3BC176 FAB
2804, 4zs6L, 0.5249, 3.45, 0.096, 212, 104, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
2805, 4x7tL, 0.5249, 3.57, 0.104, 211, 106, STRUCTURE OF OMALIZUMAB FAB FRAGMENT CRYSTAL FORM 2
2806, 4m7lH, 0.5249, 3.54, 0.087, 112, 104, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
2807, 4jreL, 0.5249, 3.84, 0.090, 219, 111, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
2808, 4hjeC, 0.5249, 3.85, 0.090, 214, 111, CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA
2809, 3tt1I, 0.5249, 3.88, 0.056, 182, 108, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
2810, 3ojdB, 0.5249, 3.73, 0.083, 585, 108, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
2811, 3iu3H, 0.5249, 3.95, 0.088, 218, 113, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
2812, 3gkwL, 0.5249, 3.83, 0.091, 120, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF NIMOTUZUMAB. AN ANTI- EPIDERMAL GROWTH FACTOR RECEPTOR ANTIBODY
2813, 3chnB, 0.5249, 3.62, 0.121, 211, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2814, 2qtjD, 0.5249, 3.93, 0.055, 198, 109, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2815, 2j1zA, 0.5249, 3.57, 0.151, 219, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-F270L
2816, 2bimA, 0.5249, 2.75, 0.106, 227, 94, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273H
2817, 2aepL, 0.5249, 3.79, 0.092, 218, 109, AN EPIDEMIOLOGICALLY SIGNIFICANT EPITOPE OF A 1998 INFLUENZA VIRUS NEURAMINIDASE FORMS A HIGHLY HYDRATED INTERFACE IN THE NA-ANTIBODY COMPLEX.
2818, 6iuvH, 0.5248, 3.84, 0.082, 218, 110, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
2819, 6flbL, 0.5248, 3.79, 0.100, 211, 110, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
2820, 6eynA, 0.5248, 3.82, 0.082, 217, 110, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
2821, 6cxyL, 0.5248, 3.57, 0.075, 213, 106, CRYSTAL STRUCTURE OF HUMAN E-CADHERIN BOUND BY MOUSE MONOCLONAL ANTIBODY FAB MAB-1_19A11 
2822, 6awqB, 0.5248, 3.52, 0.000, 213, 105, ANOMALOUS CHLORIDE SIGNAL REVEALS THE POSITION OF SERTRALINE COMPLEXED WITH THE SEROTONIN TRANSPORTER AT THE CENTRAL SITE
2823, 6awoB, 0.5248, 3.87, 0.081, 222, 111, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH SERTRALINE AT THE CENTRAL SITE
2824, 5ye4B, 0.5248, 3.80, 0.045, 240, 112, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
2825, 5vgaB, 0.5248, 3.66, 0.150, 213, 107, ALTERNATIVE MODEL FOR FAB 36-65
2826, 5tl5H, 0.5248, 3.60, 0.113, 213, 106, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
2827, 5t78C, 0.5248, 3.57, 0.094, 214, 106, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
2828, 5n2kM, 0.5248, 3.77, 0.101, 213, 109, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
2829, 5iczA, 0.5248, 3.78, 0.100, 216, 110, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
2830, 5i66A, 0.5248, 3.68, 0.083, 211, 108, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 8B6 A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER
2831, 5hpmA, 0.5248, 3.56, 0.094, 212, 106, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
2832, 5fhcA, 0.5248, 3.78, 0.092, 219, 109, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
2833, 5drnB, 0.5248, 3.62, 0.113, 213, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
2834, 5do2L, 0.5248, 3.62, 0.093, 213, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
2835, 5cmaA, 0.5248, 3.58, 0.085, 213, 106, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
2836, 5b3jF, 0.5248, 3.57, 0.104, 218, 106, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
2837, 4zfgL, 0.5248, 3.83, 0.081, 219, 111, DUAL-SPECIFICITY FAB 5A12 IN COMPLEX WITH ANGIOPOIETIN 2
2838, 4ocsL, 0.5248, 3.54, 0.104, 210, 106, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.10 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2839, 4o5iX, 0.5248, 3.55, 0.094, 218, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/361/2011 (H3N2) INFLUENZA HEMAGGLUTININ
2840, 4jo1L, 0.5248, 3.81, 0.101, 222, 109, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 JR-FL GP120
2841, 4ijtA, 0.5248, 3.53, 0.113, 211, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM II)
2842, 4hjeD, 0.5248, 3.94, 0.055, 200, 109, CRYSTAL STRUCTURE OF P53 CORE DOMAIN IN COMPLEX WITH DNA
2843, 4dkfL, 0.5248, 3.77, 0.100, 212, 110, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB2
2844, 4dkeL, 0.5248, 3.84, 0.091, 224, 110, CRYSTAL STRUCTURE OF HUMAN INTERLEUKIN-34 BOUND TO FAB1.1
2845, 4am0E, 0.5248, 3.73, 0.102, 215, 108, STRUCTURE OF DENGUE VIRUS STRAIN 4 DIII IN COMPLEX WITH FAB 2H12
2846, 3d0aB, 0.5248, 3.69, 0.111, 199, 108, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
2847, 3chnC, 0.5248, 3.83, 0.073, 475, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
2848, 3bgfH, 0.5248, 3.83, 0.073, 475, 110, X-RAY CRYSTAL STRUCTURE OF THE SARS CORONAVIRUS SPIKE RECEPTOR BINDING DOMAIN IN COMPLEX WITH F26G19 FAB
2849, 2wgxA, 0.5248, 3.86, 0.056, 195, 108, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
2850, 2qtjB, 0.5248, 3.86, 0.056, 195, 108, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
2851, 2nz9E, 0.5248, 3.61, 0.113, 129, 106, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
2852, 2nljA, 0.5248, 3.75, 0.082, 228, 110, POTASSIUM CHANNEL KCSA(M96V)-FAB COMPLEX IN KCL
2853, 2j20A, 0.5248, 3.51, 0.124, 216, 105, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R273C
2854, 2esgB, 0.5248, 3.58, 0.104, 214, 106, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
2855, 2dwdB, 0.5248, 3.61, 0.113, 217, 106, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN TL+
2856, 1t04B, 0.5248, 3.81, 0.091, 218, 110, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB IN C2 SPACE GROUP
2857, 1nakL, 0.5248, 3.81, 0.091, 218, 110, IGG1 FAB FRAGMENT (83.1) COMPLEX WITH 16-RESIDUE PEPTIDE (RESIDUES 304-321 OF HIV-1 GP120 (MN ISOLATE))
2858, 1igaB, 0.5248, 3.54, 0.104, 211, 106, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
2859, 1bqhK, 0.5248, 3.81, 0.082, 224, 110, MURINE CD8AA ECTODOMAIN FRAGMENT IN COMPLEX WITH H-2KB/VSV8
2860, 6mi2D, 0.5247, 3.83, 0.083, 221, 109, STRUCTURE OF THE HUMAN 4-1BB / UTOMILUMAB FAB COMPLEX 
2861, 6mamD, 0.5247, 3.62, 0.123, 216, 106, CLEAVED EBOLA GP IN COMPLEX WITH A BROADLY NEUTRALIZING HUMAN ANTIBODY; ADI-15946 
2862, 6fg2H, 0.5247, 3.52, 0.095, 212, 105, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
2863, 6fbjL, 0.5247, 3.56, 0.094, 213, 106, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
2864, 6a77L, 0.5247, 3.77, 0.091, 218, 110, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE FAB FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
2865, 5x19B, 0.5247, 3.61, 0.093, 213, 107, CO BOUND CYTOCHROME C OXIDASE AT 100 MICRO SEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
2866, 5vjqH, 0.5247, 3.80, 0.081, 221, 111, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
2867, 5tudF, 0.5247, 3.50, 0.124, 215, 105, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
2868, 5sx4L, 0.5247, 3.57, 0.094, 214, 106, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3.
2869, 5iopA, 0.5247, 3.58, 0.085, 213, 106, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
2870, 5i1eL, 0.5247, 3.55, 0.094, 211, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV1-39
2871, 5drzA, 0.5247, 3.69, 0.083, 213, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 ANTIBODY F240 FAB IN COMPLEX WITH GP41 PEPTIDE
2872, 5cfcC, 0.5247, 3.43, 0.096, 212, 104, CRYSTAL STRUCTURE OF HUMAN CARDIOVIRUS SAFV-3
2873, 5bo1L, 0.5247, 3.44, 0.106, 213, 104, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
2874, 5bk5C, 0.5247, 3.53, 0.104, 216, 106, CRYSTAL STRUCTURE OF THE ANTI-CIRCUMSPOROZOITE PROTEIN 663 GERMLINE ANTIBODY
2875, 5a8fC, 0.5247, 4.02, 0.055, 198, 109, STRUCTURE AND GENOME RELEASE MECHANISM OF HUMAN CARDIOVIRUS SAFFOLD VIRUS-3
2876, 4ubdL, 0.5247, 3.94, 0.055, 200, 109, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2877, 4jzjH, 0.5247, 3.55, 0.094, 212, 106, CRYSTAL STRUCTURE OF RECEPTOR-FAB COMPLEX
2878, 4ibuB, 0.5247, 3.55, 0.085, 214, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
2879, 3zknD, 0.5247, 3.84, 0.089, 212, 112, BACE2 FAB INHIBITOR COMPLEX
2880, 3zkmL, 0.5247, 3.92, 0.055, 197, 109, BACE2 FAB COMPLEX
2881, 3q01B, 0.5247, 3.83, 0.073, 475, 110, AN INDUCED FIT MECHANISM REGULATES P53 DNA BINDING KINETICS TO CONFER SEQUENCE SPECIFICITY
2882, 3mo1A, 0.5247, 3.88, 0.109, 216, 110, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
2883, 3hmwH, 0.5247, 3.86, 0.065, 195, 108, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
2884, 2uy6A, 0.5247, 3.83, 0.073, 475, 110, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
2885, 2ioiA, 0.5247, 3.63, 0.084, 216, 107, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN AT 1.55 A
2886, 1z3gH, 0.5247, 3.59, 0.104, 212, 106, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
2887, 1oczO, 0.5247, 3.86, 0.056, 195, 108, BOVINE HEART CYTOCHROME C OXIDASE IN AZIDE-BOUND STATE
2888, 1mhhD, 0.5247, 3.83, 0.073, 475, 110, ANTIBODY-ANTIGEN COMPLEX
2889, 1kzyB, 0.5247, 3.56, 0.113, 212, 106, CRYSTAL STRUCTURE OF THE 53BP1 BRCT REGION COMPLEXED TO TUMOR SUPPRESSOR P53
2890, 1gzhC, 0.5247, 3.78, 0.083, 218, 109, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF HUMAN 53BP1 BOUND TO THE P53 TUMOR SUPRESSOR
2891, 6njmI, 0.5246, 3.57, 0.151, 217, 106, STRUCTURE OF A COMPLEX 
2892, 6idgH, 0.5246, 3.83, 0.073, 475, 110, ANTIBODY 64M-5 FAB IN COMPLEX WITH DT(6-4)T 
2893, 6e63L, 0.5246, 3.98, 0.135, 125, 111, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY TB31F 
2894, 6bfqL, 0.5246, 3.72, 0.073, 210, 109, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
2895, 6a3wJ, 0.5246, 3.79, 0.056, 215, 108, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
2896, 5ye4D, 0.5246, 3.77, 0.073, 212, 109, CRYSTAL STRUCTURE OF THE COMPLEX OF DI-ACETYLATED HISTONE H4 AND 1A9D7 FAB FRAGMENT 
2897, 5x2qL, 0.5246, 3.53, 0.123, 213, 106, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
2898, 5x2oJ, 0.5246, 3.63, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
2899, 5v6lM, 0.5246, 2.71, 0.106, 226, 94, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
2900, 5t6pA, 0.5246, 3.61, 0.104, 212, 106, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
2901, 5sx5L, 0.5246, 3.86, 0.109, 233, 110, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2902, 5njdM, 0.5246, 3.61, 0.075, 213, 107, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
2903, 5k9jL, 0.5246, 3.56, 0.094, 213, 106, CRYSTAL STRUCTURE OF MULTIDONOR HV6-1-CLASS BROADLY NEUTRALIZING INFLUENZA A ANTIBODY 56.A.09 ISOLATED FOLLOWING H5 IMMUNIZATION.
2904, 5itfA, 0.5246, 3.55, 0.085, 211, 106, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
2905, 5hysB, 0.5246, 3.59, 0.104, 218, 106, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
2906, 5gkaB, 0.5246, 4.31, 0.080, 258, 112, CRYO-EM STRUCTURE OF HUMAN AICHI VIRUS
2907, 5e2tL, 0.5246, 3.56, 0.094, 214, 106, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY AT8 FAB
2908, 5buaA, 0.5246, 3.58, 0.113, 217, 106, LYSINE 120-ACETYLATED P53 DNA BINDING DOMAIN IN A COMPLEX WITH DNA.
2909, 4xakD, 0.5246, 4.31, 0.080, 258, 112, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
2910, 4uv4L, 0.5246, 3.59, 0.094, 213, 106, CRYSTAL STRUCTURE OF ANTI-FPR FPRO0165 FAB FRAGMENT
2911, 4ubdD, 0.5246, 3.76, 0.082, 215, 110, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2912, 4r9yH, 0.5246, 3.94, 0.055, 198, 109, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
2913, 4r7dD, 0.5246, 3.52, 0.133, 217, 105, FAB HU 15C1
2914, 4qthH, 0.5246, 3.54, 0.133, 217, 105, CRYSTAL STRUCTURE OF ANTI-UPAR FAB 8B12
2915, 4p1xF, 0.5246, 3.97, 0.083, 233, 109, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
2916, 4m6mL, 0.5246, 3.57, 0.104, 218, 106, CRYSTAL STRUCTURE OF ANTI-IL-23 ANTIBODY CNTO1959 AT PH 9.5
2917, 4jo2M, 0.5246, 3.74, 0.073, 218, 109, CRYSTAL STRUCTURE OF RABBIT MAB R56 FAB IN COMPLEX WITH V3 CROWN OF HIV-1 CONSENSUS A GP120
2918, 4jlrB, 0.5246, 3.08, 0.111, 216, 99, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
2919, 4gw5A, 0.5246, 3.88, 0.037, 187, 108, CQYN MEDITOPE - CETUXIMAB FAB
2920, 4cc8I, 0.5246, 3.74, 0.102, 214, 108, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2921, 4cc8H, 0.5246, 2.72, 0.106, 227, 94, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2922, 4cc8F, 0.5246, 3.75, 0.092, 214, 109, PRE-FUSION STRUCTURE OF TRIMERIC HIV-1 ENVELOPE GLYCOPROTEIN DETERMINED BY CRYO-ELECTRON MICROSCOPY
2923, 3zkmD, 0.5246, 3.83, 0.056, 195, 108, BACE2 FAB COMPLEX
2924, 3v6oE, 0.5246, 3.94, 0.055, 195, 109, LEPTIN RECEPTOR-ANTIBODY COMPLEX
2925, 3ts8C, 0.5246, 3.80, 0.000, 218, 110, CRYSTAL STRUCTURE OF A MULTIDOMAIN HUMAN P53 TETRAMER BOUND TO THE NATURAL CDKN1A(P21) P53-RESPONSE ELEMENT
2926, 3se8H, 0.5246, 3.81, 0.100, 221, 110, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC03 IN COMPLEX WITH HIV-1 GP120
2927, 3oklA, 0.5246, 3.68, 0.111, 215, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO
2928, 2rcsH, 0.5246, 3.58, 0.094, 212, 106, IMMUNOGLOBULIN 48G7 GERMLINE FAB-AFFINITY MATURATION OF AN ESTEROLYTIC ANTIBODY
2929, 1xcqF, 0.5246, 3.64, 0.066, 116, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
2930, 1v7nN, 0.5246, 3.61, 0.103, 212, 107, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
2931, 1t5rB, 0.5246, 3.50, 0.133, 217, 105, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
2932, 1rivL, 0.5246, 3.81, 0.082, 220, 110, ANTI-COCAINE ANTIBODY M82G2 COMPLEXED WITH META- OXYBENZOYLECGONINE
2933, 1ejoL, 0.5246, 3.59, 0.094, 215, 106, FAB FRAGMENT OF NEUTRALISING MONOCLONAL ANTIBODY 4C4 COMPLEXED WITH G-H LOOP FROM FMDV.
2934, 1a4jH, 0.5246, 3.63, 0.132, 216, 106, DIELS ALDER CATALYTIC ANTIBODY GERMLINE PRECURSOR
2935, 6mwxO, 0.5245, 3.61, 0.075, 212, 107, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2936, 6mwxG, 0.5245, 3.52, 0.086, 213, 105, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2937, 6mwvC, 0.5245, 3.57, 0.104, 212, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2938, 6mefL, 0.5245, 3.57, 0.085, 213, 106, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
2939, 6igoD, 0.5245, 3.57, 0.075, 217, 106, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
2940, 6cnjG, 0.5245, 4.11, 0.064, 333, 109, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
2941, 6bb4H, 0.5245, 3.58, 0.114, 216, 105, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
2942, 5x1bB, 0.5245, 3.88, 0.065, 199, 108, CO BOUND CYTOCHROME C OXIDASE AT 20 NSEC AFTER PUMP LASER IRRADIATION TO RELEASE CO FROM O2 REDUCTION CENTER
2943, 5wb9H, 0.5245, 3.79, 0.073, 218, 110, CRYSTAL STRUCTURE OF CD4 BINDING SITE ANTIBODY N60P23 IN COMPLEX WITH HIV-1 CLADE A/E STRAIN 93TH057 GP120 CORE 
2944, 5vzxI, 0.5245, 3.61, 0.113, 217, 106, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2945, 5sx5K, 0.5245, 3.60, 0.094, 213, 106, CRYSTAL STRUCTURE OF PANITUMUMAB IN COMPLEX WITH EPIDERMAL GROWTH FACTOR RECEPTOR DOMAIN 3 MUTANT S468R.
2946, 5mp3B, 0.5245, 3.71, 0.093, 218, 108, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
2947, 5mcwA, 0.5245, 3.56, 0.094, 211, 106, P53-DNA COMPLEX 4 
2948, 5kmvI, 0.5245, 3.79, 0.091, 224, 110, CRYSTAL STRUCTURE OF CRENEZUMAB FAB
2949, 5h35I, 0.5245, 4.02, 0.062, 255, 112, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
2950, 5e8eB, 0.5245, 3.70, 0.120, 216, 108, CRYSTAL STRUCTURE OF THROMBIN BOUND TO AN EXOSITE 1-SPECIFIC IGA FAB
2951, 4zykB, 0.5245, 3.55, 0.104, 216, 106, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
2952, 4xvtH, 0.5245, 3.49, 0.095, 210, 105, CRYSTAL STRUCTURE OF HIV-1 93TH057 COREE GP120 WITH ANTIBODY 45- VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
2953, 4uujB, 0.5245, 3.55, 0.094, 212, 106, POTASSIUM CHANNEL KCSA-FAB WITH TETRAHEXYLAMMONIUM
2954, 4ubdX, 0.5245, 3.88, 0.089, 227, 112, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2955, 4ubdT, 0.5245, 3.88, 0.089, 227, 112, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2956, 4ubdH, 0.5245, 3.88, 0.089, 227, 112, CRYSTAL STRUCTURE OF A NEUTRALIZING HUMAN MONOCLONAL ANTIBODY WITH 1968 H3 HA
2957, 4rgmC, 0.5245, 3.53, 0.133, 217, 105, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
2958, 4pljH, 0.5245, 3.61, 0.113, 213, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
2959, 4ouuL, 0.5245, 3.97, 0.083, 234, 109, ANTI-MT1-MMP MONOCLONAL ANTIBODY
2960, 4odhL, 0.5245, 3.88, 0.089, 227, 112, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.UCA A POTENT V1V2- DIRECTED HIV-1 NEUTRALIZING ANTIBODY
2961, 4j3oC, 0.5245, 3.52, 0.143, 219, 105, CRYSTAL STRUCTURE OF THE FIMD USHER TRAVERSED BY THE PILUS TIP COMPLEX ASSEMBLY COMPOSED OF FIMC:FIMF:FIMG:FIMH
2962, 4hk0A, 0.5245, 3.77, 0.110, 217, 109, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
2963, 3okoA, 0.5245, 3.83, 0.091, 218, 110, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.8)KDO(2.4)KDO
2964, 3o41B, 0.5245, 3.50, 0.114, 212, 105, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
2965, 3iu3C, 0.5245, 3.94, 0.064, 271, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY BASILIXIMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
2966, 2uylX, 0.5245, 3.57, 0.162, 218, 105, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
2967, 2oldB, 0.5245, 3.56, 0.104, 216, 106, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(2)21 CRYSTAL FORM
2968, 2j4wL, 0.5245, 3.76, 0.091, 217, 110, STRUCTURE OF A PLASMODIUM VIVAX APICAL MEMBRANE ANTIGEN 1- FAB F8.12.19 COMPLEX
2969, 2adyA, 0.5245, 3.73, 0.110, 218, 109, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX IV)
2970, 1uywH, 0.5245, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
2971, 1uwxM, 0.5245, 3.73, 0.110, 218, 109, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
2972, 1q9lA, 0.5245, 3.56, 0.094, 212, 106, S25-2 FAB UNLIGANDED 2
2973, 1ngyA, 0.5245, 3.81, 0.118, 120, 110, CHIMERIC MATURE FAB 7G12-APO
2974, 1kegH, 0.5245, 3.86, 0.064, 218, 109, ANTIBODY 64M-2 FAB COMPLEXED WITH DTT(6-4)TT
2975, 1fptL, 0.5245, 3.80, 0.100, 216, 110, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
2976, 1a4kH, 0.5245, 2.70, 0.106, 226, 94, DIELS ALDER CATALYTIC ANTIBODY WITH TRANSITION STATE ANALOGUE
2977, 6o3aA, 0.5244, 3.78, 0.089, 220, 112, CRYSTAL STRUCTURE OF FRIZZLED 7 CRD IN COMPLEX WITH F7.B FAB 
2978, 6mwxK, 0.5244, 3.61, 0.123, 219, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2979, 6mwxC, 0.5244, 3.62, 0.075, 213, 107, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-69 ANTIBODY 
2980, 6mwvO, 0.5244, 3.56, 0.151, 218, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2981, 6mwvK, 0.5244, 3.87, 0.056, 199, 108, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2982, 6mwvG, 0.5244, 3.61, 0.123, 219, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-58 ANTIBODY 
2983, 6mwcO, 0.5244, 3.66, 0.123, 217, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2984, 6mwcK, 0.5244, 3.71, 0.073, 228, 109, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2985, 6mwcG, 0.5244, 3.64, 0.075, 214, 107, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2986, 6mwcC, 0.5244, 3.76, 0.064, 228, 109, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-5 ANTIBODY 
2987, 6mw9O, 0.5244, 3.57, 0.104, 212, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2988, 6mw9K, 0.5244, 3.60, 0.094, 213, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2989, 6mw9G, 0.5244, 3.60, 0.094, 213, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2990, 6mw9C, 0.5244, 3.60, 0.094, 213, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-3 ANTIBODY 
2991, 6muiO, 0.5244, 3.75, 0.062, 217, 112, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2992, 6muiK, 0.5244, 3.77, 0.093, 218, 108, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2993, 6muiG, 0.5244, 3.65, 0.132, 217, 106, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2994, 6muiC, 0.5244, 3.47, 0.143, 210, 105, CRYOEM STRUCTURE OF CHIMERIC EASTERN EQUINE ENCEPHALITIS VIRUS WITH FAB OF EEEV-42 ANTIBODY 
2995, 6d0uD, 0.5244, 2.83, 0.104, 199, 96, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
2996, 5uddT, 0.5244, 3.78, 0.073, 215, 109, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
2997, 5th9L, 0.5244, 3.53, 0.143, 217, 105, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
2998, 5ob5H, 0.5244, 3.60, 0.123, 217, 106, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
2999, 5n7wL, 0.5244, 3.71, 0.102, 215, 108, COMPUTATIONALLY DESIGNED FUNCTIONAL ANTIBODY 
3000, 5mp3L, 0.5244, 3.62, 0.132, 216, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3001, 5i74B, 0.5244, 3.39, 0.087, 216, 104, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH BR-CITALOPRAM AT THE CENTRAL SITE
3002, 5b3jL, 0.5244, 3.52, 0.105, 212, 105, ACTIVATION OF NMDA RECEPTORS AND THE MECHANISM OF INHIBITION BY IFENPRODIL
3003, 5anyL, 0.5244, 3.89, 0.065, 197, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3004, 5anyK, 0.5244, 3.71, 0.083, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3005, 4p1xH, 0.5244, 3.71, 0.111, 218, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
3006, 4nylB, 0.5244, 3.56, 0.151, 219, 106, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3007, 4nkoA, 0.5244, 3.57, 0.104, 213, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3008, 4m61C, 0.5244, 3.80, 0.082, 216, 110, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3009, 4jr9L, 0.5244, 3.57, 0.143, 219, 105, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK
3010, 4jo4L, 0.5244, 3.85, 0.090, 217, 111, CRYSTAL STRUCTURE OF RABBIT MAB R20 FAB
3011, 4jm4L, 0.5244, 3.61, 0.084, 212, 107, CRYSTAL STRUCTURE OF PGT 135 FAB
3012, 4hixL, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF A HUMANISED 3D6 FAB BOUND TO AMYLOID BETA PEPTIDE
3013, 3u9pL, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF MURINE SIDEROCALIN IN COMPLEX WITH AN FAB FRAGMENT
3014, 3qumC, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
3015, 3lrgA, 0.5244, 3.73, 0.110, 218, 109, STRUCTURE OF ANTI-HUNTINGTIN VL DOMAIN
3016, 3iglA, 0.5244, 3.73, 0.110, 218, 109, DIVERSITY IN DNA RECOGNITION BY P53 REVEALED BY CRYSTAL STRUCTURES WITH HOOGSTEEN BASE PAIRS (P53-DNA COMPLEX 1)
3017, 2w9eH, 0.5244, 3.73, 0.110, 218, 109, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
3018, 2h32H, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF THE PRE-B CELL RECEPTOR
3019, 2a6kH, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
3020, 1um4H, 0.5244, 3.73, 0.110, 218, 109, CATALYTIC ANTIBODY 21H3 WITH HAPTEN
3021, 1sbsL, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF AN ANTI-HCG FAB
3022, 1q9lC, 0.5244, 3.73, 0.110, 218, 109, S25-2 FAB UNLIGANDED 2
3023, 1it9H, 0.5244, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT FROM A HUMANIZED VERSION OF THE ANTI-HUMAN FAS ANTIBODY HFE7A
3024, 1iaiH, 0.5244, 3.73, 0.110, 218, 109, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
3025, 1fskK, 0.5244, 3.73, 0.110, 218, 109, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3026, 1blnC, 0.5244, 3.73, 0.110, 218, 109, ANTI-P-GLYCOPROTEIN FAB MRK-16
3027, 6ncpB, 0.5243, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
3028, 6fy3L, 0.5243, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
3029, 6eynD, 0.5243, 3.58, 0.075, 213, 106, STRUCTURE OF THE 8D6 (ANTI-IGE) FAB 
3030, 6c5kL, 0.5243, 3.57, 0.104, 211, 106, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
3031, 5y11A, 0.5243, 3.56, 0.094, 214, 106, SFTSV GN WITH NEUTRALIZING ANTIBODY MAB4-5
3032, 5x2qJ, 0.5243, 3.71, 0.092, 220, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3033, 5ocxL, 0.5243, 3.62, 0.084, 211, 107, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CII-C-13-CIT 
3034, 5mcwB, 0.5243, 3.57, 0.160, 218, 106, P53-DNA COMPLEX 4 
3035, 5mcvA, 0.5243, 3.81, 0.091, 218, 110, P53-DNA COMPLEX 3 
3036, 5lwyH, 0.5243, 3.57, 0.094, 212, 106, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2 IN COMPLEX WITH A C18 FREE FATTY ACID
3037, 5ivzA, 0.5243, 3.73, 0.110, 218, 109, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
3038, 5ezlB, 0.5243, 3.73, 0.110, 218, 109, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
3039, 5cfdC, 0.5243, 4.02, 0.062, 258, 112, CRYSTAL STRUCTURE OF DTT TREATED HUMAN CARDIOVIRUS SAFV-3
3040, 4z8fL, 0.5243, 3.53, 0.075, 117, 106, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -P5(DT)P- 3 
3041, 4yo0D, 0.5243, 3.69, 0.103, 115, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
3042, 4risL, 0.5243, 3.53, 0.152, 219, 105, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
3043, 4orgB, 0.5243, 3.54, 0.113, 211, 106, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.04 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3044, 4nrxE, 0.5243, 3.75, 0.064, 214, 109, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3045, 4jreC, 0.5243, 3.64, 0.094, 214, 106, CRYSTAL STRUCTURE OF NITRATE/NITRITE EXCHANGER NARK WITH NITRITE BOUND
3046, 4jlrL, 0.5243, 3.61, 0.104, 219, 106, CRYSTAL STRUCTURE OF A DESIGNED RESPIRATORY SYNCYTIAL VIRUS IMMUNOGEN IN COMPLEX WITH MOTAVIZUMAB
3047, 4ibwA, 0.5243, 3.56, 0.104, 212, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3048, 3zdyE, 0.5243, 3.67, 0.112, 218, 107, INTEGRIN ALPHAIIB BETA3 HEADPIECE AND RGD PEPTIDE COMPLEX
3049, 3oz9L, 0.5243, 3.55, 0.087, 114, 104, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
3050, 3okkA, 0.5243, 3.86, 0.056, 197, 108, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO
3051, 3ncjH, 0.5243, 3.90, 0.092, 215, 109, CRYSTAL STRUCTURE OF FAB15 MUT8
3052, 3lh8A, 0.5243, 3.72, 0.064, 211, 109, CRYSTAL STRUCTURE OF MOUSE VPS26B IN SPACEGROUP P41 21 2
3053, 3eo1H, 0.5243, 3.83, 0.082, 216, 110, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3054, 3eo1B, 0.5243, 3.79, 0.091, 217, 110, STRUCTURE OF THE FAB FRAGMENT OF GC-1008 IN COMPLEX WITH TRANSFORMING GROWTH FACTOR-BETA 3
3055, 3bszH, 0.5243, 3.62, 0.123, 220, 106, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3056, 2uylV, 0.5243, 3.58, 0.142, 219, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3057, 2uy7G, 0.5243, 3.79, 0.082, 219, 110, CRYSTAL STRUCTURE OF THE P PILUS ROD SUBUNIT PAPA
3058, 2hjfB, 0.5243, 3.80, 0.092, 219, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRABUTYLAMMONIUM (TBA)
3059, 2geqB, 0.5243, 3.60, 0.151, 214, 106, CRYSTAL STRUCTURE OF A P53 CORE DIMER BOUND TO DNA
3060, 2g5bG, 0.5243, 3.66, 0.113, 214, 106, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3061, 2g5bC, 0.5243, 3.62, 0.093, 212, 107, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3062, 1fskH, 0.5243, 3.68, 0.120, 214, 108, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3063, 1fskE, 0.5243, 3.72, 0.090, 194, 111, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3064, 1fskB, 0.5243, 3.62, 0.132, 219, 106, COMPLEX FORMATION BETWEEN A FAB FRAGMENT OF A MONOCLONAL IGG ANTIBODY AND THE MAJOR ALLERGEN FROM BIRCH POLLEN BET V 1
3065, 1eo8L, 0.5243, 3.75, 0.064, 219, 109, INFLUENZA VIRUS HEMAGGLUTININ COMPLEXED WITH A NEUTRALIZING ANTIBODY
3066, 1emtH, 0.5243, 3.81, 0.082, 218, 110, FAB ANTIBODY FRAGMENT OF AN C60 ANTIFULLERENE ANTIBODY
3067, 1cz8X, 0.5243, 3.53, 0.104, 216, 106, VASCULAR ENDOTHELIAL GROWTH FACTOR IN COMPLEX WITH AN AFFINITY MATURED ANTIBODY
3068, 1cu4L, 0.5243, 3.90, 0.065, 199, 108, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4 IN COMPLEX WITH ITS PEPTIDE EPITOPE
3069, 6nmpB, 0.5242, 3.88, 0.065, 200, 108, SFX STRUCTURE OF OXIDIZED CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
3070, 6ev1A, 0.5242, 3.71, 0.128, 119, 109, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
3071, 6eleL, 0.5242, 3.56, 0.085, 213, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3072, 6db6H, 0.5242, 3.64, 0.112, 213, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 311-11D IN COMPLEX WITH A HIV-1 GP120 V3 PEPTIDE FROM MN STRAIN 
3073, 6bpaE, 0.5242, 4.31, 0.080, 258, 112, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
3074, 6a67L, 0.5242, 3.56, 0.094, 214, 106, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY FLD21.140 
3075, 5th9M, 0.5242, 3.69, 0.121, 209, 107, STRUCTURE DETERMINATION OF A POTENT SELECTIVE ANTIBODY INHIBITOR OF HUMAN MMP9 (GS-5745 BOUND TO MMP-9)
3076, 5i75B, 0.5242, 3.81, 0.101, 213, 109, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE AND BR-CITALOPRAM AT THE ALLOSTERIC SITE
3077, 4rftd, 0.5242, 3.55, 0.077, 208, 104, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
3078, 4nj9H, 0.5242, 3.58, 0.085, 211, 106, CRYSTAL STRUCTURE OF FAB 8B10 IN COMPLEX WITH MPTS
3079, 4n90I, 0.5242, 3.55, 0.113, 211, 106, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
3080, 4lmqL, 0.5242, 3.50, 0.105, 210, 105, DEVELOPMENT AND PRECLINICAL CHARACTERIZATION OF A HUMANIZED ANTIBODY TARGETING CXCL12
3081, 4kuzL, 0.5242, 3.84, 0.056, 197, 108, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
3082, 4gw1A, 0.5242, 3.88, 0.090, 216, 111, CQFD MEDITOPE
3083, 4fqhH, 0.5242, 3.46, 0.124, 211, 105, CRYSTAL STRUCTURE OF FAB CR9114
3084, 3qa3B, 0.5242, 3.53, 0.143, 220, 105, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3085, 3jbaL, 0.5242, 3.73, 0.083, 225, 109, THE U4 ANTIBODY EPITOPE ON HUMAN PAPILLOMAVIRUS 16 IDENTIFIED BY CRYO- EM
3086, 3i75A, 0.5242, 3.67, 0.085, 283, 106, ANTIBODY STRUCTURE
3087, 3gi9L, 0.5242, 3.77, 0.073, 216, 109, CRYSTAL STRUCTURE OF APCT TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3088, 3fb5B, 0.5242, 3.77, 0.073, 216, 109, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 14.5 A OPENING AT T112
3089, 3dggA, 0.5242, 3.81, 0.101, 215, 109, CRYSTAL STRUCTURE OF FABOX108
3090, 2xa8L, 0.5242, 3.62, 0.132, 216, 106, CRYSTAL STRUCTURE OF THE FAB DOMAIN OF OMALIZUMAB AT 2.41A
3091, 2kh2B, 0.5242, 3.09, 0.111, 216, 99, SOLUTION STRUCTURE OF A SCFV-IL-1B COMPLEX
3092, 2bipA, 0.5242, 3.57, 0.104, 212, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-H168R-V203A-N239Y-R249S- N268D
3093, 1yedB, 0.5242, 3.76, 0.056, 189, 107, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.4)
3094, 1t4wA, 0.5242, 3.59, 0.142, 217, 106, STRUCTURAL DIFFERENCES IN THE DNA BINDING DOMAINS OF HUMAN P53 AND ITS C. ELEGANS ORTHOLOG CEP-1: STRUCTURE OF C. ELEGANS CEP-1
3095, 1gzhA, 0.5242, 3.54, 0.143, 217, 105, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF HUMAN 53BP1 BOUND TO THE P53 TUMOR SUPRESSOR
3096, 6ogxL, 0.5241, 3.60, 0.151, 214, 106, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
3097, 6j11H, 0.5241, 3.60, 0.151, 214, 106, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
3098, 6j11F, 0.5241, 3.60, 0.151, 214, 106, MERS-COV SPIKE N-TERMINAL DOMAIN AND 7D10 SCFV COMPLEX 
3099, 6dfiL, 0.5241, 3.52, 0.105, 210, 105, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z021 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII 
3100, 6cw2B, 0.5241, 3.78, 0.092, 208, 109, CRYSTAL STRUCTURE OF A YEAST SAGA TRANSCRIPTIONAL COACTIVATOR ADA2/GCN5 HAT SUBCOMPLEX; CRYSTAL FORM 1 
3101, 6csfL, 0.5241, 3.62, 0.093, 213, 107, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH D-ALANINE BOUND 
3102, 6azxB, 0.5241, 3.62, 0.132, 219, 106, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
3103, 6aq7L, 0.5241, 2.73, 0.106, 226, 94, STRUCTURE OF POM6 FAB FRAGMENT COMPLEXED WITH MOUSE PRPC
3104, 6a3wD, 0.5241, 3.70, 0.081, 211, 111, COMPLEX STRUCTURE OF 4-1BB AND UTOMILUMAB 
3105, 5xcxB, 0.5241, 3.57, 0.085, 211, 106, CRYSTAL STRUCTURE OF TS2/16 FV-CLASP FRAGMENT
3106, 5w1kH, 0.5241, 3.68, 0.065, 226, 108, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3107, 5vh4L, 0.5241, 3.74, 0.092, 215, 109, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
3108, 5uddR, 0.5241, 3.38, 0.078, 212, 103, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3109, 5k59F, 0.5241, 3.55, 0.094, 214, 106, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
3110, 5jxaH, 0.5241, 3.82, 0.091, 218, 110, CRYSTAL STRUCTURE OF LIGAND-FREE VRC03 ANTIGEN-BINDING FRAGMENT.
3111, 5ir1A, 0.5241, 4.17, 0.055, 163, 109, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
3112, 5ezlL, 0.5241, 3.87, 0.082, 217, 110, CRYSTAL STRUCTURE OF FAB OF PARASITE INVASION INHIBITORY ANTIBODY C1 - MONOCLINIC FORM
3113, 4xzuB, 0.5241, 3.62, 0.094, 214, 106, CRYSTAL STRUCTURE OF THE HUMAN FACTOR VIII C2 DOMAIN IN COMPLEX WITH MURINE 3E6 INHIBITORY ANTIBODY
3114, 4pljC, 0.5241, 3.56, 0.085, 214, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3115, 4p1xD, 0.5241, 3.59, 0.094, 216, 106, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
3116, 4ouuA, 0.5241, 3.62, 0.093, 212, 107, ANTI-MT1-MMP MONOCLONAL ANTIBODY
3117, 4otxM, 0.5241, 3.80, 0.073, 222, 110, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
3118, 4mwfB, 0.5241, 3.87, 0.090, 224, 111, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3119, 4kteL, 0.5241, 3.54, 0.095, 115, 105, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE148 FROM NON-HUMAN PRIMATE
3120, 4k7pH, 0.5241, 3.63, 0.103, 212, 107, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3121, 4k3jL, 0.5241, 3.58, 0.104, 219, 106, CRYSTAL STRUCTURE OF ONARTUZUMAB FAB IN COMPLEX WITH MET AND HGF-BETA
3122, 4evnI, 0.5241, 3.59, 0.104, 212, 106, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3123, 4evnG, 0.5241, 3.63, 0.103, 217, 107, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3124, 3vg9C, 0.5241, 3.56, 0.094, 218, 106, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 2.7 A RESOLUTION
3125, 3sgeI, 0.5241, 3.73, 0.083, 254, 109, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
3126, 3qnxA, 0.5241, 3.92, 0.056, 185, 108, ORTHORHOMBIC FORM OF HUMAN IGA1 FAB FRAGMENT SHARING SAME FV AS IGG
3127, 3oknA, 0.5241, 3.82, 0.091, 226, 110, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO(2.4)KDO(2.4)KDO
3128, 3ojdA, 0.5241, 4.21, 0.087, 196, 115, ANTI-INDOLICIDIN MONOCLONAL ANTIBODY V2D2 (FAB FRAGMENT)
3129, 3kmdA, 0.5241, 3.97, 0.064, 187, 109, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3130, 3hnvH, 0.5241, 3.56, 0.075, 210, 106, CS-35 FAB COMPLEX WITH OLIGOARABINOFURANOSYL TETRASACCHARIDE (BRANCH PART OF HEXASACCHARIDE)
3131, 3f7vB, 0.5241, 3.58, 0.112, 128, 107, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 23 A OPENING AT T112
3132, 3cmoY, 0.5241, 3.58, 0.113, 120, 106, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3133, 3bszN, 0.5241, 3.57, 0.094, 215, 106, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3134, 2uylA, 0.5241, 3.56, 0.094, 199, 106, CRYSTAL STRUCTURE OF A MONOCLONAL ANTIBODY DIRECTED AGAINST AN ANTIGENIC DETERMINANT COMMON TO OGAWA AND INABA SEROTYPES OF VIBRIO CHOLERAE O1
3135, 2qqkL, 0.5241, 3.59, 0.113, 213, 106, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
3136, 2oz4L, 0.5241, 3.59, 0.104, 211, 106, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
3137, 2jixG, 0.5241, 3.59, 0.103, 216, 107, CRYSTAL STRUCTURE OF ABT-007 FAB FRAGMENT WITH THE SOLUBLE DOMAIN OF EPO RECEPTOR
3138, 2biqA, 0.5241, 3.63, 0.066, 116, 106, HUMAN P53 CORE DOMAIN MUTANT T123A-M133L-H168R-V203A-N239Y- R249S-N268D
3139, 1xcqB, 0.5241, 3.65, 0.104, 160, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3140, 1pw3A, 0.5241, 3.64, 0.113, 213, 106, CRYSTAL STRUCTURE OF JTOR68S
3141, 1l4iA, 0.5241, 3.59, 0.094, 213, 106, CRYSTAL STRUCTURE OF THE PERIPLASMIC CHAPERONE SFAE
3142, 6o39A, 0.5240, 3.57, 0.104, 211, 106, CRYSTAL STRUCTURE OF FRIZZLED 5 CRD IN COMPLEX WITH F2.I FAB 
3143, 6cruC, 0.5240, 3.55, 0.085, 212, 106, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) 
3144, 6c5kB, 0.5240, 3.91, 0.098, 231, 112, S25-23 FAB IN COMPLEX WITH CHLAMYDIACEAE LPS (CRYSTAL FORM 2) 
3145, 5xzcE, 0.5240, 3.56, 0.085, 213, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3146, 5wuxL, 0.5240, 3.64, 0.112, 213, 107, TNFALPHA-CERTOLIZUMAB FAB
3147, 5n09L, 0.5240, 3.48, 0.095, 213, 105, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3148, 5mp1J, 0.5240, 3.57, 0.113, 201, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3149, 5mhsG, 0.5240, 4.02, 0.062, 257, 112, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
3150, 5mhrP, 0.5240, 3.65, 0.132, 217, 106, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3151, 5lghH, 0.5240, 3.61, 0.093, 213, 107, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM II SAME AS 5L7X BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88 5L9D
3152, 5l7xH, 0.5240, 3.50, 0.095, 211, 105, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM II
3153, 5i73B, 0.5240, 3.85, 0.109, 216, 110, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL AND ALLOSTERIC SITES
3154, 5i1kH, 0.5240, 3.74, 0.101, 213, 109, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV5-51/IGKV3-20
3155, 5gznD, 0.5240, 3.57, 0.094, 217, 106, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
3156, 5dfvF, 0.5240, 3.77, 0.073, 221, 110, CRYSTAL STRUCTURE OF HUMAN CD81 LARGE EXTRACELLULAR LOOP IN COMPLEX WITH MURINE FAB FRAGMENT K04
3157, 4nwtH, 0.5240, 3.78, 0.073, 221, 110, CRYSTAL STRUCTURE OF THE ANTI-HUMAN NGF FAB APE1531
3158, 4mauL, 0.5240, 3.83, 0.100, 224, 110, CRYSTAL STRUCTURE OF ANTI-ST2L ANTIBODY C2244
3159, 4buhA, 0.5240, 3.63, 0.132, 219, 106, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
3160, 3okdA, 0.5240, 3.61, 0.104, 219, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KDO
3161, 3l95L, 0.5240, 3.57, 0.142, 218, 106, CRYSTAL STRUCTURE OF THE HUMAN NOTCH1 NEGATIVE REGULATORY REGION (NRR) BOUND TO THE FAB FRAGMENT OF AN ANTAGONIST ANTIBODY
3162, 3fb7B, 0.5240, 3.57, 0.113, 214, 106, OPEN KCSA POTASSIUM CHANNEL IN THE PRESENCE OF RB+ ION
3163, 3f83A, 0.5240, 3.95, 0.055, 200, 109, STRUCTURE OF FUSION COMPLEX OF THE MINOR PILIN CFAE AND MAJOR PILIN CFAB OF CFA/I PILI FROM ETEC E. COLI
3164, 3aazL, 0.5240, 3.82, 0.082, 220, 110, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3165, 3aazB, 0.5240, 3.58, 0.104, 212, 106, CRYSTAL STRUCTURE OF THE HUMANIZED RECOMBINANT FAB FRAGMENT OF A MURINE; ANTIBODY
3166, 2z92B, 0.5240, 3.84, 0.091, 222, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9 IN COMPLEX WITH CTX3C_ABCDE
3167, 2vdoH, 0.5240, 3.81, 0.101, 215, 109, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQAGDV
3168, 2vc2H, 0.5240, 3.57, 0.143, 218, 105, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST L-739758
3169, 2r0kL, 0.5240, 3.58, 0.085, 211, 106, PROTEASE DOMAIN OF HGFA WITH INHIBITOR FAB58
3170, 1vgeH, 0.5240, 3.63, 0.112, 214, 107, TR1.9 FAB FRAGMENT OF A HUMAN IGG1 KAPPA AUTOANTIBODY
3171, 1rziD, 0.5240, 3.60, 0.084, 214, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3172, 1rihH, 0.5240, 3.92, 0.056, 185, 108, CRYSTAL STRUCTURE OF FAB 14F7 A UNIQUE ANTI-TUMOR ANTIBODY SPECIFIC FOR N-GLYCOLYL GM3
3173, 1otuF, 0.5240, 3.80, 0.092, 218, 109, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148Q MUTANT AND FAB COMPLEX
3174, 1mjuH, 0.5240, 3.52, 0.143, 111, 105, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
3175, 1jnnH, 0.5240, 2.86, 0.062, 189, 96, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3176, 1dbmH, 0.5240, 3.53, 0.075, 212, 106, MOLECULAR BASIS OF CROSS-REACTIVITY AND THE LIMITS OF ANTIBODY-ANTIGEN COMPLEMENTARITY
3177, 1ae6H, 0.5240, 4.67, 0.068, 218, 118, IGG-FAB FRAGMENT OF MOUSE MONOCLONAL ANTIBODY CTM01
3178, 6ogxD, 0.5239, 3.62, 0.132, 219, 106, TERNARY COMPLEX OF OX40R (TNFRSF4) BOUND TO FAB1 AND FAB2 
3179, 6ncpD, 0.5239, 3.96, 0.055, 232, 109, CRYSTAL STRUCTURE OF HIV-1 BROADLY NEUTRALIZING ANTIBODY ACS202 
3180, 6igoA, 0.5239, 3.58, 0.094, 213, 106, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
3181, 6fg2I, 0.5239, 3.66, 0.065, 213, 108, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3182, 6ev2C, 0.5239, 3.73, 0.083, 214, 109, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3183, 6ddvA, 0.5239, 3.59, 0.094, 205, 106, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3184, 6dc8L, 0.5239, 3.87, 0.071, 213, 113, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 8B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3185, 6azkB, 0.5239, 3.80, 0.091, 205, 110, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3186, 6au5A, 0.5239, 3.80, 0.091, 205, 110, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
3187, 5xzcC, 0.5239, 3.84, 0.091, 218, 110, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3188, 5w24H, 0.5239, 3.79, 0.073, 211, 109, CRYSTAL STRUCTURE OF 5C4 FAB
3189, 5vphC, 0.5239, 3.65, 0.076, 214, 105, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3190, 5t1mC, 0.5239, 3.58, 0.113, 217, 106, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
3191, 5nb5L, 0.5239, 3.78, 0.064, 232, 110, PRINCIPLES FOR COMPUTATIONAL DESIGN OF ANTIBODIES
3192, 5mx3A, 0.5239, 3.55, 0.113, 216, 106, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3193, 5mhrG, 0.5239, 3.70, 0.065, 236, 107, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3194, 5mhgL, 0.5239, 3.53, 0.143, 219, 105, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH TETRAIODOBPA 
3195, 5mf7B, 0.5239, 3.61, 0.084, 212, 107, P53-DNA COMPLEX 6 
3196, 5i71B, 0.5239, 3.59, 0.104, 212, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
3197, 5hysF, 0.5239, 4.19, 0.079, 508, 114, STRUCTURE OF IGE COMPLEXED WITH OMALIZUMAB
3198, 5dk3A, 0.5239, 3.61, 0.142, 228, 106, CRYSTAL STRUCTURE OF PEMBROLIZUMAB A FULL LENGTH IGG4 ANTIBODY
3199, 4xmlL, 0.5239, 3.61, 0.142, 229, 106, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424
3200, 4wfgG, 0.5239, 3.53, 0.105, 210, 105, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
3201, 4wfeG, 0.5239, 3.86, 0.090, 219, 111, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
3202, 4r7nN, 0.5239, 3.86, 0.090, 219, 111, FAB C2E3
3203, 4r7nL, 0.5239, 3.64, 0.084, 214, 107, FAB C2E3
3204, 4r0lB, 0.5239, 3.86, 0.073, 225, 110, ANTI-CANINE CD28 ANTIBODY 1C6 BOUND CANINE CD28
3205, 4hweH, 0.5239, 3.87, 0.073, 216, 110, CRYSTAL STRUCTURE OF ECTODOMAIN 3 OF THE IL-13 RECEPTOR ALPHA1 IN COMPLEX WITH A HUMAN NEUTRALIZING MONOCLONAL ANTIBODY FRAGMENT
3206, 4evnM, 0.5239, 3.80, 0.082, 221, 110, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3207, 4dw2L, 0.5239, 3.51, 0.133, 211, 105, THE CRYSTAL STRUCTURE OF UPA IN COMPLEX WITH THE FAB FRAGMENT OF MAB- 112
3208, 4dcqB, 0.5239, 3.81, 0.101, 211, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 3B5H10 AN ANTIBODY-SPECIFIC FOR EXTENDED POLYGLUTAMINE REPEATS (ORTHORHOMBIC FORM)
3209, 4d9lL, 0.5239, 3.79, 0.100, 214, 110, FAB STRUCTURE OF ANTI-HIV-1 GP120 V2 MAB 697
3210, 3wxwH, 0.5239, 3.80, 0.091, 219, 110, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 2
3211, 3sy0A, 0.5239, 3.77, 0.082, 218, 110, S25-2- A(2-8)-A(2-4)KDO TRISACCHARIDE COMPLEX
3212, 3stzB, 0.5239, 3.57, 0.075, 213, 106, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH NITROXIDE SPIN LABEL
3213, 3rvxC, 0.5239, 3.63, 0.093, 212, 107, CRYSTAL STRUCTURE OF DER P 1 COMPLEXED WITH FAB 4C1
3214, 3mlyM, 0.5239, 3.85, 0.072, 120, 111, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A UR29 V3 PEPTIDE
3215, 3mj6A, 0.5239, 3.77, 0.073, 218, 109, CRYSTAL STRUCTURE OF THE GAMMADELTA T CELL COSTIMULATORY RECEPTOR JUNCTIONAL ADHESION MOLECULE-LIKE PROTEIN JAML
3216, 3kmdC, 0.5239, 3.66, 0.081, 222, 111, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3217, 2ypvH, 0.5239, 3.62, 0.123, 217, 106, CRYSTAL STRUCTURE OF THE MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN IN COMPLEX WITH A BACTERICIDAL ANTIBODY
3218, 2vdkH, 0.5239, 3.61, 0.132, 218, 106, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3219, 2g5bA, 0.5239, 3.81, 0.091, 219, 110, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3220, 1tupB, 0.5239, 3.57, 0.094, 212, 106, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
3221, 1tsrB, 0.5239, 3.95, 0.055, 232, 109, P53 CORE DOMAIN IN COMPLEX WITH DNA
3222, 6okqE, 0.5238, 3.77, 0.092, 216, 109, CRYSTAL STRUCTURE OF THE SF12 FAB 
3223, 6nknB, 0.5238, 3.59, 0.104, 211, 106, TIME-RESOLVED SFX STRUCTURE OF THE PR INTERMEDIATE OF CYTOCHROME C OXIDASE AT ROOM TEMPERATURE 
3224, 6ggfA, 0.5238, 3.61, 0.093, 213, 107, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL- MOLECULE STABILIZER PK9328 
3225, 6cnkG, 0.5238, 3.58, 0.104, 218, 106, STRUCTURE OF THE 3ALPHA2BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
3226, 6bpaF, 0.5238, 3.75, 0.083, 219, 109, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
3227, 6azlB, 0.5238, 3.62, 0.104, 211, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3228, 6awpB, 0.5238, 3.53, 0.124, 213, 105, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH FLUVOXAMINE AT THE CENTRAL SITE
3229, 5x2qK, 0.5238, 3.84, 0.056, 188, 108, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH GLYCINE
3230, 5x2oL, 0.5238, 3.84, 0.091, 218, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3231, 5wuvL, 0.5238, 3.65, 0.075, 215, 107, CRYSTAL STRUCTURE OF CERTOLIZUMAB FAB
3232, 5w23J, 0.5238, 3.60, 0.085, 218, 106, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3233, 5vkkH, 0.5238, 3.57, 0.094, 215, 106, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD22 EPRATUZUMAB
3234, 5vh4B, 0.5238, 3.84, 0.101, 210, 109, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-TNFA ANTIBODY INFLIXIMAB IN AN I-CENTERED ORTHORHOMBIC CRYSTAL FORM
3235, 5t78A, 0.5238, 3.84, 0.101, 210, 109, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3236, 5mp1F, 0.5238, 3.59, 0.094, 211, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3237, 5mf7A, 0.5238, 3.59, 0.094, 211, 106, P53-DNA COMPLEX 6 
3238, 5itfB, 0.5238, 3.58, 0.086, 114, 105, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
3239, 5id1A, 0.5238, 3.78, 0.073, 213, 109, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
3240, 5gz0C, 0.5238, 3.78, 0.073, 221, 110, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3241, 5etuA, 0.5238, 3.71, 0.111, 214, 108, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
3242, 5cjqH, 0.5238, 3.76, 0.092, 218, 109, CRYSTAL STRUCTURE OF A TRIMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
3243, 4wfhG, 0.5238, 3.67, 0.103, 214, 107, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
3244, 4rqqB, 0.5238, 3.74, 0.127, 119, 110, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
3245, 4r7dP, 0.5238, 3.53, 0.152, 219, 105, FAB HU 15C1
3246, 4ot1L, 0.5238, 3.57, 0.113, 212, 106, STRUCTURAL BASIS FOR THE RECOGNITION OF HUMAN CYTOMEGALOVIRUS GLYCOPROTEIN B BY THE NEUTRALIZING HUMAN ANTIBODY SM5-1
3247, 4m7kL, 0.5238, 3.59, 0.104, 211, 106, CRYSTAL STRUCTURE OF ANTI-TISSUE FACTOR ANTIBODY 10H10
3248, 4ibqD, 0.5238, 3.64, 0.095, 214, 105, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C
3249, 4hk3J, 0.5238, 3.93, 0.062, 227, 113, I2 FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3250, 4h0gA, 0.5238, 3.95, 0.055, 200, 109, CRYSTAL STRUCTURE OF MIMICRY-RECOGNIZING NATIVE 2D10 SCFV
3251, 4ffvD, 0.5238, 3.84, 0.109, 215, 110, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH 11A19 FAB
3252, 3v0wL, 0.5238, 3.86, 0.090, 219, 111, CRYSTAL STRUCTURE OF FAB WN1 222-5 IN COMPLEX WITH LPS
3253, 3t77A, 0.5238, 3.58, 0.132, 217, 106, S25-2- A(2-4)KDO DISACCHARIDE COMPLEX
3254, 3o45B, 0.5238, 3.84, 0.065, 194, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
3255, 3mxvL, 0.5238, 3.84, 0.065, 194, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-SHH 5E1 CHIMERA
3256, 3ietA, 0.5238, 3.70, 0.084, 210, 107, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
3257, 3d09A, 0.5238, 2.73, 0.106, 226, 94, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND-SITE SUPPRESSOR MUTATIONS H168R AND T123A
3258, 3c2aM, 0.5238, 3.84, 0.046, 196, 108, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
3259, 2vdqH, 0.5238, 3.83, 0.064, 218, 109, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE HHLGGAKQRGDV
3260, 2r69L, 0.5238, 3.64, 0.104, 211, 106, CRYSTAL STRUCTURE OF FAB 1A1D-2 COMPLEXED WITH E-DIII OF DENGUE VIRUS AT 3.8 ANGSTROM RESOLUTION
3261, 2pcpB, 0.5238, 3.82, 0.091, 220, 110, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3262, 2pcpA, 0.5238, 3.81, 0.091, 218, 110, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3263, 2mryA, 0.5238, 3.50, 0.133, 216, 105, NMR SOLUTION STRUCTURE OF COPPER BINDING PROTEIN IN THE APO FORM
3264, 2c1oH, 0.5238, 3.55, 0.113, 216, 106, ENAIIHIS FAB FRAGMENT IN THE FREE FORM
3265, 1n8zA, 0.5238, 3.58, 0.094, 213, 106, CRYSTAL STRUCTURE OF EXTRACELLULAR DOMAIN OF HUMAN HER2 COMPLEXED WITH HERCEPTIN FAB
3266, 1lmkG, 0.5238, 3.80, 0.092, 219, 109, THE STRUCTURE OF A BIVALENT DIABODY
3267, 1ibgL, 0.5238, 3.70, 0.083, 218, 109, STRUCTURE AND SPECIFICITY OF THE ANTI-DIGOXIN ANTIBODY 40-50
3268, 1faiH, 0.5238, 3.59, 0.094, 213, 106, THREE-DIMENSIONAL STRUCTURE OF TWO CRYSTAL FORMS OF FAB R19.9 FROM A MONOCLONAL ANTI-ARSONATE ANTIBODY
3269, 6oknB, 0.5237, 3.63, 0.123, 216, 106, OX40R (TNFRSF4) BOUND TO FAB 1A7 
3270, 6nb8L, 0.5237, 3.73, 0.083, 215, 109, CRYSTAL STRUCTURE OF ANTI- SARS-COV HUMAN NEUTRALIZING S230 ANTIBODY FAB FRAGMENT 
3271, 6bf4C, 0.5237, 3.87, 0.065, 188, 108, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
3272, 5vjqB, 0.5237, 3.75, 0.092, 217, 109, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3273, 5vebB, 0.5237, 3.63, 0.084, 212, 107, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
3274, 5myxA, 0.5237, 3.57, 0.085, 213, 106, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
3275, 5mthH, 0.5237, 3.63, 0.093, 213, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3276, 5mp1C, 0.5237, 3.86, 0.072, 217, 111, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3277, 5anyJ, 0.5237, 3.89, 0.100, 210, 110, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3278, 5anyI, 0.5237, 3.56, 0.065, 239, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VIRUS IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK265
3279, 5a1zG, 0.5237, 3.65, 0.093, 211, 107, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
3280, 4zypG, 0.5237, 3.54, 0.067, 214, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3281, 4q6iA, 0.5237, 3.62, 0.132, 220, 106, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
3282, 4p1xB, 0.5237, 3.89, 0.065, 193, 108, CRYSTAL STRUCTURE OF STAPHYLOCOCCAL LUK PREPORE
3283, 4nrxA, 0.5237, 3.78, 0.073, 218, 109, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3284, 4n90E, 0.5237, 3.87, 0.071, 242, 113, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
3285, 4i9wG, 0.5237, 3.80, 0.082, 209, 110, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
3286, 4hkbE, 0.5237, 3.59, 0.094, 211, 106, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
3287, 4evnK, 0.5237, 3.53, 0.152, 219, 105, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3288, 4cadK, 0.5237, 3.60, 0.123, 217, 106, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3289, 4cadH, 0.5237, 3.64, 0.084, 212, 107, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
3290, 3j3oL, 0.5237, 3.61, 0.132, 215, 106, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
3291, 3i75B, 0.5237, 3.93, 0.065, 188, 108, ANTIBODY STRUCTURE
3292, 2z4qA, 0.5237, 3.65, 0.124, 216, 105, CRYSTAL STRUCTURE OF A MURINE ANTIBODY FAB 528
3293, 2vxtH, 0.5237, 3.86, 0.090, 219, 111, CRYSTAL STRUCTURE OF HUMAN IL-18 COMPLEXED TO MURINE REFERENCE ANTIBODY 125-2H FAB
3294, 2vdrH, 0.5237, 3.69, 0.112, 204, 107, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO A CHIMERIC FIBRINOGEN GAMMA CHAIN PEPTIDE LGGAKQRGDV
3295, 2vdlH, 0.5237, 3.82, 0.110, 215, 109, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE
3296, 2b1aH, 0.5237, 3.59, 0.142, 216, 106, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH UG1033 PEPTIDE
3297, 1xctC, 0.5237, 2.23, 0.151, 98, 86, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
3298, 1uywM, 0.5237, 3.88, 0.109, 218, 110, CRYSTAL STRUCTURE OF THE ANTIFLAVIVIRUS FAB4G2
3299, 1t4kC, 0.5237, 3.59, 0.085, 214, 106, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3300, 1p7kH, 0.5237, 3.71, 0.064, 238, 109, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
3301, 1p2cD, 0.5237, 3.58, 0.113, 217, 106, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3302, 1nlbH, 0.5237, 3.81, 0.082, 221, 110, CRYSTAL STRUCTURE OF ANTI-HCV MONOCLONAL ANTIBODY 19D9D6
3303, 1jptL, 0.5237, 3.58, 0.075, 213, 106, CRYSTAL STRUCTURE OF FAB D3H44
3304, 1d5iH, 0.5237, 3.59, 0.113, 219, 106, UNLIGANDED GERMLINE PRECURSOR OF AN OXY-COPE CATALYTIC ANTIBODY
3305, 1a0qL, 0.5237, 3.52, 0.124, 219, 105, 29G11 COMPLEXED WITH PHENYL [1-(1-N-SUCCINYLAMINO)PENTYL] PHOSPHONATE
3306, 6rcqA, 0.5236, 3.63, 0.123, 212, 106, PFRH5-BINDING MONOCLONAL ANTIBODY R5.011 
3307, 6njmN, 0.5236, 3.55, 0.094, 215, 106, STRUCTURE OF A COMPLEX 
3308, 6njmM, 0.5236, 3.59, 0.132, 219, 106, STRUCTURE OF A COMPLEX 
3309, 6mnrL, 0.5236, 3.73, 0.083, 220, 109, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
3310, 6i9iL, 0.5236, 3.74, 0.083, 214, 109, RIFT VALLEY FEVER VIRUS GN IN COMPLEX WITH A NEUTRALIZING ANTIBODY FRAGMENT 
3311, 6d0uF, 0.5236, 3.80, 0.109, 218, 110, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3312, 6bzwB, 0.5236, 3.80, 0.109, 218, 110, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3313, 6bb4M, 0.5236, 3.65, 0.065, 120, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3314, 6a4kM, 0.5236, 3.58, 0.094, 213, 106, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
3315, 5yl1A, 0.5236, 3.57, 0.113, 218, 106, T=1 SUBVIRAL PARTICLE OF PENAEUS VANNAMEI NODAVIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-37  and 251-368) 
3316, 5xrqL, 0.5236, 4.02, 0.062, 257, 112, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
3317, 5xbmD, 0.5236, 3.79, 0.083, 229, 109, STRUCTURE OF SCARB2-JL2 COMPLEX 
3318, 5x5xH, 0.5236, 3.63, 0.094, 214, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-OSTEOCALCIN C-TERMINAL PEPTIDE ANTIBODY KTM219
3319, 5x2nL, 0.5236, 3.84, 0.101, 210, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
3320, 5w42H, 0.5236, 3.82, 0.073, 220, 110, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/MINNESOTA/11/2010 (H3N2) 
3321, 5vjqD, 0.5236, 3.78, 0.073, 221, 110, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT (I29F; S52T; Y53F) AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
3322, 5vebL, 0.5236, 3.82, 0.071, 221, 112, CRYSTAL STRUCTURE OF A FAB BINDING TO EXTRACELLULAR DOMAIN 5 OF CADHERIN-6
3323, 5ockL, 0.5236, 3.82, 0.071, 221, 112, CRYSTAL STRUCTURE OF ACPA E4 IN COMPLEX WITH CEP1 
3324, 5mesL, 0.5236, 3.60, 0.133, 219, 105, MCL1 FAB COMPLEX IN COMPLEX WITH COMPOUND 29
3325, 5m63N, 0.5236, 3.70, 0.081, 223, 111, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
3326, 5i6xB, 0.5236, 3.61, 0.132, 219, 106, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
3327, 5eocL, 0.5236, 3.76, 0.110, 207, 109, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
3328, 4rgmH, 0.5236, 3.86, 0.090, 219, 111, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO THE NEUTRALIZING ANTIBODY 20B1
3329, 4r97B, 0.5236, 3.86, 0.090, 219, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF KKO
3330, 4plkK, 0.5236, 3.78, 0.073, 226, 109, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3331, 4oz4A, 0.5236, 3.57, 0.152, 220, 105, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3332, 4mswB, 0.5236, 3.72, 0.083, 218, 109, Y78 ESTER MUTANT OF KCSA IN HIGH K+
3333, 4izlC, 0.5236, 3.62, 0.104, 217, 106, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3334, 4edwL, 0.5236, 3.82, 0.091, 220, 110, NERVE GROWTH FACTOR IN COMPLEX WITH FAB FROM HUMANIZED VERSION OF MOUSE MAB 911 (TANEZUMAB)
3335, 3wxvH, 0.5236, 3.62, 0.112, 211, 107, CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1
3336, 3t65A, 0.5236, 3.78, 0.092, 218, 109, S25-2- A(2-8)KDO DISACCHARIDE COMPLEX
3337, 3t4yA, 0.5236, 3.56, 0.094, 213, 106, S25-2- KDO MONOSACCHARIDE COMPLEX
3338, 3so3B, 0.5236, 3.83, 0.082, 221, 110, STRUCTURES OF FAB-PROTEASE COMPLEXES REVEAL A HIGHLY SPECIFIC NON- CANONICAL MECHANISM OF INHIBITION.
3339, 3qpqE, 0.5236, 3.58, 0.113, 211, 106, CRYSTAL STRUCTURE OF ANTI-TLR3 ANTIBODY C1068 FAB
3340, 3nabH, 0.5236, 3.84, 0.091, 222, 110, CRYSTAL STRUCTURE OF FAB15 MUT6
3341, 3m4eE, 0.5236, 3.58, 0.000, 213, 106, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
3342, 3m4eA, 0.5236, 3.81, 0.000, 218, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
3343, 3idxL, 0.5236, 3.42, 0.106, 211, 104, CRYSTAL STRUCTURE OF HIV-GP120 CORE IN COMPLEX WITH CD4-BINDING SITE ANTIBODY B13 SPACE GROUP C222
3344, 2vq1A, 0.5236, 3.47, 0.144, 215, 104, ANTI TRIMERIC LEWIS X FAB54-5C10-A
3345, 2vdpH, 0.5236, 3.59, 0.075, 213, 106, INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO FIBRINOGEN GAMMA CHAIN PEPTIDELGGAKQAGDV
3346, 2o5yL, 0.5236, 3.58, 0.113, 217, 106, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
3347, 2ataB, 0.5236, 3.63, 0.131, 211, 107, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
3348, 1zglP, 0.5236, 3.66, 0.150, 216, 107, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
3349, 1xgyH, 0.5236, 3.91, 0.065, 185, 108, CRYSTAL STRUCTURE OF ANTI-META I RHODOPSIN FAB FRAGMENT K42- 41L
3350, 1tqbC, 0.5236, 3.62, 0.113, 213, 106, OVINE RECOMBINANT PRP(114-234) VRQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3351, 1p2cE, 0.5236, 3.57, 0.105, 209, 105, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3352, 1opgL, 0.5236, 3.77, 0.109, 216, 110, OPG2 FAB FRAGMENT
3353, 1m7dA, 0.5236, 3.49, 0.133, 216, 105, CRYSTAL STRUCTURE OF A MONOCLONAL FAB SPECIFIC FOR SHIGELLA FLEXNERI Y LIPOPOLYSACCHARIDE COMPLEXED WITH A TRISACCHARIDE
3354, 1lmkE, 0.5236, 3.72, 0.074, 227, 108, THE STRUCTURE OF A BIVALENT DIABODY
3355, 1i8mB, 0.5236, 3.67, 0.103, 213, 107, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
3356, 1hklH, 0.5236, 3.59, 0.085, 215, 106, FREE AND LIGANDED FORM OF AN ESTEROLYTIC CATALYTIC ANTIBODY
3357, 6okqC, 0.5235, 3.55, 0.104, 214, 106, CRYSTAL STRUCTURE OF THE SF12 FAB 
3358, 6iuvD, 0.5235, 3.52, 0.095, 213, 105, CRYSTAL STRUCTURE OF INFLUENZA A VIRUS H5 HEMAGGLUTININ GLOBULAR HEAD IN COMPLEX WITH THE FAB OF ANTIBODY 3C11 
3359, 6gk7H, 0.5235, 3.59, 0.113, 216, 106, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-27.1; DOUBLE MUTANT (S31Y; T100I) OF CBTAU-27.1; IN COMPLEX WITH TAU PEPTIDE A8119B (RESIDUES 299-318) 
3360, 6ev2A, 0.5235, 3.81, 0.091, 218, 110, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3361, 6dcaO, 0.5235, 3.57, 0.113, 216, 106, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY 6B2 TARGETING A NON- PHOSPHORYLATED TAU EPITOPE. 
3362, 6cseB, 0.5235, 3.82, 0.062, 216, 113, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
3363, 6bzwD, 0.5235, 3.65, 0.103, 214, 107, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3364, 6b5pH, 0.5235, 3.67, 0.111, 208, 108, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN ANTIBODY CIS42
3365, 6b08C, 0.5235, 3.75, 0.083, 219, 109, CRYSTAL STRUCTURE OF PFS25 IN COMPLEX WITH THE TRANSMISSION BLOCKING ANTIBODY 1276
3366, 5zv3H, 0.5235, 3.59, 0.113, 212, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-28.1 IN COMPLEX WITH ITS TAU PEPTIDE 
3367, 5w3pH, 0.5235, 4.01, 0.062, 278, 112, ANTIBODY C706 IN COMPLEX WTH BETA-AMYLOID PEPTIDE 1-16
3368, 5w1kM, 0.5235, 3.58, 0.085, 214, 106, JUNV GP1 CR1-10 FAB CR1-28 FAB COMPLEX 
3369, 5u5oA, 0.5235, 3.70, 0.128, 119, 109, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P1) 
3370, 5t6pC, 0.5235, 3.53, 0.152, 219, 105, CRYSTAL STRUCTURE OF THERAPEUTIC MAB AR20.5 IN COMPLEX WITH MUC1 PEPTIDE
3371, 5nbwH, 0.5235, 3.54, 0.152, 219, 105, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
3372, 5n2kK, 0.5235, 3.58, 0.104, 216, 106, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3373, 5mvjH, 0.5235, 3.64, 0.093, 215, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3374, 5m63L, 0.5235, 3.76, 0.073, 217, 109, CRYSTAL STRUCTURE OF GROUP B STREPTOCOCCUS TYPE III DP2 OLIGOSACCHARIDE BOUND TO FAB NVS-1-19-5
3375, 5gjsL, 0.5235, 3.86, 0.063, 293, 111, CRYSTAL STRUCTURE OF H1 HEMAGGLUTININ FROM A/CALIFORNIA/04/2009 IN COMPLEX WITH A NEUTRALIZING ANTIBODY 3E1
3376, 5girA, 0.5235, 3.86, 0.063, 293, 111, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH ITS LIGAND PEPTIDE
3377, 5fhbH, 0.5235, 3.72, 0.083, 214, 108, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 100
3378, 5f3bF, 0.5235, 3.59, 0.113, 216, 106, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
3379, 4xvsH, 0.5235, 3.86, 0.090, 219, 111, CRYSTAL STRUCTURE OF HIV-1 DONOR 45 D45-01DG5 COREE GP120 WITH ANTIBODY 45-VRC01.H01+07.O-863513/45-VRC01.L01+07.O-110653 (VRC07_1995)
3380, 4webL, 0.5235, 3.64, 0.121, 218, 107, STRUCTURE OF THE CORE ECTODOMAIN OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN 2
3381, 4qtiH, 0.5235, 3.90, 0.065, 198, 108, CRYSTAL STRUCTURE OF HUMAN UPAR IN COMPLEX WITH ANTI-UPAR FAB 8B12
3382, 4qexH, 0.5235, 3.70, 0.102, 242, 108, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3383, 4nrxD, 0.5235, 3.82, 0.071, 216, 112, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66 IN COMPLEX WITH GP41 MPER PEPTIDE
3384, 4mwfL, 0.5235, 3.65, 0.123, 219, 106, STRUCTURE OF HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 CORE BOUND TO BROADLY NEUTRALIZING ANTIBODY AR3C
3385, 4k24L, 0.5235, 3.85, 0.083, 211, 109, STRUCTURE OF ANTI-UPAR FAB ATN-658 IN COMPLEX WITH UPAR
3386, 4izlD, 0.5235, 3.65, 0.104, 214, 106, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3387, 4hkbI, 0.5235, 3.60, 0.132, 215, 106, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
3388, 4g3yL, 0.5235, 3.73, 0.064, 238, 109, CRYSTAL STRUCTURE OF TNF-ALPHA IN COMPLEX WITH INFLIXIMAB FAB FRAGMENT
3389, 3tt3H, 0.5235, 3.82, 0.091, 213, 110, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3390, 3qwoL, 0.5235, 3.69, 0.110, 217, 109, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
3391, 3pp4H, 0.5235, 3.70, 0.084, 210, 107, EPITOPE CHARACTERIZATION AND CRYSTAL STRUCTURE OF GA101 PROVIDE INSIGHTS INTO THE MOLECULAR BASIS FOR THE TYPE I / TYPE II DISTINCTION OF ANTI- CD20 ANTIBODIES
3392, 3okeA, 0.5235, 3.56, 0.113, 215, 106, CRYSTAL STRUCTURE OF S25-39 IN COMPLEX WITH KO
3393, 3muhL, 0.5235, 3.77, 0.073, 223, 109, CRYSTAL STRUCTURE OF PG9 LIGHT CHAIN
3394, 3i02C, 0.5235, 3.70, 0.081, 220, 111, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3395, 3hmwL, 0.5235, 3.62, 0.132, 215, 106, CRYSTAL STRUCTURE OF USTEKINUMAB FAB
3396, 2vdmH, 0.5235, 3.59, 0.132, 213, 106, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST TIROFIBAN
3397, 2r56L, 0.5235, 3.59, 0.113, 216, 106, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3398, 2j1yD, 0.5235, 3.62, 0.083, 212, 108, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-G245S-N268D
3399, 2fjfE, 0.5235, 3.78, 0.073, 221, 110, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3400, 2ez0F, 0.5235, 3.79, 0.073, 219, 110, CRYSTAL STRUCTURE OF THE S107A/E148Q/Y445A MUTANT OF ECCLC IN COMPLEX WITH A FAB FRAGMENT
3401, 2ataC, 0.5235, 3.86, 0.083, 214, 109, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
3402, 1ynkH, 0.5235, 3.63, 0.113, 213, 106, IDENTIFICATION OF KEY RESIDUES OF THE NC6.8 FAB ANTIBODY FRAGMENT BINDING TO SYNTHETIC SWEETENERS: CRYSTAL STRUCTURE OF NC6.8 CO-CRYSTALIZED WITH HIGH POTENCY SWEETENER COMPOUND SC45647
3403, 1t5rG, 0.5235, 3.42, 0.069, 287, 101, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3404, 1t3fB, 0.5235, 3.64, 0.132, 216, 106, THREE DIMENSIONAL STRUCTURE OF A HUMANIZED ANTI-IFN-GAMMA FAB (HUZAF) IN P21 21 21 SPACE GROUP
3405, 1q9oC, 0.5235, 3.84, 0.092, 216, 109, S45-18 FAB UNLIGANDED
3406, 1mjuL, 0.5235, 3.51, 0.095, 214, 105, 1.22 ANGSTROM RESOLUTION CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12
3407, 1kcrL, 0.5235, 3.73, 0.083, 218, 109, CRYSTAL STRUCTURE OF ANTIBODY PC283 IN COMPLEX WITH PS1 PEPTIDE
3408, 6oe5C, 0.5234, 3.59, 0.113, 215, 106, SPLAYED OPEN PREFUSION RSV F CAPTURED BY CR9501 AND MOTAVIZUMAB FABS 
3409, 6n81L, 0.5234, 3.57, 0.085, 207, 106, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
3410, 6n81D, 0.5234, 3.76, 0.111, 206, 108, CRYSTAL STRUCTURE OF GII.4 2002 NOROVIRUS P DOMAIN IN COMPLEX WITH CROSS-REACTIVE HUMAN ANTIBODY A1227 
3411, 6faxH, 0.5234, 3.84, 0.081, 228, 111, COMPLEX OF HUMAN CD40 ECTODOMAIN WITH LOB 7.4 FAB
3412, 6e9qF, 0.5234, 3.72, 0.084, 213, 107, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-6 
3413, 6dlaH, 0.5234, 3.79, 0.064, 228, 109, CRYSTAL STRUCTURES OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:7969D2 
3414, 6bzwF, 0.5234, 3.58, 0.142, 217, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
3415, 6bzuD, 0.5234, 3.81, 0.091, 218, 110, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 19B3 
3416, 6bf4L, 0.5234, 3.77, 0.092, 206, 109, CRYSTAL STRUCTURE OF HIV-1 CLADE AE STRAIN CNE55 GP120 CORE IN COMPLEX WITH NEUTRALIZING ANTIBODY VRC-PG05 THAT TARGETS THE CENTER OF THE SILENT FACE ON THE OUTER DOMAIN OF GP120
3417, 5x2pL, 0.5234, 3.82, 0.083, 228, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
3418, 5x2oK, 0.5234, 3.59, 0.104, 212, 106, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ARGININE
3419, 5w23M, 0.5234, 3.66, 0.123, 218, 106, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3420, 5vr9L, 0.5234, 4.02, 0.062, 277, 112, CH1/CKAPPA FAB BASED ON MATUZUMAB
3421, 5vqmH, 0.5234, 3.77, 0.073, 220, 110, CLOSTRIDIUM DIFFICILE TCDB-GTD BOUND TO PA41 FAB
3422, 5vk6B, 0.5234, 3.59, 0.094, 214, 106, OPEN CONFORMATION OF KCSA NON-INACTIVATING E71A MUTANT
3423, 5tzuL, 0.5234, 3.84, 0.091, 218, 110, CRYSTAL STRUCTURE OF HUMAN CD47 ECD BOUND TO FAB OF B6H12.2
3424, 5lcvL, 0.5234, 3.50, 0.095, 210, 105, STRUCTURAL BASIS OF ZIKA AND DENGUE VIRUS POTENT ANTIBODY CROSS- NEUTRALIZATION
3425, 5lapB, 0.5234, 3.86, 0.073, 220, 110, P53 CANCER MUTANT Y220C WITH CYS182 ALKYLATION
3426, 5l0qE, 0.5234, 3.58, 0.142, 217, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3427, 5kvfH, 0.5234, 3.56, 0.106, 212, 104, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
3428, 5k59L, 0.5234, 3.65, 0.140, 196, 107, CRYSTAL STRUCTURE OF LUKGH FROM STAPHYLOCOCCUS AUREUS IN COMPLEX WITH A NEUTRALISING ANTIBODY
3429, 5jueH, 0.5234, 3.63, 0.084, 214, 107, CRYSTAL STRUCTURE OF UIC2 FAB
3430, 5dmgF, 0.5234, 3.87, 0.090, 219, 111, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3431, 4zffB, 0.5234, 3.58, 0.104, 211, 106, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
3432, 4yqxL, 0.5234, 3.88, 0.046, 192, 108, MOUSE IL-2 BOUND TO JES6-1 SCFV FRAGMENT
3433, 4ydiH, 0.5234, 3.63, 0.093, 211, 107, CRYSTAL STRUCTURE OF BROAD AND POTENTLY NEUTRALIZING VRC01-CLASS ANTIBODY Z258-VRC27.01 ISOLATED FROM HUMAN DONOR Z258 IN COMPLEX WITH HIV-1 GP120 FROM CLADE A STRAIN Q23.17
3434, 4wffG, 0.5234, 3.52, 0.133, 211, 105, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
3435, 4r9yN, 0.5234, 3.88, 0.065, 195, 108, CRYSTAL STRUCTURE OF KKOFAB IN COMPLEX WITH PLATELET FACTOR 4
3436, 4qexI, 0.5234, 3.77, 0.073, 219, 110, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
3437, 4plkH, 0.5234, 4.04, 0.062, 269, 112, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3438, 4mhhL, 0.5234, 3.78, 0.083, 219, 109, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
3439, 4k7pX, 0.5234, 3.51, 0.152, 219, 105, GENERATION AND CHARACTERIZATION OF A UNIQUE REAGENT THAT RECOGNIZES A PANEL OF RECOMBINANT HUMAN MONOCLONAL ANTIBODY THERAPEUTICS IN THE PRESENCE OF ENDOGENOUS HUMAN IGG
3440, 4jj5B, 0.5234, 3.58, 0.133, 219, 105, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
3441, 4hs8L, 0.5234, 3.55, 0.132, 213, 106, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY HU5B3.V3
3442, 4g7yL, 0.5234, 3.48, 0.095, 211, 105, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.8 A)
3443, 3ulvL, 0.5234, 3.57, 0.085, 211, 106, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3444, 3naaH, 0.5234, 3.57, 0.085, 211, 106, CRYSTAL STRUCTURE OF FAB15 MUT5
3445, 2jk5B, 0.5234, 3.81, 0.082, 216, 110, POTASSIUM CHANNEL KCSA IN COMPLEX WITH TETRABUTYLAMMONIUM IN HIGH K
3446, 1uwxH, 0.5234, 3.42, 0.125, 215, 104, P1.2 SEROSUBTYPE ANTIGEN DERIVED FROM N. MENINGITIDIS PORA IN COMPLEX WITH FAB FRAGMENT
3447, 1tpxC, 0.5234, 3.83, 0.082, 226, 110, OVINE RECOMBINANT PRP(114-234) ARQ VARIANT IN COMPLEX WITH THE FAB OF THE VRQ14 ANTIBODY
3448, 1qppB, 0.5234, 3.59, 0.113, 217, 106, CRYSTAL STRUCTURES OF SELF CAPPING PAPD CHAPERONE HOMODIMERS
3449, 1nmcB, 0.5234, 3.49, 0.124, 214, 105, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
3450, 1nj9B, 0.5234, 3.59, 0.113, 218, 106, COCAINE HYDROLYTIC ANTIBODY 15A10
3451, 1ngwL, 0.5234, 3.55, 0.123, 217, 106, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3452, 1ngwA, 0.5234, 3.49, 0.133, 216, 105, CHIMERIC AFFINITY MATURED FAB 7G12 COMPLEXED WITH MESOPORPHYRIN
3453, 1kcvL, 0.5234, 3.57, 0.113, 215, 106, CRYSTAL STRUCTURE OF ANTIBODY PC282
3454, 1gpoM, 0.5234, 3.53, 0.075, 212, 106, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
3455, 1d6vH, 0.5234, 3.72, 0.101, 216, 109, CONFORMATION EFFECTS IN BIOLOGICAL CATALYSIS INTRODUCED BY OXY-COPE ANTIBODY MATURATION
3456, 6qkdT, 0.5233, 3.59, 0.104, 212, 106, CRYSTAL STRUCTURE OF VHH-BASED FAB-FRAGMENT OF ANTIBODY BCD-085 
3457, 6ggaA, 0.5233, 3.63, 0.093, 213, 107, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9284 
3458, 6gfeM, 0.5233, 3.68, 0.065, 212, 108, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
3459, 6gfeL, 0.5233, 3.89, 0.056, 196, 108, HIGH-RESOLUTION STRUCTURE OF A THERAPEUTIC FULL-LENGTH ANTI-NPRA ANTIBODY WITH EXCEPTIONAL CONFORMATIONAL DIVERSITY 
3460, 6emjL, 0.5233, 3.65, 0.103, 212, 107, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3461, 6e9kB, 0.5233, 3.82, 0.101, 220, 109, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-5 
3462, 6aynC, 0.5233, 3.55, 0.094, 212, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3463, 5x2pK, 0.5233, 3.74, 0.100, 225, 110, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMATE
3464, 5wduH, 0.5233, 3.63, 0.113, 215, 106, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
3465, 5mp3H, 0.5233, 3.59, 0.094, 210, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
3466, 5i1aL, 0.5233, 3.55, 0.105, 117, 105, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV3-11
3467, 5epmF, 0.5233, 3.77, 0.074, 209, 108, CERATOTOXIN VARIANT IN COMPLEX WITH SPECIFIC ANTIBODY FAB FRAGMENT
3468, 4o4yL, 0.5233, 3.89, 0.091, 210, 110, CRYSTAL STRUCTURE OF THE ANTI-HINGE RABBIT ANTIBODY 2095-2 IN COMPLEX WITH IDES HINGE PEPTIDE
3469, 4nylD, 0.5233, 3.83, 0.101, 218, 109, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
3470, 4nkoD, 0.5233, 3.77, 0.092, 210, 109, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3471, 4jhaL, 0.5233, 3.78, 0.093, 216, 108, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3472, 4evnE, 0.5233, 3.56, 0.123, 217, 106, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3473, 4dgvH, 0.5233, 3.53, 0.086, 213, 105, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY HCV1 P2(1) FORM
3474, 4aeiN, 0.5233, 3.80, 0.100, 217, 110, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3475, 3tt1M, 0.5233, 3.58, 0.085, 218, 106, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3476, 3r1gL, 0.5233, 3.63, 0.084, 211, 107, STRUCTURE BASIS OF ALLOSTERIC INHIBITION OF BACE1 BY AN EXOSITE- BINDING ANTIBODY
3477, 3nfpH, 0.5233, 3.63, 0.093, 214, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
3478, 3mlwI, 0.5233, 3.74, 0.083, 225, 109, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 1006-15D IN COMPLEX WITH AN MN V3 PEPTIDE
3479, 3lmjL, 0.5233, 3.58, 0.104, 212, 106, STRUCTURE OF HUMAN ANTI HIV 21C FAB
3480, 3h3pI, 0.5233, 3.79, 0.110, 218, 109, CRYSTAL STRUCTURE OF HIV EPITOPE-SCAFFOLD 4E10 FV COMPLEX
3481, 3eobL, 0.5233, 3.66, 0.123, 219, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
3482, 3cmoH, 0.5233, 3.00, 0.112, 212, 98, HIV NEUTRALIZING MONOCLONAL ANTIBODY YZ18
3483, 2i9lH, 0.5233, 3.65, 0.074, 122, 108, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3484, 2i9lF, 0.5233, 3.85, 0.082, 215, 110, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3485, 2i9lE, 0.5233, 3.59, 0.094, 213, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3486, 2g5bE, 0.5233, 3.59, 0.094, 213, 106, CRYSTAL STRUCTURE OF THE ANTI-BAX MONOCLONAL ANTIBODY 6A7 AND A BAX PEPTIDE.
3487, 2exyF, 0.5233, 3.63, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE E148Q MUTANT OF ECCLC FAB COMPLEXED IN ABSENCE OF BOUND IONS
3488, 2c1oB, 0.5233, 3.65, 0.159, 218, 107, ENAIIHIS FAB FRAGMENT IN THE FREE FORM
3489, 1z7z2, 0.5233, 3.78, 0.082, 221, 110, CRYO-EM STRUCTURE OF HUMAN COXSACKIEVIRUS A21 COMPLEXED WITH FIVE DOMAIN ICAM-1KILIFI
3490, 1um5H, 0.5233, 3.64, 0.093, 213, 107, CATALYTIC ANTIBODY 21H3 WITH ALCOHOL SUBSTRATE
3491, 1nqbC, 0.5233, 3.84, 0.046, 196, 108, TRIVALENT ANTIBODY FRAGMENT
3492, 1nmcH, 0.5233, 3.60, 0.104, 215, 106, COMPLEX BETWEEN NC10 ANTI-INFLUENZA VIRUS NEURAMINIDASE SINGLE CHAIN ANTIBODY WITH A 15 RESIDUE LINKER AND INFLUENZA VIRUS NEURAMINIDASE
3493, 1il1B, 0.5233, 3.60, 0.104, 215, 106, CRYSTAL STRUCTURE OF G3-519 AN ANTI-HIV MONOCLONAL ANTIBODY
3494, 1i9jL, 0.5233, 3.58, 0.085, 211, 106, TESTOSTERONE COMPLEX STRUCTURE OF THE RECOMBINANT MONOCLONAL WILD TYPE ANTI-TESTOSTERONE FAB FRAGMENT
3495, 1f11C, 0.5233, 3.53, 0.087, 214, 104, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3496, 1d5bA, 0.5233, 3.62, 0.084, 212, 107, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
3497, 1cicA, 0.5233, 3.50, 0.133, 216, 105, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
3498, 6mlkL, 0.5232, 3.91, 0.045, 242, 112, STRUCTURE OF THIOESTERASE FROM DEBS WITH A THIOESTERASE-SPECIFIC ANTIBODY 
3499, 6k7oL, 0.5232, 3.81, 0.083, 219, 109, COMPLEX STRUCTURE OF LILRB4 AND H128-3 ANTIBODY 
3500, 6fg2M, 0.5232, 3.64, 0.084, 212, 107, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
3501, 6dlbH, 0.5232, 3.65, 0.140, 218, 107, CRYSTAL STRUCTURE OF AN INFLUENZA A HEMAGGLUTININ ANTIBODY FAB CH65:1203D4 CHIMERA 
3502, 6dc7L, 0.5232, 3.46, 0.105, 218, 105, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
3503, 6b0nE, 0.5232, 3.66, 0.075, 211, 107, CRYSTAL STRUCTURE OF THE CLEAVAGE-INDEPENDENT PREFUSION HIV ENV GLYCOPROTEIN TRIMER OF THE CLADE A BG505 ISOLATE (NFL CONSTRUCT) IN COMPLEX WITH FABS PGT122 AND PGV19 AT 3.39 A 
3504, 6azkC, 0.5232, 3.80, 0.083, 121, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3505, 6a4kN, 0.5232, 3.57, 0.094, 211, 106, HUMAN ANTIBODY 32D6 FAB IN COMPLEX WITH H1N1 INFLUENZA A VIRUS HA1 
3506, 5xhvQ, 0.5232, 3.79, 0.073, 221, 110, CRYSTAL STRUCTURE OF FAB S40 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ HA1 SUBUNIT.
3507, 5x2mK, 0.5232, 3.69, 0.092, 226, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3508, 5tq2H, 0.5232, 3.66, 0.123, 217, 106, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT GLUN1 AND GLUN2A
3509, 5o14H, 0.5232, 3.57, 0.123, 215, 106, CO-CRYSTAL STRUCTURE OF A CROSS-REACTIVE BACTERICIDAL HUMAN ANTIBODY TARGETING MENINGOCOCCAL VACCINE ANTIGEN FACTOR H BINDING PROTEIN
3510, 5ebmB, 0.5232, 3.57, 0.075, 214, 106, KCSA T75G MUTANT IN THE NONCONDUCTIVE STATE
3511, 5eblB, 0.5232, 3.77, 0.083, 214, 109, KCSA T75G IN THE CONDUCTIVE STATE
3512, 5bo1M, 0.5232, 3.76, 0.093, 228, 108, CRYSTAL STRUCTURE OF A HUMAN JAG1 FRAGMENT IN COMPLEX WITH AN ANTI- JAG1 FAB
3513, 5aolB, 0.5232, 3.51, 0.151, 215, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND 3-BROMO-5- (TRIFLUOROMETHYL)BENZENE-12-DIAMINE
3514, 4zs6D, 0.5232, 3.66, 0.075, 126, 107, RECEPTOR BINDING DOMAIN AND FAB COMPLEX
3515, 4z95L, 0.5232, 3.57, 0.085, 214, 106, FAB STRUCTURE OF ANTIBODY S1-15 IN COMPLEX WITH SSDNA DNA 5 -5(DT)-P- 3 
3516, 4xcfH, 0.5232, 3.84, 0.091, 222, 110, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
3517, 4qo1B, 0.5232, 3.82, 0.091, 219, 110, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
3518, 4nrzH, 0.5232, 3.82, 0.091, 219, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
3519, 4nryH, 0.5232, 3.61, 0.142, 219, 106, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3520, 4nnpY, 0.5232, 3.56, 0.143, 217, 105, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
3521, 4k8rL, 0.5232, 3.52, 0.133, 211, 105, AN ANTIBODY AGAINST THE C-TERMINAL DOMAIN OF PCSK9 LOWERS LDL CHOLESTEROL LEVELS IN VIVO
3522, 4ibuD, 0.5232, 3.85, 0.109, 217, 110, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3523, 4hfwH, 0.5232, 4.69, 0.050, 263, 119, ANTI ROTAVIRUS ANTIBODY
3524, 4fp8L, 0.5232, 3.78, 0.091, 217, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3525, 3vw3H, 0.5232, 3.76, 0.083, 232, 109, ANTIBODY 64M-5 FAB IN COMPLEX WITH A DOUBLE-STRANDED DNA (6-4) PHOTOPRODUCT
3526, 3ujiH, 0.5232, 3.65, 0.074, 122, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2558 IN COMPLEX WITH MN PEPTIDE
3527, 3tt1L, 0.5232, 3.54, 0.162, 219, 105, CRYSTAL STRUCTURE OF LEUT IN THE OUTWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
3528, 3s96A, 0.5232, 3.58, 0.143, 219, 105, CRYSTAL STRUCTURE OF 3B5H10
3529, 3rvvC, 0.5232, 3.65, 0.112, 216, 107, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3530, 3iyoB, 0.5232, 3.60, 0.094, 211, 106, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
3531, 3iyoA, 0.5232, 3.63, 0.123, 214, 106, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
3532, 2r2hA, 0.5232, 3.56, 0.114, 217, 105, STRUCTURE OF S25-2 IN COMPLEX WITH KO
3533, 2i9lD, 0.5232, 3.77, 0.056, 218, 108, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3534, 2i9lC, 0.5232, 3.62, 0.075, 211, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3535, 2i9lB, 0.5232, 3.84, 0.082, 227, 110, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3536, 2i9lA, 0.5232, 3.69, 0.140, 218, 107, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3537, 2gkiA, 0.5232, 3.71, 0.104, 182, 106, HEAVY AND LIGHT CHAIN VARIABLE SINGLE DOMAINS OF AN ANTI-DNA BINDING ANTIBODY HYDROLYZE BOTH DOUBLE- AND SINGLE-STRANDED DNAS WITHOUT SEQUENCE SPECIFICITY
3538, 2fgwL, 0.5232, 3.63, 0.084, 212, 107, X-RAY STRUCTURES OF FRAGMENTS FROM BINDING AND NONBINDING VERSIONS OF A HUMANIZED ANTI-CD18 ANTIBODY: STRUCTURAL INDICATIONS OF THE KEY ROLE OF VH RESIDUES 59 TO 65
3539, 1yjdL, 0.5232, 3.71, 0.150, 216, 107, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
3540, 1xf4A, 0.5232, 3.67, 0.093, 214, 107, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
3541, 1t5rE, 0.5232, 3.55, 0.123, 216, 106, STRUCTURE OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
3542, 1ngxB, 0.5232, 3.85, 0.100, 205, 110, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
3543, 6rcoC, 0.5231, 3.80, 0.073, 221, 109, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
3544, 6ml8L, 0.5231, 3.64, 0.103, 212, 107, CRYSTAL STRUCTURE OF HEMAGGLUTININ FROM H1N1 INFLUENZA A VIRUS A/DENVER/57 BOUND TO THE C05 ANTIBODY 
3545, 6eluI, 0.5231, 3.58, 0.113, 212, 106, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
3546, 6bb4J, 0.5231, 3.56, 0.094, 214, 106, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3547, 6axpA, 0.5231, 3.86, 0.046, 197, 108, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
3548, 6al1L, 0.5231, 3.55, 0.104, 210, 106, THE NZ-1 FAB COMPLEXED WITH THE PDZ TANDEM FRAGMENT OF A. AEOLICUS S2P HOMOLOG WITH THE PA12 TAG INSERTED BETWEEN THE RESIDUES 181 AND 184 
3549, 5y9cL, 0.5231, 3.63, 0.093, 214, 107, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
3550, 5vplC, 0.5231, 3.79, 0.083, 218, 109, CRYSTAL STRUCTURE OF DER F 1 COMPLEXED WITH FAB 4C1
3551, 5t1kC, 0.5231, 3.88, 0.065, 199, 108, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
3552, 5i15L, 0.5231, 3.81, 0.083, 226, 109, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
3553, 5hd8F, 0.5231, 3.80, 0.083, 214, 109, CRYSTAL STRUCTURE OF DISULFIDE CROSS-LINKED D417C CLC-EC1
3554, 5bk3L, 0.5231, 3.63, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3555, 4rftj, 0.5231, 3.65, 0.112, 214, 107, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
3556, 4rftA, 0.5231, 3.96, 0.055, 196, 109, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
3557, 4r7dF, 0.5231, 3.79, 0.073, 214, 110, FAB HU 15C1
3558, 4qhmC, 0.5231, 3.59, 0.075, 213, 106, I3.1 (UNBOUND) FROM CH103 LINEAGE
3559, 4q6iF, 0.5231, 3.82, 0.100, 216, 110, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
3560, 4nnpL, 0.5231, 3.75, 0.083, 218, 108, CRYSTAL STRUCTURE OF APO MANGANESE ABC TRANSPORTER MNTC FROM STAPHYLOCOCCUS AUREUS BOUND TO AN ANTAGONISTIC FAB FRAGMENT
3561, 4lu5M, 0.5231, 3.57, 0.123, 215, 106, STRUCTURE OF MURINE IGG2A A20G2-FAB IN COMPLEX WITH VACCINIA ANTIGEN A33R AT THE RESOLUTION OF 2.9 ANGSTROMS
3562, 4kxzL, 0.5231, 3.80, 0.092, 218, 109, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3563, 4kphM, 0.5231, 3.61, 0.104, 211, 106, STRUCTURE OF THE FAB FRAGMENT OF N62 A PROTECTIVE MONOCLONAL ANTIBODY TO THE NONREDUCING END OF FRANCISELLA TULARENSIS O-ANTIGEN
3564, 4i2xD, 0.5231, 4.12, 0.064, 468, 109, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3565, 4gajL, 0.5231, 4.12, 0.064, 468, 109, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 411-424)
3566, 4evnO, 0.5231, 3.54, 0.152, 219, 105, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3567, 4dwhC, 0.5231, 3.82, 0.091, 219, 110, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC (2.5 A RESOLUTION)
3568, 3wkmM, 0.5231, 3.61, 0.142, 219, 106, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
3569, 3wkmL, 0.5231, 3.82, 0.091, 219, 110, THE PERIPLASMIC PDZ TANDEM FRAGMENT OF THE RSEP HOMOLOGUE FROM AQUIFEX AEOLICUS IN COMPLEX WITH THE FAB FRAGMENT
3570, 3m4dB, 0.5231, 3.61, 0.142, 219, 106, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3571, 3m3rA, 0.5231, 3.82, 0.082, 235, 110, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
3572, 3iyoD, 0.5231, 3.58, 0.094, 214, 106, CRYO-EM MODEL OF VIRION-SIZED HEV VIRION-SIZED CAPSID
3573, 3hr5L, 0.5231, 3.58, 0.104, 212, 106, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3574, 3eobA, 0.5231, 3.67, 0.094, 213, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM II
3575, 3bpcA, 0.5231, 4.04, 0.062, 271, 112, CO-CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH 5-DEOXY-4- EPI-23-DEHYDRO KDO (4.8) KDO
3576, 2z91B, 0.5231, 3.96, 0.091, 216, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3577, 2xqyK, 0.5231, 3.81, 0.073, 222, 110, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
3578, 2i9lG, 0.5231, 3.58, 0.085, 212, 106, STRUCTURE OF FAB 7D11 FROM A NEUTRALIZING ANTIBODY AGAINST THE POXVIRUS L1 PROTEIN
3579, 2gsiA, 0.5231, 3.57, 0.113, 217, 106, CRYSTAL STRUCTURE OF A MURINE FAB IN COMPLEX WITH AN 11 RESIDUE PEPTIDE DERIVED FROM STAPHYLOCOCCAL NUCLEASE
3580, 2fjhL, 0.5231, 3.79, 0.100, 216, 110, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
3581, 1tupA, 0.5231, 3.64, 0.084, 212, 107, TUMOR SUPPRESSOR P53 COMPLEXED WITH DNA
3582, 1tsrA, 0.5231, 3.67, 0.140, 209, 107, P53 CORE DOMAIN IN COMPLEX WITH DNA
3583, 1pdkA, 0.5231, 3.55, 0.104, 203, 106, PAPD-PAPK CHAPERONE-PILUS SUBUNIT COMPLEX FROM E.COLI P PILUS
3584, 1p2cA, 0.5231, 3.62, 0.104, 211, 106, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
3585, 6megL, 0.5230, 3.63, 0.093, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3586, 6hbgB, 0.5230, 3.59, 0.085, 214, 106, ECHOVIRUS 18 NATIVE PARTICLE 
3587, 6fy3H, 0.5230, 3.52, 0.133, 211, 105, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-3D; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
3588, 6ewbH, 0.5230, 3.56, 0.124, 217, 105, CRYSTAL STRUCTURE OF GII.4 UNSW 2012 P DOMAIN IN COMPLEX WITH FAB 10E9 
3589, 6eljL, 0.5230, 4.19, 0.055, 163, 109, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3590, 6ddmA, 0.5230, 4.29, 0.045, 163, 110, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
3591, 6dcwH, 0.5230, 3.67, 0.093, 211, 107, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-27.1 FAB IN COMPLEX WITH A HUMAN TAU PEPTIDE 
3592, 6cdmE, 0.5230, 3.83, 0.081, 217, 111, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3593, 6azkD, 0.5230, 3.58, 0.113, 218, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- HYDROXYPROPYL)-L-ARGININE MEDITOPE VARIANT
3594, 6axpB, 0.5230, 3.63, 0.084, 213, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
3595, 6arpC, 0.5230, 3.61, 0.132, 219, 106, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
3596, 5yfiH, 0.5230, 3.67, 0.103, 213, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
3597, 5wduU, 0.5230, 3.53, 0.143, 195, 105, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
3598, 5vkhB, 0.5230, 3.83, 0.082, 219, 110, CLOSED CONFORMATION OF KCSA Y82A-F103A MUTANT
3599, 5ushL, 0.5230, 3.64, 0.112, 215, 107, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
3600, 5mp5C, 0.5230, 3.79, 0.073, 221, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3601, 5mp1H, 0.5230, 2.99, 0.124, 201, 97, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 7.5 
3602, 5kzcH, 0.5230, 3.59, 0.113, 214, 106, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
3603, 5cp7G, 0.5230, 3.60, 0.113, 215, 106, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3604, 5c2bL, 0.5230, 3.88, 0.063, 293, 111, ANTI-CXCL13 PARENTAL SCFV - 3B4
3605, 5bk3F, 0.5230, 3.88, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3606, 4zykL, 0.5230, 4.12, 0.064, 461, 109, CRYSTAL STRUCTURE OF QUATERNARY-SPECIFIC RSV-NEUTRALIZING HUMAN ANTIBODY AM14
3607, 4xccH, 0.5230, 3.59, 0.104, 219, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB CRYSTALIZED IN THE PRESENCE OF PHOSPHATIDYLCHOLINE (06:0 PC); I422 SPACE GROUP
3608, 4xbgA, 0.5230, 3.66, 0.093, 214, 107, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA): 2.73 A RESOLUTION
3609, 4qhmA, 0.5230, 3.54, 0.152, 216, 105, I3.1 (UNBOUND) FROM CH103 LINEAGE
3610, 4o02H, 0.5230, 3.54, 0.105, 211, 105, ALPHAVBETA3 INTEGRIN IN COMPLEX WITH MONOCLONAL ANTIBODY FAB FRAGMENT.
3611, 4kxzM, 0.5230, 3.58, 0.113, 218, 106, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
3612, 4hfwB, 0.5230, 3.61, 0.142, 219, 106, ANTI ROTAVIRUS ANTIBODY
3613, 4aeiL, 0.5230, 3.63, 0.113, 215, 106, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
3614, 3q48A, 0.5230, 3.63, 0.084, 214, 107, CRYSTAL STRUCTURE OF PSEUDOMONAS AERUGINOSA CUPB2 CHAPERONE
3615, 3o41L, 0.5230, 3.90, 0.065, 196, 108, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 15-MER PEPTIDE EPITOPE
3616, 3mnvB, 0.5230, 3.90, 0.065, 196, 108, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
3617, 3m4eF, 0.5230, 3.08, 0.111, 215, 99, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN BOUND TO BETA-CYCLODEXTRIN
3618, 3l1oL, 0.5230, 3.63, 0.112, 212, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY MN423 FAB FRAGMENT WITH FREE COMBINING SITE CRYSTALLIZED IN THE PRESENCE OF ZINC
3619, 3iy6A, 0.5230, 3.50, 0.087, 213, 104, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB E FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB E COMPLEX
3620, 3if1A, 0.5230, 4.49, 0.043, 247, 115, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
3621, 3i02A, 0.5230, 3.83, 0.064, 226, 109, CRYSTAL STRUCTURE OF S54-10 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3622, 2vukA, 0.5230, 3.83, 0.083, 210, 109, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL-MOLECULE DRUG PHIKAN083
3623, 2r2eA, 0.5230, 3.59, 0.085, 212, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3624, 2r2bA, 0.5230, 3.62, 0.113, 215, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3625, 2r1xA, 0.5230, 3.79, 0.083, 223, 109, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3626, 2q76A, 0.5230, 3.62, 0.123, 218, 106, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
3627, 2itdB, 0.5230, 3.81, 0.091, 220, 110, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN BARIUM CHLORIDE
3628, 2bobB, 0.5230, 3.75, 0.092, 220, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN THALLIUM WITH TETRABUTYLAMMONIUM (TBA)
3629, 1moeB, 0.5230, 3.57, 0.085, 213, 106, THE THREE-DIMENSIONAL STRUCTURE OF AN ENGINEERED SCFV T84.66 DIMER OR DIABODY IN VL TO VH LINKAGE.
3630, 1f90L, 0.5230, 3.82, 0.080, 221, 112, FAB FRAGMENT OF MONOCLONAL ANTIBODY (LNKB-2) AGAINST HUMAN INTERLEUKIN-2 IN COMPLEX WITH ANTIGENIC PEPTIDE
3631, 1f11A, 0.5230, 3.85, 0.036, 242, 112, F124 FAB FRAGMENT FROM A MONOCLONAL ANTI-PRES2 ANTIBODY
3632, 1egjL, 0.5230, 3.64, 0.103, 212, 107, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
3633, 1bfoC, 0.5230, 3.65, 0.112, 212, 107, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3634, 1axsA, 0.5230, 3.75, 0.083, 219, 109, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3635, 6ggbA, 0.5229, 3.72, 0.083, 215, 109, P53 CANCER MUTANT Y220C IN COMPLEX WITH SMALL-MOLECULE STABILIZER PK9318 
3636, 6gc2L, 0.5229, 3.82, 0.083, 214, 109, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
3637, 6cshC, 0.5229, 3.63, 0.132, 218, 106, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 EMPTIED PARTICLE (PH 5.5 AND 33 DEGREES CELSIUS) 
3638, 6c5hL, 0.5229, 3.52, 0.087, 111, 104, S25-5 FAB IN COMPLEX WITH CHLAMYDIACEAE-SPECIFIC LPS ANTIGEN 
3639, 6bzyL, 0.5229, 3.53, 0.124, 217, 105, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE 22D11 BROADLY NEUTRALIZING ANTIBODY 
3640, 6apdO, 0.5229, 3.65, 0.075, 213, 107, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
3641, 5x4gB, 0.5229, 3.80, 0.082, 226, 110, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-CD147 MONOCLONAL ANTIBODY 6H8
3642, 5v52D, 0.5229, 3.85, 0.082, 227, 110, STRUCTURE OF TIGIT BOUND TO NECTIN-2 (CD112)
3643, 5uxqB, 0.5229, 3.84, 0.081, 217, 111, STRUCTURE OF ANTI-HIV TRIMER APEX ANTIBODY PGT143
3644, 5utyD, 0.5229, 3.80, 0.082, 218, 110, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.MUT4 BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M N300M N302M T320L IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.1 ANGSTROM
3645, 5umnD, 0.5229, 3.69, 0.103, 213, 107, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3646, 5udcL, 0.5229, 3.83, 0.073, 221, 110, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3647, 5szfH, 0.5229, 3.66, 0.123, 218, 106, 2A10 FAB FRAGMENT 2.54 ANGSTOMS
3648, 5mu2B, 0.5229, 2.99, 0.134, 194, 97, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3649, 5i1gL, 0.5229, 3.59, 0.113, 218, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-53/IGKV3-11
3650, 5i1dA, 0.5229, 3.72, 0.130, 208, 108, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
3651, 5i0zA, 0.5229, 3.87, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
3652, 5ecgA, 0.5229, 3.66, 0.085, 214, 106, CRYSTAL STRUCTURE OF THE BRCT DOMAINS OF 53BP1 IN COMPLEX WITH P53 AND H2AX-PSER139 (GAMMAH2AX)
3653, 5cp3A, 0.5229, 3.45, 0.125, 107, 104, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES IN COMPLEX WITH SULFATHIAZOLE
3654, 5bk3B, 0.5229, 3.62, 0.132, 215, 106, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
3655, 5anmC, 0.5229, 3.65, 0.140, 219, 107, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3656, 4ttdL, 0.5229, 3.87, 0.056, 195, 108, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3657, 4ttdD, 0.5229, 3.55, 0.152, 219, 105, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3658, 4r7dL, 0.5229, 3.53, 0.152, 217, 105, FAB HU 15C1
3659, 4oz4L, 0.5229, 3.54, 0.152, 219, 105, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3660, 4mxwV, 0.5229, 3.58, 0.113, 212, 106, STRUCTURE OF HETEROTRIMERIC LYMPHOTOXIN LTA1B2 BOUND TO LYMPHOTOXIN BETA RECEPTOR LTBR AND ANTI-LTA FAB
3661, 4ma3A, 0.5229, 3.64, 0.103, 212, 107, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
3662, 4ki5D, 0.5229, 3.58, 0.104, 212, 106, CYSTAL STRUCTURE OF HUMAN FACTOR VIII C2 DOMAIN IN A TERNARY COMPLEX WITH MURINE INHBITORY ANTIBODIES 3E6 AND G99
3663, 4jhaH, 0.5229, 3.62, 0.085, 240, 106, CRYSTAL STRUCTURE OF RSV-NEUTRALIZING HUMAN ANTIBODY D25
3664, 4ibtC, 0.5229, 3.64, 0.132, 219, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R
3665, 4hs6A, 0.5229, 3.66, 0.112, 216, 107, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
3666, 4hgwA, 0.5229, 3.58, 0.094, 215, 106, CRYSTAL STRUCTURE OF S25-2 IN COMPLEX WITH A 56-DEHYDRO-KDO DISACCHARIDE
3667, 4fqrd, 0.5229, 3.64, 0.113, 214, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3668, 4evnC, 0.5229, 3.60, 0.123, 211, 106, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
3669, 3vi3F, 0.5229, 3.85, 0.046, 198, 108, CRYSTAL STRUCTURE OF ALPHA5BETA1 INTEGRIN HEADPIECE (LIGAND-FREE FORM)
3670, 3sqbA, 0.5229, 3.61, 0.104, 214, 106, STRUCTURE OF THE MAJOR TYPE 1 PILUS SUBUNIT FIMA BOUND TO THE FIMC CHAPERONE
3671, 3qa3H, 0.5229, 4.33, 0.062, 215, 113, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3672, 3or7B, 0.5229, 3.63, 0.132, 216, 106, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71I
3673, 3m4dA, 0.5229, 3.56, 0.104, 215, 106, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3674, 2vdnH, 0.5229, 3.49, 0.094, 213, 106, RE-REFINEMENT OF INTEGRIN ALPHAIIBBETA3 HEADPIECE BOUND TO ANTAGONIST EPTIFIBATIDE
3675, 2ombD, 0.5229, 3.64, 0.142, 213, 106, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(1)21 CRYSTAL FORM
3676, 2hvjB, 0.5229, 3.80, 0.109, 127, 110, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN LOW K+
3677, 2f58L, 0.5229, 3.59, 0.104, 217, 106, IGG1 FAB FRAGMENT (58.2) COMPLEX WITH 12-RESIDUE CYCLIC PEPTIDE (INCLUDING RESIDUES 315-324 OF HIV-1 GP120) (MN ISOLATE)
3678, 1xcqG, 0.5229, 3.82, 0.054, 242, 111, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
3679, 1s5hA, 0.5229, 3.61, 0.094, 213, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX T75C MUTANT IN K+
3680, 1jnnL, 0.5229, 3.59, 0.104, 211, 106, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3681, 6r8xB, 0.5228, 3.78, 0.092, 217, 109, COAGULATION FACTOR XI CATALYTIC DOMAIN IN COMPLEX WITH FAB-PORTION OF MAA868 
3682, 6mejH, 0.5228, 3.59, 0.113, 218, 106, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
3683, 6ii4L, 0.5228, 3.63, 0.075, 211, 107, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4A-14 
3684, 6idhL, 0.5228, 3.58, 0.113, 218, 106, ANTIBODY 64M-5 FAB IN LIGAND-FREE FORM 
3685, 6id4D, 0.5228, 3.70, 0.083, 120, 108, COMPLEX OF HLA-A*11:01 BINDING TO ALLOANTIBODY 2E3 
3686, 6d0uL, 0.5228, 3.89, 0.065, 192, 108, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
3687, 6cseL, 0.5228, 3.62, 0.132, 218, 106, CRYSTAL STRUCTURE OF SODIUM/ALANINE SYMPORTER AGCS WITH L-ALANINE BOUND 
3688, 6aynB, 0.5228, 3.60, 0.113, 217, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3689, 5ziaA, 0.5228, 3.55, 0.095, 213, 105, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
3690, 5v6lL, 0.5228, 3.51, 0.133, 214, 105, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A37 IN COMPLEX WITH V3 PEPTIDE JR-FL
3691, 5u7mD, 0.5228, 3.51, 0.133, 214, 105, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-378806 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
3692, 5otjL, 0.5228, 3.66, 0.093, 211, 107, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
3693, 5nhrL, 0.5228, 3.60, 0.151, 218, 106, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2B LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV CUBIC CRYSTAL FORM
3694, 5nbwB, 0.5228, 3.60, 0.104, 211, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT 22F12 IN COMPLEX WITH 3- HYDROXYBENZO[A]PYRENE
3695, 5mx3L, 0.5228, 3.45, 0.095, 218, 105, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3696, 5mvjA, 0.5228, 3.50, 0.114, 211, 105, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
3697, 5mu2N, 0.5228, 3.80, 0.092, 226, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3698, 5k0uC, 0.5228, 3.90, 0.065, 197, 108, CRYOEM STRUCTURE OF THE FULL VIRION OF A HUMAN RHINOVIRUS C
3699, 5j75B, 0.5228, 3.60, 0.104, 218, 106, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
3700, 5i6zB, 0.5228, 3.53, 0.152, 217, 105, X-RAY STRUCTURE OF THE TS2 HUMAN SEROTONIN TRANSPORTER
3701, 5hi4L, 0.5228, 3.64, 0.093, 213, 107, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3702, 5hdqH, 0.5228, 3.79, 0.073, 221, 110, MNTC CO-STRUCTURE WITH MAB 305-78-7
3703, 5f88D, 0.5228, 3.91, 0.071, 218, 113, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3704, 5f88C, 0.5228, 2.94, 0.103, 191, 97, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
3705, 5ebwB, 0.5228, 3.89, 0.090, 224, 111, KCSA WITH G77ESTER MUTATION
3706, 4xcyA, 0.5228, 3.57, 0.113, 212, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
3707, 4nkoF, 0.5228, 3.87, 0.063, 293, 111, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3708, 4i2xB, 0.5228, 3.87, 0.090, 219, 111, CRYSTAL STRUCTURE OF SIGNAL REGULATORY PROTEIN GAMMA (SIRP-GAMMA) IN COMPLEX WITH FABOX117
3709, 4gw5C, 0.5228, 3.45, 0.087, 216, 104, CQYN MEDITOPE - CETUXIMAB FAB
3710, 4g7vL, 0.5228, 3.65, 0.103, 212, 107, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (R217E 2.5 A)
3711, 4g6aD, 0.5228, 3.62, 0.104, 216, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
3712, 4fqvI, 0.5228, 3.65, 0.093, 219, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
3713, 4fqhA, 0.5228, 3.59, 0.104, 211, 106, CRYSTAL STRUCTURE OF FAB CR9114
3714, 3s96C, 0.5228, 3.57, 0.113, 211, 106, CRYSTAL STRUCTURE OF 3B5H10
3715, 3lizL, 0.5228, 3.39, 0.078, 211, 103, CRYSTAL STRUCTURE OF BLA G 2 COMPLEXED WITH FAB 4C3
3716, 3ikcC, 0.5228, 3.77, 0.083, 225, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)-7-O-METHYL-KDO
3717, 3hzyA, 0.5228, 3.85, 0.128, 212, 109, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO(2.4)KDO
3718, 3fctA, 0.5228, 3.69, 0.140, 217, 107, MATURE METAL CHELATASE CATALYTIC ANTIBODY WITH HAPTEN
3719, 3d0aD, 0.5228, 3.85, 0.092, 215, 109, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R249S AND SECOND SITE SUPPRESSOR MUTATION H168R IN SEQUENCE-SPECIFIC COMPLEX WITH DNA
3720, 2wucL, 0.5228, 3.59, 0.085, 213, 106, CRYSTAL STRUCTURE OF HGFA IN COMPLEX WITH THE ALLOSTERIC NON- INHIBITORY ANTIBODY FAB40.DELTATRP AND AC-KQLR-CHLOROMETHYLKETONE
3721, 2wgxB, 0.5228, 3.60, 0.113, 213, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-Y236F-N239Y-T253I- N268D
3722, 2r0lL, 0.5228, 3.82, 0.091, 220, 110, SHORT FORM HGFA WITH INHIBITORY FAB75
3723, 2qr0S, 0.5228, 3.77, 0.073, 220, 109, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3724, 2qr0G, 0.5228, 3.61, 0.085, 215, 106, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3725, 2pcxA, 0.5228, 3.88, 0.036, 242, 112, CRYSTAL STRUCTURE OF P53DBD(R282Q) AT 1.54-ANGSTROM RESOLUTION
3726, 2pcpC, 0.5228, 3.68, 0.121, 213, 107, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
3727, 2oldA, 0.5228, 3.31, 0.127, 111, 102, BENCE JONES KWR PROTEIN- IMMUNOGLOBULIN LIGHT CHAIN DIMER P3(2)21 CRYSTAL FORM
3728, 2mcg2, 0.5228, 3.83, 0.092, 216, 109, THREE-DIMENSIONAL STRUCTURE OF A LIGHT CHAIN DIMER CRYSTALLIZED IN WATER. CONFORMATIONAL FLEXIBILITY OF A MOLECULE IN TWO CRYSTAL FORMS
3729, 2hffL, 0.5228, 3.60, 0.151, 218, 106, CRYSTAL STRUCTURE OF CB2 FAB
3730, 1zglR, 0.5228, 3.75, 0.083, 218, 109, CRYSTAL STRUCTURE OF 3A6 TCR BOUND TO MBP/HLA-DR2A
3731, 1ncaL, 0.5228, 3.61, 0.113, 218, 106, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3732, 1d5bL, 0.5228, 4.63, 0.051, 255, 118, UNLIGANDED MATURE OXY-COPE CATALYTIC ANTIBODY
3733, 1ct8B, 0.5228, 3.38, 0.107, 233, 103, CATALYTIC ANTIBODY 7C8 COMPLEX
3734, 1axsL, 0.5228, 3.82, 0.091, 218, 110, MATURE OXY-COPE CATALYTIC ANTIBODY WITH HAPTEN
3735, 6mg4A, 0.5227, 3.63, 0.140, 213, 107, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
3736, 6cdmB, 0.5227, 3.80, 0.082, 213, 110, STRUCTURE OF VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
3737, 6b5nL, 0.5227, 3.81, 0.091, 214, 110, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN PROTECTIVE ANTIBODY CIS43
3738, 6azlD, 0.5227, 3.64, 0.084, 213, 107, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3739, 6al5H, 0.5227, 3.60, 0.104, 210, 106, COMPLEX BETWEEN CD19 (N138Q MUTANT) AND B43 FAB
3740, 5xzcD, 0.5227, 3.84, 0.082, 228, 110, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
3741, 5x2mL, 0.5227, 3.81, 0.083, 121, 109, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-GLUTAMINE
3742, 5w06H, 0.5227, 3.81, 0.082, 229, 110, HUMAN TISSUE FACTOR IN COMPLEX WITH ANTIBODY M1587
3743, 5udcH, 0.5227, 3.63, 0.093, 213, 107, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3744, 5nhwL, 0.5227, 3.65, 0.084, 211, 107, CRYSTAL STRUCTURE OF THE BIMAGRUMAB FAB
3745, 5mu2D, 0.5227, 3.58, 0.123, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3746, 5mp5H, 0.5227, 3.82, 0.073, 215, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
3747, 5i8oL, 0.5227, 3.85, 0.072, 224, 111, HMM5 FAB IN COMPLEX WITH DISACCHARIDE
3748, 5f3bB, 0.5227, 3.78, 0.092, 218, 109, STRUCTURE OF MYOSTATIN IN COMPLEX WITH CHIMERIC RK35 ANTIBODY
3749, 5drnL, 0.5227, 3.63, 0.104, 211, 106, CONTEXT-INDEPENDENT ANTI-HYPUSINE ANTIBODY FABHPU24 IN COMPLEX WITH HYPUSINE
3750, 5cjsF, 0.5227, 3.51, 0.152, 217, 105, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
3751, 4yo0B, 0.5227, 3.53, 0.143, 215, 105, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-HUMAN PODOPLANIN ANTIBODY NZ-1 WITH BOUND PA PEPTIDE
3752, 4qxtA, 0.5227, 3.61, 0.094, 213, 106, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH FC27-MSP2 14-30
3753, 4ps4L, 0.5227, 3.89, 0.065, 194, 108, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND M1295 FAB
3754, 4oz4B, 0.5227, 3.59, 0.075, 214, 106, X-RAY STRUCTURE OF THE DC8E8 FAB APO-FORM CRYSTALLIZED AT PH 8.5 AND REFINED TO 3.0 A.
3755, 4np4H, 0.5227, 3.90, 0.065, 194, 108, CLOSTRIDIUM DIFFICILE TOXIN B CROP DOMAIN IN COMPLEX WITH FAB DOMAINS OF NEUTRALIZING ANTIBODY BEZLOTOXUMAB
3756, 4lcuB, 0.5227, 3.64, 0.084, 214, 107, STRUCTURE OF KCSA WITH E118A MUTATION
3757, 4isvB, 0.5227, 3.64, 0.084, 213, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF 1C2 A MONOCLONAL ANTIBODY SPECIFIC FOR POLY-GLUTAMINE
3758, 4fqrj, 0.5227, 3.63, 0.084, 213, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
3759, 4fqiH, 0.5227, 3.90, 0.065, 205, 108, CRYSTAL STRUCTURE OF FAB CR9114 IN COMPLEX WITH A H5N1 INFLUENZA VIRUS HEMAGGLUTININ
3760, 4bklA, 0.5227, 3.56, 0.152, 216, 105, CRYSTAL STRUCTURE OF THE ARTHRITOGENIC ANTIBODY M2139 (FAB FRAGMENT) IN COMPLEX WITH THE TRIPLE-HELICAL J1 PEPTIDE
3761, 3qrgL, 0.5227, 3.52, 0.087, 216, 104, CRYSTAL STRUCTURE OF ANTIRSVF FAB B21M
3762, 3o2dH, 0.5227, 3.48, 0.077, 215, 104, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
3763, 3o11A, 0.5227, 3.56, 0.094, 211, 106, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
3764, 3m4dC, 0.5227, 3.73, 0.102, 238, 108, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3765, 3m3rE, 0.5227, 3.66, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
3766, 3m2lA, 0.5227, 3.56, 0.133, 211, 105, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
3767, 3kmdD, 0.5227, 3.83, 0.109, 220, 110, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
3768, 3kj4B, 0.5227, 3.56, 0.133, 211, 105, STRUCTURE OF RAT NOGO RECEPTOR BOUND TO 1D9 ANTAGONIST ANTIBODY
3769, 3hplB, 0.5227, 3.71, 0.120, 215, 108, KCSA E71H-F103A MUTANT IN THE CLOSED STATE
3770, 3gi8L, 0.5227, 3.65, 0.123, 218, 106, CRYSTAL STRUCTURE OF APCT K158A TRANSPORTER BOUND TO 7F11 MONOCLONAL FAB FRAGMENT
3771, 2z91D, 0.5227, 3.60, 0.094, 219, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY 10C9
3772, 2r1wA, 0.5227, 3.82, 0.091, 215, 110, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3773, 2h1lU, 0.5227, 3.72, 0.073, 221, 109, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
3774, 2fjfC, 0.5227, 3.96, 0.055, 232, 109, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
3775, 2eh8L, 0.5227, 3.50, 0.133, 217, 105, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE
3776, 2ac0B, 0.5227, 3.81, 0.091, 216, 110, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
3777, 2ac0A, 0.5227, 3.73, 0.083, 217, 109, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
3778, 2a6iB, 0.5227, 3.58, 0.104, 215, 106, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE KLASIPTHTSPL
3779, 1za6B, 0.5227, 3.59, 0.104, 218, 106, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
3780, 1yjdH, 0.5227, 3.74, 0.083, 218, 109, CRYSTAL STRUCTURE OF HUMAN CD28 IN COMPLEX WITH THE FAB FRAGMENT OF A MITOGENIC ANTIBODY (5.11A1)
3781, 1t66L, 0.5227, 3.56, 0.104, 217, 106, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
3782, 1ngxH, 0.5227, 3.72, 0.084, 213, 107, CHIMERIC GERMLINE FAB 7G12 WITH JEFFAMINE FRAGMENT BOUND
3783, 1ncbL, 0.5227, 3.57, 0.113, 213, 106, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
3784, 1mlbA, 0.5227, 3.87, 0.072, 217, 111, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG-WHITE LYSOZYME
3785, 1klfI, 0.5227, 3.70, 0.121, 209, 107, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
3786, 1cloL, 0.5227, 3.63, 0.084, 114, 107, ANTI-CARCINOEMBRYONIC ANTIGEN MONOCLONAL ANTIBODY A5B7
3787, 6njnL, 0.5226, 3.64, 0.094, 213, 106, STRUCTURE OF A COMPLEX 
3788, 6mqsB, 0.5226, 3.60, 0.151, 218, 106, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3789, 6flbH, 0.5226, 3.71, 0.074, 215, 108, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 2 
3790, 6flaA, 0.5226, 3.57, 0.113, 212, 106, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
3791, 6erxO, 0.5226, 3.85, 0.100, 212, 110, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
3792, 6bb4L, 0.5226, 3.65, 0.093, 213, 107, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
3793, 5wduM, 0.5226, 3.81, 0.073, 215, 110, HIV-1 ENV BG505 SOSIP.664 H72C-H564C TRIMER IN COMPLEX WITH BNABS PGT122 FAB 35O22 FAB AND NIH45-46 SCFV
3794, 5w3eC, 0.5226, 3.81, 0.091, 216, 110, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (33 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
3795, 5uddS, 0.5226, 3.60, 0.094, 217, 106, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
3796, 5th2A, 0.5226, 3.84, 0.091, 222, 110, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
3797, 5nuzA, 0.5226, 3.60, 0.094, 211, 106, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
3798, 5l0qF, 0.5226, 3.88, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
3799, 5hi5L, 0.5226, 3.88, 0.063, 293, 111, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3800, 5h35G, 0.5226, 3.88, 0.063, 293, 111, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
3801, 5dyoA, 0.5226, 3.96, 0.055, 200, 109, FAB43.1 COMPLEX WITH FLOURESCEIN
3802, 5cp7E, 0.5226, 3.69, 0.112, 219, 107, CRYSTAL STRUCTURE OF AN ANTIGEN-BINDING FRAGMENT OF MONOCLONAL ANTIBODY AGAINST SULFONAMIDES
3803, 5bq7A, 0.5226, 3.57, 0.113, 212, 106, CRYSTAL STRUCTURE OF CHIKUNGUNYA VIRUS-HUMAN FAB 5F-10 FRAGMENT
3804, 4zypE, 0.5226, 3.52, 0.152, 220, 105, CRYSTAL STRUCTURE OF MOTAVIZUMAB AND QUATERNARY-SPECIFIC RSV- NEUTRALIZING HUMAN ANTIBODY AM14 IN COMPLEX WITH PREFUSION RSV F GLYCOPROTEIN
3805, 4yhnF, 0.5226, 3.54, 0.105, 208, 105, DABIGATRAN REVERSAL AGENT
3806, 4qy8A, 0.5226, 3.55, 0.152, 216, 105, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8) IN COMPLEX WITH 3D7-MSP2 14-30
3807, 4qxuL, 0.5226, 3.89, 0.065, 199, 108, NOVEL INHIBITION MECHANISM OF MEMBRANE METALLOPROTEASE BY AN EXOSITE- SWIVELING CONFORMATIONAL ANTIBODY
3808, 4qxgH, 0.5226, 3.64, 0.093, 211, 107, ANTIGEN BINDING FRAGMENT OF AN ANTI IFNAR1 ANTIBODY
3809, 4m7lL, 0.5226, 3.63, 0.123, 218, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN HUMAN TISSUE FACTOR EXTRACELLULAR DOMAIN AND ANTIBODY 10H10 FAB FRAGMENT
3810, 4kq3L, 0.5226, 3.87, 0.065, 198, 108, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO3186
3811, 4ht1L, 0.5226, 3.88, 0.056, 198, 108, HUMAN TWEAK IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY
3812, 4gw5B, 0.5226, 3.82, 0.082, 219, 110, CQYN MEDITOPE - CETUXIMAB FAB
3813, 4gb32, 0.5226, 3.84, 0.091, 324, 110, HUMAN COXSACKIEVIRUS B3 STRAIN RD COAT PROTEIN
3814, 4f9lD, 0.5226, 3.81, 0.083, 217, 109, CRYSTAL STRUCTURE OF THE HUMAN BTN3A1 ECTODOMAIN IN COMPLEX WITH THE 20.1 SINGLE CHAIN ANTIBODY
3815, 4d9rE, 0.5226, 3.63, 0.132, 219, 106, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
3816, 4cmhB, 0.5226, 3.97, 0.091, 216, 110, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
3817, 4bz2H, 0.5226, 3.66, 0.112, 214, 107, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 2D73
3818, 3ulvE, 0.5226, 3.60, 0.123, 214, 106, STRUCTURE OF QUATERNARY COMPLEX OF HUMAN TLR3ECD WITH THREE FABS (FORM2)
3819, 3sgdL, 0.5226, 2.94, 0.082, 205, 97, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3820, 3qq9L, 0.5226, 3.52, 0.133, 213, 105, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-HUMAN RSV (RESPIRATORY SYNCYTIAL VIRUS) F PROTEIN MAB 101F
3821, 3q3gH, 0.5226, 3.83, 0.000, 218, 110, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
3822, 3mltH, 0.5226, 3.51, 0.114, 215, 105, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
3823, 3m4dF, 0.5226, 3.85, 0.091, 213, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3824, 3ld8B, 0.5226, 3.84, 0.092, 212, 109, STRUCTURE OF JMJD6 AND FAB FRAGMENTS
3825, 3hzmA, 0.5226, 3.88, 0.063, 215, 111, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO
3826, 3bszL, 0.5226, 3.64, 0.131, 211, 107, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3827, 2zclH, 0.5226, 3.91, 0.036, 242, 112, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
3828, 2y5tB, 0.5226, 4.74, 0.042, 255, 120, CRYSTAL STRUCTURE OF THE PATHOGENIC AUTOANTIBODY CIIC1 IN COMPLEX WITH THE TRIPLE-HELICAL C1 PEPTIDE
3829, 2qr0M, 0.5226, 3.59, 0.104, 211, 106, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3830, 2itcB, 0.5226, 3.64, 0.084, 213, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN SODIUM CHLORIDE
3831, 2hg5B, 0.5226, 3.86, 0.100, 215, 110, CS+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
3832, 2h1lV, 0.5226, 3.83, 0.091, 214, 110, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
3833, 2ataD, 0.5226, 3.63, 0.140, 213, 107, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX II)
3834, 2adyB, 0.5226, 3.67, 0.132, 217, 106, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX IV)
3835, 1t4kA, 0.5226, 3.72, 0.103, 205, 107, CRYSTAL STRUCTURE OF UNLIGANDED ALDOLASE ANTIBODY 93F3 FAB
3836, 1rziP, 0.5226, 3.64, 0.132, 218, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
3837, 1ottF, 0.5226, 3.83, 0.091, 220, 110, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL E148A MUTANT AND FAB COMPLEX
3838, 1mfcH, 0.5226, 3.65, 0.103, 213, 107, HIGH RESOLUTION STRUCTURES OF ANTIBODY FAB FRAGMENT COMPLEXED WITH CELL-SURFACE OLIGOSACCHARIDE OF PATHOGENIC SALMONELLA
3839, 1c5dL, 0.5226, 3.85, 0.100, 220, 110, THE CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A RAT MONOCLONAL ANTIBODY AGAINST THE MAIN IMMUNOGENIC REGION OF THE HUMAN MUSCLE ACETYLCHOLINE RECEPTOR
3840, 6mg5A, 0.5225, 3.56, 0.085, 114, 106, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO IN COMPLEX WITH COUMARIN 1 
3841, 6ev2E, 0.5225, 3.63, 0.132, 219, 106, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
3842, 6emjB, 0.5225, 3.79, 0.073, 218, 109, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3843, 6crsC, 0.5225, 3.61, 0.132, 220, 106, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 A-PARTICLE (PH 7.2 AND 4 DEGREES CELSIUS) 
3844, 6aynD, 0.5225, 3.59, 0.085, 211, 106, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-(3- AMINOPROPYL)-L-ARGININE MEDITOPE VARIANT
3845, 5v6mL, 0.5225, 3.62, 0.075, 217, 106, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V3 FAB 10A3 IN COMPLEX WITH V3 PEPTIDE CONB
3846, 5utzK, 0.5225, 3.76, 0.092, 216, 109, HUMAN IL-2/FAB COMPLEX 
3847, 5udcG, 0.5225, 4.76, 0.033, 256, 120, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
3848, 5nuzH, 0.5225, 3.91, 0.080, 232, 112, JUNIN VIRUS GP1 GLYCOPROTEIN IN COMPLEX WITH AN ANTIBODY FAB FRAGMENT
3849, 5n2kO, 0.5225, 3.81, 0.083, 216, 109, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
3850, 5n09M, 0.5225, 3.79, 0.092, 216, 109, CRYSTAL STRUCTURE OF L107C/A313C COVALENTLY LINKED DENGUE 2 VIRUS ENVELOPE GLYCOPROTEIN DIMER IN COMPLEX WITH THE FAB FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3851, 5mthL, 0.5225, 3.78, 0.109, 213, 110, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
3852, 5jqdD, 0.5225, 3.60, 0.094, 215, 106, ANTIBODY FAB FRAGMENT
3853, 5j75A, 0.5225, 3.65, 0.123, 218, 106, FLUOROGEN ACTIVATING PROGEIN AM2.2 IN COMPLEX WITH ML342
3854, 5hi3L, 0.5225, 3.66, 0.103, 217, 107, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
3855, 5e1aB, 0.5225, 3.89, 0.090, 224, 111, STRUCTURE OF KCSA WITH L24C/R117C MUTATIONS
3856, 5anmB, 0.5225, 3.78, 0.055, 215, 109, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
3857, 4xxdD, 0.5225, 3.88, 0.063, 293, 111, CRYSTAL STRUCTURE OF MID-REGION AMYLOID BETA CAPTURE BY SOLANEZUMAB
3858, 4tscL, 0.5225, 3.55, 0.181, 217, 105, STRUCTURE OF A LYSOZYME ANTIBODY COMPLEX
3859, 4q6iL, 0.5225, 3.55, 0.143, 218, 105, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
3860, 4pljL, 0.5225, 3.57, 0.104, 215, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
3861, 4k23L, 0.5225, 3.86, 0.100, 230, 110, STRUCTURE OF ANTI-UPAR FAB ATN-658
3862, 4ibsD, 0.5225, 3.57, 0.123, 218, 106, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H (FORM I)
3863, 4gxvL, 0.5225, 3.64, 0.084, 213, 107, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
3864, 4guqA, 0.5225, 3.64, 0.112, 212, 107, STRUCTURE OF MUTS139F P73 DNA BINDING DOMAIN COMPLEXED WITH 20BP DNA RESPONSE ELEMENT
3865, 4g6aL, 0.5225, 3.58, 0.113, 212, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY AP33
3866, 4fqhL, 0.5225, 3.88, 0.065, 199, 108, CRYSTAL STRUCTURE OF FAB CR9114
3867, 3us0C, 0.5225, 3.99, 0.064, 197, 109, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
3868, 3sgdI, 0.5225, 3.88, 0.056, 198, 108, CRYSTAL STRUCTURE OF THE MOUSE MAB 17.2
3869, 3qpxL, 0.5225, 3.63, 0.094, 217, 106, CRYSTAL STRUCTURE OF FAB C2507
3870, 3nz8H, 0.5225, 3.70, 0.074, 216, 108, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
3871, 3mclH, 0.5225, 3.52, 0.133, 211, 105, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3872, 3m4dD, 0.5225, 3.83, 0.100, 211, 110, CRYSTAL STRUCTURE OF THE M113N MUTANT OF ALPHA-HEMOLYSIN
3873, 3m3rD, 0.5225, 3.60, 0.123, 213, 106, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
3874, 3iy7A, 0.5225, 3.68, 0.121, 215, 107, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB F FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB F COMPLEX
3875, 3eoaA, 0.5225, 3.69, 0.081, 214, 111, CRYSTAL STRUCTURE THE FAB FRAGMENT OF EFALIZUMAB IN COMPLEX WITH LFA-1 I DOMAIN FORM I
3876, 3chnS, 0.5225, 3.67, 0.084, 213, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
3877, 3b2vL, 0.5225, 4.67, 0.068, 235, 118, CRYSTAL STRUCTURE OF THE EXTRACELLULAR REGION OF THE EPIDERMAL GROWTH FACTOR RECEPTOR IN COMPLEX WITH THE FAB FRAGMENT OF IMC-11F8
3878, 2x7lD, 0.5225, 3.81, 0.091, 220, 110, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
3879, 2v7hH, 0.5225, 3.59, 0.104, 219, 106, CRYSTAL STRUCTURE OF AN IMMUNOGEN SPECIFIC ANTI- MANNOPYRANOSIDE MONOCLONAL ANTIBODY FAB FRAGMENT
3880, 2r56M, 0.5225, 3.68, 0.140, 215, 107, CRYSTAL STRUCTURE OF A RECOMBINANT IGE FAB FRAGMENT IN COMPLEX WITH BOVINE BETA-LACTOGLOBULIN ALLERGEN
3881, 2r1yA, 0.5225, 3.61, 0.104, 213, 106, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
3882, 2oz4H, 0.5225, 3.86, 0.100, 215, 110, STRUCTURAL PLASTICITY IN IGSF DOMAIN 4 OF ICAM-1 MEDIATES CELL SURFACE DIMERIZATION
3883, 2or9M, 0.5225, 3.48, 0.095, 210, 105, THE STRUCTURE OF THE ANTI-C-MYC ANTIBODY 9E10 FAB FRAGMENT/EPITOPE PEPTIDE COMPLEX REVEALS A NOVEL BINDING MODE DOMINATED BY THE HEAVY CHAIN HYPERVARIABLE LOOPS
3884, 2ojzI, 0.5225, 3.70, 0.065, 213, 108, ANTI-DNA ANTIBODY ED10
3885, 2j1wB, 0.5225, 3.61, 0.170, 219, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V143A-V203A-N239Y-N268D
3886, 2h1lX, 0.5225, 3.83, 0.054, 214, 112, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
3887, 2eh8H, 0.5225, 3.39, 0.117, 233, 103, CRYSTAL STRUCTURE OF THE COMPLEX OF HUMANIZED KR127 FAB AND PRES1 PEPTIDE EPITOPE
3888, 2ac0D, 0.5225, 3.63, 0.140, 213, 107, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX I)
3889, 1fj1D, 0.5225, 3.64, 0.103, 212, 107, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3890, 1fj1B, 0.5225, 3.76, 0.073, 220, 109, LYME DISEASE ANTIGEN OSPA IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB LA-2
3891, 6okqB, 0.5224, 3.63, 0.132, 217, 106, CRYSTAL STRUCTURE OF THE SF12 FAB 
3892, 6e65L, 0.5224, 3.75, 0.102, 214, 108, CRYSTAL STRUCTURE OF MALARIA TRANSMISSION-BLOCKING ANTIGEN PFS48/45 6C IN COMPLEX WITH ANTIBODY 85RF45.1 
3893, 6d9gB, 0.5224, 3.59, 0.123, 218, 106, X-RAY STRUCTURE OF THE FAB FRAGMENT OF 15B8; A MURINE MONOCLONAL ANTIBODY SPECIFIC FOR THE HUMAN SEROTONIN TRANSPORTER 
3894, 6by2B, 0.5224, 3.58, 0.104, 212, 106, CLOSED AND DEEP-INACTIVATED CONFORMATION OF KCSA-T75A MUTANT 
3895, 6b9yA, 0.5224, 3.64, 0.123, 218, 106, TRASTUZUMAB FAB V3 IN COMPLEX WITH 5-PHENYL MEDITOPE VARIANT 
3896, 6au5B, 0.5224, 3.90, 0.065, 194, 108, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
3897, 5ziaK, 0.5224, 3.57, 0.087, 213, 104, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
3898, 5utzC, 0.5224, 3.83, 0.083, 200, 108, HUMAN IL-2/FAB COMPLEX 
3899, 5mu2J, 0.5224, 3.58, 0.113, 218, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
3900, 5mhrI, 0.5224, 3.51, 0.096, 212, 104, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
3901, 5fb8A, 0.5224, 3.96, 0.092, 196, 109, STRUCTURE OF INTERLEUKIN-16 BOUND TO THE 14.1 ANTIBODY
3902, 5e2vL, 0.5224, 3.69, 0.121, 218, 107, ANTI-TAU AT8 FAB WITH DOUBLY PHOSPHORYLATED TAU PEPTIDE
3903, 5dqjB, 0.5224, 3.59, 0.113, 213, 106, STRUCTURE OF UNLIGANDED S55-5 FAB
3904, 5dmgD, 0.5224, 3.75, 0.036, 217, 111, X-RAY STRUCTURE OF THE FAB FRAGMENT OF THE ANTI TAU ANTIBODY RB86 IN COMPLEX WITH THE PHOSPHORYLATED TAU PEPTIDE (416-430)
3905, 5cmaB, 0.5224, 3.82, 0.092, 227, 109, ANTI-B7-H3 MONOCLONAL ANTIBODY CH8H9 FAB FRAGMENT
3906, 5bvjC, 0.5224, 3.88, 0.063, 293, 111, THE MOLECULAR MODE OF ACTION AND SPECIES SPECIFICITY OF CANAKINUMAB A HUMAN MONOCLONAL ANTIBODY NEUTRALIZING IL-1BETA
3907, 5aumB, 0.5224, 3.87, 0.063, 293, 111, CRYSTAL STRUCTURE OF A FAB FRAGMENT WITH THE LIGAND PEPTIDE
3908, 4rft7, 0.5224, 3.46, 0.106, 106, 104, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
3909, 4qo1A, 0.5224, 3.66, 0.084, 214, 107, P53 DNA BINDING DOMAIN IN COMPLEX WITH NB139
3910, 4qhmG, 0.5224, 3.76, 0.092, 585, 109, I3.1 (UNBOUND) FROM CH103 LINEAGE
3911, 4q2zB, 0.5224, 3.65, 0.084, 213, 107, FAB FRAGMENT OF HIV VACCINE-ELICITED CD4BS-DIRECTED ANTIBODY GE356 FROM A NON-HUMAN PRIMATE
3912, 4ongL, 0.5224, 3.60, 0.104, 217, 106, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-40
3913, 4onfL, 0.5224, 3.88, 0.091, 220, 110, FAB FRAGMENT OF 3D6 IN COMPLEX WITH AMYLOID BETA 1-7
3914, 4odtL, 0.5224, 3.60, 0.104, 211, 106, FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15 IN COMPLEX WITH LIPID A CARBOHYDRATE BACKBONE
3915, 4nryA, 0.5224, 3.55, 0.152, 217, 105, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66
3916, 4njaL, 0.5224, 3.74, 0.083, 208, 109, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
3917, 4kmtH, 0.5224, 3.57, 0.104, 218, 106, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY 5-51/O12
3918, 4j1uE, 0.5224, 3.86, 0.115, 216, 113, CRYSTAL STRUCTURE OF ANTIBODY 93F3 UNSTABLE VARIANT
3919, 3stlB, 0.5224, 3.90, 0.056, 195, 108, KCSA POTASSIUM CHANNEL MUTANT Y82C WITH CADMIUM BOUND
3920, 3qynA, 0.5224, 3.89, 0.065, 199, 108, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3921, 3o6lL, 0.5224, 3.84, 0.083, 218, 109, ANTI-TAT HIV 11H6H1 FAB  COMPLEXED WITH A 15-MER TAT PEPTIDE
3922, 3hzkA, 0.5224, 3.98, 0.064, 198, 109, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.4)KDO
3923, 3hr5P, 0.5224, 3.74, 0.083, 213, 108, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
3924, 3gnmL, 0.5224, 3.76, 0.083, 213, 108, THE CRYSTAL STRUCTURE OF THE JAA-F11 MONOCLONAL ANTIBODY FAB FRAGMENT
3925, 3gc3A, 0.5224, 3.69, 0.084, 210, 107, CRYSTAL STRUCTURE OF ARRESTIN2S AND CLATHRIN
3926, 3bdyL, 0.5224, 3.71, 0.111, 214, 108, DUAL SPECIFIC BH1 FAB IN COMPLEX WITH VEGF
3927, 2zjsH, 0.5224, 3.60, 0.094, 216, 106, CRYSTAL STRUCTURE OF SECYE TRANSLOCON FROM THERMUS THERMOPHILUS WITH A FAB FRAGMENT
3928, 2qr0W, 0.5224, 3.65, 0.103, 212, 107, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3929, 2qr0Q, 0.5224, 3.61, 0.075, 214, 106, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3930, 2qr0K, 0.5224, 3.82, 0.091, 220, 110, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
3931, 2hfeB, 0.5224, 3.77, 0.073, 220, 109, RB+ COMPLEX OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
3932, 2adiA, 0.5224, 3.69, 0.140, 213, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH BARIUM
3933, 2a6dB, 0.5224, 3.67, 0.112, 218, 107, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
3934, 1xf2B, 0.5224, 3.87, 0.071, 213, 113, STRUCTURE OF FAB DNA-1 COMPLEXED WITH DT3
3935, 1nsnL, 0.5224, 3.58, 0.104, 218, 106, THE CRYSTAL STRUCTURE OF ANTIBODY N10-STAPHYLOCOCCAL NUCLEASE COMPLEX AT 2.9 ANGSTROMS RESOLUTION
3936, 1iqwL, 0.5224, 3.62, 0.104, 216, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THE MOUSE ANTI- HUMAN FAS ANTIBODY HFE7A
3937, 1fptH, 0.5224, 3.60, 0.123, 217, 106, THREE-DIMENSIONAL STRUCTURE OF THE COMPLEX BETWEEN THE FAB FRAGMENT OF AN NEUTRALIZING ANTIBODY FOR TYPE 1 POLIOVIRUS AND ITS VIRAL EPITOPE
3938, 1fl5L, 0.5224, 3.59, 0.085, 217, 106, THE UNLIGANDED GERMLINE PRECURSOR TO THE SULFIDE OXIDASE CATALYTIC ANTIBODY 28B4.
3939, 1bfoE, 0.5224, 3.82, 0.109, 213, 110, CAMPATH-1G IGG2B RAT MONOCLONAL FAB
3940, 6ii8I, 0.5223, 3.61, 0.094, 214, 106, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4B-18 
3941, 6eleB, 0.5223, 3.62, 0.132, 216, 106, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
3942, 6e9hB, 0.5223, 4.31, 0.055, 163, 110, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-3 
3943, 6bpaB, 0.5223, 3.80, 0.092, 127, 109, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 3E9 
3944, 6azlC, 0.5223, 3.85, 0.081, 217, 111, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N- CARBOXYETHYLARGININE MEDITOPE VARIANT
3945, 6a9kL, 0.5223, 3.55, 0.105, 212, 105, CRYSTAL STRUCTURE OF THE COMPLEX OF THE HYDROLYTIC ANTIBODY FAB 9C10 WITH A TRANSITION-STATE ANALOG 
3946, 5yd5A, 0.5223, 3.65, 0.123, 214, 106, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
3947, 5w23N, 0.5223, 3.63, 0.123, 218, 106, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
3948, 5vkeB, 0.5223, 3.64, 0.093, 214, 107, OPEN CONFORMATION OF KCSA DEEP-INACTIVATED
3949, 5vigB, 0.5223, 3.81, 0.083, 218, 109, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
3950, 5vcoC, 0.5223, 3.51, 0.124, 217, 105, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3951, 5myoA, 0.5223, 3.81, 0.073, 218, 109, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
3952, 5mx3B, 0.5223, 3.48, 0.135, 214, 104, STRUCTURE OF DC8E8 FAB CRYSTALLIZED AT PH 8.5
3953, 5mvzA, 0.5223, 3.63, 0.112, 212, 107, FAB 4AB007 BOUND TO INTERLEUKIN-1-BETA
3954, 5mo3L, 0.5223, 3.98, 0.092, 195, 109, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
3955, 5i76C, 0.5223, 3.65, 0.123, 217, 106, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
3956, 5i5kH, 0.5223, 3.55, 0.143, 218, 105, STRUCTURE OF COMPLEMENT C5 IN COMPLEX WITH ECULIZUMAB
3957, 5e08L, 0.5223, 3.59, 0.113, 219, 106, SPECIFIC RECOGNITION OF A SINGLE-STRANDED RNA SEQUENCE BY AN ENGINEERED SYNTHETIC ANTIBODY FRAGMENT
3958, 5c6wJ, 0.5223, 3.61, 0.142, 217, 106, ANTI-CXCL13 SCFV - E10
3959, 4yhdB, 0.5223, 3.38, 0.078, 329, 103, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
3960, 4ut7L, 0.5223, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURE OF THE SCFV FRAGMENT OF THE BROADLY NEUTRALIZING HUMAN ANTIBODY EDE2 A11
3961, 4toyH, 0.5223, 3.81, 0.082, 220, 110, STRUCTURE OF 35O22 FAB A HIV-1 NEUTRALIZING ANTIBODY
3962, 4pp2C, 0.5223, 3.63, 0.075, 213, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
3963, 4p24F, 0.5223, 3.63, 0.075, 213, 107, PORE FORMING TOXIN
3964, 4odsL, 0.5223, 3.63, 0.084, 213, 107, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S55-3
3965, 4ocwL, 0.5223, 3.58, 0.113, 211, 106, CRYSTAL STRUCTURE OF HUMAN FAB CAP256-VRC26.06 A POTENT V1V2-DIRECTED HIV-1 NEUTRALIZING ANTIBODY
3966, 4nkoC, 0.5223, 3.70, 0.112, 211, 107, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
3967, 4m61A, 0.5223, 3.84, 0.082, 219, 110, CRYSTAL STRUCTURE OF UNLIGANDED ANTI-DNA FAB A52
3968, 4lriA, 0.5223, 3.85, 0.091, 213, 110, ANTI CMV FAB FRAGMENT
3969, 4j4pD, 0.5223, 3.58, 0.104, 217, 106, THE COMPLEX OF HUMAN IGE-FC WITH TWO BOUND FAB FRAGMENTS
3970, 4hk0C, 0.5223, 3.59, 0.113, 215, 106, UCA FAB (UNBOUND) FROM CH65-CH67 LINEAGE
3971, 4fp8M, 0.5223, 3.86, 0.100, 220, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
3972, 3utzA, 0.5223, 3.63, 0.123, 217, 106, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
3973, 3qynD, 0.5223, 3.65, 0.113, 214, 106, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
3974, 3npsB, 0.5223, 3.74, 0.120, 213, 108, CRYSTAL STRUCTURE OF MEMBRANE-TYPE SERINE PROTEASE 1 (MT-SP1) IN COMPLEX WITH THE FAB INHIBITOR S4
3975, 3mclL, 0.5223, 3.67, 0.084, 213, 107, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP P21
3976, 3iy2A, 0.5223, 3.42, 0.135, 215, 104, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 6 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 6 COMPLEX
3977, 3ijyC, 0.5223, 3.77, 0.092, 217, 109, STRUCTURE OF S67-27 IN COMPLEX WITH KDO(2.8)KDO
3978, 3ijsC, 0.5223, 3.63, 0.084, 212, 107, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
3979, 3ijhC, 0.5223, 3.69, 0.121, 219, 107, STRUCTURE OF S67-27 IN COMPLEX WITH KO
3980, 3ghbM, 0.5223, 3.89, 0.071, 251, 112, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
3981, 3c09B, 0.5223, 3.65, 0.112, 215, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
3982, 3bszM, 0.5223, 3.63, 0.112, 212, 107, CRYSTAL STRUCTURE OF THE TRANSTHYRETIN-RETINOL BINDING PROTEIN-FAB COMPLEX
3983, 2w9lG, 0.5223, 3.57, 0.085, 212, 106, CANINE ADENOVIRUS TYPE 2 FIBRE HEAD IN COMPLEX WITH CAR DOMAIN D1 AND SIALIC ACID
3984, 2o5zL, 0.5223, 3.61, 0.094, 211, 106, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB 5-BETA- ANDROSTANE-317-DIONE COMPLEX
3985, 2j1yC, 0.5223, 3.64, 0.132, 219, 106, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-G245S-N268D
3986, 2iooA, 0.5223, 3.61, 0.151, 218, 106, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DOMAIN
3987, 2hfgL, 0.5223, 3.81, 0.073, 221, 110, CRYSTAL STRUCTURE OF HBR3 BOUND TO CB3S-FAB
3988, 2b0sH, 0.5223, 3.55, 0.162, 218, 105, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 V3 FAB 2219 IN COMPLEX WITH MN PEPTIDE
3989, 2adgA, 0.5223, 3.64, 0.084, 213, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425
3990, 1r3iL, 0.5223, 3.77, 0.073, 221, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN RB+
3991, 1ncdH, 0.5223, 3.67, 0.084, 215, 107, REFINED CRYSTAL STRUCTURE OF THE INFLUENZA VIRUS N9 NEURAMINIDASE-NC41 FAB COMPLEX
3992, 1nc4D, 0.5223, 3.66, 0.065, 238, 108, CRYSTAL STRUCTURE OF MONOCLONAL ANTIBODY 2D12.5 FAB COMPLEXED WITH GD- DOTA
3993, 1l7tL, 0.5223, 3.90, 0.071, 283, 112, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-TESTOSTERONE FAB FRAGMENT
3994, 1jnlL, 0.5223, 3.53, 0.086, 113, 105, CRYSTAL STRUCTURE OF FAB-ESTRADIOL COMPLEXES
3995, 1bbdL, 0.5223, 3.71, 0.055, 241, 110, THREE DIMENSIONAL STRUCTURE OF THE FAB FRAGMENT OF A NEUTRALIZING ANTIBODY TO HUMAN RHINOVIRUS SEROTYPE 2
3996, 1a8jH, 0.5223, 3.61, 0.094, 211, 106, IMMUNOGLOBULIN LAMBDA LIGHT CHAIN DIMER (MCG) COMPLEX WITH ASPARTAME
3997, 6rcoA, 0.5222, 3.95, 0.071, 290, 113, PFRH5-BINDING MONOCLONAL ANTIBODY R5.004 
3998, 6mqsD, 0.5222, 3.60, 0.103, 218, 107, VACCINE-ELICITED NHP FP-TARGETING HIV NEUTRALIZING ANTIBODY A12V163- A.01 IN COMPLEX WITH HIV FUSION PEPTIDE (RESIDUE 512-519) 
3999, 6mhgW, 0.5222, 3.54, 0.152, 211, 105, CRYO-EM STRUCTURE OF THE CIRCUMSPOROZOITE PROTEIN OF PLASMODIUM FALCIPARUM WITH A VACCINE-ELICITED ANTIBODY REVEALS MATURATION OF INTER-ANTIBODY CONTACTS 
4000, 6jmrD, 0.5222, 3.71, 0.103, 115, 107, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
4001, 6gk8H, 0.5222, 3.51, 0.152, 219, 105, CRYSTAL STRUCTURE OF ANTI-TAU ANTIBODY DMCBTAU-28.1; DOUBLE MUTANT (S32R; E35K) OF CBTAU-28.1; IN COMPLEX WITH TAU PEPTIDE A7731 (RESIDUES 52-71) 
4002, 6eluC, 0.5222, 3.60, 0.104, 217, 106, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4003, 6ellL, 0.5222, 3.46, 0.106, 215, 104, FAB FRAGMENT. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN ANTIBODY DRUG DISCOVERY
4004, 6cnvH, 0.5222, 3.79, 0.073, 222, 109, INFLUENZA B/BRISBANE HEMAGGLUTININ FAB CR9115 SD84H COMPLEX 
4005, 6bzwH, 0.5222, 3.59, 0.085, 213, 106, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY AP33 
4006, 6b5sH, 0.5222, 3.64, 0.123, 215, 106, STRUCTURE OF PFCSP PEPTIDE 25 WITH HUMAN ANTIBODY CIS42
4007, 6axpD, 0.5222, 3.97, 0.092, 190, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4008, 6axpC, 0.5222, 3.79, 0.073, 226, 110, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-OCTYLARGININE MEDITOPE VARIANT
4009, 6avnL, 0.5222, 3.59, 0.094, 209, 106, CRYSTAL STRUCTURE OF UNBOUND ANTI-HIV ANTIBODY FAB PGV19 AT 2.5 A 
4010, 5w3lC, 0.5222, 3.45, 0.096, 107, 104, CRYOEM STRUCTURE OF RHINOVIRUS B14 IN COMPLEX WITH C5 FAB (4 DEGREES CELSIUS MOLAR RATIO 1:3 FULL PARTICLE)
4011, 5w24L, 0.5222, 3.53, 0.152, 217, 105, CRYSTAL STRUCTURE OF 5C4 FAB
4012, 5u6fA, 0.5222, 3.52, 0.152, 216, 105, BACTERIAL ADHESIN FROM MOBILUNCUS MULIERIS CONTAINING INTRAMOLECULAR DISULFIDE; ISOPEPTIDE; AND ESTER BOND CROSS-LINKS (SPACE GROUP P21) 
4013, 5t0yH, 0.5222, 3.56, 0.142, 217, 106, 2A10 ANTIBODY FAB FRAGMENT
4014, 5o1gA, 0.5222, 3.55, 0.096, 216, 104, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB487 
4015, 5mhrH, 0.5222, 3.51, 0.086, 175, 105, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4016, 5kvfL, 0.5222, 3.58, 0.104, 215, 106, ZIKA SPECIFIC ANTIBODY ZV-64 BOUND TO ZIKA ENVELOPE DIII
4017, 5k93A, 0.5222, 3.96, 0.090, 123, 111, PAPD WILD-TYPE CHAPERONE
4018, 5dqjL, 0.5222, 3.60, 0.132, 218, 106, STRUCTURE OF UNLIGANDED S55-5 FAB
4019, 5abaB, 0.5222, 3.92, 0.056, 191, 108, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL- MOLECULE STABILIZER PHIKAN5149
4020, 4zffL, 0.5222, 3.84, 0.056, 187, 107, DUAL-ACTING FAB 5A12 IN COMPLEX WITH VEGF
4021, 4yhdE, 0.5222, 3.64, 0.093, 213, 107, STAPHYLOCOCCAL ALPHA-HEMOLYSIN H35A MUTANT MONOMER
4022, 4wuuE, 0.5222, 3.75, 0.074, 226, 108, STRUCTURE OF ESK1 IN COMPLEX WITH HLA-A*0201/WT1
4023, 4rftJ, 0.5222, 3.66, 0.113, 211, 106, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4024, 4rft5, 0.5222, 3.66, 0.103, 212, 107, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4025, 4rfeD, 0.5222, 3.83, 0.100, 221, 110, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
4026, 4qhmE, 0.5222, 3.75, 0.054, 215, 112, I3.1 (UNBOUND) FROM CH103 LINEAGE
4027, 4pljD, 0.5222, 3.65, 0.113, 219, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE IV) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4028, 4o58L, 0.5222, 3.65, 0.112, 211, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY F045-092 IN COMPLEX WITH A/VICTORIA/3/1975 (H3N2) INFLUENZA HEMAGGLUTININ
4029, 4m1dM, 0.5222, 3.68, 0.103, 219, 107, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 CYCLIC PEPTIDE MN
4030, 4lriB, 0.5222, 3.64, 0.112, 215, 107, ANTI CMV FAB FRAGMENT
4031, 4jn2L, 0.5222, 3.83, 0.073, 221, 110, AN ANTIDOTE FOR DABIGATRAN
4032, 4jn2A, 0.5222, 3.53, 0.114, 215, 105, AN ANTIDOTE FOR DABIGATRAN
4033, 4izlB, 0.5222, 3.34, 0.119, 112, 101, STRUCTURE OF THE N248A MUTANT OF THE PANTON-VALENTINE LEUCOCIDIN S COMPONENT FROM STAPHYLOCOCCUS AUREUS
4034, 4dtgL, 0.5222, 3.69, 0.093, 219, 107, HEMOSTATIC EFFECT OF A MONOCLONAL ANTIBODY MAB 2021 BLOCKING THE INTERACTION BETWEEN FXA AND TFPI IN A RABBIT HEMOPHILIA MODEL
4035, 4d9rH, 0.5222, 3.78, 0.073, 222, 109, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4036, 3qumH, 0.5222, 3.55, 0.133, 217, 105, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4037, 3or6B, 0.5222, 3.60, 0.085, 213, 106, ON THE STRUCTURAL BASIS OF MODAL GATING BEHAVIOR IN K+CHANNELS - E71Q
4038, 3o2dL, 0.5222, 3.83, 0.073, 214, 110, CRYSTAL STRUCTURE OF HIV-1 PRIMARY RECEPTOR CD4 IN COMPLEX WITH A POTENT ANTIVIRAL ANTIBODY
4039, 3nn8H, 0.5222, 3.61, 0.113, 218, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4040, 3m3rF, 0.5222, 3.62, 0.083, 215, 108, CRYSTAL STRUCTURE OF THE M113F ALPHA-HEMOLYSIN MUTANT COMPLEXED WITH BETA-CYCLODEXTRIN
4041, 3l5wL, 0.5222, 3.76, 0.092, 214, 109, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN IL-13 AND C836 FAB
4042, 3j8dD, 0.5222, 3.63, 0.084, 212, 107, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
4043, 3j8dA, 0.5222, 3.40, 0.126, 205, 103, CRYOELECTRON MICROSCOPY OF DENGUE-FAB E104 COMPLEX AT PH 5.5
4044, 3ixtB, 0.5222, 4.75, 0.050, 255, 120, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4045, 2x7lL, 0.5222, 3.57, 0.113, 215, 106, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4046, 2vxsL, 0.5222, 3.41, 0.069, 288, 101, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
4047, 2vl5B, 0.5222, 3.78, 0.092, 217, 109, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
4048, 2h1lQ, 0.5222, 3.89, 0.056, 196, 108, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4049, 2cgrH, 0.5222, 3.63, 0.104, 205, 106, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
4050, 2ahiA, 0.5222, 3.54, 0.171, 220, 105, STRUCTURAL BASIS OF DNA RECOGNITION BY P53 TETRAMERS (COMPLEX III)
4051, 2a6jH, 0.5222, 2.91, 0.133, 210, 98, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36- 65
4052, 1yy8C, 0.5222, 3.59, 0.123, 217, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
4053, 1xf4H, 0.5222, 3.87, 0.046, 197, 108, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4054, 1p2cB, 0.5222, 3.66, 0.093, 213, 107, CRYSTAL STRUCTURE ANALYSIS OF AN ANTI-LYSOZYME ANTIBODY
4055, 1igjB, 0.5222, 3.89, 0.063, 268, 111, 26-10 FAB:DIGOXIN COMPLEX-AFFINITY AND SPECIFICITY DUE TO SURFACE COMPLEMENTARITY
4056, 6mnsL, 0.5221, 3.73, 0.083, 223, 109, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
4057, 6m87B, 0.5221, 4.30, 0.045, 163, 110, FAB 10A6 IN COMPLEX WITH MPTS 
4058, 6hf1C, 0.5221, 4.17, 0.055, 163, 109, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
4059, 6h3hA, 0.5221, 3.63, 0.086, 212, 105, FAB FRAGMENT OF ANTIBODY AGAINST FULLERENE C60 
4060, 6gc2H, 0.5221, 3.85, 0.081, 217, 111, ABLIFT: ANTIBODY STABILITY AND AFFINITY OPTIMIZATION BY COMPUTATIONAL DESIGN OF THE VARIABLE LIGHT-HEAVY CHAIN INTERFACE 
4061, 6fy2X, 0.5221, 3.74, 0.093, 216, 108, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4062, 6fy0H, 0.5221, 3.48, 0.106, 213, 104, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4063, 6dwiK, 0.5221, 3.56, 0.096, 213, 104, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4064, 6dwaL, 0.5221, 3.64, 0.094, 217, 106, STRUCTURE OF THE 4497 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4065, 6d2pL, 0.5221, 3.63, 0.123, 219, 106, CRYSTAL STRUCTURE OF IOMA-CLASS CLK31 FAB FROM AN HIV-1 NAIVE DONOR IN COMPLEX WITH A GERMLINE-TARGETING GP120 ENGINEERED OUTER DOMAIN EOD- GT8 AT 2.6 A 
4066, 6cueq, 0.5221, 3.62, 0.104, 219, 106, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4067, 6cs5C, 0.5221, 4.03, 0.062, 278, 112, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 ABORTIVE PRODUCT 2 (PH 7.2 AND 4 DEGREES CELSIUS) 
4068, 6bfsH, 0.5221, 3.63, 0.132, 219, 106, THE MECHANISM OF GM-CSF INHIBITION BY HUMAN GM-CSF AUTO-ANTIBODIES 
4069, 6au5D, 0.5221, 3.79, 0.083, 218, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
4070, 6au5C, 0.5221, 3.79, 0.083, 217, 109, STRUCTURE OF CETUXIMAB WITH AMINOHEPTANOIC ACID-LINKED N-BUTYLARGININE MEDITOPE VARIANT
4071, 5x2nK, 0.5221, 3.64, 0.103, 212, 107, CRYSTAL STRUCTURE OF THE MEDAKA FISH TASTE RECEPTOR T1R2A-T1R3 LIGAND BINDING DOMAINS IN COMPLEX WITH L-ALANINE
4072, 5th2D, 0.5221, 3.53, 0.143, 216, 105, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4073, 5te4H, 0.5221, 3.64, 0.104, 116, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VRC01-CLASS ANTIBODY N6 IN COMPLEX WITH HIV-1 CLADE G STRAIN X2088 GP120 CORE
4074, 5tdpC, 0.5221, 3.88, 0.063, 293, 111, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ANTI-HER2 ANTIBODY 4D5 WITH REDESIGNED HEAVY AND LIGHT CHAIN INTERFACES
4075, 5t3xH, 0.5221, 3.72, 0.084, 213, 107, 3.9 ANGSTROM CRYSTAL STRUCTURE OF A FULLY AND NATIVELY GLYCOSYLATED BG505 SOSIP.664 HIV-1 ENV TRIMER IN COMPLEX WITH THE BROADLY NEUTRALIZING ANTIBODIES IOMA AND 10-1074.
4076, 5o1iB, 0.5221, 3.58, 0.133, 425, 105, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB710 
4077, 5nivA, 0.5221, 3.58, 0.133, 425, 105, CRYSTAL STRUCTURE OF 5D3 FAB
4078, 5mv3D, 0.5221, 3.51, 0.095, 210, 105, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4079, 5mu2L, 0.5221, 3.61, 0.104, 217, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4080, 5mheL, 0.5221, 3.62, 0.140, 213, 107, CRYSTAL STRUCTURE OF ANTI-T4 FAB FRAGMENT WITH T4 
4081, 5id1C, 0.5221, 3.62, 0.121, 217, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4082, 5hpmC, 0.5221, 3.91, 0.065, 199, 108, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4083, 5g4nB, 0.5221, 3.85, 0.073, 214, 110, CRYSTAL STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH A DIFLUORINATED DERIVATIVE OF THE SMALL MOLECULE STABILIZER PHIKAN083
4084, 5ec2B, 0.5221, 3.93, 0.065, 198, 108, KCSA WITH V76ESTER+G77DA MUTATIONS
4085, 5dlmM, 0.5221, 3.87, 0.082, 222, 110, COMPLEX OF INFLUENZA M2E AND ANTIBODY
4086, 4zxbB, 0.5221, 3.64, 0.093, 213, 107, STRUCTURE OF THE HUMAN INSULIN RECEPTOR ECTODOMAIN IRDELTABETA CONSTRUCT IN COMPLEX WITH FOUR FAB MOLECULES
4087, 4ydlB, 0.5221, 3.83, 0.091, 213, 110, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4088, 4qyoA, 0.5221, 3.80, 0.092, 210, 109, CRYSTAL STRUCTURE OF ANTI-MSP2 FV FRAGMENT (MAB6D8)IN COMPLEX WITH MSP2 14-22
4089, 4oduB, 0.5221, 3.83, 0.045, 217, 111, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
4090, 4lbeB, 0.5221, 3.44, 0.106, 211, 104, STRUCTURE OF KCSA WITH R122A MUTATION
4091, 4gw1D, 0.5221, 3.79, 0.083, 215, 109, CQFD MEDITOPE
4092, 4gw1B, 0.5221, 3.82, 0.073, 209, 110, CQFD MEDITOPE
4093, 4g6jL, 0.5221, 3.80, 0.062, 222, 112, CRYSTAL STRUCTURE OF HUMAN IL-1BETA IN COMPLEX WITH THE THERAPEUTIC ANTIBODY BINDING FRAGMENT OF CANAKINUMAB
4094, 4fqrp, 0.5221, 3.80, 0.073, 213, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4095, 4dn3H, 0.5221, 3.77, 0.083, 219, 109, CRYSTAL STRUCTURE OF ANTI-MCP-1 ANTIBODY CNTO888
4096, 3qo0A, 0.5221, 3.81, 0.083, 226, 109, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC PEPTIDE) SHARING SAME FV AS IGA
4097, 3opzM, 0.5221, 3.67, 0.075, 211, 106, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4098, 3opzL, 0.5221, 3.67, 0.103, 219, 107, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4099, 3o45L, 0.5221, 3.53, 0.105, 210, 105, CRYSTAL STRUCTURE OF 101F FAB BOUND TO 17-MER PEPTIDE EPITOPE
4100, 3nz8B, 0.5221, 3.78, 0.093, 129, 108, CRYSTAL STRUCTURE OF THE HIV-2 NEUTRALIZING FAB FRAGMENT 7C8
4101, 3mlzL, 0.5221, 4.51, 0.078, 230, 116, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 3074 IN COMPLEX WITH A VI191 V3 PEPTIDE
4102, 3j8zM, 0.5221, 3.88, 0.082, 211, 110, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
4103, 3j8zL, 0.5221, 3.82, 0.091, 220, 110, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
4104, 3j8zK, 0.5221, 3.63, 0.093, 213, 107, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
4105, 3j8zJ, 0.5221, 3.51, 0.133, 216, 105, CRYO-EM RECONSTRUCTION OF QUASI-HPV16 COMPLEX WITH H16.1A FAB
4106, 3j3oH, 0.5221, 3.82, 0.091, 220, 110, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 160S POLIOVIRUS AND C3-FAB COMPLEX
4107, 3ixtL, 0.5221, 3.75, 0.092, 224, 109, CRYSTAL STRUCTURE OF MOTAVIZUMAB FAB BOUND TO PEPTIDE EPITOPE
4108, 3hc3H, 0.5221, 3.57, 0.085, 213, 106, BHA10 IGG1 FAB DOUBLE MUTANT VARIANT - ANTIBODY DIRECTED AT HUMAN LTBR
4109, 3gb7B, 0.5221, 3.73, 0.083, 230, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+
4110, 2xwrB, 0.5221, 3.87, 0.046, 197, 108, CRYSTAL STRUCTURE OF THE DNA-BINDING DOMAIN OF HUMAN P53 WITH EXTENDED N TERMINUS
4111, 2x7lK, 0.5221, 3.63, 0.123, 212, 106, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4112, 2wmpA, 0.5221, 3.68, 0.112, 217, 107, STRUCTURE OF THE E. COLI CHAPERONE PAPD IN COMPLEX WITH THE PILIN DOMAIN OF THE PAPGII ADHESIN
4113, 2vxsM, 0.5221, 3.68, 0.112, 218, 107, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
4114, 2vq1E, 0.5221, 3.56, 0.124, 212, 105, ANTI TRIMERIC LEWIS X FAB54-5C10-A
4115, 2qqlL, 0.5221, 3.64, 0.084, 212, 107, NEUROPILIN-2 A1A2B1B2 DOMAINS IN COMPLEX WITH A SEMAPHORIN-BLOCKING FAB
4116, 2j1kG, 0.5221, 3.63, 0.084, 213, 107, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
4117, 2fauA, 0.5221, 3.87, 0.046, 197, 108, CRYSTAL STRUCTURE OF HUMAN VPS26
4118, 2atpB, 0.5221, 3.65, 0.103, 212, 107, CRYSTAL STRUCTURE OF A CD8AB HETERODIMER
4119, 2adjA, 0.5221, 3.70, 0.121, 217, 107, CRYSTAL STRUCTURE OF MONOCLONAL ANTI-CD4 ANTIBODY Q425 IN COMPLEX WITH CALCIUM
4120, 2a6kB, 0.5221, 3.59, 0.151, 218, 106, CRYSTAL STRUCTURE ANALYSIS OF THE GERMLINE ANTIBODY 36-65 FAB IN COMPLEX WITH THE DODECAPEPTIDE SLGDNLTNHNLR
4121, 1t66C, 0.5221, 3.79, 0.101, 223, 109, THE STRUCTURE OF FAB WITH INTERMEDIATE AFFINITY FOR FLUORESCEIN.
4122, 1sy6L, 0.5221, 3.63, 0.084, 114, 107, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
4123, 1r3lA, 0.5221, 3.65, 0.084, 212, 107, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN CS+
4124, 1lk3I, 0.5221, 3.64, 0.103, 212, 107, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4125, 1e6oH, 0.5221, 3.82, 0.091, 220, 110, CRYSTAL STRUCTURE OF FAB13B5 AGAINST HIV-1 CAPSID PROTEIN P24
4126, 6ev1K, 0.5220, 3.82, 0.091, 221, 110, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4127, 6eluL, 0.5220, 3.65, 0.093, 212, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4128, 6crpC, 0.5220, 3.65, 0.093, 213, 107, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 ABORTIVE PRODUCT 1 (PH 7.2 AND 4 DEGREES CELSIUS) 
4129, 6baeA, 0.5220, 3.73, 0.074, 211, 108, TRASTUZUMAB FAB V3 IN COMPLEX WITH CQFDLSTRRLKC 
4130, 5werL, 0.5220, 3.63, 0.113, 219, 106, CRYSTAL STRUCTURE OF TAPBPR AND H2-DD COMPLEX
4131, 5vr9H, 0.5220, 3.48, 0.133, 212, 105, CH1/CKAPPA FAB BASED ON MATUZUMAB
4132, 5uddK, 0.5220, 3.47, 0.133, 212, 105, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4133, 5tpwH, 0.5220, 3.60, 0.113, 218, 106, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN COMPLEX WITH ZINC AT THE GLUN2A
4134, 5t1lD, 0.5220, 3.61, 0.132, 217, 106, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4135, 5mvjC, 0.5220, 3.69, 0.095, 214, 105, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4136, 5lxgH, 0.5220, 3.57, 0.105, 115, 105, REVISED CRYSTAL STRUCTURE OF THE HUMAN ADIPONECTIN RECEPTOR 1 IN AN OPEN CONFORMATION
4137, 5ivzD, 0.5220, 3.57, 0.105, 115, 105, CETUXIMAB FAB IN COMPLEX WITH ARG8CIR MEDITOPE VARIANT
4138, 5i0zB, 0.5220, 3.57, 0.105, 115, 105, CRYSTAL STRUCTURE OF THE SINGLE DOMAIN CATALYTIC ANTIBODY 3D8-VH
4139, 4xcyE, 0.5220, 3.57, 0.105, 115, 105, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4140, 4nrzA, 0.5220, 3.86, 0.100, 220, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING ANTIBODY M66.6
4141, 4n0yH, 0.5220, 3.51, 0.095, 211, 105, STRUCTURE OF THE HEPATITIS C ENVELOPE GLYCOPROTEIN E1 ANTIGENIC REGION 314-324 BOUND TO THE CROSS-NEUTRALIZING ANTIBODY IGH526
4142, 4mhhI, 0.5220, 3.83, 0.082, 212, 110, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4143, 4ibtA, 0.5220, 3.64, 0.112, 212, 107, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION T284R
4144, 4gagL, 0.5220, 3.89, 0.056, 200, 108, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33 IN COMPLEX WITH ITS HCV EPITOPE (E2 RESIDUES 412-423)
4145, 4fnlM, 0.5220, 3.60, 0.104, 217, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4146, 4bz1L, 0.5220, 3.09, 0.111, 215, 99, STRUCTURE OF DENGUE VIRUS EDIII IN COMPLEX WITH FAB 3E31
4147, 3nfsH, 0.5220, 3.63, 0.131, 215, 107, CRYSTAL STRUCTURE THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB
4148, 3kykL, 0.5220, 3.61, 0.123, 216, 106, CRYSTAL STRUCTURE OF LI33 IGG1 FAB
4149, 3j70S, 0.5220, 3.59, 0.085, 214, 106, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4150, 3j70N, 0.5220, 4.03, 0.080, 123, 112, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4151, 3j70B, 0.5220, 3.73, 0.086, 286, 105, MODEL OF GP120 INCLUDING VARIABLE REGIONS IN COMPLEX WITH CD4 AND 17B
4152, 3iy3A, 0.5220, 3.45, 0.096, 115, 104, VARIABLE DOMAINS OF THE COMPUTER GENERATED MODEL (WAM) OF FAB 8 FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS- FAB 8 COMPLEX
4153, 3if1C, 0.5220, 3.62, 0.123, 211, 106, CRYSTAL STRUCTURE OF 237MAB IN COMPLEX WITH A GALNAC
4154, 3eyvA, 0.5220, 3.82, 0.083, 218, 109, ANTI-LEWIS Y FAB FRAGMENT WITH LEWIS Y ANTIGEN IN THE PRESENCE OF ZINC IONS
4155, 3ejyF, 0.5220, 3.64, 0.132, 219, 106, STRUCTURE OF E203H MUTANT OF E.COLI CL-/H+ ANTIPORTER CLC-EC1
4156, 3cxdL, 0.5220, 3.53, 0.114, 213, 105, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH ITS EPITOPE PEPTIDE
4157, 3anzG, 0.5220, 3.64, 0.103, 212, 107, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4158, 2r23A, 0.5220, 3.83, 0.100, 219, 110, CRYSTAL STRUCTURE OF S25-2 FAB IN COMPLEX WITH KDO ANALOGUES
4159, 2qr0A, 0.5220, 3.83, 0.091, 219, 110, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4160, 2fjhA, 0.5220, 3.70, 0.081, 218, 111, STRUCTURE OF THE B20-4 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4161, 1xf5D, 0.5220, 3.59, 0.113, 217, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4162, 1xedF, 0.5220, 4.50, 0.078, 230, 116, CRYSTAL STRUCTURE OF A LIGAND-BINDING DOMAIN OF THE HUMAN POLYMERIC IG RECEPTOR PIGR
4163, 1tziA, 0.5220, 3.61, 0.094, 214, 106, CRYSTAL STRUCTURE OF THE FAB YADS2 COMPLEXED WITH H-VEGF
4164, 1i7zA, 0.5220, 3.99, 0.036, 312, 111, ANTIBODY GNC92H2 BOUND TO LIGAND
4165, 1ct8D, 0.5220, 3.97, 0.082, 224, 110, CATALYTIC ANTIBODY 7C8 COMPLEX
4166, 1cicC, 0.5220, 3.86, 0.082, 220, 110, IDIOTOPE-ANTI-IDIOTOPE FAB-FAB COMPLEX; D1.3-E225
4167, 6novB, 0.5219, 3.77, 0.101, 211, 109, A FAB DERIVED FROM IXEKIZUMAB 
4168, 6hf1F, 0.5219, 3.76, 0.092, 216, 109, MUTANT OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH AN ANTIBODY FAB 
4169, 6hbkQ, 0.5219, 3.74, 0.083, 213, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4170, 6hbkH, 0.5219, 3.65, 0.130, 119, 108, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4171, 6fg2L, 0.5219, 3.84, 0.100, 213, 110, CRYSTAL STRUCTURE OF FAB OF NATALIZUMAB IN COMPLEX WITH FAB OF NAA84. 
4172, 6ffjG, 0.5219, 3.68, 0.083, 120, 108, ANTI-TUMOR ANTIBODY 14F7-DERIVED SINGLE CHAIN FRAGMENT VARIABLE (SCFV) 
4173, 6ffjA, 0.5219, 3.84, 0.082, 223, 110, ANTI-TUMOR ANTIBODY 14F7-DERIVED SINGLE CHAIN FRAGMENT VARIABLE (SCFV) 
4174, 6dezL, 0.5219, 3.76, 0.083, 225, 108, ANTI-PHOSPHOTYROSINE ANTIBODY PY20-4D5 FAB COMPLEXED WITH SULFATE 
4175, 6ddvB, 0.5219, 3.82, 0.073, 222, 110, CRYSTAL STRUCTURE ANALYSIS OF THE EPITOPE OF AN ANTI-MICA ANTIBODY 
4176, 6cdpB, 0.5219, 3.59, 0.113, 217, 106, VACCINE-ELICITED HIV-1 NEUTRALIZING ANTIBODY VFP20.01 IN COMPLEX WITH HIV-1 FUSION PEPTIDE RESIDUE 512-519 
4177, 6apdL, 0.5219, 3.90, 0.056, 196, 108, CRYSTAL STRUCTURE OF RSV F BOUND BY AM22 AND THE INFANT ANTIBODY ADI- 19425
4178, 6a78M, 0.5219, 3.59, 0.113, 215, 106, CRYSTAL STRUCTURE OF THE FIFTH IMMUNOGLOBULIN DOMAIN (IG5) OF HUMAN ROBO1 IN COMPLEX WITH THE SCFV FRAGMENT OF MURINE MONOCLONAL ANTIBODY B5209B 
4179, 5yfiL, 0.5219, 3.65, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE CLINICALLY IMPORTANT GPCR IN COMPLEX WITH FUNCTIONAL ANTIBODY 
4180, 5w0dB, 0.5219, 3.59, 0.160, 218, 106, INFERRED PRECURSOR (UCA) OF THE HUMAN ANTIBODY LINEAGE K03.12 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ H1 SOLOMON ISLANDS/03/2006
4181, 5vjoD, 0.5219, 3.78, 0.082, 209, 110, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4182, 5mthB, 0.5219, 3.65, 0.084, 211, 107, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACEGROUP P21 
4183, 5mp3A, 0.5219, 3.73, 0.094, 210, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 30-MER TAU PEPTIDE AT PH 6.5 
4184, 5mo3H, 0.5219, 3.73, 0.094, 210, 106, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 8.5 
4185, 5l0qB, 0.5219, 3.73, 0.094, 210, 106, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4186, 5k8aL, 0.5219, 3.56, 0.105, 113, 105, NIST FAB
4187, 5ijvL, 0.5219, 3.65, 0.123, 215, 106, CRYSTAL STRUCTURE OF BOVINE FAB E03
4188, 5d93F, 0.5219, 3.65, 0.123, 219, 106, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM A MOUSE QSOX1-SPECIFIC ANTIBODY
4189, 5d1zC, 0.5219, 3.53, 0.133, 211, 105, ISDB NEAT1 BOUND BY CLONE D4-10
4190, 4xmpH, 0.5219, 3.61, 0.094, 213, 106, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC08 IN COMPLEX WITH HIV-1 CLADE A STRAIN Q842.D12 GP120
4191, 4tvpD, 0.5219, 3.89, 0.063, 294, 111, CRYSTAL STRUCTURE OF THE HIV-1 BG505 SOSIP.664 ENV TRIMER ECTODOMAIN COMPRISING ATOMIC-LEVEL DEFINITION OF PRE-FUSION GP120 AND GP41 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22
4192, 4rfeF, 0.5219, 3.54, 0.152, 217, 105, CRYSTAL STRUCTURE OF ADCC-POTENT ANTI-HIV-1 RHESUS MACAQUE ANTIBODY JR4 FAB
4193, 4oawB, 0.5219, 3.64, 0.084, 213, 107, FAB STRUCTURE OF ANTI-HIV GP120 V2 MAB 2158
4194, 4nm8H, 0.5219, 3.67, 0.084, 211, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4195, 4nkdF, 0.5219, 3.82, 0.092, 218, 109, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4196, 4njaH, 0.5219, 3.52, 0.094, 111, 106, CRYSTAL STRUCTURE OF FAB 6C8 IN COMPLEX WITH MPTS
4197, 4kvpD, 0.5219, 3.63, 0.084, 214, 107, HUMAN P53 CORE DOMAIN MUTANT V157F
4198, 4kuzH, 0.5219, 3.63, 0.112, 219, 107, CRYSTAL STRUCTURE OF ANTI-EMMPRIN ANTIBODY 4A5 FAB IN TRIGONAL FORM
4199, 4k2uI, 0.5219, 3.84, 0.109, 220, 110, CRYSTAL STRUCTURE OF PFEBA-175 F1 IN COMPLEX WITH R218 ANTIBODY FAB FRAGMENT
4200, 4jhwL, 0.5219, 3.61, 0.104, 214, 106, CRYSTAL STRUCTURE OF RESPIRATORY SYNCYTIAL VIRUS FUSION GLYCOPROTEIN STABILIZED IN THE PREFUSION CONFORMATION BY HUMAN ANTIBODY D25
4201, 4j8rB, 0.5219, 3.62, 0.132, 218, 106, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
4202, 4i9wE, 0.5219, 3.82, 0.073, 210, 110, HUMAN TWO PORE DOMAIN K+ CHANNEL TRAAK (K2P4.1) - FAB COMPLEX STRUCTURE
4203, 4hkbG, 0.5219, 4.52, 0.043, 238, 115, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4204, 4hkbA, 0.5219, 4.52, 0.043, 238, 115, CH67 FAB (UNBOUND) FROM THE CH65-67 LINEAGE
4205, 4fqrf, 0.5219, 3.64, 0.075, 211, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4206, 4buhB, 0.5219, 3.57, 0.084, 226, 107, HUMAN IGE AGAINST THE MAJOR ALLERGEN BET V 1 - CRYSTAL STRUCTURE OF CLONE M0418 SCFV
4207, 3mlsH, 0.5219, 3.66, 0.083, 232, 108, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 MAB 2557 FAB IN COMPLEX WITH A HIV- 1 GP120 V3 MIMOTOPE
4208, 3mj9A, 0.5219, 3.67, 0.075, 206, 107, CRYSTAL STRUCTURE OF JAML IN COMPLEX WITH THE STIMULATORY ANTIBODY HL4E10
4209, 3m2lC, 0.5219, 3.71, 0.092, 222, 109, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4210, 3igaB, 0.5219, 3.61, 0.132, 219, 106, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LI+ AND K+
4211, 3h42L, 0.5219, 3.65, 0.121, 213, 107, CRYSTAL STRUCTURE OF PCSK9 IN COMPLEX WITH FAB FROM LDLR COMPETITIVE ANTIBODY
4212, 3bwuC, 0.5219, 3.51, 0.096, 110, 104, CRYSTAL STRUCTURE OF THE TERNARY COMPLEX OF FIMD (N-TERMINAL DOMAIN FIMDN) WITH FIMC AND THE N-TERMINALLY TRUNCATED PILUS SUBUNIT FIMF (FIMFT)
4213, 2xqyL, 0.5219, 3.62, 0.113, 214, 106, CRYSTAL STRUCTURE OF PSEUDORABIES CORE FRAGMENT OF GLYCOPROTEIN H IN COMPLEX WITH FAB D6.3
4214, 2x7lF, 0.5219, 3.73, 0.073, 235, 109, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4215, 2x7lB, 0.5219, 3.69, 0.103, 211, 107, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4216, 2vukB, 0.5219, 3.59, 0.160, 218, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL-MOLECULE DRUG PHIKAN083
4217, 2ht2F, 0.5219, 3.74, 0.083, 219, 109, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL Y445H MUTANT AND FAB COMPLEX
4218, 2e27L, 0.5219, 3.75, 0.083, 219, 109, CRYSTAL STRUCTURE OF FV FRAGMENT OF ANTI-CIGUATOXIN ANTIBODY COMPLEXED WITH ABC-RING OF CIGUATOXIN
4219, 1s3kL, 0.5219, 3.67, 0.131, 212, 107, CRYSTAL STRUCTURE OF A HUMANIZED FAB (HU3S193) IN COMPLEX WITH THE LEWIS Y TETRASACCHARIDE
4220, 1klfE, 0.5219, 3.51, 0.095, 213, 105, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
4221, 1k4dB, 0.5219, 3.38, 0.107, 213, 103, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF K+
4222, 1hzhK, 0.5219, 3.81, 0.073, 216, 110, CRYSTAL STRUCTURE OF THE INTACT HUMAN IGG B12 WITH BROAD AND POTENT ACTIVITY AGAINST PRIMARY HIV-1 ISOLATES: A TEMPLATE FOR HIV VACCINE DESIGN
4223, 1f8tL, 0.5219, 3.58, 0.075, 208, 106, FAB (LNKB-2) OF MONOCLONAL ANTIBODY CRYSTAL STRUCTURE
4224, 6mtpH, 0.5218, 3.80, 0.110, 231, 109, CRYSTAL STRUCTURE OF VRC42.04 FAB IN COMPLEX WITH GP41 PEPTIDE 
4225, 6hbkK, 0.5218, 4.00, 0.035, 242, 113, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4226, 6ev1C, 0.5218, 3.68, 0.132, 212, 106, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4227, 6cvbC, 0.5218, 3.84, 0.073, 236, 110, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 IN COMPLEX WITH 6 -SIALYL-N- ACETYLLACTOSAMINE 
4228, 5utzL, 0.5218, 3.81, 0.082, 215, 110, HUMAN IL-2/FAB COMPLEX 
4229, 5utzG, 0.5218, 3.66, 0.113, 115, 106, HUMAN IL-2/FAB COMPLEX 
4230, 5otjA, 0.5218, 3.87, 0.091, 221, 110, MONOMERIC POLCALCIN (PHL P 7) IN COMPLEX WITH TWO IDENTICAL ALLERGEN- SPECIFIC ANTIBODIES 
4231, 5o1hA, 0.5218, 3.93, 0.065, 194, 108, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB539 
4232, 5myoC, 0.5218, 3.87, 0.082, 220, 110, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 6 IN COMPLEX WITH HUMAN ABETA-PE3-12-PEGB
4233, 5hpmD, 0.5218, 3.81, 0.100, 214, 110, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4234, 5hi3D, 0.5218, 3.60, 0.094, 211, 106, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
4235, 5gznL, 0.5218, 3.71, 0.083, 220, 109, STRUCTURE OF NEUTRALIZING ANTIBODY BOUND TO ZIKA ENVELOPE PROTEIN
4236, 5fuzL, 0.5218, 3.87, 0.100, 211, 110, EXTENDING THE HALF-LIFE OF A FAB FRAGMENT THROUGH GENERATION OF A HUMANISED ANTI-HUMAN SERUM ALBUMIN (HSA) FV DOMAIN: AN INVESTIGATION INTO THE CORRELATION BETWEEN AFFINITY AND SERUM HALF-LIFE
4237, 5cjsL, 0.5218, 3.81, 0.073, 218, 110, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4238, 5a3iC, 0.5218, 3.79, 0.073, 220, 110, CRYSTAL STRUCTURE OF A COMPLEX FORMED BETWEEN FLD194 FAB AND TRANSMISSIBLE MUTANT H5 HAEMAGGLUTININ
4239, 4zptL, 0.5218, 3.66, 0.093, 213, 107, STRUCTURE OF MERS-CORONAVIRUS SPIKE RECEPTOR-BINDING DOMAIN (ENGLAND1 STRAIN) IN COMPLEX WITH VACCINE-ELICITED MURINE NEUTRALIZING ANTIBODY D12 (CRYSTAL FORM 1)
4240, 4yhoL, 0.5218, 3.57, 0.066, 231, 106, REVERSAL AGENT FOR DABIGATRAN
4241, 4nm8I, 0.5218, 3.83, 0.055, 226, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4242, 4nkdH, 0.5218, 4.04, 0.070, 229, 114, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4243, 4gw5D, 0.5218, 3.89, 0.063, 293, 111, CQYN MEDITOPE - CETUXIMAB FAB
4244, 4d9qE, 0.5218, 3.63, 0.112, 212, 107, INHIBITING ALTERNATIVE PATHWAY COMPLEMENT ACTIVATION BY TARGETING THE EXOSITE ON FACTOR D
4245, 4cniL, 0.5218, 3.66, 0.112, 214, 107, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4246, 4agoB, 0.5218, 2.97, 0.113, 200, 97, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN5174
4247, 3sddD, 0.5218, 3.59, 0.113, 218, 106, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-BETA-LACTOSYLCERAMIDE
4248, 3ru8H, 0.5218, 3.61, 0.104, 217, 106, STRUCTURE OF AN HIV EPITOPE SCAFFOLD IN COMPLEX WITH NEUTRALIZING ANTIBODY B12 FAB
4249, 3mnvC, 0.5218, 3.61, 0.104, 217, 106, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING HIV ANTIBODY 13H11 FAB FRAGMENT
4250, 3macH, 0.5218, 3.87, 0.046, 196, 108, CRYSTAL STRUCTURE OF GP41-DERIVED PROTEIN COMPLEXED WITH FAB 8062
4251, 3iy1A, 0.5218, 3.57, 0.133, 211, 105, VARIABLE DOMAINS OF THE WAM OF FAB B FITTED INTO THE CRYOEM RECONSTRUCTION OF THE VIRUS-FAB B COMPLEX
4252, 3gjeL, 0.5218, 3.43, 0.067, 107, 104, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4253, 3gjeA, 0.5218, 3.56, 0.160, 216, 106, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4254, 3ghbL, 0.5218, 3.05, 0.092, 205, 98, CRYSTAL STRUCTURE OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE W2RW020
4255, 3cm9D, 0.5218, 3.64, 0.112, 212, 107, SOLUTION STRUCTURE OF HUMAN SIGA2
4256, 3cm9C, 0.5218, 3.76, 0.073, 444, 109, SOLUTION STRUCTURE OF HUMAN SIGA2
4257, 3cm9B, 0.5218, 3.64, 0.132, 219, 106, SOLUTION STRUCTURE OF HUMAN SIGA2
4258, 3cm9A, 0.5218, 3.77, 0.073, 218, 109, SOLUTION STRUCTURE OF HUMAN SIGA2
4259, 2x7lI, 0.5218, 4.52, 0.043, 238, 115, IMPLICATIONS OF THE HIV-1 REV DIMER STRUCTURE AT 3.2A RESOLUTION FOR MULTIMERIC BINDING TO THE REV RESPONSE ELEMENT
4260, 2w0fB, 0.5218, 3.71, 0.081, 214, 111, POTASSIUM CHANNEL KCSA-FAB COMPLEX WITH TETRAOCTYLAMMONIUM
4261, 2pcpD, 0.5218, 4.51, 0.069, 237, 116, ANTIBODY FAB COMPLEXED WITH PHENCYCLIDINE
4262, 2nr6D, 0.5218, 3.71, 0.140, 215, 107, CRYSTAL STRUCTURE OF THE COMPLEX OF ANTIBODY AND THE ALLERGEN BLA G 2
4263, 2j6eL, 0.5218, 3.70, 0.140, 213, 107, CRYSTAL STRUCTURE OF AN AUTOIMMUNE COMPLEX BETWEEN A HUMAN IGM RHEUMATOID FACTOR AND IGG1 FC REVEALS A NOVEL FC EPITOPE AND EVIDENCE FOR AFFINITY MATURATION
4264, 2j21B, 0.5218, 3.69, 0.121, 213, 107, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-N268D-R282W
4265, 2ih3B, 0.5218, 3.86, 0.046, 196, 108, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
4266, 2hvkB, 0.5218, 3.64, 0.132, 219, 106, CRYSTAL STRUCTURE OF THE KCSA-FAB-TBA COMPLEX IN HIGH K+
4267, 2dweB, 0.5218, 3.82, 0.091, 214, 110, CRYSTAL STRUCTURE OF KCSA-FAB-TBA COMPLEX IN RB+
4268, 1xf4L, 0.5218, 3.63, 0.140, 213, 107, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4269, 1xctB, 0.5218, 3.70, 0.142, 213, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
4270, 1sy6H, 0.5218, 3.66, 0.093, 216, 107, CRYSTAL STRUCTURE OF CD3GAMMAEPSILON HETERODIMER IN COMPLEX WITH OKT3 FAB FRAGMENT
4271, 1otsF, 0.5218, 3.57, 0.123, 211, 106, STRUCTURE OF THE ESCHERICHIA COLI CLC CHLORIDE CHANNEL AND FAB COMPLEX
4272, 1lk3H, 0.5218, 3.80, 0.083, 226, 109, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4273, 1hu8B, 0.5218, 3.61, 0.085, 212, 106, CRYSTAL STRUCTURE OF THE MOUSE P53 CORE DNA-BINDING DOMAIN AT 2.7A RESOLUTION
4274, 6qnaD, 0.5217, 3.64, 0.123, 219, 106, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
4275, 6ev2G, 0.5217, 3.82, 0.082, 211, 110, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN IN COMPLEX WITH LAMINARIHEXAOSE 
4276, 6e9iD, 0.5217, 3.66, 0.113, 115, 106, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
4277, 6cbvL, 0.5217, 3.77, 0.092, 215, 109, CRYSTAL STRUCTURE OF BRIL BOUND TO AN AFFINITY MATURED SYNTHETIC ANTIBODY. 
4278, 6bb4N, 0.5217, 3.80, 0.083, 212, 109, FAB/EPITOPE COMPLEX OF MOUSE MONOCLONAL ANTIBODY C5.2 TARGETING A PHOSPHO-TAU EPITOPE. 
4279, 5xzcB, 0.5217, 3.67, 0.104, 214, 106, CRYO-EM STRUCTURE OF P300-P53 PROTEIN COMPLEX 
4280, 5wawL, 0.5217, 3.88, 0.046, 196, 108, FCABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY
4281, 5w4lD, 0.5217, 3.43, 0.038, 238, 105, CRYSTAL STRUCTURE OF THE NON-NEUTRALIZING AND ADCC-POTENT C11-LIKE ANTIBODY N12-I3 IN COMPLEX WITH HIV-1 CLADE A/E GP120 THE CD4 MIMETIC M48U1 AND THE ANTIBODY N5-I5.
4282, 5vzrH, 0.5217, 3.80, 0.073, 225, 109, CRYSTAL STRUCTURE OF MERS-COV NEUTRALIZING ANTIBODY G4 FAB
4283, 5udcC, 0.5217, 3.59, 0.123, 220, 106, CRYSTAL STRUCTURE OF RSV F A2 BOUND TO MEDI8897
4284, 5u6aA, 0.5217, 3.68, 0.074, 218, 108, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- PEG3-MEDITOPE
4285, 5mu0J, 0.5217, 3.45, 0.096, 107, 104, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4286, 5mhsD, 0.5217, 3.44, 0.096, 212, 104, T1L REOVIRUS SIGMA1 COMPLEXED WITH 5C6 FAB FRAGMENTS
4287, 5ibuG, 0.5217, 3.44, 0.096, 212, 104, FAB (UNBOUND)
4288, 5hi4D, 0.5217, 3.57, 0.096, 216, 104, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
4289, 5gz0A, 0.5217, 3.88, 0.073, 462, 110, CRYSTAL STRUCTURE OF FM329 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4290, 5fhcL, 0.5217, 3.88, 0.073, 462, 110, CRYSTAL STRUCTURE OF PROTECTIVE HUMAN ANTIBODIES 100 AND 114 IN COMPLEX WITH EBOLA VIRUS FUSION GLYCOPROTEIN (GP)
4291, 5ff6C, 0.5217, 3.88, 0.073, 462, 110, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4292, 5f96H, 0.5217, 3.88, 0.073, 462, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.12 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4293, 4z5rJ, 0.5217, 3.60, 0.104, 217, 106, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4294, 4ydlH, 0.5217, 3.65, 0.112, 212, 107, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY C38- VRC18.02 IN COMPLEX WITH HIV-1 CLADE AE STRAIN 93TH057GP120
4295, 4wfhE, 0.5217, 3.78, 0.102, 215, 108, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND NONCONDUCTIVE CONFORMATION
4296, 4nm4H, 0.5217, 3.82, 0.091, 213, 110, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4297, 4nkoE, 0.5217, 3.55, 0.113, 213, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4298, 4n90G, 0.5217, 3.91, 0.056, 188, 108, CRYSTAL STRUCTURE OF TERNARY COMPLEX OF TRAIL DR5 AND FAB FRAGMENT FROM A DR5 AGONIST ANTIBODY
4299, 4kq4H, 0.5217, 3.65, 0.103, 212, 107, CRYSTAL STRUCTURE OF ANTI-IL-17A ANTIBODY CNTO7357
4300, 4k3dM, 0.5217, 3.64, 0.112, 212, 107, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
4301, 4jpwH, 0.5217, 3.66, 0.103, 212, 107, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY 12A21 IN COMPLEX WITH HIV-1 STRAIN 93TH057 GP120 MUTANT
4302, 4j8rD, 0.5217, 3.67, 0.094, 213, 106, STRUCTURE OF AN OCTAPEPTIDE REPEAT OF THE PRION PROTEIN BOUND TO THE POM2 FAB ANTIBODY FRAGMENT
4303, 4ibzC, 0.5217, 3.82, 0.092, 218, 109, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4304, 4hdiL, 0.5217, 3.82, 0.091, 219, 110, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4305, 4fqrv, 0.5217, 3.54, 0.133, 211, 105, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4306, 4eneF, 0.5217, 3.87, 0.062, 219, 112, STRUCTURE OF THE N- AND C-TERMINAL TRIMMED CLC-EC1 CL-/H+ ANTIPORTER AND FAB COMPLEX
4307, 4aeiM, 0.5217, 3.89, 0.037, 186, 108, CRYSTAL STRUCTURE OF THE AAHII-FAB4C1 COMPLEX
4308, 3w11D, 0.5217, 3.44, 0.096, 211, 104, INSULIN RECEPTOR ECTODOMAIN CONSTRUCT COMPRISING DOMAINS L1-CR IN COMPLEX WITH HUMAN INSULIN ALPHA-CT PEPTIDE(704-719) AND FAB 83-7
4309, 3vgaC, 0.5217, 3.77, 0.080, 215, 112, CRYSTAL STRUCTURE OF HUMAN ADENOSINE A2A RECEPTOR WITH AN ALLOSTERIC INVERSE-AGONIST ANTIBODY AT 3.1 A RESOLUTION
4310, 3sdcD, 0.5217, 3.43, 0.135, 214, 104, CRYSTAL STRUCTURE OF AUTOREACTIVE-VALPHA14-VBETA6 NKT TCR IN COMPLEX WITH CD1D-GLOBOTRIHEXOSYLCERAMIDE
4311, 3qynC, 0.5217, 3.65, 0.084, 213, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING 2 BASE PAIR SPACER BETWEEN HALF SITES
4312, 3qnzA, 0.5217, 3.64, 0.131, 211, 107, ORTHORHOMBIC FORM OF IGG1 FAB FRAGMENT (IN COMPLEX WITH ANTIGENIC TUBULIN PEPTIDE) SHARING SAME FV AS IGA
4313, 3oz9H, 0.5217, 3.90, 0.065, 232, 108, CRYSTAL STRUCTURE OF ANTI-GP41 FAB NC-1
4314, 3mbxL, 0.5217, 3.66, 0.113, 218, 106, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY X836
4315, 3ldbB, 0.5217, 3.70, 0.093, 211, 107, STRUCTURE OF JMJD6 COMPLEXD WITH ALPHA-KETOGLUTARATE AND FAB FRAGMENT.
4316, 3kmdB, 0.5217, 3.83, 0.092, 217, 109, CRYSTAL STRUCTURE OF THE P53 CORE DOMAIN BOUND TO A FULL CONSENSUS SITE AS A SELF-ASSEMBLED TETRAMER
4317, 3j3pL, 0.5217, 3.60, 0.094, 211, 106, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4318, 3h0tA, 0.5217, 3.62, 0.085, 214, 106, HEPCIDIN-FAB COMPLEX
4319, 3e8uL, 0.5217, 3.67, 0.103, 217, 107, CRYSTAL STRUCTURE AND THERMODYNAMIC ANALYSIS OF DIAGNOSTIC FAB 106.3 COMPLEXED WITH BNP 5-13 (C10A) REVEAL BASIS OF SELECTIVE MOLECULAR RECOGNITION
4320, 3c09L, 0.5217, 3.64, 0.094, 214, 106, CRYSTAL STRUCTURE THE FAB FRAGMENT OF MATUZUMAB (FAB72000) IN COMPLEX WITH DOMAIN III OF THE EXTRACELLULAR REGION OF EGFR
4321, 3anzY, 0.5217, 3.78, 0.083, 225, 109, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4322, 2w9lJ, 0.5217, 3.63, 0.140, 213, 107, CANINE ADENOVIRUS TYPE 2 FIBRE HEAD IN COMPLEX WITH CAR DOMAIN D1 AND SIALIC ACID
4323, 2vxsN, 0.5217, 3.61, 0.094, 213, 106, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
4324, 2nz9C, 0.5217, 3.66, 0.075, 211, 106, CRYSTAL STRUCTURE OF BOTULINUM NEUROTOXIN TYPE A COMPLEXED WITH MONOCLONAL ANTIBODY AR2
4325, 2fjfW, 0.5217, 3.64, 0.093, 213, 107, STRUCTURE OF THE G6 FAB A PHAGE DERIVED VEGF BINDING FAB
4326, 1tzgL, 0.5217, 3.86, 0.073, 220, 110, CRYSTAL STRUCTURE OF HIV-1 NEUTRALIZING HUMAN FAB 4E10 IN COMPLEX WITH A 13-RESIDUE PEPTIDE CONTAINING THE 4E10 EPITOPE ON GP41
4327, 1tetL, 0.5217, 3.60, 0.085, 217, 106, CRYSTAL STRUCTURE OF AN ANTICHOLERA TOXIN PEPTIDE COMPLEX AT 2.3 ANGSTROMS
4328, 1pkqF, 0.5217, 3.80, 0.101, 223, 109, MYELIN OLIGODENDROCYTE GLYCOPROTEIN-(8-18C5) FAB-COMPLEX
4329, 1mcrA, 0.5217, 3.88, 0.100, 211, 110, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4330, 1igfM, 0.5217, 3.80, 0.091, 219, 110, CRYSTAL STRUCTURES OF AN ANTIBODY TO A PEPTIDE AND ITS COMPLEX WITH PEPTIDE ANTIGEN AT 2.8 ANGSTROMS
4331, 1dclA, 0.5217, 3.66, 0.104, 115, 106, MCG A LAMBDA V TYPE LIGHT-CHAIN DIMER (BENCE-JONES PROTEIN) CRYSTALLIZED FROM AMMONIUM SULFATE
4332, 1cf8L, 0.5217, 3.64, 0.094, 214, 106, CONVERGENCE OF CATALYTIC ANTIBODY AND TERPENE CYCLASE MECHANISMS: POLYENE CYCLIZATION DIRECTED BY CARBOCATION-PI INTERACTIONS
4333, 1ad9H, 0.5217, 3.87, 0.090, 225, 111, IGG-FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY CTM01
4334, 1ad0C, 0.5217, 3.38, 0.087, 213, 103, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
4335, 6hbkc, 0.5216, 3.74, 0.083, 223, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4336, 6hbkT, 0.5216, 3.70, 0.083, 220, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4337, 6hbkN, 0.5216, 3.90, 0.065, 192, 108, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4338, 6fxnO, 0.5216, 3.58, 0.143, 219, 105, CRYSTAL STRUCTURE OF HUMAN BAFF IN COMPLEX WITH FAB FRAGMENT OF ANTI- BAFF ANTIBODY BELIMUMAB
4339, 6fbjH, 0.5216, 3.65, 0.084, 213, 107, MONOCLONAL ANTIBODY TARGETING MATRIX METALLOPROTEINASE 7 
4340, 6ehwB, 0.5216, 3.54, 0.133, 211, 105, SCFV ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION MAKING IN DRUG DISCOVERY
4341, 6crrC, 0.5216, 3.67, 0.132, 217, 106, CRYOEM STRUCTURE OF HUMAN ENTEROVIRUS D68 FULL NATIVE VIRION (PH 7.2 AND 4 DEGREES CELSIUS) 
4342, 6bzvD, 0.5216, 3.54, 0.152, 114, 105, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE GL PRECURSOR OF THE BROADLY NEUTRALIZING ANTIBODY 19B3 
4343, 6bahA, 0.5216, 3.86, 0.091, 220, 110, TRASTUZUMAB FAB V3 WITH 5-DIPHENYL MEDITOPE VARIANT 
4344, 6b5lL, 0.5216, 3.51, 0.105, 239, 105, STRUCTURE OF PFCSP PEPTIDE 20 WITH HUMAN PROTECTIVE ANTIBODY CIS43
4345, 6azxD, 0.5216, 3.96, 0.083, 196, 109, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 663 ANTIBODY
4346, 6arpA, 0.5216, 3.64, 0.104, 219, 106, STRUCTURE OF A MUTANT CETUXIMAB FAB FRAGMENT 
4347, 5y9cH, 0.5216, 3.83, 0.073, 219, 110, CRYSTAL STRUCTURE OF HPV58 PENTAMER IN COMPLEX WITH THE FAB FRAGMENT OF ANTIBODY A12A3
4348, 5xbmE, 0.5216, 3.61, 0.151, 220, 106, STRUCTURE OF SCARB2-JL2 COMPLEX 
4349, 5w23L, 0.5216, 3.55, 0.181, 217, 105, CRYSTAL STRUCTURE OF RSV F IN COMPLEX WITH 5C4 FAB
4350, 5njdW, 0.5216, 3.90, 0.065, 200, 108, STRUCTURE OF INTERLEUKIN 23 IN COMPLEX WITH BRIAKINUMAB FAB
4351, 5n2kI, 0.5216, 3.62, 0.143, 219, 105, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4352, 5mu0F, 0.5216, 3.88, 0.119, 216, 109, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4353, 5i71C, 0.5216, 3.65, 0.112, 216, 107, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH S-CITALOPRAM AT THE CENTRAL SITE
4354, 5i6xC, 0.5216, 3.50, 0.076, 211, 105, X-RAY STRUCTURE OF THE TS3 HUMAN SEROTONIN TRANSPORTER COMPLEXED WITH PAROXETINE AT THE CENTRAL SITE
4355, 5hyqC, 0.5216, 3.89, 0.063, 294, 111, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4356, 5f9oH, 0.5216, 3.96, 0.090, 123, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING VH1-46 GERMLINE-DERIVED CD4- BINDING SITE-DIRECTED ANTIBODY CH235.09 IN COMPLEX WITH HIV-1 CLADE A/E 93TH057 GP120
4357, 5e2wL, 0.5216, 3.69, 0.150, 213, 107, ANTI-TAU AT8 FAB WITH TRIPLY PHOSPHORYLATED TAU PEPTIDE
4358, 5c0nL, 0.5216, 3.58, 0.113, 216, 106, DEVELOPMENT OF A MONOCLONAL ANTIBODY TARGETING SECRETED AP2 TO TREAT DIABETES AND FATTY LIVER DISEASE
4359, 5b6fG, 0.5216, 3.64, 0.084, 211, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
4360, 4z5rP, 0.5216, 3.78, 0.093, 214, 108, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4361, 4xmkL, 0.5216, 3.63, 0.142, 216, 106, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
4362, 4wv1A, 0.5216, 3.61, 0.113, 216, 106, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
4363, 4w2pA, 0.5216, 3.47, 0.107, 216, 103, ANTI-MARBURGVIRUS NUCLEOPROTEIN SINGLE DOMAIN ANTIBODY C
4364, 4rftM, 0.5216, 3.64, 0.113, 219, 106, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4365, 4nztL, 0.5216, 3.76, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE ANTIBODY-BINDING REGION OF PROTEIN M (PROTEIN M TD) IN COMPLEX WITH ANTI-INFLEUNZA HEMAGGLUTININ ANTIBODY CR9114 FAB
4366, 4hdiA, 0.5216, 3.65, 0.123, 215, 106, CRYSTAL STRUCTURE OF 3E5 IGG3 FAB FROM MUS MUSCULUS
4367, 4gmsL, 0.5216, 3.81, 0.082, 219, 110, CRYSTAL STRUCTURE OF HETEROSUBTYPIC FAB S139/1 IN COMPLEX WITH INFLUENZA A H3 HEMAGGLUTININ
4368, 4fqrx, 0.5216, 3.51, 0.076, 213, 105, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4369, 4fqrt, 0.5216, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4370, 3v6fL, 0.5216, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4371, 3uzeA, 0.5216, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 3 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
4372, 3m2lE, 0.5216, 3.89, 0.063, 215, 111, CRYSTAL STRUCTURE OF THE M113F MUTANT OF ALPHA-HEMOLYSIN
4373, 3ijhA, 0.5216, 3.78, 0.081, 214, 111, STRUCTURE OF S67-27 IN COMPLEX WITH KO
4374, 2p7tB, 0.5216, 3.61, 0.104, 237, 106, CRYSTAL STRUCTURE OF KCSA MUTANT
4375, 2ih1B, 0.5216, 4.42, 0.070, 238, 115, ION SELECTIVITY IN A SEMI-SYNTHETIC K+ CHANNEL LOCKED IN THE CONDUCTIVE CONFORMATION
4376, 2hlfF, 0.5216, 3.59, 0.113, 215, 106, STRUCTURE OF THE ESCHERICHIS COLI CLC CHLORIDE CHANNEL Y445E MUTANT AND FAB COMPLEX
4377, 2h1lM, 0.5216, 3.63, 0.094, 214, 106, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4378, 2fjgL, 0.5216, 3.61, 0.113, 218, 106, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4379, 1yeeH, 0.5216, 3.61, 0.113, 215, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
4380, 1xf5C, 0.5216, 3.59, 0.085, 213, 106, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4381, 1p7kB, 0.5216, 3.79, 0.092, 210, 109, CRYSTAL STRUCTURE OF AN ANTI-SSDNA ANTIGEN-BINDING FRAGMENT (FAB) BOUND TO 4-(2-HYDROXYETHYL)PIPERAZINE-1-ETHANESULFONIC ACID (HEPES)
4382, 1mjjL, 0.5216, 3.82, 0.081, 221, 111, HIGH RESOLUTION CRYSTAL STRUCTURE OF THE COMPLEX OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS6-12 AND A TRANSITION- STATE ANALOG
4383, 1ad0A, 0.5216, 3.53, 0.133, 216, 105, FAB FRAGMENT OF ENGINEERED HUMAN MONOCLONAL ANTIBODY A5B7
4384, 6qnaL, 0.5215, 3.45, 0.086, 214, 105, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
4385, 6qnaF, 0.5215, 3.49, 0.095, 214, 105, STRUCTURE OF BOVINE ANTI-RSV HYBRID FAB B13HC-B4LC 
4386, 6m87L, 0.5215, 3.67, 0.103, 216, 107, FAB 10A6 IN COMPLEX WITH MPTS 
4387, 6idlN, 0.5215, 3.68, 0.103, 214, 107, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS II PARTICLE) 
4388, 6idlJ, 0.5215, 3.67, 0.103, 214, 107, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS II PARTICLE) 
4389, 6idkN, 0.5215, 3.64, 0.084, 213, 107, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS I PARTICLE) 
4390, 6idkL, 0.5215, 3.87, 0.055, 220, 110, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS I PARTICLE) 
4391, 6idkJ, 0.5215, 3.67, 0.104, 216, 106, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 5.0 (CLASS I PARTICLE) 
4392, 6idiN, 0.5215, 3.57, 0.114, 216, 105, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 8.0. 
4393, 6idiL, 0.5215, 3.66, 0.113, 217, 106, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 8.0. 
4394, 6idiJ, 0.5215, 3.60, 0.094, 217, 106, CRYO-EM STRUCTURE OF IMMATURE DENGUE VIRUS SEROTYPE 3 IN COMPLEX WITH HUMAN ANTIBODY 1H10 FAB AT PH 8.0. 
4395, 6hhtYA, 0.5215, 3.60, 0.094, 215, 106, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4396, 6hhtX, 0.5215, 3.64, 0.113, 214, 106, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4397, 6hhtWB, 0.5215, 3.78, 0.045, 126, 110, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4398, 6hhtVA, 0.5215, 4.21, 0.055, 163, 109, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4399, 6hhtU, 0.5215, 3.51, 0.096, 212, 104, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4400, 6hhtTB, 0.5215, 3.62, 0.132, 217, 106, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4401, 6hhtSA, 0.5215, 3.61, 0.123, 211, 106, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4402, 6hhtR, 0.5215, 3.66, 0.093, 213, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4403, 6hhtQB, 0.5215, 3.66, 0.084, 213, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4404, 6hhtPA, 0.5215, 3.59, 0.152, 219, 105, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4405, 6hhtO, 0.5215, 3.69, 0.084, 229, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4406, 6hhtNB, 0.5215, 3.89, 0.063, 293, 111, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4407, 6hhtMA, 0.5215, 3.59, 0.142, 217, 106, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4408, 6hhtL, 0.5215, 3.65, 0.103, 212, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4409, 6hhtKB, 0.5215, 3.64, 0.112, 212, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4410, 6hhtJA, 0.5215, 3.55, 0.133, 211, 105, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4411, 6hhtI, 0.5215, 3.90, 0.065, 199, 108, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4412, 6hhtHB, 0.5215, 3.67, 0.084, 211, 107, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4413, 6hhtGA, 0.5215, 3.82, 0.091, 222, 110, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4414, 6hhtF, 0.5215, 3.56, 0.143, 220, 105, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4415, 6hhtEB, 0.5215, 3.83, 0.091, 217, 110, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4416, 6hhtDA, 0.5215, 3.58, 0.133, 216, 105, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4417, 6hhtC, 0.5215, 3.51, 0.076, 213, 105, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4418, 6hhtBB, 0.5215, 3.44, 0.096, 211, 104, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4419, 6hhtAA, 0.5215, 3.45, 0.096, 211, 104, struct.pdbx_descriptor               Echovirus 18 capsid protein 1; Echovirus 18 capsid protein 2; Echovirus 18 capsid protein 3  
4420, 6hblr, 0.5215, 3.78, 0.083, 215, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4421, 6hblo, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4422, 6hbll, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4423, 6hbli, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4424, 6hblf, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4425, 6hblc, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4426, 6hblZ, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4427, 6hblW, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4428, 6hblT, 0.5215, 3.58, 0.117, 111, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4429, 6hblQ, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4430, 6hblN, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4431, 6hblK, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4432, 6hblH, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4433, 6hblE, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4434, 6hblB, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 OPEN PARTICLE WITHOUT THREE PENTAMERS 
4435, 6hbhB, 0.5215, 4.54, 0.043, 238, 115, ECHOVIRUS 18 A-PARTICLE 
4436, 6ev1G, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4437, 6cnjK, 0.5215, 4.54, 0.043, 238, 115, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4438, 6ch9D, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF A NATIVELY-GLYCOSYLATED B41 SOSIP.664 HIV-1 ENVELOPE TRIMER IN COMPLEX WITH THE BROADLY-NEUTRALIZING ANTIBODIES BG18 AND 35O22 
4439, 6cezL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF RABBIT ANTI-HIV-1 GP120 V2 FAB 16C2 IN COMPLEX WITH V2 PEPTIDE CONB 
4440, 5vicL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z004 BOUND TO DENV-1 ENVELOPE PROTEIN DIII
4441, 5u7oD, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF HIV-1 BG505 SOSIP.664 PREFUSION ENV TRIMER BOUND TO SMALL MOLECULE HIV-1 ENTRY INHIBITOR BMS-626529 IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 3.8 ANGSTROM
4442, 5tq0H, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF AMINO TERMINAL DOMAINS OF THE NMDA RECEPTOR SUBUNIT GLUN1 AND GLUN2A IN THE PRESENCE OF EDTA
4443, 5t0yI, 0.5215, 4.54, 0.043, 238, 115, 2A10 ANTIBODY FAB FRAGMENT
4444, 5o1dA, 0.5215, 4.54, 0.043, 238, 115, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB481 
4445, 5iieL, 0.5215, 4.54, 0.043, 238, 115, STRUCTURE OF THE UNLIGANDED ANTI-HIV ANTIBODY DH501 THAT BINDS GP120 V3 GLYCAN AND THE BASE OF V3
4446, 5i2iD, 0.5215, 4.54, 0.043, 238, 115, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4447, 5i1dL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV3-23/IGKV4-1
4448, 5ff6D, 0.5215, 4.54, 0.043, 238, 115, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4449, 5esvB, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CH03 ISOLATED FROM DONOR CH0219 IN COMPLEX WITH SCAFFOLDED TRIMERIC HIV-1 ENV V1V2 DOMAIN FROM THE CLADE C SUPERINFECTING STRAIN OF DONOR CAP256.
4450, 5aomA, 0.5215, 4.54, 0.043, 238, 115, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE PHIKAN883
4451, 4z5rT, 0.5215, 4.54, 0.043, 238, 115, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4452, 4z5rR, 0.5215, 4.54, 0.043, 238, 115, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4453, 4z5rA, 0.5215, 4.54, 0.043, 238, 115, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4454, 4xmkM, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
4455, 4xcnA, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDIC ACID (06:0 PA); 2.9 A RESOLUTION
4456, 4rirL, 0.5215, 4.54, 0.043, 238, 115, STRUCTURAL ANALYSIS OF THE UNMUTATED ANCESTOR OF THE HIV-1 ENVELOPE V2 REGION ANTIBODY CH58 ISOLATED FROM AN RV144 HIV-1 VACCINE EFFICACY TRIAL VACCINEE AND ASSOCIATED WITH DECREASED TRANSMISSION RISK
4457, 4rftV, 0.5215, 4.54, 0.043, 238, 115, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4458, 4rftB, 0.5215, 4.54, 0.043, 238, 115, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4459, 4qexM, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4460, 4qexL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF PFEBA-175 RII IN COMPLEX WITH A FAB FRAGMENT FROM INHIBITORY ANTIBODY R217
4461, 4okvB, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4462, 4mhhK, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/VIET NAM/1203/2004 (H5N1)
4463, 4m6oL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF ANTI-NGF ANTIBODY CNTO7309
4464, 4hlzL, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF FAB C179 IN COMPLEX WITH A H2N2 INFLUENZA VIRUS HEMAGGLUTININ
4465, 4cniB, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF THE FAB PORTION OF OLOKIZUMAB IN COMPLEX WITH IL-6
4466, 3u0tD, 0.5215, 4.54, 0.043, 238, 115, FAB-ANTIBODY COMPLEX
4467, 3tt3L, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF LEUT IN THE INWARD-OPEN CONFORMATION IN COMPLEX WITH FAB
4468, 3ls4L, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT IN COMPLEX WITH THC
4469, 3ietC, 0.5215, 4.54, 0.043, 238, 115, CRYSTAL STRUCTURE OF 237MAB WITH ANTIGEN
4470, 3hc0H, 0.5215, 3.66, 0.082, 211, 110, BHA10 IGG1 WILD-TYPE FAB - ANTIBODY DIRECTED AT HUMAN LTBR
4471, 2w60A, 0.5215, 3.90, 0.064, 218, 109, ANTI CITRULLINATED COLLAGEN TYPE 2 ANTIBODY ACC4
4472, 2r8sL, 0.5215, 3.94, 0.036, 236, 112, HIGH RESOLUTION STRUCTURE OF A SPECIFIC SYNTHETIC FAB BOUND TO P4-P6 RNA RIBOZYME DOMAIN
4473, 2a6dH, 0.5215, 3.61, 0.094, 212, 106, CRYSTAL STRUCTURE ANALYSIS OF THE ANTI-ARSONATE GERMLINE ANTIBODY 36-65 IN COMPLEX WITH A PHAGE DISPLAY DERIVED DODECAPEPTIDE RLLIADPPSPRE
4474, 1yeeL, 0.5215, 3.66, 0.085, 211, 106, STRUCTURE OF A CATALYTIC ANTIBODY IGG2A FAB FRAGMENT (D2.5)
4475, 1wcbL, 0.5215, 3.89, 0.036, 242, 112, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4476, 1r3kA, 0.5215, 3.77, 0.101, 212, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN LOW CONCENTRATION OF TL+
4477, 1r3jA, 0.5215, 3.76, 0.092, 217, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF TL+
4478, 1q9oA, 0.5215, 3.89, 0.056, 197, 108, S45-18 FAB UNLIGANDED
4479, 1pskH, 0.5215, 3.57, 0.095, 211, 105, THE CRYSTAL STRUCTURE OF AN FAB FRAGMENT THAT BINDS TO THE MELANOMA-ASSOCIATED GD2 GANGLIOSIDE
4480, 1nd0C, 0.5215, 3.83, 0.100, 216, 110, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4481, 1n64L, 0.5215, 3.59, 0.113, 220, 106, CRYSTAL STRUCTURE ANALYSIS OF THE IMMUNODOMINANT ANTIGENIC SITE ON HEPATITIS C VIRUS PROTEIN BOUND TO MAB 19D9D6
4482, 1lk3L, 0.5215, 3.83, 0.091, 214, 110, ENGINEERED HUMAN INTERLEUKIN-10 MONOMER COMPLEXED TO 9D7 FAB FRAGMENT
4483, 1klfA, 0.5215, 3.76, 0.075, 213, 106, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
4484, 1i7zC, 0.5215, 3.89, 0.056, 195, 108, ANTIBODY GNC92H2 BOUND TO LIGAND
4485, 1cd0A, 0.5215, 3.60, 0.085, 217, 106, STRUCTURE OF HUMAN LAMDA-6 LIGHT CHAIN DIMER JTO
4486, 6anaL, 0.5214, 3.60, 0.085, 217, 106, LL2 FAB IN COMPLEX WITH ANTI-KAPPA VHH DOMAIN
4487, 5vgjL, 0.5214, 3.60, 0.094, 217, 106, CRYSTAL STRUCTURE OF THE HUMAN FAB VRC38.01 AN HIV-1 V1V2-DIRECTED NEUTRALIZING ANTIBODY ISOLATED FROM DONOR N90 BOUND TO A SCAFFOLDED WITO V1V2 DOMAIN
4488, 5u5mA, 0.5214, 3.60, 0.094, 215, 106, CRYSTAL STRUCTURE OF I83E MEDITOPE-ENABLED TRASTUZUMAB WITH AZIDO- MEDITOPE
4489, 5u5fA, 0.5214, 3.84, 0.082, 227, 110, MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT IN COMPLEX WITH (AC) CQFDA(PH)2STRRLRCGGSK
4490, 5u3dA, 0.5214, 3.73, 0.120, 214, 108, STRUCTURE OF MEDITOPE ENABLED TRASTUZUMAB I83E VARIANT
4491, 5th2B, 0.5214, 4.18, 0.055, 163, 109, CETUXIMAB FAB IN COMPLEX WITH L5Q MEDITOPE VARIANT
4492, 5t1lC, 0.5214, 4.20, 0.055, 163, 109, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4493, 5mv4J, 0.5214, 3.59, 0.113, 213, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4494, 5mu0D, 0.5214, 3.59, 0.113, 212, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (IA03)
4495, 5l88H, 0.5214, 3.65, 0.142, 218, 106, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM I NON-PARSIMONIOUS MODEL
4496, 5id1B, 0.5214, 3.59, 0.113, 217, 106, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4497, 5i76A, 0.5214, 3.59, 0.094, 214, 106, CRYSTAL STRUCTURE OF FM318 A RECOMBINANT FAB ADOPTED FROM CETUXIMAB
4498, 5hi5D, 0.5214, 3.69, 0.094, 205, 106, BINDING SITE ELUCIDATION AND STRUCTURE GUIDED DESIGN OF MACROCYCLIC IL-17A ANTAGONISTS
4499, 5f6hL, 0.5214, 3.67, 0.104, 214, 106, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
4500, 5cjsH, 0.5214, 3.75, 0.073, 207, 109, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4501, 4ygvF, 0.5214, 3.56, 0.113, 216, 106, REVERSAL AGENT FOR DABIGATRAN
4502, 4xcyH, 0.5214, 3.67, 0.113, 215, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4503, 4xcyG, 0.5214, 3.58, 0.133, 217, 105, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH PHOSPHATIDYLGLYCEROL (06:0 PG)
4504, 4xakH, 0.5214, 3.74, 0.073, 213, 109, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY M336 IN COMPLEX WITH MERS CO-V RBD
4505, 4wffE, 0.5214, 3.76, 0.110, 217, 109, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND NONCONDUCTIVE CONFORMATION
4506, 4rfts, 0.5214, 3.59, 0.085, 214, 106, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4507, 4pb0L, 0.5214, 3.84, 0.082, 218, 110, STRUCTURE OF THE FAB FRAGMENT OF THE ANTI-FRANCISELLA TULARENSIS GROEL ANTIBODY AB53
4508, 4l5fH, 0.5214, 3.69, 0.140, 219, 107, CRYSTAL STRUCTURE OF DENV1-E106 FAB BOUND TO DENV-1 ENVELOPE PROTEIN DIII
4509, 4kxzN, 0.5214, 3.56, 0.086, 213, 105, CRYSTAL STRUCTURE OF TGFB2 IN COMPLEX WITH GC2008.
4510, 4kvpC, 0.5214, 3.66, 0.103, 212, 107, HUMAN P53 CORE DOMAIN MUTANT V157F
4511, 4jdtH, 0.5214, 3.65, 0.112, 212, 107, CRYSTAL STRUCTURE OF CHIMERIC GERM-LINE PRECURSOR OF NIH45-46 FAB IN COMPLEX WITH GP120 OF 93TH057 HIV-1
4512, 4ibzD, 0.5214, 3.56, 0.152, 219, 105, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4513, 4g80D, 0.5214, 3.82, 0.118, 198, 110, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4514, 4fqrn, 0.5214, 3.72, 0.121, 219, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4515, 4cadB, 0.5214, 3.69, 0.150, 220, 107, MECHANISM OF FARNESYLATED CAAX PROTEIN PROCESSING BY THE INTEGRAL MEMBRANE PROTEASE RCE1
4516, 3uo1L, 0.5214, 3.56, 0.162, 210, 105, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4517, 3u0tC, 0.5214, 2.93, 0.093, 205, 97, FAB-ANTIBODY COMPLEX
4518, 3rvtC, 0.5214, 3.58, 0.123, 219, 106, STRUCTURE OF 4C1 FAB IN P212121 SPACE GROUP
4519, 3qhzL, 0.5214, 3.63, 0.132, 111, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-INFLUENZA FAB 2D1
4520, 3opzN, 0.5214, 3.55, 0.124, 217, 105, CRYSTAL STRUCTURE OF TRANS-SIALIDASE IN COMPLEX WITH THE FAB FRAGMENT OF A NEUTRALIZING MONOCLONAL IGG ANTIBODY
4521, 3fb8B, 0.5214, 3.65, 0.104, 217, 106, KCSA POTASSIUM CHANNEL IN THE OPEN-CONDUCTIVE STATE WITH 20 A OPENING AT T112 IN THE PRESENCE OF RB+ ION
4522, 3fb6B, 0.5214, 3.63, 0.094, 214, 106, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 16 A OPENING AT T112
4523, 3f7yB, 0.5214, 3.64, 0.094, 214, 106, KCSA POTASSIUM CHANNEL IN THE PARTIALLY OPEN STATE WITH 17 A OPENING AT T112
4524, 3f5wB, 0.5214, 3.61, 0.085, 214, 106, KCSA POTASSIUM CHANNEL IN THE OPEN-INACTIVATED STATE WITH 32 A OPENING AT T112
4525, 3chnD, 0.5214, 3.82, 0.091, 216, 110, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4526, 3chnA, 0.5214, 3.65, 0.084, 213, 107, SOLUTION STRUCTURE OF HUMAN SECRETORY IGA1
4527, 2qtjC, 0.5214, 3.67, 0.103, 218, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4528, 2qtjA, 0.5214, 3.68, 0.112, 217, 107, SOLUTION STRUCTURE OF HUMAN DIMERIC IMMUNOGLOBULIN A
4529, 2qr0E, 0.5214, 3.85, 0.091, 217, 110, STRUCTURE OF VEGF COMPLEXED TO A FAB CONTAINING TYR AND SER IN THE CDRS
4530, 2q76C, 0.5214, 3.84, 0.091, 214, 110, MOUSE ANTI-HEN EGG WHITE LYSOZYME ANTIBODY F10.6.6 FAB FRAGMENT
4531, 2j1kX, 0.5214, 3.61, 0.094, 213, 106, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
4532, 2j1kJ, 0.5214, 3.63, 0.140, 213, 107, CAV-2 FIBRE HEAD IN COMPLEX WITH CAR D1
4533, 2esgA, 0.5214, 3.50, 0.077, 212, 104, SOLUTION STRUCTURE OF THE COMPLEX BETWEEN IMMUNOGLOBULIN IGA1 AND HUMAN SERUM ALBUMIN
4534, 2atkB, 0.5214, 3.82, 0.073, 217, 110, STRUCTURE OF A MUTANT KCSA K+ CHANNEL
4535, 1zwiB, 0.5214, 3.85, 0.100, 220, 110, STRUCTURE OF MUTANT KCSA POTASSIUM CHANNEL
4536, 1q9kA, 0.5214, 3.75, 0.083, 224, 109, S25-2 FAB UNLIGANDED 1
4537, 1q1jM, 0.5214, 3.76, 0.083, 216, 109, CRYSTAL STRUCTURE ANALYSIS OF ANTI-HIV-1 FAB 447-52D IN COMPLEX WITH V3 PEPTIDE
4538, 1pg7Z, 0.5214, 3.89, 0.072, 227, 111, MURINE 6A6 FAB IN COMPLEX WITH HUMANIZED ANTI-TISSUE FACTOR D3H44 FAB
4539, 1nccH, 0.5214, 3.88, 0.100, 211, 110, CRYSTAL STRUCTURES OF TWO MUTANT NEURAMINIDASE-ANTIBODY COMPLEXES WITH AMINO ACID SUBSTITUTIONS IN THE INTERFACE
4540, 1lmkA, 0.5214, 4.21, 0.055, 163, 109, THE STRUCTURE OF A BIVALENT DIABODY
4541, 1ktrH, 0.5214, 3.65, 0.132, 216, 106, CRYSTAL STRUCTURE OF THE ANTI-HIS TAG ANTIBODY 3D5 SINGLE- CHAIN FRAGMENT (SCFV) IN COMPLEX WITH A OLIGOHISTIDINE PEPTIDE
4542, 1klfC, 0.5214, 3.89, 0.089, 218, 112, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
4543, 1k4cB, 0.5214, 3.80, 0.073, 223, 109, POTASSIUM CHANNEL KCSA-FAB COMPLEX IN HIGH CONCENTRATION OF K+
4544, 1igaA, 0.5214, 3.90, 0.065, 195, 108, MODEL OF HUMAN IGA1 DETERMINED BY SOLUTION SCATTERING CURVE- FITTING AND HOMOLOGY MODELLING
4545, 6df2A, 0.5213, 3.82, 0.092, 209, 109, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
4546, 6cxcX, 0.5213, 3.89, 0.056, 192, 108, 3.9A CRYO-EM STRUCTURE OF MURINE ANTIBODY BOUND AT A NOVEL EPITOPE OF RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN 
4547, 6cxcI, 0.5213, 3.61, 0.075, 211, 106, 3.9A CRYO-EM STRUCTURE OF MURINE ANTIBODY BOUND AT A NOVEL EPITOPE OF RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN 
4548, 6cxcG, 0.5213, 3.66, 0.093, 213, 107, 3.9A CRYO-EM STRUCTURE OF MURINE ANTIBODY BOUND AT A NOVEL EPITOPE OF RESPIRATORY SYNCYTIAL VIRUS FUSION PROTEIN 
4549, 6cphE, 0.5213, 3.75, 0.072, 221, 111, CRYSTAL STRUCTURE OF A TCR 
4550, 5ziaG, 0.5213, 3.66, 0.123, 218, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
4551, 5vjoB, 0.5213, 3.69, 0.113, 219, 106, COMPLEX BETWEEN HYHEL10 FAB FRAGMENT HEAVY CHAIN MUTANT I29F AND PEKIN DUCK EGG LYSOZYME ISOFORM I (DEL-I) 
4552, 5vcoA, 0.5213, 3.62, 0.132, 213, 106, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4553, 5ob5L, 0.5213, 3.51, 0.106, 216, 104, FAB COMPLEX WITH GROBETA. ABVANCE: INCREASING OUR KNOWLEDGE OF ANTIBODY STRUCTURAL SPACE TO ENABLE FASTER AND BETTER DECISION-MAKING IN ANTIBODY DRUG DISCOVERY.
4554, 5nh3L, 0.5213, 3.49, 0.143, 212, 105, CRYSTAL STRUCTURE OF THE ACTIVIN RECEPTOR TYPE-2A LIGAND BINDING DOMAIN IN COMPLEX WITH BIMAGRUMAB FV
4555, 5mv4V, 0.5213, 3.64, 0.112, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4556, 5mu2H, 0.5213, 3.64, 0.112, 212, 107, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4557, 5l9dH, 0.5213, 3.64, 0.112, 212, 107, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM I PARSIMONIOUS MODEL
4558, 5itfD, 0.5213, 3.64, 0.112, 212, 107, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4559, 5itfC, 0.5213, 3.75, 0.073, 475, 109, CETUXIMAB FAB IN COMPLEX WITH 2-BROMOPHENYLALANINE MEDITOPE VARIANT
4560, 5iczB, 0.5213, 3.75, 0.073, 475, 109, CETUXIMAB FAB IN COMPLEX WITH GQFDLSTRRLKG PEPTIDE
4561, 5i15H, 0.5213, 3.75, 0.073, 475, 109, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV1-39
4562, 5hpmB, 0.5213, 3.75, 0.073, 475, 109, CETUXIMAB FAB IN COMPLEX WITH CYCLIC LINKED MEDITOPE
4563, 5cipL, 0.5213, 3.64, 0.075, 213, 107, CRYSTAL STRUCTURE OF UNBOUND 4E10
4564, 5anmD, 0.5213, 3.60, 0.113, 212, 106, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4565, 4z5rV, 0.5213, 4.03, 0.080, 123, 112, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4566, 4tqeH, 0.5213, 4.05, 0.080, 123, 112, STRUCTURE OF TAU PEPTIDE IN COMPLEX WITH TAU5 ANTIBODY FAB FRAGMENT
4567, 4rftm, 0.5213, 3.75, 0.073, 475, 109, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4568, 4rftT, 0.5213, 3.65, 0.112, 212, 107, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4569, 4pp2A, 0.5213, 3.65, 0.103, 212, 107, THE CRYSTAL STRUCTURE OF DER P 1 ALLERGEN COMPLEXED WITH FAB FRAGMENT OF MAB 10B9
4570, 4nm8J, 0.5213, 3.68, 0.112, 219, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4571, 4nkdD, 0.5213, 3.56, 0.096, 215, 104, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4572, 4kk6F, 0.5213, 3.84, 0.109, 220, 110, STRUCTURE OF CLC-EC1 DELTANC CONSTRUCT IN 20MM BROMIDE
4573, 4ibzA, 0.5213, 3.89, 0.063, 221, 111, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273C AND SECOND-SITE SUPPRESSOR MUTATION T284R
4574, 4fnlL, 0.5213, 3.78, 0.064, 238, 109, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05
4575, 3us0D, 0.5213, 3.72, 0.103, 114, 107, STRUCTURE OF P63 DNA BINDING DOMAIN IN COMPLEX WITH A 22 BASE PAIR A/T RICH RESPONSE ELEMENT CONTAINING A TWO BASE PAIR AT SPACER BETWEEN HALF SITES
4576, 3o6kL, 0.5213, 2.93, 0.093, 205, 97, CRYSTAL STRUCTURE OF ANTI-TAT HIV FAB 11H6H1
4577, 3nfpA, 0.5213, 3.64, 0.112, 212, 107, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF THERAPEUTIC ANTIBODY DACLIZUMAB IN COMPLEX WITH IL-2RA (CD25) ECTODOMAIN
4578, 3c2aL, 0.5213, 3.75, 0.073, 475, 109, ANTIBODY FAB FRAGMENT 447-52D IN COMPLEX WITH UG1033 PEPTIDE
4579, 35c8H, 0.5213, 3.62, 0.075, 215, 106, CATALYTIC ANTIBODY 5C8 FAB-INHIBITOR COMPLEX
4580, 2ybgD, 0.5213, 3.62, 0.094, 114, 106, STRUCTURE OF LYS120-ACETYLATED P53 CORE DOMAIN
4581, 2vxsO, 0.5213, 3.62, 0.094, 114, 106, STRUCTURE OF IL-17A IN COMPLEX WITH A POTENT FULLY HUMAN NEUTRALISING ANTIBODY
4582, 2jelL, 0.5213, 3.62, 0.094, 114, 106, JEL42 FAB/HPR COMPLEX
4583, 2cd0A, 0.5213, 3.70, 0.124, 244, 105, STRUCTURE OF HUMAN LAMBDA-6 LIGHT CHAIN DIMER WIL
4584, 1wtlB, 0.5213, 3.77, 0.073, 220, 109, COMPARISON OF CRYSTAL STRUCTURES OF TWO HOMOLOGOUS PROTEINS: STRUCTURAL ORIGIN OF ALTERED DOMAIN INTERACTIONS IN IMMUNOGLOBULIN LIGHT CHAIN DIMERS
4585, 1u6aL, 0.5213, 3.71, 0.103, 211, 107, CRYSTAL STRUCTURE OF THE BROADLY NEUTRALIZING ANTI-HIV FAB F105
4586, 1qunO, 0.5213, 3.62, 0.094, 211, 106, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4587, 1qunK, 0.5213, 3.59, 0.085, 213, 106, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4588, 1ob1E, 0.5213, 3.34, 0.127, 111, 102, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
4589, 1ay1L, 0.5213, 3.67, 0.112, 218, 107, ANTI TAQ FAB TP7
4590, 1afvM, 0.5213, 3.67, 0.103, 217, 107, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
4591, 1a3lH, 0.5213, 3.83, 0.091, 215, 110, CATALYSIS OF A DISFAVORED REACTION: AN ANTIBODY EXO DIELS- ALDERASE-TSA-INHIBITOR COMPLEX AT 1.95 A RESOLUTION
4592, 6mqrL, 0.5212, 3.84, 0.100, 215, 110, VACCINE-ELICITED NHP FP-TARGETING NEUTRALIZING ANTIBODY 0PV-A.01 IN COMPLEX WITH FP (RESIDUE 512-519) 
4593, 6mefH, 0.5212, 3.65, 0.084, 213, 107, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4594, 6dc7M, 0.5212, 3.84, 0.091, 216, 110, APO FAB STRUCTURE OF MOUSE MONOCLONAL ANTIBODY 8B2 
4595, 5yd5C, 0.5212, 3.83, 0.073, 213, 110, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH EPITOPE PEPTIDE (MUTATION N3A) 
4596, 5xrqH, 0.5212, 3.84, 0.091, 216, 110, CRYSTAL STRUCTURE OF HUMAN MONOCLONAL ANTIBODY H3V-47 
4597, 5whjL, 0.5212, 3.77, 0.083, 212, 108, CRYSTAL STRUCTURE OF FAB FRAGMENT OF ANTI-FCRN ANTIBODY DX-2507
4598, 5vtaF, 0.5212, 3.77, 0.073, 219, 109, CO-CRYSTAL STRUCTURE OF DPPIV WITH A CHEMIBODY INHIBITOR 
4599, 5tl5L, 0.5212, 3.60, 0.075, 217, 106, COMPLEX BETWEEN HUMAN CD27 AND ANTIBODY M2177
4600, 5o1cA, 0.5212, 3.83, 0.109, 220, 110, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB184 
4601, 5n2kG, 0.5212, 4.21, 0.046, 163, 109, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4602, 5mv4G, 0.5212, 4.32, 0.055, 163, 110, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED CII616-639 EPITOPE OF COLLAGEN TYPE II (PTM23)
4603, 5mv3S, 0.5212, 3.62, 0.094, 211, 106, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4604, 5mv3B, 0.5212, 3.79, 0.082, 213, 110, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4605, 5i9qB, 0.5212, 3.66, 0.113, 115, 106, CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
4606, 5i8kL, 0.5212, 3.52, 0.133, 211, 105, HHH1 FAB FRAGMENT
4607, 5hyqD, 0.5212, 3.92, 0.056, 193, 108, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4608, 5eukD, 0.5212, 3.66, 0.093, 213, 107, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4609, 5eocM, 0.5212, 3.97, 0.083, 192, 109, CRYSTAL STRUCTURE OF FAB C2 IN COMPLEX WITH A CYCLIC VARIANT OF HEPATITIS C VIRUS E2 EPITOPE I
4610, 4z5rL, 0.5212, 3.65, 0.123, 217, 106, RONTALIZUMAB FAB BOUND TO INTERFERON-A2
4611, 4yhmL, 0.5212, 3.83, 0.082, 213, 110, REVERSAL AGENT FOR DABIGATRAN
4612, 4wfeE, 0.5212, 3.56, 0.096, 216, 104, HUMAN TRAAK K+ CHANNEL IN A K+ BOUND CONDUCTIVE CONFORMATION
4613, 4wcyH, 0.5212, 3.79, 0.109, 217, 110, FAB FRAGMENT OF MOUSE AZ130 MONOCLONAL ANTIBODY
4614, 4rqqL, 0.5212, 3.91, 0.065, 193, 108, CRYSTAL STRUCTURE OF HUMAN FAB PGDM1400 A BROADLY REACTIVE AND POTENT HIV-1 NEUTRALIZING ANTIBODY
4615, 4rftp, 0.5212, 3.63, 0.140, 214, 107, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4616, 4k3dL, 0.5212, 3.58, 0.143, 217, 105, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV1H12 WITH ULTRALONG CDR H3
4617, 4jm2B, 0.5212, 3.60, 0.143, 111, 105, CRYSTAL STRUCTURE OF PGT 135 FAB IN COMPLEX WITH GP120 CORE PROTEIN FROM HIV-1 STRAIN JR-FL BOUND TO CD4 AND 17B FAB
4618, 4hfwL, 0.5212, 3.49, 0.125, 108, 104, ANTI ROTAVIRUS ANTIBODY
4619, 4guoB, 0.5212, 3.68, 0.103, 214, 107, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4620, 4g80H, 0.5212, 2.86, 0.094, 198, 96, CRYSTAL STRUCTURE OF VOLTAGE SENSING DOMAIN OF CI-VSP WITH FRAGMENT ANTIBODY (WT 3.8 A)
4621, 3zmeA, 0.5212, 2.86, 0.094, 198, 96, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE SMALL MOLECULE PHIKAN7242
4622, 3vd0K, 0.5212, 3.85, 0.062, 219, 112, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4623, 3v7aF, 0.5212, 3.55, 0.105, 210, 105, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
4624, 3u0tA, 0.5212, 3.58, 0.085, 217, 106, FAB-ANTIBODY COMPLEX
4625, 3nn8F, 0.5212, 3.82, 0.110, 218, 109, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4626, 3ngbH, 0.5212, 3.61, 0.094, 213, 106, CRYSTAL STRUCTURE OF BROADLY AND POTENTLY NEUTRALIZING ANTIBODY VRC01 IN COMPLEX WITH HIV-1 GP120
4627, 3mltB, 0.5212, 3.77, 0.100, 224, 110, CRYSTAL STRUCTURE OF ANTI-HIV-1 V3 FAB 2557 IN COMPLEX WITH A UG1033 V3 PEPTIDE
4628, 3lhaB, 0.5212, 3.65, 0.123, 218, 106, CRYSTAL STRUCTURE OF MOUSE VPS26B(R240S/G241A/E242S) IN SPACEGROUP P41 21 2
4629, 3j3pH, 0.5212, 3.86, 0.080, 240, 112, CONFORMATIONAL SHIFT OF A MAJOR POLIOVIRUS ANTIGEN CONFIRMED BY IMMUNO-CRYOGENIC ELECTRON MICROSCOPY: 135S POLIOVIRUS AND C3-FAB COMPLEX
4630, 3gjfL, 0.5212, 3.78, 0.074, 220, 108, RATIONAL DEVELOPMENT OF HIGH-AFFINITY T-CELL RECEPTOR-LIKE ANTIBODIES
4631, 2vl5D, 0.5212, 3.47, 0.086, 211, 105, STRUCTURE OF ANTI-COLLAGEN TYPE II FAB CIIC1
4632, 2rmnA, 0.5212, 3.90, 0.082, 217, 110, THE SOLUTION STRUCTURE OF THE P63 DNA-BINDING DOMAIN
4633, 2mkwA, 0.5212, 3.58, 0.104, 217, 106, SOLUTION STRUCTURE OF 6AJL2 AND 6AJL2-R24G AMYLOIDOGENICS LIGHT CHAIN PROTEINS
4634, 2h8pB, 0.5212, 3.90, 0.056, 197, 108, STRUCTURE OF A K CHANNEL WITH AN AMIDE TO ESTER SUBSTITUTION IN THE SELECTIVITY FILTER
4635, 2h1lO, 0.5212, 3.53, 0.114, 212, 105, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4636, 2brrY, 0.5212, 3.67, 0.103, 218, 107, COMPLEX OF THE NEISSERIAL PORA P1.4 EPITOPE PEPTIDE AND TWO FAB-FRAGMENTS (ANTIBODY MN20B9.34)
4637, 2adfH, 0.5212, 3.68, 0.103, 218, 107, CRYSTAL STRUCTURE AND PARATOPE DETERMINATION OF 82D6A3 AN ANTITHROMBOTIC ANTIBODY DIRECTED AGAINST THE VON WILLEBRAND FACTOR A3-DOMAIN
4638, 1z3gL, 0.5212, 3.61, 0.104, 218, 106, CRYSTAL STRUCTURE OF COMPLEX BETWEEN PVS25 AND FAB FRAGMENT OF MALARIA TRANSMISSION BLOCKING ANTIBODY 2A8
4639, 1v7nL, 0.5212, 3.80, 0.073, 202, 109, HUMAN THROMBOPOIETIN FUNCTIONAL DOMAIN COMPLEXED TO NEUTRALIZING ANTIBODY TN1 FAB
4640, 1qunM, 0.5212, 3.56, 0.094, 216, 106, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4641, 1qunI, 0.5212, 3.83, 0.091, 213, 110, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4642, 1oaqH, 0.5212, 3.83, 0.091, 213, 110, FREE CONFORMATION AB1 OF THE IGE SPE-7
4643, 1mlcA, 0.5212, 3.58, 0.124, 215, 105, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4644, 7ahlD, 0.5211, 3.60, 0.085, 217, 106, ALPHA-HEMOLYSIN FROM STAPHYLOCOCCUS AUREUS
4645, 6medC, 0.5211, 3.64, 0.123, 219, 106, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4646, 6hbkf, 0.5211, 3.88, 0.100, 211, 110, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4647, 6hbkZ, 0.5211, 3.85, 0.101, 210, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4648, 6hbkW, 0.5211, 3.55, 0.105, 215, 105, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4649, 6hbkE, 0.5211, 4.21, 0.046, 163, 109, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4650, 6hbkB, 0.5211, 3.44, 0.136, 215, 103, ECHOVIRUS 18 OPEN PARTICLE WITHOUT ONE PENTAMER 
4651, 6e9iL, 0.5211, 3.66, 0.094, 214, 106, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
4652, 6e4xY, 0.5211, 3.73, 0.093, 212, 107, HUMAN ANTIBODY S5V2-29 IN COMPLEX WITH INFLUENZA HEMAGGLUTININ A/TEXAS/50/2012 (H3N2) 
4653, 6dwiI, 0.5211, 3.94, 0.083, 198, 109, STRUCTURE OF THE 4462 ANTIBODY FAB FRAGMENT BOUND TO A STAPHYLOCOCCUS AUREUS WALL TECHOIC ACID ANALOG 
4654, 6df2L, 0.5211, 3.62, 0.075, 211, 106, IMPROVED ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-S5-4D5 FAB COMPLEXED WITH PHOSPHOTYROSINE PEPTIDE 
4655, 6by3B, 0.5211, 3.90, 0.056, 195, 108, OPEN AND CONDUCTIVE CONFORMATION OF KCSA-T75A MUTANT 
4656, 6bpcC, 0.5211, 3.86, 0.083, 206, 108, PLASMODIUM VIVAX RETICULOCYTE BINDING PROTEIN 2B (PVRBP2B) BOUND TO MONOCLONAL ANTIBODY 4F7 
4657, 5ziaH, 0.5211, 3.84, 0.091, 220, 110, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
4658, 5ur8A, 0.5211, 3.64, 0.124, 218, 105, HUMAN ANTIBODY FRAGMENT (FAB) TO MENINGOCOCCAL FACTOR H BINDING PROTEIN
4659, 5ugyI, 0.5211, 3.66, 0.104, 116, 106, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4660, 5t1mB, 0.5211, 3.87, 0.082, 224, 110, CETUXIMAB FAB IN COMPLEX WITH CQYDLSTRRLKC
4661, 5ocaL, 0.5211, 3.78, 0.055, 219, 109, PCSK9:FAB COMPLEX WITH DEXTRAN SULFATE
4662, 5n2kA, 0.5211, 3.82, 0.084, 282, 107, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4663, 5mp5E, 0.5211, 3.89, 0.100, 220, 110, CRYSTAL STRUCTURE OF DC8E8 FAB IN THE COMPLEX WITH A 14-MER TAU PEPTIDE AT PH 6.5 
4664, 5kzcB, 0.5211, 3.59, 0.076, 206, 105, CRYSTAL STRUCTURE OF AN HIV-1 GP120 ENGINEERED OUTER DOMAIN WITH A MAN9 GLYCAN AT POSITION N276 IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODY VRC01
4665, 5j3dL, 0.5211, 3.59, 0.123, 216, 106, CRYSTAL STRUCTURE OF HUMAN FAB 14N4 IN COMPLEX WITH POST-FUSION RSV F
4666, 5iv2D, 0.5211, 3.94, 0.093, 233, 108, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4667, 5icyC, 0.5211, 3.61, 0.123, 111, 106, CETUXIMAB FAB IN COMPLEX WITH LINEAR MEDITOPE
4668, 5f88B, 0.5211, 3.65, 0.112, 212, 107, CETUXIMAB FAB IN COMPLEX WITH L5Y MEDITOPE VARIANT
4669, 5f6hP, 0.5211, 3.89, 0.065, 199, 108, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
4670, 5etuC, 0.5211, 3.84, 0.091, 225, 110, CETUXIMAB FAB IN COMPLEX WITH L5E MEDITOPE VARIANT
4671, 5cjsE, 0.5211, 3.75, 0.092, 218, 109, CRYSTAL STRUCTURE OF A MONOMERIC INFLUENZA HEMAGGLUTININ STEM IN COMPLEX WITH AN BROADLY NEUTRALIZING ANTIBODY CR9114
4672, 4yhiL, 0.5211, 3.56, 0.105, 213, 105, REVERSAL AGENT FOR DABIGATRAN
4673, 4uaoB, 0.5211, 3.57, 0.114, 213, 105, CRYSTAL STRUCTURE OF APICAL MEMBRANE ANTIGEN 1 FROM PLASMODIUM KNOWLESI IN COMPLEX WITH AN INVASION INHIBITORY ANTIBODY
4674, 4rftS, 0.5211, 2.86, 0.094, 198, 96, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4675, 4rft4, 0.5211, 2.86, 0.094, 198, 96, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4676, 4r7nR, 0.5211, 3.63, 0.103, 120, 107, FAB C2E3
4677, 4nwvC, 0.5211, 3.66, 0.123, 214, 106, CRYSTAL STRUCTURE OF ORSAY VIRUS-LIKE PARTICLE
4678, 4nm4I, 0.5211, 3.90, 0.063, 293, 111, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR8043
4679, 4nkdB, 0.5211, 3.94, 0.070, 226, 114, CRYSTAL STRUCTURE OF ENGINEERED ANTI-EE SCFV ANTIBODY FRAGMENT
4680, 4kvcL, 0.5211, 4.51, 0.043, 238, 115, 2H2 FAB FRAGMENT OF IMMATURE DENGUE VIRUS
4681, 4hs6L, 0.5211, 4.51, 0.043, 238, 115, HEPATITUS C ENVELOPE GLYCOPROTEIN E2 FRAGMENT 412-423 WITH HUMANIZED AND AFFINITY-MATURED ANTIBODY MRCT10.V362
4682, 4hj0Q, 0.5211, 4.51, 0.043, 238, 115, CRYSTAL STRUCTURE OF THE HUMAN GIPR ECD IN COMPLEX WITH GIPG013 FAB AT 3-A RESOLUTION
4683, 4fqvJ, 0.5211, 4.51, 0.043, 238, 115, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY CR9114 BOUND TO H7 INFLUENZA HEMAGGLUTININ
4684, 3wsqL, 0.5211, 4.51, 0.043, 238, 115, STRUCTURE OF HER2 WITH AN FAB
4685, 3lexB, 0.5211, 3.42, 0.087, 213, 103, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
4686, 3l7fB, 0.5211, 3.44, 0.087, 208, 104, STRUCTURE OF IL-13 ANTIBODY H2L6 A HUMANIZED VARIANT OF C836
4687, 3j30H, 0.5211, 3.66, 0.075, 211, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
4688, 3j30F, 0.5211, 3.64, 0.075, 215, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
4689, 3j30D, 0.5211, 3.65, 0.112, 212, 107, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
4690, 3j30B, 0.5211, 3.61, 0.113, 212, 106, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB CHK152
4691, 3j2xH, 0.5211, 3.69, 0.074, 219, 108, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4692, 3j2xF, 0.5211, 3.82, 0.073, 229, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4693, 3j2xD, 0.5211, 3.75, 0.083, 221, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4694, 3j2xB, 0.5211, 3.74, 0.092, 218, 109, ELECTRON CRYO-MICROSCOPY OF CHIKUNGUNYA VLP IN COMPLEX WITH NEUTRALIZING ANTIBODY FAB M242
4695, 3dsfL, 0.5211, 3.54, 0.113, 214, 106, CRYSTAL STRUCTURE OF ANTI-OSTEOPONTIN ANTIBODY 23C3 IN COMPLEX WITH W43A MUTATED EPITOPE PEPTIDE
4696, 3ck0L, 0.5211, 3.51, 0.114, 216, 105, ANTI-ANTI-IDIOTYPIC ANTIBODY AGAINST HUMAN ANGIOTENSIN II COMPLEX WITH HUMAN ANGIOTENSIN II
4697, 2zchH, 0.5211, 3.75, 0.083, 217, 109, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN COMPLEXED WITH AN ACTIVATING ANTIBODY
4698, 2w9lX, 0.5211, 3.88, 0.082, 214, 110, CANINE ADENOVIRUS TYPE 2 FIBRE HEAD IN COMPLEX WITH CAR DOMAIN D1 AND SIALIC ACID
4699, 2fatL, 0.5211, 3.66, 0.093, 215, 107, AN ANTI-UROKINASE PLASMINOGEN ACTIVATOR RECEPTOR (UPAR) ANTIBODY: CRYSTAL STRUCTURE AND BINDING EPITOPE
4700, 1yy8A, 0.5211, 3.83, 0.091, 214, 110, CRYSTAL STRUCTURE OF THE FAB FRAGMENT FROM THE MONOCLONAL ANTIBODY CETUXIMAB/ERBITUX/IMC-C225
4701, 1xcqH, 0.5211, 3.65, 0.084, 212, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55AL57HY64W) IN SPACE GROUP P21
4702, 1wcbA, 0.5211, 3.83, 0.091, 216, 110, PLP-DEPENDENT CATALYTIC ANTIBODY 15A9 IN COMPLEX WITH ITS HAPTEN
4703, 1tqcC, 0.5211, 3.52, 0.087, 212, 104, OVINE RECOMBINANT PRP(114-234) ARR VARIANT IN COMPLEX WITH THE VRQ14 FAB FRAGMENT (IGG2A)
4704, 1rurH, 0.5211, 3.64, 0.093, 213, 107, CRYSTAL STRUCTURE (I) OF NATIVE DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED AT SSRL BEAMLINE 9- 1.
4705, 1rsfA, 0.5211, 3.53, 0.114, 211, 105, NMR STRUCTURE OF MONOMERIC CAR D1 DOMAIN
4706, 1nd0A, 0.5211, 3.64, 0.123, 219, 106, CATIONIC CYCLIZATION ANTIBODY 4C6 COMPLEX WITH TRANSITION STATE ANALOG
4707, 1mlcC, 0.5211, 3.64, 0.113, 214, 106, MONOCLONAL ANTIBODY FAB D44.1 RAISED AGAINST CHICKEN EGG- WHITE LYSOZYME COMPLEXED WITH LYSOZYME
4708, 1mieL, 0.5211, 4.22, 0.055, 163, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF ESTEROLYTIC ANTIBODY MS5-393
4709, 1lhzB, 0.5211, 4.20, 0.055, 163, 109, STRUCTURE OF A HUMAN BENCE-JONES DIMER CRYSTALLIZED IN U.S. SPACE SHUTTLE MISSION STS-95: 293K
4710, 1afvL, 0.5211, 3.67, 0.094, 213, 106, HIV-1 CAPSID PROTEIN (P24) COMPLEX WITH FAB25.3
4711, 6m87J, 0.5210, 4.34, 0.018, 346, 110, FAB 10A6 IN COMPLEX WITH MPTS 
4712, 6glwD, 0.5210, 3.83, 0.082, 223, 110, STRUCTURE OF GALECTIN-10 IN COMPLEX WITH THE FAB FRAGMENT OF A CHARCOT-LEYDEN CRYSTAL SOLUBILIZING ANTIBODY; 1D11 
4713, 6fy2H, 0.5210, 3.65, 0.104, 115, 106, CRYSTAL STRUCTURE OF A V2P-REACTIVE RV144 VACCINE-LIKE ANTIBODY; CAP228-16H; IN COMPLEX WITH A HETEROLOGOUS CAP225 V1V2 
4714, 6flaH, 0.5210, 3.64, 0.132, 212, 106, 3H5 FAB BOUND TO EDIII OF DENV 2 XTAL FORM 1 
4715, 6ev1E, 0.5210, 3.60, 0.123, 218, 106, CRYSTAL STRUCTURE OF ANTIBODY AGAINST SCHIZOPHYLLAN 
4716, 6df0L, 0.5210, 3.72, 0.094, 210, 106, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
4717, 6d0uI, 0.5210, 3.91, 0.072, 215, 111, CRYSTAL STRUCTURE OF C05 V110P/A117E MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ; HA1 SUBUNIT 
4718, 6a0zL, 0.5210, 3.59, 0.057, 215, 105, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY 13D4 BOUND TO H5N1 INFLUENZA HEMAGGLUTININ; HA HEAD REGION 
4719, 5ziaO, 0.5210, 3.66, 0.123, 219, 106, CRYSTAL STRUCTURE OF HUMAN ANTI-TAU ANTIBODY CBTAU-24.1 IN COMPLEX WITH ITS PHOSPHORYLATED TAU PEPTIDE 
4720, 5o1gB, 0.5210, 3.76, 0.092, 220, 109, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB487 
4721, 5ijvC, 0.5210, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURE OF BOVINE FAB E03
4722, 5hyqB, 0.5210, 3.84, 0.082, 217, 110, CETUXIMAB FAB IN COMPLEX WITH AMIDATED MEDITOPE
4723, 5h35B, 0.5210, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURES OF THE TRIC TRIMERIC INTRACELLULAR CATION CHANNEL ORTHOLOGUE FROM SULFOLOBUS SOLFATARICUS
4724, 5f6hJ, 0.5210, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURE OF TIER 2 NEUTRALIZING ANTIBODY DH427 FROM A RHESUS MACAQUE
4725, 5eukB, 0.5210, 3.84, 0.082, 217, 110, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4726, 5esqC, 0.5210, 3.84, 0.082, 217, 110, CETUXIMAB FAB IN COMPLEX WITH CYCLIC BETA-ALANINE-LINKED MEDITOPE
4727, 5bk3D, 0.5210, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURE OF THE NEUTRALIZING ANTI-CIRCUMSPOROZOITE PROTEIN 580 ANTIBODY
4728, 5anmA, 0.5210, 3.84, 0.082, 217, 110, CRYSTAL STRUCTURE OF IGE FC IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4729, 4ygvB, 0.5210, 3.63, 0.094, 213, 106, REVERSAL AGENT FOR DABIGATRAN
4730, 4yblC, 0.5210, 3.68, 0.103, 216, 107, CRYSTAL STRUCTURE OF THE STABILIZED INNER DOMAIN OF CLADE A/E HIV-1 GP120 IN COMPLEX WITH THE ADCC MEDIATING ANTI-HIV-1 ANTIBODY A32
4731, 4wfgE, 0.5210, 3.84, 0.100, 229, 110, HUMAN TRAAK K+ CHANNEL IN A TL+ BOUND CONDUCTIVE CONFORMATION
4732, 4rfnL, 0.5210, 3.97, 0.081, 123, 111, CRYSTAL STRUCTURE OF ADCC-POTENT RHESUS MACAQUE ANTIBODY JR4 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND M48
4733, 4p59L, 0.5210, 3.53, 0.124, 212, 105, HER3 EXTRACELLULAR DOMAIN IN COMPLEX WITH FAB FRAGMENT OF MOR09825
4734, 4k3eM, 0.5210, 3.65, 0.084, 213, 107, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
4735, 4k3eL, 0.5210, 3.92, 0.091, 218, 110, CRYSTAL STRUCTURE OF BOVINE ANTIBODY BLV5B8 WITH ULTRALONG CDR H3
4736, 4ibyA, 0.5210, 3.56, 0.086, 213, 105, HUMAN P53 CORE DOMAIN WITH HOT SPOT MUTATION R273H AND SECOND-SITE SUPPRESSOR MUTATION S240R
4737, 4hxbL, 0.5210, 3.68, 0.123, 219, 106, CRYSTAL STRUCTURE OF 6B9 FAB
4738, 4gxvM, 0.5210, 3.85, 0.109, 218, 110, CRYSTAL STRUCTURE OF ANTI-INFLUENZA VIRUS ANTIBODY 1F1
4739, 4gayL, 0.5210, 3.95, 0.071, 126, 113, STRUCTURE OF THE BROADLY NEUTRALIZING ANTIBODY AP33
4740, 4fqrl, 0.5210, 3.72, 0.121, 219, 107, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4741, 4fp8O, 0.5210, 3.63, 0.123, 214, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4742, 4evnA, 0.5210, 3.64, 0.123, 218, 106, CRYSTAL STRUCTURE OF FAB CR6261 (SOMATIC HEAVY CHAIN WITH GERMLINE- REVERTED LIGHT CHAIN)
4743, 4etqB, 0.5210, 3.63, 0.121, 213, 107, VACCINIA VIRUS D8L IMV ENVELOPE PROTEIN IN COMPLEX WITH FAB OF MURINE IGG2A LA5
4744, 4dzbB, 0.5210, 3.58, 0.085, 217, 106, MUCOSAL-ASSOCIATED INVARIANT T CELL RECEPTOR VALPHA7.2JALPHA33-VBETA2
4745, 3v6fB, 0.5210, 3.78, 0.083, 215, 109, CRYSTAL STRUCTURE OF AN ANTI-HBV E-ANTIGEN MONOCLONAL FAB FRAGMENT (E6) UNBOUND
4746, 3u30E, 0.5210, 3.51, 0.087, 213, 104, CRYSTAL STRUCTURE OF A LINEAR-SPECIFIC UBIQUITIN FAB BOUND TO LINEAR UBIQUITIN
4747, 3u0tB, 0.5210, 3.78, 0.083, 219, 109, FAB-ANTIBODY COMPLEX
4748, 3qo1A, 0.5210, 3.85, 0.091, 217, 110, MONOCLINIC FORM OF IGG1 FAB FRAGMENT (APO FORM) SHARING SAME FV AS IGA
4749, 3q3gK, 0.5210, 3.74, 0.072, 211, 111, CRYSTAL STRUCTURE OF A-DOMAIN IN COMPLEX WITH ANTIBODY
4750, 3o11L, 0.5210, 3.63, 0.085, 211, 106, ANTI-BETA-AMYLOID ANTIBODY C706 FAB IN SPACE GROUP C2
4751, 3lexL, 0.5210, 3.60, 0.075, 213, 106, 2F5 EPITOPE SCAFFOLD ELICITED ANTI-HIV-1 MONOCLONAL ANTIBODY 11F10 IN COMPLEX WITH HIV-1 GP41
4752, 3i50L, 0.5210, 3.64, 0.123, 212, 106, CRYSTAL STRUCTURE OF THE WEST NILE VIRUS ENVELOPE GLYCOPROTEIN IN COMPLEX WITH THE E53 ANTIBODY FAB
4753, 3hzvA, 0.5210, 3.79, 0.073, 220, 109, CRYSTAL STRUCTURE OF S73-2 ANTIBODY IN COMPLEX WITH ANTIGEN KDO(2.8) KDO(2.4)KDO
4754, 2yk1L, 0.5210, 3.88, 0.046, 196, 108, STRUCTURE OF HUMAN ANTI-NICOTINE FAB FRAGMENT IN COMPLEX WITH NICOTINE
4755, 2eh7L, 0.5210, 3.36, 0.117, 213, 103, CRYSTAL STRUCTURE OF HUMANIZED KR127 FAB
4756, 1xiwH, 0.5210, 3.83, 0.091, 220, 110, CRYSTAL STRUCTURE OF HUMAN CD3-E/D DIMER IN COMPLEX WITH A UCHT1 SINGLE-CHAIN ANTIBODY FRAGMENT
4757, 1pz5A, 0.5210, 3.69, 0.132, 217, 106, STRUCTURAL BASIS OF PEPTIDE-CARBOHYDRATE MIMICRY IN AN ANTIBODY COMBINING SITE
4758, 1ob1B, 0.5210, 3.52, 0.087, 212, 104, CRYSTAL STRUCTURE OF A FAB COMPLEX WHITH PLASMODIUM FALCIPARUM MSP1-19
4759, 1mf2L, 0.5210, 3.83, 0.091, 220, 110, ANTI HIV1 PROTEASE FAB COMPLEX
4760, 1klfG, 0.5210, 3.65, 0.084, 213, 107, FIMH ADHESIN-FIMC CHAPERONE COMPLEX WITH D-MANNOSE
4761, 1igcL, 0.5210, 3.61, 0.113, 217, 106, IGG1 FAB FRAGMENT (MOPC21) COMPLEX WITH DOMAIN III OF PROTEIN G FROM STREPTOCOCCUS
4762, 1i8mH, 0.5210, 3.57, 0.105, 213, 105, CRYSTAL STRUCTURE OF A RECOMBINANT ANTI-SINGLE-STRANDED DNA ANTIBODY FRAGMENT COMPLEXED WITH DT5
4763, 6novD, 0.5209, 3.64, 0.123, 218, 106, A FAB DERIVED FROM IXEKIZUMAB 
4764, 6de7D, 0.5209, 3.47, 0.107, 210, 103, CRYSTAL STRUCTURE AT 4.3 A RESOLUTION OF GLYCOSYLATED HIV-1 CLADE A BG505 SOSIP.664 PREFUSION ENV TRIMER WITH INTERDOMAIN STABILIZATION 113C-429GCG IN COMPLEX WITH BROADLY NEUTRALIZING ANTIBODIES PGT122 AND 35O22 
4765, 6c6zC, 0.5209, 3.88, 0.100, 211, 110, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
4766, 5ywpN, 0.5209, 3.54, 0.087, 210, 103, JEV-2H4 FAB COMPLEX 
4767, 5xlib, 0.5209, 3.65, 0.093, 211, 107, STRUCTURE OF ANTI-ANGIOTENSIN II TYPE2 RECEPTOR ANTIBODY (D5711-4A03) 
4768, 5xbmB, 0.5209, 3.36, 0.097, 213, 103, STRUCTURE OF SCARB2-JL2 COMPLEX 
4769, 5utfD, 0.5209, 3.42, 0.144, 215, 104, CRYSTAL STRUCTURE OF A STABILIZED DS-SOSIP.6MUT BG505 GP140 HIV-1 ENV TRIMER CONTAINING MUTATIONS I201C-P433C (DS) L154M Y177W N300M N302M T320L I420M IN COMPLEX WITH HUMAN ANTIBODIES PGT122 AND 35O22 AT 4.3 A
4770, 5uknL, 0.5209, 3.92, 0.065, 197, 108, STRUCTURE OF UNLIGANDED ANTI-GP120 CD4BS ANTIBODY DH522UCA FAB
4771, 5tlkF, 0.5209, 3.65, 0.123, 219, 106, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4772, 5mv3G, 0.5209, 3.60, 0.087, 213, 104, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4773, 5lwiB, 0.5209, 3.67, 0.112, 213, 107, ISRAELI ACUTE PARALYSIS VIRUS HEATED TO 63 DEGREE - EMPTY PARTICLE
4774, 5l0qC, 0.5209, 3.66, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN ADAM10 D+C DOMAIN AND A CONFORMATION SPECIFIC MAB 8C7.
4775, 5iv2B, 0.5209, 3.68, 0.084, 213, 107, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4776, 5iopC, 0.5209, 3.86, 0.072, 221, 111, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4777, 5ff6B, 0.5209, 3.50, 0.114, 212, 105, CETUXIMAB FAB IN COMPLEX WITH L10Q MEDITOPE VARIANT
4778, 5eukC, 0.5209, 3.69, 0.130, 244, 108, CETUXIMAB FAB IN COMPLEX WITH F3H MEDITOPE VARIANT
4779, 5d96I, 0.5209, 3.60, 0.152, 219, 105, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
4780, 5d1xA, 0.5209, 3.61, 0.075, 211, 106, ISDB NEAT2 BOUND BY D4-30
4781, 5b6fC, 0.5209, 3.76, 0.073, 209, 109, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF AN ANTI-LEUKOTRIENE C4 MONOCLONAL ANTIBODY COMPLEXED WITH LTC4
4782, 5ab9B, 0.5209, 3.64, 0.113, 219, 106, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE 7-ETHYL-3-(PIPERIDIN-4-YL)-1H-INDOLE
4783, 5a1zJ, 0.5209, 3.82, 0.091, 224, 110, CRYO-EM STRUCTURE OF DENGUE VIRUS SEROTYPE 2 STRAIN PVP94- 07 COMPLEXED WITH HUMAN ANTIBODY 2D22 FAB AT 37 DEGREES C
4784, 4rgnE, 0.5209, 3.64, 0.094, 211, 106, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4785, 4rftW, 0.5209, 3.66, 0.123, 219, 106, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4786, 4rftP, 0.5209, 3.54, 0.095, 207, 105, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4787, 4q6iD, 0.5209, 3.57, 0.143, 218, 105, CRYSTAL STRUCTURE OF MURINE 2D5 FAB A POTENT ANTI-CD4 HIV-1- NEUTRALIZING ANTIBODY IN COMPLEX WITH CD4
4788, 4fqrr, 0.5209, 3.39, 0.126, 188, 103, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4789, 4fqrh, 0.5209, 3.64, 0.132, 219, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ
4790, 4ffwH, 0.5209, 3.66, 0.084, 122, 107, CRYSTAL STRUCTURE OF DIPEPTIDYL PEPTIDASE IV (DPP4 DPP-IV CD26) IN COMPLEX WITH FAB + SITAGLIPTIN
4791, 3vd1B, 0.5209, 3.65, 0.132, 215, 106, STRUCTURE OF P73 DNA BINDING DOMAIN TETRAMER MODULATES P73 TRANSACTIVATION
4792, 3v7aE, 0.5209, 3.86, 0.062, 219, 112, STRUCTURAL BASIS FOR BROAD DETECTION OF GENOGROUP II NOROVIRUSES BY A MONOCLONAL ANTIBODY THAT BINDS TO A SITE OCCLUDED IN THE VIRAL PARTICLE
4793, 3uzvB, 0.5209, 3.62, 0.104, 215, 106, CRYSTAL STRUCTURE OF THE DENGUE VIRUS SEROTYPE 2 ENVELOPE PROTEIN DOMAIN III IN COMPLEX WITH THE VARIABLE DOMAINS OF MAB 4E11
4794, 3utzD, 0.5209, 3.05, 0.102, 205, 98, ENDOGENOUS-LIKE INHIBITORY ANTIBODIES TARGETING ACTIVATED METALLOPROTEINASE MOTIFS SHOW THERAPEUTIC POTENTIAL
4795, 3u2sL, 0.5209, 3.67, 0.132, 213, 106, CRYSTAL STRUCTURE OF PG9 FAB IN COMPLEX WITH V1V2 REGION FROM HIV-1 STRAIN ZM109
4796, 3iywH, 0.5209, 3.85, 0.091, 213, 110, WEST NILE VIRUS IN COMPLEX WITH FAB FRAGMENTS OF MAB CR4354 (FITTED COORDINATES OF ENVELOPE PROTEINS AND FAB FRAGMENTS OF ONE ICOSAHEDRAL ASU)
4797, 3eo0B, 0.5209, 3.62, 0.132, 219, 106, STRUCTURE OF THE TRANSFORMING GROWTH FACTOR-BETA NEUTRALIZING ANTIBODY GC-1008
4798, 3ejzF, 0.5209, 3.89, 0.036, 205, 112, STRUCTURE OF E203V MUTANT E.COLI CL-/H+ EXCHANGER CLC-EC1
4799, 3bkyL, 0.5209, 3.82, 0.083, 222, 109, CRYSTAL STRUCTURE OF CHIMERIC ANTIBODY C2H7 FAB IN COMPLEX WITH A CD20 PEPTIDE
4800, 3anzR, 0.5209, 3.71, 0.083, 218, 108, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4801, 2hffA, 0.5209, 3.52, 0.095, 213, 105, CRYSTAL STRUCTURE OF CB2 FAB
4802, 2h1lP, 0.5209, 3.83, 0.082, 221, 110, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4803, 2cgrL, 0.5209, 3.87, 0.036, 242, 112, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
4804, 1za6D, 0.5209, 3.49, 0.087, 211, 104, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4805, 1yqvH, 0.5209, 3.77, 0.083, 211, 109, THE CRYSTAL STRUCTURE OF THE ANTIBODY FAB HYHEL5 COMPLEX WITH LYSOZYME AT 1.7A RESOLUTION
4806, 1xf5B, 0.5209, 3.68, 0.103, 217, 107, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (H74C Y64W)IN SPACE GROUP P21212
4807, 1xf3B, 0.5209, 4.06, 0.045, 236, 111, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4808, 1xf3A, 0.5209, 3.85, 0.091, 213, 110, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P65
4809, 1orqA, 0.5209, 3.83, 0.091, 216, 110, X-RAY STRUCTURE OF A VOLTAGE-DEPENDENT POTASSIUM CHANNEL IN COMPLEX WITH AN FAB
4810, 1oopB, 0.5209, 3.65, 0.084, 213, 107, THE CRYSTAL STRUCTURE OF SWINE VESICULAR DISEASE VIRUS
4811, 1gpoL, 0.5209, 3.84, 0.091, 220, 110, CRYSTAL STRUCTURE OF THE RATIONALLY DESIGNED ANTIBODY M41 AS A FAB FRAGMENT
4812, 1egjH, 0.5209, 3.65, 0.084, 213, 107, DOMAIN 4 OF THE BETA COMMON CHAIN IN COMPLEX WITH AN ANTIBODY
4813, 1cr9L, 0.5209, 3.70, 0.103, 214, 107, CRYSTAL STRUCTURE OF THE ANTI-PRION FAB 3F4
4814, 1cgsH, 0.5209, 3.72, 0.132, 218, 106, LOCAL AND TRANSMITTED CONFORMATIONAL CHANGES ON COMPLEXATION OF AN ANTI-SWEETENER FAB
4815, 6otcL, 0.5208, 3.66, 0.123, 217, 106, SYNTHETIC FAB BOUND TO MARBURG VIRUS VP35 INTERFERON INHIBITORY DOMAIN 
4816, 6meiH, 0.5208, 3.87, 0.037, 197, 108, BROADLY NEUTRALIZING ANTIBODIES AGAINST HCV USE A CDRH3 DISULFIDE MOTIF TO RECOGNIZE AN E2 GLYCOPROTEIN SITE THAT CAN BE TARGETED FOR VACCINE DESIGN 
4817, 6jmrF, 0.5208, 3.45, 0.135, 111, 104, CD98HC EXTRACELLULAR DOMAIN BOUND TO HBJ127 FAB AND MEM-108 FAB 
4818, 6df1L, 0.5208, 3.72, 0.112, 220, 107, ANTI-PHOSPHOTYROSINE ANTIBODY 4G10-4D5 FAB COMPLEXED WITH SULFATE 
4819, 6c6zH, 0.5208, 4.21, 0.055, 163, 109, CRYSTAL STRUCTURE OF POTENT NEUTRALIZING ANTIBODY CDC2-C2 IN COMPLEX WITH MERS-COV S1 RBD
4820, 6bitL, 0.5208, 4.20, 0.055, 163, 109, SIRPALPHA ANTIBODY COMPLEX
4821, 6bi2L, 0.5208, 3.56, 0.143, 218, 105, TRASTUZUMAB FAB D185A (LIGHT CHAIN) MUTANT BIOTIN CONJUGATION.
4822, 6bi0L, 0.5208, 3.66, 0.084, 213, 107, TRASTUZUMAB FAB N158A D185A K190A (LIGHT CHAIN) TRIPLE MUTANT.
4823, 5yy4A, 0.5208, 3.65, 0.093, 213, 107, CRYSTAL STRUCTURE OF THE SCFV ANTIBODY 4B08 WITH SULFATED EPITOPE PEPTIDE 
4824, 5ugyH, 0.5208, 3.77, 0.092, 208, 109, INFLUENZA HEMAGGLUTININ IN COMPLEX WITH A NEUTRALIZING ANTIBODY
4825, 5uddJ, 0.5208, 3.93, 0.083, 199, 109, CRYSTAL STRUCTURE OF RSV F B9320 BOUND TO MEDI8897
4826, 5tlkC, 0.5208, 3.83, 0.091, 220, 110, COMPLEX BETWEEN HUMAN CD27 AND FAB FRAGMENTS OF ANTIBODIES M2177 AND H2191
4827, 5t1kD, 0.5208, 3.72, 0.083, 229, 108, CETUXIMAB FAB IN COMPLEX WITH CQFDA(PH)2STRRLKC
4828, 5t0yA, 0.5208, 3.58, 0.114, 212, 105, 2A10 ANTIBODY FAB FRAGMENT
4829, 5o1eB, 0.5208, 3.54, 0.096, 211, 104, P53 CANCER MUTANT Y220C IM COMPLEX WITH COMPOUND MB577 
4830, 5mvjE, 0.5208, 3.78, 0.073, 229, 109, STRUCTURE OF DC8E8 FAB AT PH 6.5 CRYSTALLIZED IN SPACE-GROUP P1 
4831, 5mv3M, 0.5208, 3.90, 0.072, 220, 111, ACC1 FAB FRAGMENT IN COMPLEX WITH CII583-591 (CG10)
4832, 5k8aA, 0.5208, 3.55, 0.133, 211, 105, NIST FAB
4833, 5icxD, 0.5208, 3.55, 0.095, 213, 105, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4834, 5i2iC, 0.5208, 3.91, 0.063, 294, 111, STRUCTURE OF CETUXIMAB FAB WITH CYCLIC F3Q VARIANT OF THE MEDITOPE
4835, 5do2D, 0.5208, 3.65, 0.093, 213, 107, COMPLEX STRUCTURE OF MERS-RBD BOUND WITH 4C2 ANTIBODY
4836, 5d96B, 0.5208, 3.91, 0.065, 199, 108, OXIDOREDUCTASE FRAGMENT OF MOUSE QSOX1 IN COMPLEX WITH A FAB FRAGMENT FROM AN ANTIBODY TARGETING MOUSE AND HUMAN QSOX1
4837, 5cd3C, 0.5208, 3.68, 0.113, 219, 106, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4838, 5aoiB, 0.5208, 3.88, 0.082, 324, 110, STRUCTURE OF THE P53 CANCER MUTANT Y220C IN COMPLEX WITH AN INDOLE-BASED SMALL MOLECULE
4839, 4xc1L, 0.5208, 3.88, 0.091, 215, 110, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SN-GLYCEROL 3- PHOSPHATE
4840, 4x0kB, 0.5208, 3.85, 0.091, 218, 110, ENGINEERED FAB FRAGMENT SPECIFIC FOR EYMPME (EE) PEPTIDE
4841, 4wv1D, 0.5208, 3.80, 0.091, 218, 110, CRYSTAL STRUCTURE OF THE FGFR2 D2 DOMAIN IN COMPLEX WITH FAB 2B.1.3
4842, 4wizN, 0.5208, 3.72, 0.094, 213, 106, 
4843, 4s1dE, 0.5208, 3.67, 0.104, 215, 106, STRUCTURE OF IGG1 FAB FRAGMENT IN COMPLEX WITH BIOTINCYTIDINAMIDE
4844, 4rftF, 0.5208, 4.56, 0.043, 252, 116, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4845, 4plkL, 0.5208, 3.61, 0.142, 216, 106, HEPATITIS E VIRUS E2S DOMAIN (GENOTYPE I) IN COMPLEX WITH A NEUTRALIZING ANTIBODY 8G12
4846, 4jb9H, 0.5208, 3.85, 0.091, 220, 110, CRYSTAL STRUCTURE OF ANTIBODY VRC06 IN COMPLEX WITH HIV-1 GP120 CORE
4847, 4fp8N, 0.5208, 3.64, 0.123, 219, 106, CRYSTAL STRUCTURE OF BROADLY NEUTRALIZING ANTIBODY C05 BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4848, 4aglB, 0.5208, 3.82, 0.073, 214, 110, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO THE STABILIZING SMALL MOLECULE PHIKAN784
4849, 3w9dD, 0.5208, 3.59, 0.085, 215, 106, STRUCTURE OF HUMAN MONOCLONAL ANTIBODY E317 FAB
4850, 3ujtL, 0.5208, 3.82, 0.082, 228, 110, STRUCTURE OF THE FAB FRAGMENT OF AB-52 AN ANTIBODY THAT BINDS THE O- ANTIGEN OF FRANCISELLA TULARENSIS
4851, 3qumB, 0.5208, 3.66, 0.112, 218, 107, CRYSTAL STRUCTURE OF HUMAN PROSTATE SPECIFIC ANTIGEN (PSA) IN FAB SANDWICH WITH A HIGH AFFINITY AND A PCA SELECTIVE ANTIBODY
4852, 3nn8E, 0.5208, 3.66, 0.075, 213, 106, CRYSTAL STRUCTURE OF ENGINEERED ANTIBODY FRAGMENT BASED ON 3D5
4853, 3ls5L, 0.5208, 3.82, 0.083, 224, 109, ANTI-TETRAHYDROCANNABINOL FAB FRAGMENT FREE FORM
4854, 3bkjH, 0.5208, 3.63, 0.123, 210, 106, CRYSTAL STRUCTURE OF FAB WO2 BOUND TO THE N TERMINAL DOMAIN OF AMYLOID BETA PEPTIDE (1-16)
4855, 3anzD, 0.5208, 3.60, 0.085, 213, 106, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4856, 2x0uB, 0.5208, 3.61, 0.085, 212, 106, STRUCTURE OF THE P53 CORE DOMAIN MUTANT Y220C BOUND TO A 2- AMINO SUBSTITUTED BENZOTHIAZOLE SCAFFOLD
4857, 2h1lW, 0.5208, 3.76, 0.074, 236, 108, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4858, 2exwF, 0.5208, 3.75, 0.083, 221, 109, CRYSTAL STRUCTURE OF A ECCLC-FAB COMPLEX IN THE ABSENCE OF BOUND IONS
4859, 2bioA, 0.5208, 3.86, 0.082, 224, 110, HUMAN P53 CORE DOMAIN MUTANT M133L-V203A-N239Y-R249S-N268D
4860, 1zanL, 0.5208, 3.66, 0.075, 215, 107, CRYSTAL STRUCTURE OF ANTI-NGF AD11 FAB
4861, 1xf4B, 0.5208, 3.85, 0.091, 215, 110, STRUCTURE OF LIGAND-FREE FAB DNA-1 IN SPACE GROUP P321 SOLVED FROM CRYSTALS WITH PERFECT HEMIHEDRAL TWINNING
4862, 1s5iL, 0.5208, 3.78, 0.092, 217, 109, FAB (LNKB-2) OF MONOCLONAL ANTIBODY TO HUMAN INTERLEUKIN-2 CRYSTAL STRUCTURE
4863, 1qunE, 0.5208, 3.89, 0.046, 198, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4864, 1qunC, 0.5208, 3.74, 0.083, 215, 109, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4865, 1iaiM, 0.5208, 3.69, 0.112, 218, 107, IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX
4866, 1eapA, 0.5208, 3.52, 0.095, 213, 105, CRYSTAL STRUCTURE OF A CATALYTIC ANTIBODY WITH A SERINE PROTEASE ACTIVE SITE
4867, 1ce1L, 0.5208, 3.83, 0.091, 212, 110, 1.9A STRUCTURE OF THE THERAPEUTIC ANTIBODY CAMPATH-1H FAB IN COMPLEX WITH A SYNTHETIC PEPTIDE ANTIGEN
4868, 1bqlH, 0.5208, 3.65, 0.084, 213, 107, STRUCTURE OF AN ANTI-HEL FAB FRAGMENT COMPLEXED WITH BOBWHITE QUAIL LYSOZYME
4869, 6nc2X, 0.5207, 3.61, 0.094, 214, 106, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4870, 6nc2W, 0.5207, 3.71, 0.103, 214, 107, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4871, 6nc2V, 0.5207, 3.85, 0.091, 220, 110, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4872, 6nc2U, 0.5207, 3.89, 0.046, 196, 108, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4873, 6nc2T, 0.5207, 3.79, 0.074, 214, 108, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4874, 6nc2L, 0.5207, 3.69, 0.104, 226, 106, AMC011 V4.2 SOSIP ENV TRIMER IN COMPLEX WITH FUSION PEPTIDE TARGETING ANTIBODY ACS202 FRAGMENT ANTIGEN BINDING 
4875, 6mg4B, 0.5207, 3.64, 0.113, 214, 106, STRUCTURE OF FULL-LENGTH HUMAN LAMBDA-6A LIGHT CHAIN JTO 
4876, 6cue7, 0.5207, 4.21, 0.055, 287, 109, CRYO-EM STRUCTURE AT 4.0 A RESOLUTION OF VACCINE-ELICITED ANTIBODY VFP7.04 IN COMPLEX WITH HIV-1 ENV BG505 DS-SOSIP; AND ANTIBODIES VRC03 AND PGT122 
4877, 6cmiD, 0.5207, 3.86, 0.091, 214, 110, CRYSTAL STRUCTURE OF THE HENDRA VIRUS ATTACHMENT G GLYCOPROTEIN BOUND TO A POTENT CROSS-REACTIVE NEUTRALIZING HUMAN MONOCLONAL ANTIBODY M102.3 
4878, 6azmA, 0.5207, 4.30, 0.045, 163, 110, CRYSTAL STRUCTURE OF THE 580 GERMLINE ANTIBODY BOUND TO CIRCUMSPOROZOITE PROTEIN NANP 5-MER
4879, 5vigL, 0.5207, 3.69, 0.102, 208, 108, CRYSTAL STRUCTURE OF ANTI-ZIKA ANTIBODY Z006 BOUND TO ZIKA VIRUS ENVELOPE PROTEIN DIII
4880, 5t1lB, 0.5207, 3.88, 0.100, 225, 110, CETUXIMAB FAB IN COMPLEX WITH CQA(PH)2DLSTRRLKC PEPTIDE
4881, 5o1dB, 0.5207, 3.69, 0.084, 213, 107, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB481 
4882, 5myxB, 0.5207, 3.92, 0.056, 197, 108, STRUCTURE OF PYROGLUTAMATE-ABETA-SPECIFIC FAB C 24 IN COMPLEX WITH HUMAN ABETA-PE3-18
4883, 5iv2C, 0.5207, 3.81, 0.083, 213, 108, CETUXIMAB FAB IN COMPLEX WITH ARG9CIR MEDITOPE VARIANT
4884, 5iopD, 0.5207, 3.60, 0.123, 217, 106, CETUXIMAB FAB IN COMPLEX WITH 4-BROMOPHENYLALANINE MEDITOPE VARIANT
4885, 5icxB, 0.5207, 3.74, 0.064, 219, 109, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4886, 5hbtC, 0.5207, 3.69, 0.104, 115, 106, COMPLEX STRUCTURE OF FAB35 AND HUMAN NACHR ALPHA1
4887, 4ygvL, 0.5207, 3.67, 0.113, 215, 106, REVERSAL AGENT FOR DABIGATRAN
4888, 4rgnG, 0.5207, 3.77, 0.091, 224, 110, STRUCTURE OF STAPHYLOCOCCAL ENTEROTOXIN B BOUND TO TWO NEUTRALIZING ANTIBODIES 14G8 AND 6D3
4889, 4r96H, 0.5207, 3.91, 0.063, 295, 111, STRUCTURE OF A LLAMA GLAMA FAB 48A2 AGAINST HUMAN CMET
4890, 4oduL, 0.5207, 3.89, 0.046, 194, 108, UNLIGANDED FAB STRUCTURE OF LIPID A-SPECIFIC ANTIBODY S1-15
4891, 4nylL, 0.5207, 3.92, 0.065, 199, 108, CRYSTAL STRUCTURE OF ADALIMUMAB FAB FRAGMENT
4892, 4lo9D, 0.5207, 3.54, 0.133, 211, 105, HUMAN P53 CORE DOMAIN MUTANT N235K
4893, 4cmhC, 0.5207, 4.02, 0.055, 186, 109, CRYSTAL STRUCTURE OF CD38 WITH A NOVEL CD38-TARGETING ANTIBODY SAR650984
4894, 3wifA, 0.5207, 3.68, 0.104, 213, 106, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT 9CL-PGF2BETA COMPLEX
4895, 3v4uL, 0.5207, 3.86, 0.091, 213, 110, STRUCTURE OF A MONOCLONAL ANTIBODY COMPLEXED WITH ITS MHC-I ANTIGEN
4896, 3qwoB, 0.5207, 3.65, 0.132, 219, 106, CRYSTAL STRUCTURE OF A MOTAVIZUMAB EPITOPE-SCAFFOLD BOUND TO MOTAVIZUMAB FAB
4897, 3hr5Q, 0.5207, 2.94, 0.093, 200, 97, M1PRIME PEPTIDE FROM IGE BOUND BY HUMANIZED ANTIBODY 47H4 FAB
4898, 3fo9A, 0.5207, 2.94, 0.093, 200, 97, CRYSTAL STRUCTURE OF ALDOLASE ANTIBODY 33F12 FAB  IN COMPLEX WITH HAPTEN 13-DIKETONE
4899, 3bkmH, 0.5207, 3.69, 0.113, 215, 106, STRUCTURE OF ANTI-AMYLOID-BETA FAB WO2 (FORM A P212121)
4900, 3anzN, 0.5207, 3.66, 0.094, 213, 106, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4901, 2o5yH, 0.5207, 3.68, 0.084, 211, 107, CRYSTAL STRUCTURE OF THE 1E9 LEUH47TRP/ARGH100TRP FAB PROGESTERONE COMPLEX
4902, 2h1lT, 0.5207, 3.79, 0.092, 214, 109, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4903, 2h1lR, 0.5207, 3.56, 0.124, 108, 105, THE STRUCTURE OF THE ONCOPROTEIN SV40 LARGE T ANTIGEN AND P53 TUMOR SUPPRESSOR COMPLEX
4904, 2fjgA, 0.5207, 3.56, 0.124, 108, 105, STRUCTURE OF THE G6 FAB A PHAGE DERIVED FAB FRAGMENT IN COMPLEX WITH VEGF
4905, 2feeL, 0.5207, 3.56, 0.124, 108, 105, STRUCTURE OF THE CL-/H+ EXCHANGER CLC-EC1 FROM E.COLI IN NABR
4906, 1za6H, 0.5207, 3.56, 0.124, 108, 105, THE STRUCTURE OF AN ANTITUMOR CH2-DOMAIN-DELETED HUMANIZED ANTIBODY
4907, 1r70B, 0.5207, 3.56, 0.124, 108, 105, MODEL OF HUMAN IGA2 DETERMINED BY SOLUTION SCATTERING CURVE FITTING AND HOMOLOGY MODELLING
4908, 1qunG, 0.5207, 3.56, 0.124, 108, 105, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4909, 1qunA, 0.5207, 3.69, 0.139, 215, 108, X-RAY STRUCTURE OF THE FIMC-FIMH CHAPERONE ADHESIN COMPLEX FROM UROPATHOGENIC E.COLI
4910, 1mpaL, 0.5207, 3.88, 0.082, 129, 110, BACTERICIDAL ANTIBODY AGAINST NEISSERIA MENINGITIDIS
4911, 1mcsB, 0.5207, 3.90, 0.072, 228, 111, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4912, 6hbjB, 0.5206, 3.56, 0.133, 219, 105, ECHOVIRUS 18 EMPTY PARTICLE 
4913, 6eluF, 0.5206, 3.65, 0.084, 212, 107, STRUCTURE OF SERUM RESISTANCE ASSOCIATED PROTEIN FROM T. B. RHODESIENSE
4914, 6e9iB, 0.5206, 3.76, 0.101, 215, 109, THE CRYSTAL STRUCTURE OF BOVINE ULTRALONG ANTIBODY BOV-4 
4915, 6bgtA, 0.5206, 3.89, 0.046, 197, 108, STRUCTURE OF TRASTUZUMAB FAB MUTANT IN COMPLEX WITH HER2 EXTRACELLULAR DOMAIN 
4916, 5xajF, 0.5206, 3.78, 0.083, 216, 109, STRUCTURAL MIMICRY OF THE DENGUE VIRUS ENVELOPE GLYCOPROTEIN REVEALED BY THE CRYSTALLOGRAPHIC STUDY OF AN IDIOTYPE-ANTI-IDIOTYPE FAB COMPLEX.
4917, 5x8lO, 0.5206, 3.66, 0.084, 213, 107, PD-L1 IN COMPLEX WITH ATEZOLIZUMAB
4918, 5ushE, 0.5206, 3.84, 0.100, 213, 110, STRUCTURE OF VACCINIA VIRUS D8 PROTEIN BOUND TO HUMAN FAB VV66
4919, 5nphH, 0.5206, 3.83, 0.091, 220, 110, STRUCTURE OF THE HEPATITIS C VIRUS STRAIN J4 GLYCOPROTEIN E2 ANTIGENIC REGION 532-540 BOUND TO THE FAB FRAGMENT OF THE NON-NEUTRALIZING ANTIBODY DAO5
4920, 5n2kE, 0.5206, 3.58, 0.123, 212, 106, STRUCTURE OF UNBOUND BRIAKINUMAB FAB
4921, 5lspT, 0.5206, 3.65, 0.123, 218, 106, 107_A07 FAB IN COMPLEX WITH FRAGMENT OF THE MET RECEPTOR
4922, 5lghL, 0.5206, 3.72, 0.112, 220, 107, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSILATED CRYSTAL FORM II SAME AS 5L7X BUT ISOMORPHOUS SETTING INDEXED SAME AS 5L88 5L9D
4923, 5l7xL, 0.5206, 3.87, 0.083, 217, 109, AFAMIN ANTIBODY FRAGMENT N14 FAB L1- GLYCOSYLATED CRYSTAL FORM II
4924, 5it2H, 0.5206, 3.66, 0.084, 212, 107, STRUCTURE OF A TRANSGLUTAMINASE 2-SPECIFIC AUTOANTIBODY 693-10-B06 FAB FRAGMENT
4925, 5id0B, 0.5206, 3.66, 0.075, 211, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4926, 5icxC, 0.5206, 3.92, 0.056, 194, 108, CETUXIMAB FAB IN COMPLEX WITH CQFDLSTRRLRCGGSK MEDITOPE
4927, 5fhaL, 0.5206, 3.76, 0.112, 213, 107, CRYSTAL STRUCTURE OF PROTECTIVE EBOLA VIRUS ANTIBODY 114
4928, 5cgyH, 0.5206, 3.85, 0.091, 211, 110, FAB FRAGMENT OF CHIKUNGUNYA VIRUS NEUTRALIZING HUMAN MONOCLONAL ANTIBODY 4J21
4929, 4xcfL, 0.5206, 3.68, 0.132, 218, 106, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41; CRYSTALS CRYOPROTECTED WITH PHOSPHATIDYLCHOLINE (03:0 PC)
4930, 4xbeL, 0.5206, 3.52, 0.095, 210, 105, CRYSTAL STRUCTURE OF HUMAN 4E10 FAB IN COMPLEX WITH ITS PEPTIDE EPITOPE ON HIV-1 GP41: CRYSTALS CRYOPROTECTED WITH SPHINGOMYELIN (02:0 SM (D18:1/2:0)).
4931, 4wizFA, 0.5206, 3.54, 0.143, 219, 105, 
4932, 4wizE, 0.5206, 3.63, 0.132, 219, 106, 
4933, 4wizCA, 0.5206, 3.77, 0.091, 224, 110, 
4934, 4whtT, 0.5206, 3.91, 0.063, 294, 111, STRUCTURE OF THE HEPATITIS C VIRUS ENVELOPE GLYCOPROTEIN E2 ANTIGENIC REGION 412-423 BOUND TO THE BROADLY NEUTRALIZING ANTIBODY 3/11 P1 CRYSTAL FORM
4935, 4rftw, 0.5206, 3.76, 0.102, 219, 108, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4936, 4rftg, 0.5206, 3.91, 0.065, 199, 108, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4937, 4rft1, 0.5206, 3.91, 0.065, 199, 108, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4938, 4qt5H, 0.5206, 3.67, 0.084, 211, 107, CRYSTAL STRUCTURE OF 3BD10: A MONOCLONAL ANTIBODY AGAINST THE TSH RECEPTOR
4939, 4otxH, 0.5206, 3.53, 0.133, 211, 105, STRUCTURE OF THE ANTI-FRANCISELLA TULARENSIS O-ANTIGEN ANTIBODY N203 FAB FRAGMENT
4940, 4ioiA, 0.5206, 3.89, 0.082, 324, 110, MEDITOPE-ENABLED TRASTUZUMAB IN COMPLEX WITH CQFDLSTRRLKC
4941, 4h8wL, 0.5206, 3.88, 0.073, 462, 110, CRYSTAL STRUCTURE OF NON-NEUTRALIZING AND ADCC-POTENT ANTIBODY N5-I5 IN COMPLEX WITH HIV-1 CLADE A/E GP120 AND SCD4.
4942, 4guoD, 0.5206, 2.94, 0.093, 200, 97, STRUCTURE OF P73 DNA BINDING DOMAIN COMPLEX WITH 12 BP DNA
4943, 4f3fA, 0.5206, 2.94, 0.093, 200, 97, CRYSTAL STRUCTURE OF MSLN7-64 MORAB-009 FAB COMPLEX
4944, 4ebqL, 0.5206, 3.64, 0.132, 219, 106, FAB STRUCTURE OF ANTI-VACCINIA VIRUS D8L ANTIGEN MOUSE IGG2A LA5
4945, 3wfhA, 0.5206, 3.77, 0.123, 216, 106, CRYSTAL STRUCTURE OF ANTI-PROSTAGLANDIN E2 FAB FRAGMENT PGE2 COMPLEX
4946, 3t2nI, 0.5206, 4.54, 0.043, 237, 115, HUMAN HEPSIN PROTEASE IN COMPLEX WITH THE FAB FRAGMENT OF AN INHIBITORY ANTIBODY
4947, 3sgeL, 0.5206, 3.57, 0.133, 217, 105, CRYSTAL STRUCTURE OF MAB 17.2 IN COMPLEX WITH R13 PEPTIDE
4948, 3ijsA, 0.5206, 3.45, 0.144, 215, 104, STRUCTURE OF S67-27 IN COMPLEX WITH TSBP
4949, 3detF, 0.5206, 3.67, 0.084, 211, 107, STRUCTURE OF THE E148A Y445A DOUBLY UNGATED MUTANT OF E.COLI CLC_EC1 CL-/H+ ANTIPORTER
4950, 3d85B, 0.5206, 3.76, 0.073, 213, 109, CRYSTAL STRUCTURE OF IL-23 IN COMPLEX WITH NEUTRALIZING FAB
4951, 3anzb, 0.5206, 3.68, 0.093, 213, 107, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4952, 3anzA, 0.5206, 3.48, 0.123, 212, 106, CRYSTAL STRUCTURE OF ALPHA-HEMOLYSIN
4953, 2w9eL, 0.5206, 3.88, 0.097, 214, 113, STRUCTURE OF ICSM 18 (ANTI-PRP THERAPEUTIC ANTIBODY) FAB FRAGMENT COMPLEXED WITH HUMAN PRP FRAGMENT 119-231
4954, 2o5xL, 0.5206, 3.62, 0.124, 214, 105, CRYSTAL STRUCTURE OF 1E9 LEUH47TRP/ARGH100TRP AN ENGINEERED DIELS- ALDERASE FAB WITH NM STEROID-BINDING AFFINITY
4955, 2ny7H, 0.5206, 3.61, 0.104, 212, 106, HIV-1 GP120 ENVELOPE GLYCOPROTEIN COMPLEXED WITH THE BROADLY NEUTRALIZING CD4-BINDING-SITE ANTIBODY B12
4956, 2iffH, 0.5206, 3.68, 0.113, 214, 106, STRUCTURE OF AN ANTIBODY-LYSOZYME COMPLEX: EFFECT OF A CONSERVATIVE MUTATION
4957, 2ddqH, 0.5206, 3.68, 0.113, 214, 106, CRYSTAL STRUCTURE OF THE FAB FRAGMENT OF A R310 ANTIBODY COMPLEXED WITH (R)-HNE-HISTIDINE ADDUCT
4958, 1xctD, 0.5206, 3.83, 0.073, 218, 110, COMPLEX HCV CORE-FAB 19D9D6-PROTEIN L MUTANT (D55A L57H Y64W) IN SPACE GROUP P21212
4959, 1rziH, 0.5206, 3.74, 0.092, 219, 109, CRYSTAL STRUCTURE OF HUMAN ANTI-HIV-1 GP120-REACTIVE ANTIBODY 47E FAB
4960, 1ruqH, 0.5206, 3.66, 0.084, 212, 107, CRYSTAL STRUCTURE (H) OF U.V.-IRRADIATED DIELS-ALDER ANTIBODY 13G5 FAB AT PH 8.0 WITH A DATA SET COLLECTED IN HOUSE.
4961, 1mcrB, 0.5206, 3.70, 0.075, 212, 106, PRINCIPLES AND PITFALLS IN DESIGNING SITE DIRECTED PEPTIDE LIGANDS
4962, 1m112, 0.5206, 3.88, 0.082, 222, 110, STRUCTURAL MODEL OF HUMAN DECAY-ACCELERATING FACTOR BOUND TO ECHOVIRUS 7 FROM CRYO-ELECTRON MICROSCOPY
4963, 6obdA, 0.5205, 3.80, 0.065, 214, 108, CRYSTAL STRUCTURE OF ANTI-GLD52 FAB COMPLEX WITH HUMAN GLD52 PEPTIDE MIMETIC 
4964, 6mnsB, 0.5205, 3.80, 0.074, 214, 108, RHESUS MACAQUE ANTI-HIV V3 ANTIBODY DH753 WITH GP120 V3 ZAM18 PEPTIDE 
4965, 6ii4F, 0.5205, 4.22, 0.055, 287, 109, CRYSTAL STRUCTURE OF H7 HEMAGGLUTININ FROM A/ANHUI/1/2013 IN COMPLEX WITH A HUMAN NEUTRALIZING ANTIBODY L4A-14 
4966, 6igoB, 0.5205, 4.23, 0.055, 287, 109, CRYSTAL STRUCTURE OF MYELIN PROTEIN ZERO-LIKE PROTEIN 1 (MPZL1) 
4967, 6fy0I, 0.5205, 4.22, 0.055, 287, 109, CRYSTAL STRUCTURE OF A V2-DIRECTED; RV144 VACCINE-LIKE ANTIBODY FROM HIV-1 INFECTION; CAP228-16H; BOUND TO A HETEROLOGOUS V2 PEPTIDE 
4968, 6cnjI, 0.5205, 4.22, 0.055, 287, 109, STRUCTURE OF THE 2ALPHA3BETA STIOCHIOMETRY OF THE HUMAN ALPHA4BETA2 NICOTINIC RECEPTOR 
4969, 6b9zA, 0.5205, 3.69, 0.104, 215, 106, TRASTUZUMAB FAB V3 
4970, 6axkB, 0.5205, 4.21, 0.055, 163, 109, CRYSTAL STRUCTURE OF FAB311 COMPLEX
4971, 5w05H, 0.5205, 4.23, 0.046, 163, 109, ANTI-TISSUE FACTOR ANTIBODY M59 A HUMANIZED VERSION OF 10H10
4972, 5vxrL, 0.5205, 4.30, 0.055, 163, 110, THE ANTIGEN-BINDING FRAGMENT OF MAB24 IN COMPLEX WITH A PEPTIDE FROM HEPATITIS C VIRUS E2 EPITOPE I (412-423)
4973, 5umnF, 0.5205, 3.87, 0.102, 207, 108, CRYSTAL STRUCTURE OF C05 VPGSGW MUTANT BOUND TO H3 INFLUENZA HEMAGGLUTININ HA1 SUBUNIT
4974, 5umiH, 0.5205, 3.73, 0.112, 206, 107, CLOSTRIDIUM DIFFICILE TCDA-CROPS BOUND TO PA50 FAB
4975, 5uelH, 0.5205, 3.62, 0.085, 214, 106, CRYSTAL STRUCTURE OF 354NC102 FAB
4976, 5tudC, 0.5205, 3.52, 0.077, 212, 104, STRUCTURAL INSIGHTS INTO THE EXTRACELLULAR RECOGNITION OF THE HUMAN SEROTONIN 2B RECEPTOR BY AN ANTIBODY
4977, 5o1aB, 0.5205, 4.00, 0.083, 198, 109, P53 CANCER MUTANT Y220C IN COMPLEX WITH COMPOUND MB240 
4978, 5mubM, 0.5205, 3.53, 0.114, 211, 105, ACC1 FAB FRAGMENT IN COMPLEX WITH CITRULLINATED C1 EPITOPE OF CII (CG05)
4979, 5mhrK, 0.5205, 3.51, 0.124, 211, 105, T3D REOVIRUS SIGMA1 COMPLEXED WITH 9BG5 FAB FRAGMENTS
4980, 5ir1C, 0.5205, 3.86, 0.091, 211, 110, CETUXIMAB FAB IN COMPLEX WITH 3-BROMOPHENYLALANINE MEDITOPE VARIANT
4981, 5id1D, 0.5205, 3.70, 0.084, 205, 107, CETUXIMAB FAB IN COMPLEX WITH MPT-CYS MEDITOPE
4982, 5id0C, 0.5205, 3.72, 0.121, 219, 107, CETUXIMAB FAB IN COMPLEX WITH AMINOHEPTANOIC ACID-LINKED MEDITOPE
4983, 5i9qH, 0.5205, 3.60, 0.151, 217, 106, CRYSTAL STRUCTURE OF 3BNC55 FAB IN COMPLEX WITH 426C.TM4DELTAV1-3 GP120
4984, 5i18H, 0.5205, 3.54, 0.133, 211, 105, CRYSTAL STRUCTURE OF HUMAN GERMLINE ANTIBODY IGHV1-69/IGKV4-1
4985, 5eorL, 0.5205, 3.87, 0.091, 216, 110, STRUCTURE OF THE MURINE ANTIBODY FAB 8E3 BOUND TO THE VACCINIA VIRUS A27 PEPTIDE 101-110
4986, 5cd3A, 0.5205, 3.90, 0.063, 295, 111, STRUCTURE OF IMMATURE VRC01-CLASS ANTIBODY DRVIA7
4987, 5aomB, 0.5205, 3.91, 0.063, 295, 111, STRUCTURE OF THE P53 CANCER MUTANT Y220C WITH BOUND SMALL MOLECULE PHIKAN883
4988, 4xmkN, 0.5205, 3.54, 0.114, 212, 105, CRYSTAL STRUCTURE OF FAB OF HIV-1 GP120 V3-SPECIFIC HUMAN MONOCLONAL ANTIBODY 2424 IN COMPLEX WITH JR-FL V3 PEPTIDE
4989, 4wizZ, 0.5205, 3.67, 0.131, 218, 107, 
4990, 4wizYB, 0.5205, 3.76, 0.073, 230, 109, 
4991, 4wizVB, 0.5205, 3.79, 0.092, 214, 109, 
4992, 4wizGB, 0.5205, 3.84, 0.101, 211, 109, 
4993, 4wizEC, 0.5205, 3.91, 0.091, 218, 110, 
4994, 4rftY, 0.5205, 3.69, 0.074, 216, 108, T=1 SUBVIRAL PARTICLE OF GROUPER NERVOUS NECROSIS VIRUS CAPSID PROTEIN DELETION MUTANT (DELTA 1-34  and 218-338)
4995, 4qwwC, 0.5205, 3.86, 0.109, 218, 110, CRYSTAL STRUCTURE OF THE FAB410-BFACHE COMPLEX
4996, 4pozC, 0.5205, 3.68, 0.114, 216, 105, FAB FRAGMENT OF DER P 1 SPECIFIC ANTIBODY 10B9
4997, 4okvD, 0.5205, 4.57, 0.052, 254, 116, CRYSTAL STRUCTURE OF ANOPHELINE ANTI-PLATELET PROTEIN WITH FAB ANTIBODY
4998, 4mhjW, 0.5205, 3.65, 0.113, 216, 106, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
4999, 4mhjK, 0.5205, 3.45, 0.087, 211, 104, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
5000, 4mhjF, 0.5205, 3.74, 0.139, 212, 108, CRYSTAL STRUCTURE OF FAB H5M9 IN COMPLEX WITH INFLUENZA VIRUS HEMAGGLUTININ FROM A/GOOSE/GUANGDONG/1/96 (H5N1)
5001, 4ma3L, 0.5205, 3.84, 0.073, 119, 110, CRYSTAL STRUCTURE OF ANTI-HINGE RABBIT ANTIBODY C2095
